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The aim of the research described in this thesis was to discover the luciferin responsible for 
bioluminescence in the New Zealand glow-worm (GW) Arachnocampa luminosa. This work was done 
in partnership with Dr Miriam Sharpe whose focus was to elucidate the luciferase.  In order to 
determine the structure of the GW luciferin, the luciferin had to be isolated from the GW and the 
structure elucidated via characterisation. However, luciferin purifications pose a unique isolation 
challenge, combining the difficulties of isolating material from source organisms, working with 
unstable materials, and working with enzymatic assays. Furthermore characterisation of luciferins is 
often difficult due to the small amounts that can be isolated and because luciferins are often highly 
unstable. Previous work on luciferins in other organisms and on the GW luciferin is reveiwed in 
Chapter 1. Chapter 1 also reviews the general literature on bioluminescence but with a focus on 
luciferins rather than luciferases.  
 
Chapters 2 describes the collection of Arachnocampa luminosa from the wild, and the development 
of a GW bioluminescence assay that enabled GW luminescent molecules to be detected. This assay 
enabled the detection of two different types of luminescence: P type luminescence and L type 
luminescence. Chapter 3 describes the separation of glow-worm lysates by reverse phase 
chromatography and how the luminescence assay was used to trace GW luminescent molecules 
through the purification process. This led to the discovery of two glow-worm luciferin precursors: 
tyrosine and xanthurenic acid that gave P type luminescence with the GW bioluminescence assay. 
The compound responsible for the L type luminescence was separated away from the compounds 
responsible for P type luminescence but could not be isolated. The compound responsible for L type 
luminescence was found to co-elute with tryptophan and is thought to be the GW luciferin. 
 
Chapter 4 describes how commercial samples of these precursors (xanthurenic acid and tyrosine), 
along with GW enzymes, were used to produce a compound (LRPA) that could be characterised by 
MS and 1H NMR. A solution of LRPA was found to produce L type luminescence with the 
luminescence assay showing LRPA to be either the GW luciferin or a closely related compound.  
 
Chapter 5 then describes the synthesis of two molecules (N-carbamyl tyrosine and phenol-O-
carbamyl tyrosine) that were candidates for a compound that co-eluted with tyrosine. Neither of 




The research on the New Zealand glow-worm described in this thesis required intensive use of LC-
MS techniques. However the research was often slowed by a shortage of glow-worms. These 
techniques were therefore used to investigate another New Zealand natural products problem 
involving insect metabolites; the origins of tutin, hyenanchin and the tutin glucosides found in New 
Zealand toxic honeys. Chapter 6 therefore describes a quantitative LC-MS study that shows that 




AMP: Adenosine monophosphate; ATP: Adenosine triphosphate; BC: bench column; BSA: Bovine 
serum albumin; BME: -Mercaptoethanol; CoA: Coenzyme A ; DCC: Dunedin City Council; DMSO: 
dimethyl sulfoxide; DoC: Department of Conservation;  DTT: Dithiothreitol; EDTA: Ethylene-diamine-
tetra-acetic acid; Ethylene glycol tetraacetic acid: EGTA; GW: Glow-worm (Arachnocampa); HE: Hot 
extract; HPLC: high performance liquid chromatography; LC: liquid chromatography; LC-MS: liquid 
chromatography – mass spectrometry; LEP: luciferin enzymatic product; LF: Luciferase fraction; LO; 
Light organ; LRE: luciferin-regenerating enzyme;  LSE: luciferin synthetic enzyme; LRP: Luminescent 
related product; LU: Luminescent units; LUC: luciferase; MeCN: methyl cyanide (acetonitrile); MOPS: 
(3-(N-morpholino)propanesulfonic acid); MS: mass spectrometry; NMR: Nuclear magnetic resonance 
spectroscopy; PPi: pyrophosphate; RP: reverse phase; SDS: Sodium dodecyl sulfate; SP: semi 
preparative; SD: standard deviation; Tris: Tris(hydroxymethyl)amino-methane; Tyr: tyrosine; UV: 
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1 Introduction: a review of the bioluminescence  literature  
1.1 An introduction to bioluminescence 
Luminescence is surprisingly widespread and is found in but not limited to tunicates, sharks, rays, ray 
finned fishes, centipedes, shrimp, millipedes, beetles, flies, nematodes, bilvalves, bacteria, 
dinoflagelates, polychaetes and fungi (Haddock et al., 2010).  Luminescence is also found  in the 
orders Echnodermata, Ostracoda, Copapoda, Amphipoda, Collembola, Cephalapoda, Gastropoda, 
Cnidaria and Ctenophora (Haddock et al., 2010). Indeed, it is only flowering plants, and terrestrial 
vertebrates such as birds, amphibians, and mammals that do not contain strongly luminescent 
species. Possibly the reason that luminescence is perceived as rare is that it is most often found in 
regions rarely frequented by humans such as the deep ocean. For a list of luminescent organisms see 
(Herring, 1987; Shimomura, 2006e). Many bioluminescence reviews have been written including 
(Haddock et al., 2010; Johnson and Shimomura, 1975; McCapra, 2000; Navizet et al., 2011; Roda, 
2011; Shimomura, 2006e; Shimomura, 2012; Widder, 2010; Wilson and Hastings, 1998) and 
(Cormier, 2013) (reprint of 1973 publication). For reviews on Arachnocampa biology see (Pugsley, 
1983) and (Meyer-Rochow, 2007) and section 1.2.7. 
1.1.1 General mechanism of light emission 
Luminescence has evolved many times, and different species use different luminescent chemical 
reactions (Haddock et al., 2010). Organisms produce light at a wide range of frequencies and 
intensities. Some creatures produce light continuously, while others flash or change their 
luminescence using nervous system or hormonal regulatory mechanisms (Rigby and Merritt, 2011; 
Tsai et al., 2014). However, in all cases bioluminescence is caused by the reaction of a “luciferase” 
enzyme with a “luciferin” small molecule as shown in Figure 1.1 (McCapra, 2000). The names 
luciferin and luciferase refer to the role these molecules play, rather than to specific compounds, 













Figure 1.1. General bioluminescence, chemiluminescence and fluorescence reactions 
 
Bioluminescence differs from chemiluminescence because it requires enzymatic catalysis, and differs 
from fluorescence because the luciferin becomes excited by a chemical reaction rather than by light 
(Figure 1.1) (Chung et al., 2008; Nakatsu et al., 2006; Navizet et al., 2011). However, in all these 
systems the general physiochemical mechanism remains the same (Fraga, 2008). First, the substrate 
is activated into an unstable energetically higher state (Adam, 2012; McCapra, 2000). Then the 
molecule collapses back to ground state, releasing the energy difference as light, or transferring the 
energy to an emitter which releases the energy as light (Figures 1.2, 1.3 and 1.4) (Pinto da Silva and 
Esteves da Silva, 2013). Bioluminescence is often far brighter and has a much higher luminescent 
quantum yield than fluorescence or chemiluminescence, because the enzyme can tune the system 
far more perfectly than any solvent (Chung et al., 2008; Milne et al., 2010). A bioluminescence 
quantum yield is defined as the number of photons emitted divided by the number of luciferin 
molecules (or moles) consumed, while a fluorescence quantum yield is defined as the number of 
photons emitted divided by the number of photons absorbed (McCapra, 2000; Seliger and McElroy, 







Figure 1.2. Schematic of the generalised luminescence mechanism with the excited luciferin product acting as the 
emitter. 
  
Figure 1.3. Schematic of energy transfer between an excited luciferin and a secondary emitter resulting in luminescence. 
 





Any luminescent system must include a molecule that can be excited to a high energy state, and a 
molecule able to emit this energy as visible light (McCapra, 2000; Pinto da Silva and Esteves da Silva, 
2013). In some systems (e.g. firefly; see section 1.2.5), the emitter molecule is the reaction modified 
excited molecule (Figure 1.2), but in others (e.g.  Latia and Aequoria; see sections 1.2.1.2 and 
1.2.2.1.2) the energy produced via excitation is transferred to another molecule that serves as the 
emitter (Figure 1.3)(McCapra, 2000; Pinto da Silva and Esteves da Silva, 2013; Titushin et al., 2011).  
 
To produce light, an emitter must not lose all its energy via non-luminescent energetic transitions, 
and the emission energy must equate to visible light (Fraga, 2008; McCapra, 2000). These latter 
properties are only fulfilled by rigid, highly conjugated molecules that can be excited to a singlet 
state (McCapra, 2000). To be a luciferin, the molecule must also be synthesised via biological 
processes from existing natural products, and be excited via enzymatic activity. The excitation in 
most bioluminescence reactions is caused by an oxidative decarboxylation (Conti et al., 1996; 
McCapra, 2000). The main exception to this is the bacterial system described in section 1.2.1.1.2. 
This reaction is technically not an oxidative decarboxylation but it still involves oxidation  followed by 
loss of a carboxyl group and is therefore a very closely related reaction (see section  1.2.1.1.2). The 
dominance of oxidation reactions is probably because oxidative reactions are one of the few 
biochemical reactions with enough energy to produce a visible photon (Day et al., 2004; McCapra, 
2000). It was therefore expected that the as yet undefined GW luciferin would undergo oxidation  
and probably a decarboxylation.  
 
Figure 1.5. General reaction scheme of bioluminescence as produced by oxidative decarboxylation 
1.1.2 Luciferin diversity 
A great diversity is observed in luciferases with hundreds so far discovered (Haddock et al., 2010; 
Lee, 2008). In contrast there are only a few known luciferins. For example, only four luciferins 
(bacterial (1.8), Cypridina (1.2), coelenterazine (1.1) and dinoflagellate (1.12) (see figures 1.6 - 1.8) 
are responsible for the vast majority of luminescence in the ocean (Haddock et al., 2010). 
 
At first glance these luciferins seem unrelated to each other (Bechara, 2015). However, closer 
examination combined with knowledge about the biosynthetic origins of these compounds, shows 
that most known luciferins, and luciferin-related chromophores, are built around five classes of 
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biological molecules: aromatic amino acids (Figure 1.6), purines and their close relatives the flavins 
(Figure 1.7), tetrapyrroles (Figure 1.8) and quinone type systems (Figure 1.10). Furthermore, most of 
these clases are based around aromatic heterocycles.  Long chain aldehyde-based luciferins also 
exist (Figure 1.9) but these always work in conjuction with a secondary emitter molecule (often a 
flavin) because they have no chromophore (Navizet et al., 2011). 
 
 
1.1. Coelenterazine (found in numerous marine organisms)  
1.2. Cypridina luciferin 
 
1.3. Earthworm Fridericia heliota luciferin 
 
1.4. Benzathiazole luciferin 
 
1.5. Green fluorescent protein (GFP) 
chromophore 
 
1.6. Kaede green chromophore 
 
1.7. Kaede red chromophore 
   





1.8. Riboflavin phosphate - Bacterial co-
luciferin and luminescence emitter 
 
1.9. Lumazine - Bacterial 
luminescence chromophore 
 
1.10. Lampteroflavin - Lampteromyces 
japonicas (fungus) chromophore 
 
Figure 1.7. Known luciferins and luminescence emitters based on flavins or purines. Flavins are also thought to be 




1.11. Euphausid Shrimp luciferin 
 
 
1.12. Dinoflagellate luciferin 
  
Figure 1.8. Tetrapyrrole porphyrin luciferins. The chromophore of the photoprotein from Motyxia sequoia is also 
believed to be porphyrin-based. 
 
 
1.13. Diplocardia longa luciferin: N-isovaleryl- 3-
amino-propanal. 
 
1.14. Latia luciferin  
 
 
1.15. Hexadecanal: a bacterial co-luciferin  
1.16. Precursor to Panellus stipticus (fungus) luciferin 
 
Figure 1.9. Long chain aldehyde luciferins. The aldehyde luciferins have no chromophores and are thought to work in 





1.17. 3-OH Hispidin a fungal luciferin 
 
1.18. Aloe-emodin a 







found in the luminous acorn 
worm, Ptychodera flava 
 
 
1.20. 2,3,5-Tribromohydroquinone. A 
chemiluminescent molecule found in 







found in the luminous acorn 






found in the luminous acorn 
worm, Ptychodera flava 
 
Figure 1.10. Hydroquinone, semiquinone and quinone type luciferins and fluorescent chromophores.  
 
The evolution of new biochemical pathways to produce secondary metabolites requires the 
modification of a biosynthetic pathway (Firn and Jones, 2000). New enzymes in contrast, can evolve 
through the introduction of a few mutations into a single enzyme-encoding gene (Wink, 2003). This 
may partially explain the paucity of luciferins compared to luciferases.  Marine organisms often do 
not need to synthesise new luciferins, because several luciferin substrates, such as bacterial luciferin 
and coelenterazine, are already readily available from the marine food chain (Shimomura, 2006a). 
However, each organism must independently develop a luciferase that is compatible with the 
ingested luciferin which causes many unrelated species to use the same luciferin but with different 
luciferases (Björn and Ghiradella, 2015). More generally, there may be fewer compounds that can 
act as a luciferin than enzymes that could be modified to act as a luciferase (Björn and Ghiradella, 
2015). However, this seems unlikely, because far more classes of natural products are able to 
chemiluminesce than bioluminesce (Björn and Ghiradella, 2015; Rees, 1998). 
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1.1.3 Luciferin-luciferase systems 
Studies on bioluminescent luciferin-luciferase systems have generally shown that a heat-susceptible 
component (luciferase enzyme) reacts with a heat-resistant component (luciferin) to produce light 
(Figure 1.11) (Lee, 2008; Shimomura, 2006b). This system was first discovered by Dubois who, while 
working on the clam Pholas dactylus and the West Indies elaterid beetle Pyrophorus, found that 
extracts that were briefly boiled would not luminesce (Dubois, 1887). However, light was restored if 
the “hot extract” was mixed with an un-boiled extract which had ceased to glow (an exhausted 
lysate). Dubois theorized that the heat labile component must be an enzyme that interacted with a 
heat stable molecule to produce light and reasoned that the heat-stable molecule was consumed in 
the reaction, leaving an exhausted lysate that was deficient of this molecule (Dubois, 1887). Addition 
of hot extract reintroduced the heat stable molecule and produced further luminescence. Dubois 
named the enzyme luciferase, and the heat stable molecule luciferin (Dubois, 1885; Dubois, 1887). 
Since then, such luciferase-luciferin systems have been discovered in hundreds of organisms and 
most could be made to luminesce in vitro by an hot-exhausted lysate reaction (Figure 1.11) 
(Shimomura, 2006e). These reactions generally also require oxygen and may require other cofactors 




Figure 1.11. Schematic of the production of hot extract (containing luciferin) and exhausted lysate (containing luciferase) 
from lysate (containing luciferin and luciferase). Recombination of the two, produced a reaction mixture that contained 
both luciferin and luciferase and that, along with necessary cofactors, produced luminescence. 
It was therefore a surprise when, in 1961, it was discovered that Ca2+ would cause aequorin, a 
protein extracted from Aequorea jellyfish, to glow even in the absence of O2 (Shimomura, 1962). No 
separate luciferin molecule was necessary for the reaction, and the light emitted was only 
proportional to the amount of protein present (Moisescu et al., 1975). The jellyfish Obelia, was 
found to contain a protein (obelin) that displayed the same properties (Campbell, 1974; Moisescu et 
al., 1975).  
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The Euphausid Shrimp Meganyctiphanes norvegica (Shimomura and Johnson, 1967; Shimomura and 
Johnson, 1968b), the parchment worm Chaetopterus (Shimomura and Johnson, 1968a) and the 
jellyfish Obelia (Campbell, 1974; Moisescu et al., 1975) were all found to contain luminescent 
proteins that showed the same behaviour. Since such proteins did not appear to follow the classical 
luciferin-luciferase system, they were named photo-proteins (Shimomura and Johnson, 1968a; 
Shimomura and Johnson, 1967; Shimomura and Johnson, 1968b).  
 
However, further research showed that these photo-proteins are actually luciferases and do in fact 
require oxygen, just not  immediately prior to producing light (Haddock et al., 2010). Instead, the 
photo-proteins ‘precharge’, allowing the reaction between oxygen and luciferin (generally 
coelenterazine) to proceed partially to form a quasi-stable peroxide intermediate (Sharpe et al., 
2014; Tsuji, 1995). The reaction then halts, with the protein still bound to the luciferin. Activation by 
a molecule such as Ca2+ then triggers the photo-protein to electronically excite the bound luciferin 
(Tsuji, 1995). Decay from this excited state produces light (Hastings, 1996). Ca2+ dependent systems 
such as those seen in many coelenterates and in protozoa are the best known (Inouye and Sasaki, 
2007; Shimomura and Johnson, 1975b; Tsuji, 1995; Ward and Seliger, 1974), but other organisms 
use photo-proteins activated by peroxides (e.g. scale worm and clam) (Michelson, 1978; Müller and 
Campbell, 1990; Nicolas, 1982) or by ATP (Sequoia millipede)(Hastings and Davenport, 1957; 
Shimomura, 2006c). 
1.1.4  Secondary emitters and fluorescent proteins 
Many marine organisms possess antenna proteins that absorb sunlight or bioluminescence and then 
re-emit it at a longer wavelength. These proteins may serve to increase the brightness, or to change 
the colour of bioluminescence (Titushin et al., 2011). For example, the photo-protein aequorin emits 
bioluminescence at a wavelength of max: 460 to 465 nm, but live Aequorea emits at max: 508 to 509 
nm. Likewise Clytia gregaria emits bioluminescence at max: 509 nm but the photo-protein alone 
emits at max: 470 nm (Titushin et al., 2011).  
 
The first fluorescent protein, green fluorescent protein (GFP) was discovered by Shimomura in 
Aequorea victoria (Shimomura, 1962). Since then, fluorescent proteins have been found in many 
different luminescent Hydrozoa and Anthozoa (Dittrich et al., 2005; Titushin et al., 2011). The GFPs 
from the jellyfish Aequorea victoria and the sea pansy Renilla reniformis are widely used biomedical 
research tools (Titushin et al., 2011). The protein varies from species to species, but so far all GFPs 
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have contained the same chromophore (Chalfie, 1995) (Figure 1.12). GFP normally produces green 
light, but mutated variants have different emission and excitation properties (Chalfie, 1995).  
 
 




1.9. Lumazine - Bacterial luminescence chromophore  
 
1.6. Kaede green chromophore 
 
  
1.7. Kaede red chromophore 
  
Figure 1.12. Secondary emitters. 
GFP is thought to absorb the energy produced by the photo-protein by Förster resonance energy 
transfer (FRET). This process is only effective at short range, which suggests that the photo-protein 
and the antenna protein directly interact with one another (Ha, 1996; Morin, 1971; Titushin et al., 
2011). However, to date no evidence have been found of such interactions (Titushin et al., 2011).  
 
Peptide based chromophores, like those of GFP, coelenterazine and Cypridina luciferin, appear to be 
formed from the cyclisation of peptides. For example, the GFP chromophore (1.5, Figure 1.12) is 
derived from the cyclisation of a Thr-Tyr-Gly tripeptide while the chromophores of the fluorescent 
protein kaede (1.6 and 1.7, Figure 1.12) from stony corals are built from a His-Tyr-Gly tripeptide 
(Dittrich et al., 2005). The website below shows an animation of Kaede chromophore formation.  
 
http://zeiss-campus.magnet.fsu.edu/tutorials/fluorescentproteins/kaedechroma/indexflash.html 




Luminescent bacteria also use a wide range of fluorescent proteins to tune their initially yellow-
green light (max: 525 nm) into a wide range of colours (Eckstein, 1990; Ruby, 1977; Sato et al., 2010). 
However the chromophores of these proteins are non-covalently bound prosthetic groups rather 
than cyclised peptides. For example, blue, red and yellow emitting proteins have been discovered in 
bacteria that contain a purine-derived chromophore called lumazine (1.9, Figure 1.12) (Chatwell et 
al., 2008; Eckstein, 1990; Ruby, 1977; Sato et al., 2010). Accessory fluorescent proteins are thought 
to increase the rate of the luminescent reaction by interacting with and destabilizing the luciferase 
enzyme-luciferin intermediate (Rowe et al., 2009; Sirokman and Hastings, 1997). 
1.1.5 Evolution of bioluminescence 
An organism may gain many advantages by producing light including: prey attraction, sexual 
communication, aposematic signalling, camouflage and protection against radical reactions and 
reactive oxygen substances (ROS) (Björn and Ghiradella, 2015). It is far less obvious how such a trait 
evolves (Björn and Ghiradella, 2015; Seliger, 1975). The ancestral luciferase presumably had another 
purpose, while the ancestral luciferin may have been synthesized as part of some unrelated 
metabolic process (Björn and Ghiradella, 2015; Seliger, 1975). Changes to either, through mutation 
or changes to the synthetic pathway could have resulted in a luminescent system (Björn and 
Ghiradella, 2015; Seliger, 1975). This could then be tuned by evolution to produce brighter 
luminescence (Björn and Ghiradella, 2015; Seliger, 1975). 
 
Many biological processes naturally produce weak luminescence and the optimisation of any of 
these processes may have resulted in bioluminescent systems (Björn and Ghiradella, 2015). For 
example, all photosynthetic organisms produce a weak bioluminescence called photosynthetic 
delayed light emission (visible bioluminescence has never been observed in non genetically modified 
higher plants) (Björn and Ghiradella, 2015). In this process, energy is lost by photosystem two and 
emitted as light by chlorophyll (Björn and Ghiradella, 2015). Luminescence also results from the 
peroxidation of unsaturated membrane lipids and a range of biological oxidative reactions (Björn 
and Ghiradella, 2015).  
 
Bioluminescence has evolved separately many times and has co-opted many different enzymes (Day 
et al., 2004). Firefly luciferases for example, are closely related to acyl-CoA synthetases, a large 
family of non-bioluminescent proteins that catalyse the condensation of ATP with a carboxylate 
functionality (Branchini et al., 2001; Nakatsu et al., 2006; Oba et al., 2006). Indeed, beetle luciferase 
still weakly functions as a fatty acid CoA ligase, while fatty acid CoA ligase from non-luminescent 
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mealworms functions weakly as a luciferase if benzathiazole luciferin is added (Day et al., 2004). 
Similarly, some benzathiazole luciferin analogues that do not produce any luminescence with 
benzathiazole luciferin produce light when catalysed by fatty acyl-CoA synthetases (Mofford et al., 
2015). It therefore seems likely that beetle luciferase has evolved from such enzymes. 
 
The bioluminescence systems of the Japanese firefly squid Hotaru-ika (Watasenia scintillans) 
(Sharpe, 2016 unpublished work) and the New Zealand glow-worm (Sharpe et al., 2015) also appear 
to use luciferases of the ANL superfamily of adenylating enzymes. However neither uses 
benzathiazole luciferin with squid using coelenterazine disulfate (Inoue, 1975) and the NZ glow-
worm using a novel luciferin that is discussed later in this thesis. This suggests that adenylating 
enzymes were co-opted for luminescence on multiple separate occasions using unrelated substrates.  
 
The ancestral bacterial luciferase was probably a flavin monooxygenase, because bacterial luciferase 
has similar mechanistic activity to cyclohexane oxygenase (McCapra, 2000; McCapra, 1990; O' Kane 
and Prasher, 1992) and because the luciferase structure is quite similar to other flavin 
monooxygenases (Fisher et al., 1995). Pholas luciferase meanwhile was probably originally a 
peroxidase because it still retains some peroxidase activity (Michelson, 1978).  
 
Living organisms possess a wide range tools for the manipulation of small peptides and secondary 
metabolites (Day et al., 2004). Modification in these processes probably led to the production of the 
luciferins (Day et al., 2004). For example, bacterial and dinoflagellate luciferins are synthesised from 
flavins and chlorophylls respectively, while benzathiazole luciferin shows a considerable amount of 
structural homology with biochemical precursors of phaeomelanin, siderophores and thiamine (Day 




1.2 Known bioluminescent systems  
This section discusses known bioluminescent systems. Only luminescent systems for which some 
chemistry is known are discussed. The topics have been divided into sections based on luciferin 
chemistry. These sections are then further split to look at the chemistry and luminescent 
mechanisms of each luciferin and the luminescent organisms that use such luciferins. Luciferase 
chemistry is not discussed in detail, as this is not the focus of this thesis. It is important to note that 
systems that have similar luciferin chemistry are not necessarily closely related. Luminescent 
Diptera, as the primary topic of this thesis, are discussed separately  in section 1.2.7. 
 
1.2.1 Flavin and aldehyde-based luciferins 
1.2.1.1 Bacterial luciferin 
Occasionally, parts of the oceans will luminesce with a milky white hue (Hastings et al., 1985; 
Widder, 2010). The glow can be seen from space, but originates from either bacteria or 
dinoflagellates (Nealson and Hastings, 1979; Widder, 2010). Luminous bacteria are Gram negative, 
abundant and widely distributed (Hastings and Nealson, 1977; Nealson and Hastings, 1979). Many 
luminescent bacteria are free-living; some live in the soil or on rotting materials, others in 
freshwater (Ruby and Morin, 1978; Widder, 2010). At least one hundred and seventy-three strains 
live in the ocean including Photobacterium, Beneckea and Vibrio species (Ruby and Morin, 1978; 
Widder, 2010). Some luminescent bacteria are parasitic or pathogenic, and Photorhabdus can infect 
both nematode worms and human flesh (Forst, 1997; Peel, 1999). Luminescent bacteria have even 
been found in metazoan nematode fossils (Poinar, 2011). Some luminescent bacteria are symbiotic 
(Ruby and McFall-Ngai, 1992; Ruby and Morin, 1978). For example Beneckea are often found living 
symbiotically in fish guts, while Photobacterium and Vibrio form light organ associations with many 
different organisms, including lantern-carrying fish and squid (Nyholm and McFall-Ngai, 2004; Ruby 
and Morin, 1978). Each fish or squid species carries only one type of bacteria: for example V. fischeri  
in Monocentrid fish; and P. leiognathi in leiognathid fish; and P. phosphoreumis  in many deep sea 
fish (Kaeding et al., 2007; Ruby and Morin, 1978).  
 
The distinction between free-living, parasitic and symbiotic bacteria is not clear (Haddock et al., 
2010; Urbanczyk et al., 2010). The bacteria symbiotic with fish are provided with nutrition and a 
stable, safe environment, while the fish are provided with the ability to luminesce (Haddock et al., 
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2010). However, these bacteria are not obligate symbionts, and can survive and reproduce equally 
well living in open water (Haddock et al., 2010; Haygood, 1993). Some researchers think that 
bacteria only live in open water until they can find a fish host (Dunlap et al., 2007; Haygood, 1993; 
Nealson and Hastings, 1979). Others have suggested that fish symbiosis serves mainly as a form of 
transport for bacteria; a way to redistribute themselves around the ocean (Dunlap et al., 2007; 
Haygood, 1993; Nealson and Hastings, 1979). Some luminescent bacteria that infect human wounds, 
like Photorhabdus luminescens, could even be described as symbiotic rather than parasitic, because 
they may prevent infection of the wound with much more dangerous bacteria (Wiles, 2014). A 
glowing flesh wound was a good sign for soldiers fighting in the American Civil War, because it 
meant that they were far more likely to survive, leading American soldiers to name the phenomenon 
‘angel’s glow’ (Wiles, 2014).  
 
Certainly many organisms are not passive hosts. Squid, for example, are able to carefully regulate 
their bacterial colonies and reject bacterial strains that fail to maintain adequate light production 
(Haddock et al., 2010; Nyholm and McFall-Ngai, 2004; Visick, 2000). Likewise, some soil nematodes 
carefully cultivate a luminous bacterium to assist in the parasitisation of caterpillars (Daborn et al., 
2002; Hastings, 1996).  
 
Bacteria can control their light production through gene regulation (Waters, 2005). This probably 
evolved to save energy, because light production can be energetically costly (Waters, 2005). For 
example, the dark mutants of Vibrio harveyi  are known to rapidly outcompete the luminescent form 
in culture (Wilson and Hastings, 1998). In bacteria, luminescence is often controlled by quorum 
sensing, in which bacteria judge bacterial density by measuring the concentrations of various 
bacterial metabolites (Castillo, 2015; Nealson and Hastings, 1979). Quorum sensing was in fact 
discovered by studying bioluminescent bacteria (Nealson et al., 1970). This communication exists not 
only between luminescent bacteria of the same species but also between bacteria of completely 
unrelated species (Castillo, 2015). Bacteria gain little by glowing at low concentrations, because they 
are unlikely to be seen, but at high concentrations the luminescence will easily be visible to fish 
enabling them to be eaten (Waters, 2005). Furthermore, it is at high concentrations that bacteria 
may most need distribution by fish ingestion (Waters, 2005).  
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1.2.1.1.1 Discovery of the mechanism of bacterial luminescence 
The discovery of the bacteria luminescent system has an interesting history. Benjamin Franklin 
(1706-1790) initially considered ocean luminescence to be an electrical phenomenon, but decided 
otherwise when it was discovered that one could strain out the luminescent material with a cloth  
(Shimomura, 2006f). Initial extracts displayed luminescence, but an exhausted lysate did not glow 
with the addition of fresh hot extract (Shimomura, 2006f). In 1953 Cormier discovered that the 
addition of kidney cortex, which was only added as a source of nonspecific protein, to weakly 
luminescent extracts caused a spectacular increase in luminescence (Cormier, 1953). The active 
ingredient from kidney cortex was identified as palmitic aldehyde (Cormier, 1953). Further 
experimentation showed that the addition of reduced flavin mononucleotide also increased 
luminescence (Cormier, 1953; McElroy et al., 1953). Therefore neither of the bacterial luciferins 
were identified directly by extraction. 
 
Identification of the specific long chain aldehydes used by bacteria came in 1972 from a mass 
spectrometry experiment which showed that dodecanal, tetradecanal and hexadecanal were 
involved in Photobacterium phosphoreum luminescence (Shimomura, 1974). Other bacteria 
appeared to also use these three aldehydes but in different proportions (Greenberg, 1979). Further 
experimentation showed that the fatty acid products could be recycled at a very fast rate to produce 
fresh aldehyde (Greenberg, 1979).  
1.2.1.1.2 Mechanism of bacterial luminescence 
Bacterial luciferase is an unusual flavin monooxygenase because it uses reduced flavin as a substrate 
(along with an aldehyde) rather than a tightly bound cofactor (Tanner et al., 1997; Tu, 2001). 
Luminescence ranges from max: 473 nm in P. phosphoreum to max: 542 nm in V. fischeri with 
quantum yields of around 10–30% (Ruby, 1977; Ruby and Morin, 1978; Seliger, 1975). 
 
The bacterial luminescent reaction is controlled by the enzyme flavin mononucleotide (FMN) 
reductase that reduces FMN to FMNH2 using NADH as the electron source (Navizet et al., 2011; 
Walsh and Chen, 1988). FMNH2 then reacts with oxygen, the luciferase enzyme and a long chain 
aldehyde to produce luminescence as described in Figure 1.13 (Navizet et al., 2011; Walsh and Chen, 
1988). In Vibrio harveyi  a complex is formed between luciferase and FMN reductase that enables 
reduced flavin to be directly transferred to the luciferase, a process that protects the reduced flavin 




Whether the aldehyde or the reduced riboflavin is the luciferin is a difficult question, because the 
riboflavin carries the emitter but the amount of light emitted is proportional to the concentration of 
aldehyde (Shimomura, 2006f). I would suggest that they are probably best considered as co-
luciferins because both are present in the peroxide intermediate (Figure 1.13). 
 
 




1.2.1.2  Latia luciferin 
The New Zealand freshwater limpet Latia neritoides lives in clear and shallow streams in the North 
Island (Meyer-Rochow and Moore, 1988). I have personally observed these limpets in Auckland in a 
small stream in Laingholm. When disturbed (for example by being stroked), the limpet produces 
mucus which glows green (λmax: 536 nm) (Shimomura and Johnson, 1968c). The structure of Latia 
luciferin was discovered in 1968 (Shimomura and Johnson, 1968c). This structure and the 
stereochemistry were confirmed by synthesis to be 1.14 (Figure 1.14) and synthetic Latia luciferin 
was found to glow with a Latia luciferase preparation (Nakatsubo et al., 1970). The luminescence 
appears to be caused by a luciferin-luciferase type reaction, although a cofactor (the so-called 
‘purple protein’ ) is also thought to be involved (Nakamura et al., 2005; Ohmiya, 2005). The 
hypothesised mechanism is shown in Figure 1.14, but when 18O2 was added to the reaction, no 
18O 
labeled CO2 could be detected (Mager, 1995). The details of the light-emitting process are therefore 
still unclear (Nakatsubo et al., 1970; Ohmiya, 2005). 
 
 
Figure 1.14. The possible mechanism of Latia luciferin (1.14) luminescence (Nakamura et al., 2005). Formic acid is 
produced as a by-product. 
As neither Latia nor its enzymatic product contain a chromophore, it is likely that the oxidation of 
Latia luciferin produces energy which is then transferred to a secondary emitter to produce 
luminescence. The purple protein does contain a chromophore-like region, but studies have 
suggested that an unknown flavin may be the true emitter (Nakamura et al., 2005; Ohmiya, 2005). If 
this is the case the bioluminescent mechanism may be similar to that of bacteria (section 1.2.1.1), 
because Latia luminescence also involves an aldehyde. 
1.2.1.3 Lumbricidae and Megascolecidae earthworms luciferin 
Three families of annelid earthworms contain luminescent members (Petushkov and Rodionova, 
2005)(Pes et al., 2016). The Enchytraeid earthworm are discussed in section 1.2.6.2 because their 
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luminescent chemistry is quite different. The families Lumbricidae and Megascolecidae together 
contain 12 species of earthworms which produce luminescent mucus (Petushkov and Rodionova, 
2005)(Pes et al., 2016). This includes our own New Zealand giant earthworm Octochaetus multiporus 
(Johnson and Haneda, 2015; Springett et al., 1998)(Figure 1.16).  
 
Figure 1.15. Diplocardia luciferin (1.13). 
 
 
Figure 1.16. Octochaetus multiporus. The luminescent 
giant earthworm of New Zealand. Photograph by and used 




Many Lumbricidae and Megascolecidae are thought to use the same aldehyde luciferin: N-isovaleryl- 
3-amino-propanal (Figure 1.15, 1.13) which was first discovered in Diplocardia longa (Ohtsuka et al., 
1976). The luciferin (1.13) is oxidised by a copper (I) containing luciferase enzyme and hydrogen 
peroxide. Since the aldehyde has no chromophore, there must exist a yet to be discovered 
secondary emitter (Petushkov and Rodionova, 2005; Rudie and Wampler, 1979).  
 
A recent LC-MS study of the earthworm Eisenia lucens (Lumbricidae) showed no sign of 1.13 showing 
that 1.13 could not be the luciferin in this species (Pes et al., 2016). However, the luminescent 
coelomic fluid of these earthworms  did contain high concentrations of riboflavin (Pes et al., 2016). 
Since the bioluminescent emission maximum of Eisenia lucens  was 493 nm (similar to the 
biolumumincence maxima of many luminescent  bacteria) it is possible that Eisenia lucens uses 
riboflavin as a luciferin, or as the luminescent emitter (Pes et al., 2016). The fatty aldehydes: palmitic 
and palmitoleic acids and hexadecenal (required for the flavin based bioluminescent system) were 
also found in the luminescent coelomic fluid by LC-MS, but there is no evidence that these are 




1.2.2 Imidazopyrazine luciferins 
1.2.2.1 Coelenterazine 
Coelenterazine (1.1) was originally named for its presence in the Cnidaria (formerly 
Coelenterata)(Shimomura and Johnson, 1975a). However coelenterazine is by far the most widely 
used luciferin and has been found in protozoans, crustaceans such as the decapods shrimps 
Oplophorus and Heterocarpus, molluscs, arrow worms and in vertebrates such as the myctophid fish 
Neoscopelus (Cormier et al., 1973; Inoue, 1977; Inoue, 1979; Inoue et al., 1976; Shimomura, 1974). It 
is found anthozoans such as the sea pansy Renilla and in all studied luminous coelenterates and 
ctenophores (Cormier, 1975; Cormier et al., 1973; Haddock et al., 2010; Jones et al., 1999; 





Figure 1.17. The marine luciferin coelenterazine and the synthetic luciferin furinmazine: a coelenterazine analogue. 
Coelenterazine is also found in many non or weakly luminescent organisms such as the red beard 
sponge Microciona prolifera (Shimomura, 2006c). Coelenterazine is used in both simple luciferin-
luciferase systems (e.g. by scyphozoans such as Pelagia noctiluca and Anthozoans such as Renilla) 
and in photoprotein systems (e.g. by hydrozoans such as Aequorea) (Haddock et al., 2010). 
 
The chemical structure was determined in parallel by two groups; one working on the sea 
pansy Renilla and the other working on the hydrozoan Aequorea (Inoue, 1979;Shimomura, 1974). 
Coelenterazine is produced by several marine animals such as copepods and the shrimp Sysellaspis 
debilis at the base of the marine food chain (Buskey, 1991; Haddock et al., 2010; Rees, 1998; Tsuji et 
al., 1972). This provides coelenterazine to organisms such as Aequorea that cannot synthesise the 
molecule and explains the wide distribution of coelenterazine among luminous organisms. 
 
Feeding experiments using deuterium labeled L-tyrosine and L-phenylalanine showed that copepods 
synthesise coelenterazine from two tyrosines and a phenylalanine (Oba et al., 2009). It is believed 
that the tripeptide precursor Phe-Tyr-Tyr is converted into coelenterazine by a non-heme iron 
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oxidase similar to isopenicillin-N-synthase (Francis et al., 2015; Thompson et al., 1995; Ward et al., 
1994). 
 
Coelenterazine is usually used unmodified (Figure 1.17) but Watasenia squid uses a disulfate form  
(Inoue et al., 1977), while a peroxidised form is used in hydrozoans in photoproteins (Ohmiya and 
Hirano, 1996) and dehydro coelenterazine is used by the luminous flying squid Symplectoteuthis 
oualaniensis (Takahashi, 1993). The myctophid fish Diaphus elucens stores coelenterazine as an enol 
ether bound to glucopyranose iduronic acid while other poorly studied forms are thought to be used 
by the shrimp Serestes, the squids Chiroteuthis and the deep sea fish Neoscopelusis (Inoue, 1979; 
Shimomura, 2006a). These coelenterazine derived luminous systems are not yet well understood 
(Shimomura, 2006c). Novel luminescent coelenterazine derivatives have also been synthesised (Vece 
and Vuocolo, 2015). Furimazine for example (Figure 1.17) has found great success in biotechnology 
reporter assays in combination with an newly-engineered luciferase (nanoluc) based on the 
luciferase of the deep sea shrimp Oplophorus gracilirostris (Hall, 2012). 
1.2.2.1.1 Mechanisms of coelenterazine luminescence 
Coelenterazine and coelenterazine-type luciferases react with O2 and sometimes ATP to produce 
coelenteramine (1.24) coelenteramide (1.25) and blue light with a quantum yield of approximately 








Figure 1.18. Coelenteramine and Coelenteramide: products of coelenterazine bioluminescence. 
 
The reaction is initiated by the binding of oxygen to coelenterazine to form a peroxide, which is 
converted into a four-membered dioxetanone ring  (Shimomura and Johnson, 1979). The ring 
undergoes a decarboxylation reaction to produce CO2 and the excited state emitter, which then 
returns to ground state to produce light and coelenteramide (Figure 1.19) (Shimomura and Johnson, 
1979). Luminescent and chemiluminescent reactions also produce coelenteramine as a side product 
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(Shimomura, 1973). Early 18O studies by Cormier were not consistent with the dioxetanone system 
mechanism (Cormier 1975) but more recent studies showed that the dioxetanone system is 
consistent and that the original contrary results were due to contamination by CO2 (Hart, 1978; 
Shimomura and Johnson, 1979). 
 
Figure 1.19. The luminescence mechanism for coelenterazine and Cypridina luciferin to produce coelenteramide (1.25) 
see Figure 1.18 .  
 
Coelenterazine produces chemiluminescence in aprotic solvents such as DMF though a mechanism 
similar to that of coelenterazine bioluminescence (Cormier, 1975). This has enabled scientists to 
determine information about coelenterazine bioluminescence by studying the chemiluminescence 
of coelenterazine analogues (Cormier et al., 1973).  These studies showed that the excited state 
intermediate was most likely excited monoanionic (singly negatively charged) coelenteramide and 
that the coelenterazine luciferase active site must provide a similar environment in terms of ionic 
strength and hydrophobicity to DMF (Cormier, 1975). This hypothesis was later confirmed when it 
was shown that although monoanionic coelenteramide did not fluoresce in aqueous environments, 
it produced a strong blue fluorescence in DMF with a similar quantum yield to the bioluminescent 
reaction. In contrast, dianionic coelenteramide  gave  yellow-green fluorescence, while the neutral 
coelenteramide gave purple fluorescence (Cormier, 1975; Shimomura, 2006b; Shimomura, 2006a). 
These experiments showed that fluorescence and chemiluminescence can be an effective way to 
study bioluminescence in a simplified system without the need for enzymes.  
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1.2.2.1.2 Coelenterazine luminescence in Hydrozoa,  Ctenophora and Radiolaria. 
The bioluminescence of Hydrozoa, Ctenophora and Radiolaria stems from the reaction of the 
coelenterazine containing photo-proteins with Ca2+ (Campbell and Herring, 1990). The photo-protein 
varies but closely related species use similar luciferases (Campbell et al., 1989; Deng et al., 2004; 
Fagan, 1993; Illarionov, 1995). For example the hydrozoan luciferases all come from the same family 
of enzymes (Tsuji, 1995). 
 
 
Figure 1.20. Photographs of the Hydorzoan Aequorea aequore (alternatively A. victoria) by Sierra Blakely (Creative 
Commons). These small transparent predatory jellyfish live in seawater and grow up to 10 cm in diameter. Their light 
organs, each composed of 200 tiny granules, encircle the edge of their umbrellas (Shimomura, 2006a). 
The survival role of bioluminescence in Hydrozoa is not yet known. Bioluminescence may act as 
warning colouration to deter predators, or act as a burglar alarm signal to attract the predators of 
the threatening predator (Haddock et al., 2010).  
 
The luminescence of Hydrozoa is due to the oxidation and excitation of coelenterazine by a 
luciferase as described in section 1.2.2.1.1. However, in contrast to other luciferin-luciferase 
systems, oxygen and coelenterazine are not required immediately previous to the luminescent 
reaction because the luciferase is stored pre-charged with both (Haddock et al., 2010; Titushin et al., 
2011). Luminescence is instead triggered by the addition of Ca2+ (Titushin et al., 2011). This puts 
luminescence under nervous system control, and enables luminescence to be triggered by 
mechanical disturbance (Titushin et al., 2011). 
 
After luminescence, the coelenteramide is removed from the protein and the protein is regenerated 
with fresh coelenterazine and O2 (Jones et al., 1999). It is not yet known whether the fresh 
coelenterazine is synthesized from a tripeptide precursor or reduced from the oxidized 
chromophore (Jones et al., 1999). However, the regeneration of the Aequorea system In vitro does 




Imidazopyrazines with the alcohol on the 2 position are inactive as chromophores which suggested 
that the coelenterazine was peroxide bound to aequorin at the 2 position (Figure 1.21) (Jones et al., 
1999). This has been confirmed by 13C NMR studies which compared the chemical shifts of bound 
and unbound coelenterazine (Jones et al., 1999).  
 
 
Figure 1.21. Coelenterazine bound to aequorin at the 2 position. 
Luciferase-bound coelenterazine was first discovered in Aequorea (Shimomura, 1973). However the 
encapsulation of coelenterazine inside the aequorin luciferase made extraction difficult (Shimomura, 
1969). Most attempts to separate the chromophore from the photo-protein resulted in 
chromophore degradation, so researchers instead studied the chromophoric degradation products 
(Shimomura, 1969). Denaturation of aequoporin with urea in the presence of 2-mercaptoethanol 
caused the formation of a blue fluorescent substance called coelenteramine (Figure 1.18). This could 
be extracted away from the protein with n-butanol (Shimomura, 1969). If aequorin which had 
ceased to luminesce was acidified, another blue fluorescent compound called coelenteramide 
(Figure 1.18) could be extracted (Shimomura, 1973). From this data, and by comparison to the 




1.2.2.1.3  Coelenterazine luminescence in Anthozoa 
The luminescence of coelenterazine utilising anthozoans such as the sea pansy Renilla, like that of 
hydrozoans such as Aequorea, is Ca2+ regulated (Haddock et al., 2010; Stepanyuk et al., 2008). 
However, unlike Hydrozoa, Renilla does not store coelenterazine and oxygen within a pre-charged 
luciferase. Instead, luminescence is controlled through the actions of a Ca2+ sensitive coelenterazine-
binding protein (CBP) (Titushin et al., 2008). CBP initially tightly binds coelenterazine, but addition of 
Ca2+ causes coelenterazine to be released (Stepanyuk et al., 2008; Titushin et al., 2008). Once free, 
the coelenterazine can react with the luciferase to cause bioluminescence through the chemical 
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mechanism described in Figure 1.19 (Haddock et al., 2010; Stepanyuk et al., 2008). The CBP, as well 





Figure 22. Coelenterazine enol sulphate  
 
Renilla and many other organisms store coelenterazine as a stabilized enol sulphate (1.26) inside 
organelles called lumisomes (Cormier et al., 1970). The enol sulphate is activated to coelenterazine 
by 3’,5’diphosphoadenosine and luciferin sulfokinase (Cormier et al., 1970). The stabilized enol 
sulphate form is not luminescent and was not initially detected by luminescence assay (Thompson, 
1997). However, Cormier discovered that luminescent assay active colenterazine was produced if 
acidified solutions of Renilla extract were heated, or if adenosine diphosphate was added and this 
enabled the isolation of the coelenterazine (Cormier et al., 1970).   
1.2.2.1.4 Coelenterazine luminescence in Cephalopoda 
Intrinsic bioluminescence (as opposed to bacterial symbiont bioluminescence which is also observed 
in squid) has only been found in the cephalopod sub family Sthenoteuthinae, containing the genera 
Ornithoteuthis, Symplectoteuthis(= Eucleoteuthis), Hyaloteuthis, Ommastrephes and Dosidicus 
(Girsch, 1976; Haddock et al., 2010). Light organs are distributed over the mantle, head, arms and 
tentacles, with the distribution and concentration of light organs being species dependent (Haddock 
et al., 2010). The evolutionary advantage of luminescence in cephalopods is not yet known (Haddock 
et al., 2010). It has been suggested that luminescence provides a method of communication both for 
sexual attraction and for aggressive displays for disguise via counter illumination (Haddock et al., 
2010; Jones and Nishiguchi, 2004). 
 
Only the luminescent system of Watasenia scintillans, the Japanese firefly squid (Figure 1.23), has 
been investigated in any detail (Hamanaka et al., 2011; Tsuji, 2002). The light organs of Watasenia 
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contain a membrane-bound luciferase that oxidises the Watasenia luciferin (coelenterazine 
disulfate) to produce light (Hamanaka et al., 2011; Tsuji, 2002). ATP and Mg+2 are essential to this 
reaction. The luciferase has not yet been isolated (Hamanaka et al., 2011; Tsuji, 2002). 
 
 
Figure 1.23. Firefly squid bioluminesce. Photo used with 
permission from Dante Fenolio. 
 
1.27. Coelenterazine disulphate 
Figure 1.24. Watasenia scintillans luciferin 
 
Coelenterazine was isolated from the luminous squid Watasenia scintillans (Inoue, 1975) and the 
structure proved by synthesis (Inoue et al., 1976). Coelenterazine was initially thought to be the 
Watasenia luciferin due to its similarity to Cypridina luciferin and to the postulated aequoporin 
luciferin, but the active luciferin in Watasenia was later shown to be coelenterazine disulphate 
(1.27) (Inoue et al., 1977). 
 
1.2.2.1.5 Coelenterazine luminescence in Pholas dactylus  
The luminescent clam Pholas dactylus was once found all over the Mediterranean and Atlantic coast 
of Europe but has become scarce and is in danger of extinction due to pollution (Micu, 2007). The 
clam produces a protective cloud of luminous mucus when threatened (max: 490 nm). This 
luminescence is produced by a photo-protein known as pholasin which utilises 
dehydrocoelenterazine as the luciferin (Kuse et al., 2008) and an unknown flavin as the 
chromophore (Müller and Campbell, 1990). The chromophore is believed to be a flavin because the 
protein has the same emission properties as hydroxyflavin, the light-emitter of the bacterial 
luciferase (Müller and Campbell, 1990). It is thought that the photoprotein is oxidised by an enzyme-
bound peroxide because superoxide dismutase does not inhibit the reaction under any conditions 
(Kuse et al., 2008). The photo-protein luminesces in vitro with the addition of ferrous ions or 
horseradish peroxidase, and is widely used in assays for the detection of these molecules (Kuse et 




1.2.3 Cypridina (Vargula) luciferin 
Cypridina luciferin (1.2, Figure 1.25) is found in luminescent ostrocods which are tiny crustaceans 
found in oceans around the world (Haddock et al., 2010; Kishi et al., 1966; Shimomura, 1957). The 
largest, Gigantocypris, is generally less than 1 cm long (Davenport, 1990; Tibbs, 1965). The 
luminescent ostrocod Cypridina hilgendorfi,  which was one of the first luminescent organisms to be 






Figure 1.25. Cypridina luciferin (1.2) and Cypridina luciferin enol sulphate (1.28) 
Luminescence is produced by a luciferin-luciferase reaction involving a luciferin with a very similar 
structure to coelenterazine (Figure 1.25, 1.2) (Kishi et al., 1966; Shimomura, 1957). The luciferase 
and luciferin are stored in separate glands, and when the ostrocod is startled it squirts both out into 
the sea water (Hastings, 1983). This produces a luminescent “smoke screen” which may be useful for 
confusing predators (Haddock et al., 2010). Alternatively luminescence may act as a swarming cue 
(Haddock et al., 2010; Hastings, 1983). Like colenterazine, Cypridina luciferin may also be stored in 
an 3 enol sulphate form (1.28) (Nakamura et al., 2014). 
 
1.2.3.1.1 Mechanism of Cypridina luminescence 
Chemically, the luminescent mechanism of Cypridina luciferin (Figure 1.26) is almost identical to that 
of coelenterazine, which is unsurprising given the close similarity between the two molecules (Ding 
et al., 2015; Shimomura, 2006b; Shimomura, 2006a). However, the corresponding luciferases are 
quite different (Ding et al., 2015). For example unlike the coelenterazine reaction, the Cypridina 
reaction requires seawater salt (NaCl, KCl, NH4Cl MgCl and CaCl are all effective (Shimomura, 
2006d)), and is inhibited by EDTA (Ding et al., 2015). The light-forming reaction is fast, but the 
hydrolysis reaction that cleaves oxidized luciferin (1.31) from the enzyme is slow which makes the 
turnover rate slow (0.03/s) (Ding et al., 2015).  The luminescence has a quantum yield of 0.30 +/- 
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0.05 and a max between 435 nm and 463 nm that is buffer dependent but not pH dependent (Ding 
et al., 2015; Shimomura, 2006a).  Cypridina luciferin may also be converted into etioluciferin (1.30) 
without light emission (Figure 1.26) (Ding et al., 2015). This side reaction increases as the solvent 
becomes more organic but the mechanism of this reaction is not known (Ding et al., 2015; 
Shimomura, 2006b; Shimomura, 2006a). Alternatively Cypridina luciferin  may be reversibly oxidised 
into inactive luciferinol (1.29) (max: 465 nm) by air (Toya et al., 1983). Luciferinol (1.29) can be 
reduced back into active Cypridina luciferin (1.2) by reduction with sodium hydrosulphite (Figure 
1.26) (Ding et al., 2015; Shimomura, 2006b; Shimomura, 2006a). The addition of lead dioxide or 
diphenylpicrylhydrazyl radicals to Cypridina luciferin mimics the enzymatic bioluminescent reaction 







Figure 1.26. Mechanism of Cypridina luciferin luminescence 
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1.2.4 Tetrapyrrole luciferins 
1.2.4.1 Dinoflagellate luciferin 
Dinoflagellates are highly motile protists that live both in the ocean and in fresh water. More than 18 
genera of dinoflagellates contain bioluminescent species, including Noctiluca scintillans (Figure 1.28), 
Lingulodinium polyedrum, and species of Pyrocystis (Baker et al., 2008a; Haddock et al., 2010). These 
organisms are often responsible for the beautiful glowing wake sometimes seen behind boats and 
sea life (Figure 1.27). Dinoflagellates are thought to flash in order to startle predators or to attract 




Figure 1.27. Photograph of dinoflagellate bioluminescence at the Yacht 
Port of Zeebrugge, Belgium. Photo by and used with permission from 
Hans Hillewaert. 
 
Figure 1.28. Photograph of Noctiluca 
scintillans by Maria Antónia Sampaiyo. 
Used with permission from Ana Amorim 
and Creative Commons. 
 
The dinoflagellate luciferin (1.12) is a tetrapyrrole with a structure very similar to that of chlorophyll 
(Figure 1.29) (Nakamura et al., 1989). Dinoflagellates possess a genetically controlled circadian 
rhythm and only luminesce at night (Morse and Mittag, 2000). The luciferin may be synthesized from 
chlorophyll at night, used for luminescence, then converted back into chlorophyll during the day for 
photosynthesis (Haddock et al., 2010; Topalov and Kishi, 2001).  
 
Luminescence involves the reaction of dinoflagellate luciferase, luciferin and O2 through the 
mechanism shown in Figure 1.29, producing blue-green light (max: 490 nm) (Morse and Mittag, 
2000). The luciferin structure was difficult to elucidate due to the oxidation sensitivity of the luciferin 
which had a half-life of only a few hours even under the best conditions (Dunlap and Hastings, 1981; 
Morse and Mittag, 2000). Nevertheless, Nakamura successfully isolated and structurally 
characterised the luciferin and its enzymatic oxidation products (Nakamura et al., 1989). They also 
found a bright blue product that was formed through a non-enzymatic non-luminescent oxidative 
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side reaction (Figure 1.29) (Nakamura et al., 1989). The chromophore (dinoflagellate luciferin 
without R2) was synthesized by Kishi but the total synthesis has yet to be completed (Morse and 
Mittag, 2000; Nakamura et al., 1989; Stojanovic and Kishi, 1994). 
 
Dinoflagellate luciferin is stored and protected by a luciferin-binding protein (LBP) (Deane et al., 
2015; Schultz et al., 2005). LBP and the dinoflagellate luciferase are then both protected within 
organelles known as scintillons which are found next to acidic vacuoles (Deane et al., 2015; Morse 
and Mittag, 2000; Schultz et al., 2005). These acidic vacuoles release protons when mechanical 
stimulation is detected by the dinoflagellate nervous system. The luminescent reaction is controlled 
by pH because dinoflagellate luciferase is inactive at pH 7.5 and maximally active at pH 6.3 and 
because the luciferin binds far more strongly to LBP at pH 7.5 than at pH 6.3 (Morse and Mittag, 
2000). Therefore an increase in acidity will release luciferin from LBP and enable the luciferin to 
react with the luciferase triggering the luminescent reaction (Deane et al., 2015; Morse and Mittag, 
2000; Schultz et al., 2005). 
 
Dinoflagellate luciferin (1.12)   
 
Figure 1.29. Dinoflagellate luciferin (1.12) luminescence reactions. 
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1.2.4.2  Euphausid shrimp luciferin 
Euphausid shrimps are oceanic crustaceans commonly known as krill. Euphausid shrimps (Figure 
1.30) flash brightly blue when mechanically disturbed (Nakamura et al., 1988b). The luciferin 
structure was elucidated by Nakamura, and is almost identical to that of dinoflagellate luciferin and 
dinoflagellate luciferase cross-reacts with Euphausid luciferin (Nakamura et al., 1989; Nakamura et 
al., 1988b; Shimomura, 1995). This means that the reaction probably proceeds with a similar 
chemical mechanism to that of dinoflagellate luciferin (Nakamura et al., 1988b). However, the 
reaction is very slow, and has not been well studied owing to the highly unstable nature of both the 





Figure 1.30. Euphausid shrimp luciferin 1.11. 
Figure 1.31. The luminescent Euphausid shrimp 




1.2.5 Benzothiazole luciferin 
Luminescence has been discovered in several insect groups: beetles, cockroaches of the genus 
Lucihormetica, and the larvae of some Mycetophiloidea (fungus gnats) (Vršanský, 2012). Of these, 
only the benzathiazole luciferin-luciferase system is well understood. There are about 1800 
luminescent Coleoptera species, in families including Lampyridae (the fireflies, see Figures 1.32 and 
1.33), Phengodidae (rail road worms, see Figure 1.34) and Elateridae (click beetles, see Figure 1.35) 
(Day et al., 2004; Fraga, 2008). The highly variable nature of lantern morphology had previously led 
researchers to think that these groups evolved luminescence separately  but recent phylogenetic 
analysis showed that beetle luciferase evolved only once  (Day et al., 2004; Day et al., 2009; Inouye, 
2010) 
 
Figure 1.32 The firefly Photuris lucicrescens 




Figure 1.33. Photuris adult luminescence (Lampyridae) 
(Creative Commons). 
 
Figure 1.34. Brasilocerus railroad-worms 
(Phengodidae) railroad-worms used with permission 
from Vadim Viviani  (Arnoldi et al., 2010). 
 
Figure 1.35 A Pyrophorus luminescent click beetle (Elateridae) 
Pyrophorus luminosus in the exhibition Darwin observador, 
Darwin naturalista in CosmoCaixa, Barcelona. Light organs 
appear as yellow patches on the pronotum. Photo by Eduard 
Solà (Creative Commons). 
 
Benzathiazole luciferin (1.4, Figure 1.37)  was first isolated from the common North American firefly 
Photinus pyralis (Bitler and McElroy, 1957), and so far all luminescent beetles have been found to 
use the same luciferin (Navizet et al., 2011; Oba, 2013). Benzathiazole luciferin (1.4) is composed of 
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two functional groups; a benzothiazole moiety and a thiazole carboxylic acid moiety connected via a 
carbon-carbon bond to produce a conjugated system (Figure 1.37) (Nakatsu et al., 2006;Navizet et 
al., 2011). In fireflies, this luciferin is biosynthesized from two L-cysteine molecules combining 
with p-benzoquinone and accompanied by the decarboxylation of L-cysteine (Oba, 2013). 
In some fireflys sulfoluciferin (Figure 1.36) appears to act as a storage form for benzathiazole 
luciferin (1.4) (Fallon et al., 2016). 
 
 
Benzathiazole luciferin (1.4)  
 
Benzathiazole sulfoluciferin (1.32) 
Figure 1.36. Benzathiazole luciferin and Benzathiazole sulfoluciferin  
1.2.5.1 Mechanisms of benzothiazole luminescence  
Beetle luciferase catalyses the reaction between beetle D-luciferin and ATP in the presence of Mg2+ 
to produce an activated D-luciferyl adenylate, as shown in Figure 1.37 (Chung et al., 2008; Nakatsu et 
al., 2006; Navizet et al., 2011). The luciferase also oxidises this molecule to a peroxide intermediate 
which reacts to form a dioxetanone intermediate. This then undergoes a decarboxylation reaction to 
produce excited (singlet state) oxyluciferin. The relaxation of the excited state to the ground state 
produces yellow green light with high efficiency (Chung et al., 2008; Nakatsu et al., 2006; Navizet et 
al., 2011). The quantum yield of this reaction in fireflies is 0.41, many times greater than any non-
biological photo emitter (Chung et al., 2008). This shows how well evolution can tune and perfect 
such a system (Milne et al., 2010). The quantum yield of the firefly luminescence reaction is regularly 
quoted as being 0.9, but this value was based on flawed early studies which ignored the effect of 
racemisation (Ando et al., 2008). Although oxyluciferin acts as the emitter in the bioluminescent 
reaction, in radical-induced chemiluminescence reactions, luciferin itself can act as the light emitter 






Equation 1: E + LH2 + ATP ￫ E.LH2-AMP + PPi 
Equation 2: E.LH2-AMP + O2 ￫ E + AMP + CO2 + oxyluciferin + light 
 
Figure 1.37. Firefly luminescence reaction. E: luciferase, LH2: benzathiazole luciferin, PPi: pyrophosphate, AMP: 
adenosine monophosphate. 
The bioluminescent mechanism is shown in Figure 1.37, Equation 1 and Equation 2. This mechanism 
is supported by X-ray crystal structures of Japanese firefly luciferase crystals which contained an  
analogue of the high-energy intermediate oxyluciferin (Nakatsu et al., 2006). Model studies on 
various dioxetane model compounds also support this mechanism (Milne et al., 2010; Navizet et al., 
2011). Previous work had questioned the validity of dioxetane mechanism, because modelling 
studies produced triplet rather than singlet excited states (Fraga, 2008). Triplet excited states in 
solution quench through non-radiative pathways and cannot be responsible for bioluminescence 
(Fraga, 2008). However, later studies showed that model analogues could be efficiently excited into 
a singlet state in some circumstances, which led to the formation of Chemical Initiated Electron 
Exchange Luminescence (CIEEL) theory (Fraga, 2008).  
 
 
1.2.5.2  Non-luminescent reactions of benzothiazole luciferin  
There are three main non-luminescent side reactions that occur between benzathiazole luciferin and 
firefly luciferase (da Silva, 2011; Pinto da Silva et al., 2012; Vieira et al., 2012). These are shown in 




Equation 3: E.LH2-AMP + O2 ￫ E.L-AMP + H2O 
Equation 4: E.L-AMP + PPi￫ E + L + AMP 
Equation 5: E.L-AMP + CoA ￫ E + L-CoA + AMP 
Equation 6 E.LH2-AMP + ATP ￫ E + Ap4A +LH2 (via an E.L-AMP intermediate) 
 
 
Figure 1.38. Non-luminescent side reactions of benzathiazole luciferin. E: luciferase, LH2: benzathiazole luciferin, PPi: 
pyrophosphate, AMP: adenosine monophosphate, L-AMP: dehydroluciferyl-AMP, Ap4A: diadenosine tetraphosphate, 
CoA: coenzyme A. 
 
The reaction product dehydroluciferyl-AMP (L-AMP) is a powerful inhibitor of the luminescent 
reaction, and can rapidly decrease the light emitted (Fraga et al., 2005). Reactions that decrease the 
concentration of L-AMP therefore modify the kinetic profile of the luminescent reaction from a flash 
profile toward stable prolonged light production (Fraga et al., 2005). Coenzyme A (CoA) for example 
will react with luciferyl-AMP to form dehydroluciferyl-CoA (Equation 5), which is a much less 
powerful inhibitor (Fraga et al., 2005). Addition of CoA also stimulates light production because CoA 
inhibits the synthesis of diadenosine tetraphosphate (Equation 6), which enables a greater 
proportion of E.LH2-AMP to react via Equation 1 and Equation 2 (da Silva, 2011; Fontes, 1998; Pinto 
da Silva et al., 2012). At high concentrations, ATP inhibits the reaction by reacting with activated D-
luciferyl adenylate (Equation 6). In general, PPi as an enzymatic product inhibits the luminescent 
reaction but may stimulate the reaction if added post-ATP, because PPi stimulates the conversion of 
luciferyl-AMP into L-CoA and therefore prevents enzyme inhibition by luciferyl-AMP (Fraga et al., 
2005). L-luciferin can act as an alternative substrate for light production because it can undergo slow 
racemisation in presence of pyrophosphate to produce D-luciferyl adenylate (Fraga, 2008; Lembert, 
1996). However, the reaction is poor because the racmic conversion is very slow and because L-




1.2.5.3 Benzothiazole luciferin analogue luminescence 
Many benzathiazole luciferin analogues have been synthesised to investigate the kinetics and 
mechanism of the luminescent reaction but nearly all displayed poorer luminescent properties than 
benzathiazole luciferin (Li et al., 2013).  
 
1.33. 6-Amino benzathiazole luciferin. 
Figure 1.39. A luminescent analogue of benzathiazole luciferin. 
The exception is 6’-amino luciferin (Figure 1.39, 1.33), which has a higher affinity to luciferase than 
luciferin (1.4) and emits light at a longer wavelength (max: 596 nm) (White, 1966). Analogue studies 
showed that that the six position of the benzothiazole, must be occupied by a strongly electron-
donating substituent because otherwise luciferin cannot interact in the proper manner with the 
active site of luciferase (Iwano et al., 2013; Li et al., 2013; Nakatsu et al., 2006). Weaker electron-
donaters at this position, such as alkyl or acyl groups, therefore prevent luminescent activity (Iwano 
et al., 2013; Li et al., 2013). By contrast, 6’-amino luciferin (1.33) shows stronger luminescence than 
native luciferin because the six position is occupied by a more electron-donating substituent (Iwano 
et al., 2013; Li et al., 2013; White, 1966). Any modification that prevented substrate recognition 
through steric effects also prevented luminescence, while modifications that increased molecular 
rigidity increased the quantum yield (Li et al., 2013).  
 
With this in mind, researchers have been able to develop a range of novel luminescent luciferins  
including N-alkylated 6’-aminoluciferins and cyclic alkyl-amino-luciferin (Evans et al., 2014; Kojima et 
al., 2013; Takakura et al., 2010; Woodroofe et al., 2008). Some of these have novel properties such 
as acid tolerance (Takakura et al., 2012), while others incorporate unusual elements such as 
selenium (Conley et al., 2012). Many synthetic analogues produce products that inhibit the 
luminescence reaction far less than oxyluciferin (Iwano et al., 2013). Some benzathiazole luciferin 
analogues have even been found to produce light when catalysed by fatty acyl-CoA synthetases that 
do not produce any luminescence with benzathiazole luciferin itself (Mofford et al., 2015). 
1.2.5.4  Colour modulation of benzathiozole luminescence 
Benzathiazole luciferin can emit light in a multitude of colours ranging from yellow-green (max: 538 
nm) to red (max: 593 nm), depending on the luciferase, pH and solvent (Hosseinkhani, 2011; Viviani, 
2002). Fireflies emit yellow-green light, click beetles emit in the green-orange, and rail-road worms 
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may display light of any shade between green and red (Hosseinkhani, 2011). In other organisms, 
emission colour may be altered by reflectors or filters (Denton et al., 1985), or by the near proximity 
of a secondary emitter such as green florescent protein (Hastings, 1996). However, Wood showed 
that the four luminescent colour types produced in click beetles (green, yellow-green, yellow, and 
orange), were caused by four different amino-acid substitutions of the same luciferase (Wood, 
1998). Many mutant luciferases have now been developed that emit light at wavelengths with max: 
534 nm to 623 nm (Branchini et al., 2001; Viviani et al., 2002). It is therefore thought that in 
Coleoptera, all observed colour modifications are caused by the differences in the luciferase active 
site (Hosseinkhani, 2011).  
 
White and co-workers  proposed that different tautomers of excited state oxyluciferin produced 
different colours (Figure 1.40) (Hopkins et al., 1967). Benzathiazole luciferin bioluminescence varies 
with pH; glowing red under alkaline conditions when the luciferin should be in keto form, but yellow 
green under more acid conditions when the luciferin should be in enol form (Hopkins et al., 1967). 
White proposed that the keto excited state produced red light whilst the enol form produced a 
yellow green light. Other colours were thought to result from some equilibrium mix of these two 
forms (Hopkins et al., 1967). If this were true, the colour displayed would result from differences in 
the polarity in the enzyme-active site, shifting the luciferin between enol and keto forms (Maghami 
et al., 2010). 
 
However, pH-derived colour shift does not occur in click beetles or railway worms, yet these 
organisms produce light in a range of colours (Imani et al., 2010). Mutated firefly luciferases with 
only a few residue changes were also pH-insensitive (Imani et al., 2010; Maghami et al., 2010). 
Furthermore, 5,5-dimethyloxyluciferin can emit both green and yellow light even though it is 
constrained to the keto form (Hirano et al., 2009). The colour differences in beetle luminescence can 
therefore not be explained by keto enol tautomerism.  Time-dependent density functional theory 
(TDDFT) calculations suggest that, for molecules of this type, the more polarizable the molecule, the 
more red-shifted the bioluminescence (Maghami et al., 2010). Enol forms could therefore give green 
to red luminescence, while the keto forms could give violet to blue luminescence (Maghami et al., 





Figure 1.40. The tautomeric explanation of benzathiazole luciferin colour modification (Maghami et al., 2010). 
McCapra proposed that the colour diversity resulted from the various rotational conformers of the 
keto form (McCapra, 2000). Red emission was thought to result from a twisted excited state (ø = 
90°, the minimum energy conformation) while green would result from a secondary energy minima 
conformation (ø < 90°) (Branchini et al., 2002). This idea is unlikely, despite being reinforced by 
theoretical calculations, because the molecule is conjugated, and the carbon-carbon bond rotational 
axis has a high degree of double bond character (Maghami et al., 2010). There therefore exists a 
large energy barrier between the twisted and planar forms (Maghami et al., 2010). Furthermore, 
since the red form results from the energy minima, it would be expected that red luminescence 
would result after disruptive perturbations of enzyme structure (e.g. after heat or acid 
denaturation), but this does not occur (Maghami et al., 2010). 
 
Recent theories state that luciferase regulates luminescent colour by influencing the resonance 
hybrid of the anionic keto form (Branchini et al., 2004; Maghami et al., 2010). The two main 
resonance structures are shown in Figure 1.41. The idea is similar to that of White (Hopkins et al., 
1967), because resonance hybrid one displays the same conjugation and same colour as the keto 
form (green), while hybrid II displays the same conjugation and same colour as the enol form (red). 
However, the excited molecules are still in the keto form, which explains previous observations 
(Imani et al., 2010). 
 
 
Figure 1.41. Resonance hybrids of the anionic keto form of the beetle oxyluciferin (Branchini et al., 2004). 
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Nakatsu et al., studied the crystal structure of firefly luciferase containing the potent inhibitor 
PTC124 and found that many protein-determined factors, including the placement of water 
molecules within the active site and changes to molecule rigidity, could also elicit subtle colour 
tuning effects (Nakatsu et al., 2006). They also discovered that luciferase could produce 
luminescence in two different conformations, which they named ‘open’ and ‘closed’ (Nakatsu et al., 
2006). The open form leaves a significantly larger pocket around the luciferin, making the molecule 
less confined, more exposed to water, and causing it to emit low energy red light (Iwano et al., 2013; 
Nakatsu et al., 2006; Støchkel et al., 2013). In contrast, the closed form with its more rigid micro-
environment would have minimal energy loss causing the emission of yellow green light (Nakatsu et 
al., 2006). 
1.2.5.5 Reasons for beetle luminescence 
Fireflies are thought to flash to attract mates and the timing and longevity of the flashing pulse 
sequences is thought to aid species recognition (Greenfield, 2001; Lloyd, 1983). Photuris females 
also mimic the coded flash responses of females of other species then eat any male that is attracted 
(Lloyd, 1975; Lloyd, 1984). Some males also flash in between the flashes of other males of the same 
species (Carlson and Copeland, 1988). This confuses the females into thinking that the male is of the 
wrong species, preventing the competing male from breeding (Carlson and Copeland, 1988). 
 
Click beetles are thought to luminesce to warn potential predators about their noxious taste 
(Greenfield, 2001; Lloyd, 1983). Interestingly, some species of cockroaches have evolved to mimic 
the luminescence of Pyrophorus click beetles very closely, stealing the advantages of click beetle 
aposematism (Vršanský, 2012).  
1.2.5.6  Firefly flashing 
Firefly flashing appears to be regulated by nitric oxide (NO) (Tsai et al., 2014). The tracheoles of the 
firefly light organ are surrounded by high concentrations of mitochondria and research suggests that 
oxygen concentration in this region is a limiting factor for both mitochondrial activity and 
luminescence (Tsai et al., 2014).  NO reduces mitochondrial activity, making more oxygen available 
for the luminescence system, initiating luminescence. In contrast,  an increase in mitochondrial 
activity decreases oxygen concentration and decreases luminescence (Tsai et al., 2014). 
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1.2.5.7 Recycling of firefly luciferin in fireflies and the energy requirements of 
luminescence 
Firefly oxyluciferin is recycled back to luciferin by a luciferin-regenerating enzyme (LRE) a protein 
that is equally expressed over the whole beetle body (Gomi and Kajiyama, 2001). This suggests that 
LRE has another function, which was co-opted to recycle luciferin. LRE amino acid sequences were 
found to be similar to a group of senescence marker proteins (SMP-30) and anterior fat proteins 
(AFP) (Day et al., 2004; Gomi and Kajiyama, 2001). Such activities may represent LREs original 
function (Day et al., 2004; Gomi and Kajiyama, 2001). Luminescence in fireflies does not appear to 
be energetically costly and firefly flashing increases metabolic rates only by 37% above resting values 
(Wilson and Hastings, 1998). However research has shown a correlation between luminescence 
levels and superoxide dismutase activity in luminous click beetle species (Neto et al., 1986). This 
indicated that luminescence may be costly because it increases the concentration of reactive oxygen 
species (ROS) (Neto et al., 1986).  
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1.2.6 Other and mixed luminescent systems 
1.2.6.1 Fish luminescence 
Luminescence is common in fish. Over a hundred fish species are well-documented as luminescent 
and there are many more where luminescence has been reported (Herring, 1990). Most luminescent 
coastal fish do not themselves produce light, but instead cultivate luminescent bacteria in special 
light organs (see section 1.2.1.1) (Haygood, 1993). Such fish include the flashlight fish Anomalops 
and Photoblepharon (Haneda and Tsuji, 1971). Such fish can become non-luminescent if they lose 




Figure 1.42. The dragon fish Pachystomias microdo. Light-producing photophores are shown beneath the eye (blue and 
orange areas). Photograph by and used with permission from Edith Widder, Ocean Research & Conservation Assoc. 
 
Some luminescent coastal fish such as Parapriacanthus, and most luminescent deep water fish such 
as lantern fishes (Diaphus), do produce their own luminescence utilizing either Cypridina or 
coelenterazine luciferin (Shimomura et al., 1980). The luciferin of many fish is unknown (Renwart 
and Mallefet, 2013; Widder, 2010). Some populations of commonly luminescent fish species are 
non-luminescent, although they have otherwise normal light-emitting organs or photophores 
(Warner, 1980). Possibly the diets of these fish lack some compound essential for luminescence or 
they possess mutations in luminescence-related genes (Warner, 1980). Non-luminescence may be 
adaptive in areas where luminescence is more dangerous than useful (Warner, 1980). 
 
There are several reasons why fish are thought to luminesce (Haddock et al., 2010). Some, such as 
the angler fishes, use luminescence as a lure to attract prey (Nolan and Rosenblatt, 1975). Others, 
such as the flashlight fish and the dragon fishes (Figure 1.42) use their lights to illuminate prey, while 
others may use their lights to confuse prey or predators (Haddock et al., 2010). Dragon fish are 
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interesting because they can produce both blue light and far red light with the same luciferin (Björn 
and Ghiradella, 2015; Douglas et al., 2000). The red light (max: 700nm) has such a long wavelength 
that most deep-sea organisms are unable to see it (Douglas et al., 2000). Only the dragon fish with 
its specially evolved eye pigments is able to perceive this light enabling it to search for prey without 
being observed (Douglas et al., 2000). Lamps may cause predators to attack only certain non-vital 
body parts, allowing the fish a chance to escape, or they may provide counter illumination 
preventing the fish from producing an easily detectable silhouette (Claes and Mallefet, 2008; 
Haddock et al., 2010). Some, such as the pony fish, may use luminescence as a sexual display 
(Herring, 2007; Sasaki et al., 2003). 
  
1.2.6.2 Enchytraeid earthworm luminescence.  
Two Enchytraeid worms (Fridericia heliota and Henlea sp.) are bioluminescent (Petushkov and 
Rodionova, 2005). These worms produce blue-green light in response to chemical, mechanical or 
electric stimuli (Petushkov and Rodionova, 2005). Petushkov proved that the two systems were 
different from one another and from the luminescent systems of other annelids (Petushkov and 
Rodionova, 2005). The luminescent system of Henlea sp. requires a luciferase, a luciferin, Ca2+ and 
O2; while the luminescent reaction of F. Heliota requires luciferase, luciferin, ATP, Mg
2+ and O2 
(Petushkov and Rodionova, 2005).  
 
The structure of Fridericia heliota luciferin (1.3) was recently found to be an unusual peptide formed 
from oxalic acid, L-lysine, modified tyrosine and γ-aminobutyric acid (Figure 1.43) (Dubinnyi et al., 
2015a; Dubinnyi et al., 2015b; Petushkov et al., 2014). Compound 1.3 was isolated by RP 
chromatography from 40 g Fridericia heliota to give 0.005 mg of luciferin. This was studied by UV, 
fluorescence, NMR, and high-resolution mass spectroscopy to give several possible structures. 
Compound 1.3 was proved correct by synthesis and  synthetic 1.3 luminesced under assay 
conditions (Dubinnyi et al., 2015a; Dubinnyi et al., 2015b; Petushkov et al., 2014).  
 
Reaction of 1.3 with Fridericia luciferase, Mg2+, ATP and O2 gave the enzymatic product shown in 
Figure 1.43 (Dubinnyi et al., 2015a; Dubinnyi et al., 2015b; Petushkov et al., 2014). This suggested 
that the reaction proceeded by the oxidative decarboxylation of the lysine fragment  (Figure 1.43) 
and it is proposed that the luminescent reaction is similar to that of the firefly (Dubinnyi et al., 




1.3. Fridericia heliota luciferin  1.34. Fridericia heliota bioluminescence product 
Figure 1.43. Mechanism of bioluminescence in Fridericia heliota (Dubinnyi et al., 2015a). 
1.2.6.3  Millipedes and centipede luminescence 
There are several species of luminous centipede, which were some of the first luminous organisms 
investigated by Harvey (Harvey, 1952). Luminous centipedes such as Orphaneous breuilabiatus 
secrete a clear, viscous liquid which glows with a prolonged green bioluminescence (λmax: 510 nm 
with a second peak at 480 nm) (Anderson, 1980). The reaction involves oxygen, a luciferin and a 
luciferase and has an unusually low pH optimum at 4.6. The reaction appears to be made up of two 
stages: an oxygen-independent fast stage and an oxygen-dependent slow one and it is thought that 
the luciferase is primed with oxygen before it acts upon the luciferin (Anderson, 1980).  
  
Figure 1.44. Luminescence of Motyxia sequoia. Photo by and used with permission from Paul Marek, Entomology 
Department, Virginia Tech 
There are eight species of luminescent millipede in the genus Motyxia and one in Polydesmida 
(Marek and Moore, 2015; Shelley, 1997). These all emit a continuous, pale turquoise glow from the 
entire dorsal surface including the antennae and legs (λmax: 495 nm, see Figure 1.44) (Marek et al., 
2011). Millipedes are blind, and so the bioluminescence is thought to be a form of aposematism to 
warn predators that the millipede can defend itself with cyanide (Marek et al., 2011). Aposematism 
is an oft-cited reason for bioluminescence but with Motyxia sequoia (previously Luminodesmus) 
there is actually experimental evidence for this (Marek et al., 2011). Luminescence is produced by 
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the reaction of ATP and Mg2+  with a photo-protein pre-charged with oxygen and an unknown 
porphyrin-based chromophore (Shimomura, 1984).  
1.2.6.4  Fungal luciferins 
There are at least 64 species of luminescent fungi (Desjardin et al., 2008). In some, the mycelia emit 
light (e.g. many Mycena species) while in others the entire fruiting body glows (e.g. the North 
American mushroom Panellus stypticus) (Bermudes, 1992). In some species, such as the Mycena 
manipularis from Borneo, the luminescence is so bright that it can be seen from 40 meters away 
(Desjardin et al., 2008). Others can only be seen by eyes adapted to the dark (Desjardin et al., 2008). 
No one yet knows why mushrooms glow. Some have suggested that the light repels negatively 
phototropic fungivours (Desjardin et al., 2008). Alternatively, it could attract insect spore dispersers, 
or be an aposematic display, or be a by-product of some metabolic function (Bechara, 2015). In 




Figure 1.45. Dark exposure of Mycena lucentipes mushrooms, found in the wetlands of Brazil. Photo by and used with 
permission from C.V. Stevani (Bechara, 2015). 
Three sesquiterpene luciferin precursors; panal, 1-O-decanoylpanal and 1-O-dodecanoylpanal 
(Figure 1.46) have been isolated from the luminous mushroom Panellus stipticus (Shimomura et al., 
1993). Panal gives chemiluminescence upon treatment with  Fe2+, H2O2, and surfactants (Nakamura 
et al., 1988a) while the other precursors give chemiluminescence on treatment with cationic 
surfactant in the presence of O2 and O2
-  (Figure 1.46) (Shimomura et al., 1993). These molecules 
have not been synthesised and the actual fungal luciferin and the luciferase are yet to be identified.  
 
A fluorescent compound was isolated from Lampteromyces japonicas (100 µg from 50 kg of 
mushroom) that was found to give a fluorescence spectrum that was identical to the Lampteromyces   
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luminescence emission spectra (λmax: 530-550nm). This compound was identified as lampteroflavin 
(1.10, pentofuranosy-1-riboflavin) by NMR, and FAB-MS2 (Figure 1.47) (Uyakul et al., 1990).  
 
 
Figure 1.46. Luminescence of Panellus stipticus (Shimomura et al., 1993). 
 
Figure 1.47. Lampteroflavin (1.10).  
Lampteromyces japonicas chromophore 
 
 
In fungi such as Neonothopanus nambi, Mycena citricolor, Panellus stipticus and Armillaria borealis, 
bioluminescence is thought to be caused by the reaction of 3-OH hispidin (1.17, Figure 1.48) with an 
unknown luciferase and O2 (Purtov et al., 2015). 3-OH hispidin is synthesised by the mushroom from 
hispidin, a well-described fungal and plant secondary metabolite, by an unknown hydroxylase O2 and 
NADPH (Purtov et al., 2015).  This luciferin was not discovered directly by isolation from a 
luminescent  mushroom. Instead separation of Pholiota squarrosa lysates by chromatography gave 
four fractions that produced luminescence by a bioluminescence assay involving a crude mix of 
fungal enzymes and NADPH (Purtov et al., 2015). Characterisation of these molecules showed them 






1.17. 3-OH Hispidin a fungal luciferin. 
 
1.35. Bisnoryangorin. A fungal 
luciferin precursor.  
 
1.36. Hispidin. A fungal luciferin 
precursor. 
Figure 1.48. Luciferins and luciferin precursors from Pholiota squarrosa. The cis and trans forms of these molecules were 
interchanged in solution. 
Commercial hispidin was then tested for activity with the cold extracts prepared from the mycelia of 
N. nambi, M. citricolor, P. stipticus and A. borealis upon addition of NADPH. In all cases dose-
dependent bioluminescence was observed which sugested that hispidin is a common luciferin 
precursor to all these fungi  (Purtov et al., 2015). 
 
The luciferin synthetic enzyme, which utilized hispidin and NADPH as substrates, could be separated  
from the insoluble luciferase by ultracentrifugation or gel-filtration using a superdex 75 column 
(Purtov et al., 2015). Commercial hispidin was therefore incubated with the partially purified 
luciferin synthetic enzyme in the presence of NADPH (Purtov et al., 2015). HPLC analysis of the 
reaction mixture showed gradual appearance of one major new component. This component was 
isolated by HPLC (19 μg was obtained from 32 μg of hispidin) and was found to produce a bright 
NADPH-independent luminescence when mixed with the cold extract of N. nambi (Purtov et al., 
2015) . The luminescence spectrum of this reaction matched the luminescence spectrum of the M. 
chlorophos fruiting body and the fluorescence emission spectrum of hispidin (Purtov et al., 2015). 
Characterisation of the product by 1H NMR spectroscopy and high resolution MS allowed 
unambiguous structural assignment of fungal luciferin as 3-hydroxylated hispidin (1.17) showing this 
molecule to be the true luciferin (Purtov et al., 2015). This molecule has not yet been synthesised 
and the mechanism of luminescence is unknown.  
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1.2.6.5 Polychaetes  
Many different polychaetes (Class: Polychaeta, Phyla: Annelida) are luminescent (Dales, 1971). Scale 
worms (Family: Polynoidae, Order: Phyllodocida) for example are covered in luminescent bristles 
that glow both when attached to the living organism and for a while after they are shed (Nicolas, 
1982). When threatened these worms shed their bristles seemingly to distract predators (Nicolas, 
1982). In contrast, fireworms of the genus Odontosyllis (Family: Syllidae, Order: Errantia) produce 
brilliant displays of green λmax: 516 nm (Herring, 1983) bioluminescence during mating swarms, by 
releasing luminescent mucus  (Deheyn, 2009; Gaston and Hall, 2015; Jayachandran et al., 2015). 
Meanwhile, the parapodia of luminescent  worms of the genus Tomopteris (Figure 1.49)(Family: 
Tomopteridae, order: Aciculata) flash yellow when the worm is disturbed, seemingly to distract 
predators (λmax:565 nm for Tomopteris nisseni and λmax: 570 nm for T. septentrionalis) (Dales, 1971; 
Fernández-Álamo, 2000; Gouveneaux and Mallefet, 2013; Latz et al., 1988). The flashing in 
Tomopteris  seems to be under nervous system control  (Gouveneaux and Mallefet, 2013; Zörner 
and Fischer, 2006).  
 
 
Figure 1.49. Planktonic polychaete worm from 
genus Tomopteris. Creative commons. 
 
Figure 1.50. Aloe-emodin (1.18) a chromophore found in 
Tomopteris polychaetes. 
 
The luminescence of the scale worm Harmothoe lunulata originates from organelles called 
photosomes, which contain a membrane bound photoprotein known as polynoidin (Nicolas, 1982). 
In vitro, in the presence of Ca2+, polynoidin emits light (max: 510 nm) in response to radical or 
superoxide-producing molecules such as hydrogen peroxide or Fe2+ (Bassot and Nicolas, 1995; 
Colepicolo et al., 1990).  
 
A photoprotein has also been purified from the luminescent parchment worm  Chaetopterus 
variopedatus (Family: Chaetopteridae, Order: Phyllodocida) which emits light (λmax: 460 nm) with 




Bioluminescence in Odontosyllis is also thought to be photoprotein based, because the luminescence 
was not oxygen-dependent and because the luminescence could not be regenerated by the mixing 
of hot extracts and exhausted lysates (Deheyn, 2009).  Luminescence however, can be produced 
from the blue viscous mucus of Odontosyllis, by the addition of peroxidase or ammonium persulfate 
(Deheyn, 2009).  
 
 Very little is known about the luciferin or the luminescent mechanism of most polychates  
(Branchini et al., 2014; Deheyn, 2009). Both scale worms  (Bassot and Nicolas, 1995; Nicolas, 1982) 
and Chaetopterus (Branchini et al., 2014) are thought to utilise a riboflavin based chromophore but 
data is still lacking. Aloe-emodin (1.18), an anthraquinone, was recently been extracted from 
Tomopteris (Figure 1.49) (Figure 1.49) and the fluorescence of this molecule is similar to the 
bioluminescence emission (Francis et al., 2014). This means that aloe-emodin is likely either the 
oxidised luciferin, or the chromophoric emitter (Francis et al., 2014). Since several reduced 
anthraquinone are known to be chemiluminescent, it seems quite likely that reduced aloe-emodin is 
theTomopteris luciferin  (Francis et al., 2014).  
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1.2.6.6 Acorn worms 
Acorn worms (Class: Enteropneusta) live in oceanic sediment and some, e.g. Ptychodera 
flava  (Family: Ptychoderidae, Order: Enteropneusta) display green bioluminescence (max: 528 nm) 
(Kanakubo and Isobe, 2005). The luciferins of acorn worms have not been well studied, but the 
bioluminescence is thought to be caused by a hydrogen peroxide-catalysed luciferin–luciferase 
reaction, because acorn worm extracts can be made to bioluminesce by the addition of horseradish 
peroxidase or diluted hydrogen peroxide (Cormier et al., 2015; Dure and Cormier, 1963; Dure and 
Cormier, 1961; Dure and Cormier, 1964; Kanakubo et al., 2005). Recently  four substances that gave 
chemiluminescence with H2O2 and riboflavin were successfully isolated from Ptychodera flava 
(Kanakubo and Isobe, 2005; Kanakubo et al., 2005). These compounds  were characterised by NMR, 
MS, and X-ray analyses and found to be compounds 1.19, 1.20, 1.21, and 1.22 (Figure 1.51) and it is 
thought that these compounds are very closely related to the Ptychodera flava luciferin (Kanakubo 














Figure 1.51. Chemiluminescent compounds isolated from Ptychodera flava. 
Structure–activity relationship studies on the chemiluminescence activity of halogenated quinone 
derivatives showed that a high halogen substitution and a 1,4-quinone skeleton are important for 




1.2.7 Diptera luminescence 
Luminescence in flies is rare, but is observed in several genera of fungus gnats (Meyer-Rochow, 
2007; Sivinski, 1998). The New Zealand glow-worm (Arachnocampa luminosa), with its vivid blue 
glow at 488 nm, is the most famous and is discussed in detail in sections 1.2.7.1 and 1.2.7.2. Other 
Arachnocampa live in Australia and Tasmania. All glow blue and spin webs to catch insect prey 
(Meyer-Rochow, 2007). Orfelia fultoni, found in the Appalachian Mountains of North America, also 
glows blue (λmax: 487 nm) and spins webs to catch insect prey (Meyer-Rochow, 2007; Sivinski, 1981; 
Sivinski, 1998). The Swedish fungus gnat Keroplates sesioides and the Japanese fungus gnat K. 
nipponicus both also emit a dim blue/white light but are non-predatory (Meyer-Rochow, 2007). 
Instead they  spin webs on the underside of fungi to catch fungal spores (Meyer-Rochow, 2007). The 
German species K.testaceus produces a faint blue white light but does not spin webs, while other 
related species such as Macrocera fasciata from European caves and M. nobilis spin webs but do not 
glow (Meyer-Rochow, 2007; Sivinski, 1998).  
 
  
Figure 1.52. Orfelia fultoni larval luminescence. Photo 
used with permission and taken by by Dante Fenolio. 
 
Figure 1.53. Arachnocampa luminosa larval luminescence. 
Photo used with permission and taken by Jolanta 
Jasiulionyte. 
 
Phylogenetic reconstruction of the glow-worm family tree suggests that ancestral glow-worms lived 
in the polar regions of Gondwana where bioluminescence would be a useful mechanism for coping 
with the long, southern polar nights (Merritt, 2009). The oldest forms appeared approximately 200 
million years ago and like some of their modern relatives, lived inside fungi, and fed upon fungal 
spores (Merritt, 2009). Light organ diversity between luminescent Diptera suggests that the trait 





1.2.7.1 Arachnocampa ecology  
The New Zealand (NZ) glow-worm Arachnocampa luminosa (previously Bolitiphila) Keroplatidae, 
Diptera (Skuse) is found all over NZ in damp areas of bush, by streams and in caves (Meyer-Rochow, 
2007). In Māori it is known as titiwai, meaning ‘to hang over water’ (Hudson, 1890). The habitat of 
the glow-worm must be damp with relative humidities above 90–95% (Meyer-Rochow, 2007). The 
larvae, the pupae and adults all bioluminesce with a pale blue light (λmax: 487 nm) but it is the larvae 
that are traditionally considered the “glow-worms” (Meyer-Rochow, 2007). Only one species of 
glow-worm is found in NZ, but eight species are endemic to mainland Australia, including A. flava 
and A. richardsae, while A. tasmaniensis is found in Tasmania (Baker et al., 2008b; Broadley, 1998). 
Differences can be observed in the morphologies of bush and cave populations (Broadley, 1998). 
However these differences are probably environmental because genetic studies have shown that the 
populations were not genetically separate (Broadley, 1998). However glow-worm populations do 
easily become isolated, because the adults are short-lived and are sluggish flyers (Broadley, 1998). 
1.2.7.1.1 Reasons for luminescence 
It seems likely that Arachnocampa larvae glow to lure insects into their sticky nets where they are 
consumed (Broadley, 1998). Almost all insects have a photoreceptor that can detect blue light and 
flying insects are often positively phototropic because they use the moon to navigate (Meyer-
Rochow, 2007). Furthermore, many insects use blue light to find open areas, because Tyndall 
scattering makes the night sky seem blue to insect eyes (Sivinski, 1998). Both habits would lure 
insects into the webs and diet of Arachnocampa.  
 
Evidence for the prey-luring hypothesis comes from an experiment by Broadley, who showed that 
glow-worm traps containing Arachnocampa caught far more insects than those from which glow-
worms had been removed (Broadley, 1998). Furthermore, most insects were caught in the sticky 
fishing lines rather than at the opening of the trap. The latter would be expected if the glow-worm 
were using an odour attractant (Broadley and Stringer, 2001). Sivinski showed the same results with 
another luminous Diptera; Orfelia fultoni (Sivinski, 1982). Some have reported that A. luminosa 
glows more strongly when hungry, which supports the lure hypothesis, but the literature is disputed 
(Broadley and Stringer, 2001; Meyer-Rochow, 2007). Larval luminescence may also serve as an 
aggressive display, and glow-worm larvae glow more strongly when fighting other larvae for habitats 
(Richards, 1960).  
 
When considering the purpose of Arachnocampa luminescence, one must take into account that 
several  non-carnivorous Diptera species also glow (Sivinski, 1982). Luminescence in these species 
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may act as an aposematic signal (Rigby and Merritt, 2011). Wild toads (Bufo bufo) for example were 
less likely to attack luminescent artificial prey than non-luminescent prey (De Cock, 2003). However 
Arachnocampa are already well defended against predation by their webs (Richards 1960). Not even 
the mighty cave weta of New Zealand will break though glow-worm nets and one weta placed 
among glow-worm nets would not break out, even after 16 days without food (Richards 1960).  
 
Non-larval Arachnocampa also show bioluminescence even though they do not feed (Broadley and 
Stringer, 2001). It has been suggested that adult bioluminescence may  act as a strategy for female 
fireflies to attract mates (Gatenby, 1959; Sivinski, 1998). Adult females are very weak fliers so rely 
upon the males to find them within the two days following pupation (the expected lifespan of a 
female GW, males live 4-6 days) (Merritt and Baker, 2001). The attraction of more than one suitor 
would also encourage male – male competition, which could ensure that the successful male is fit 
(Merritt and Baker, 2001).  
 
This theory was based on the observations that female pupae and adult females are particularly 
luminescent, and glow more strongly in response to touch and that males are attracted to female 
pupae, and will sit upon them to wait for the female to hatch (Broadley and Stringer, 2001). If no 
males are present when the female hatches swollen with eggs, the female will start to glow very 
strongly (Broadley and Stringer, 2001). However, once the eggs (about 130) have been laid the adult 
female will cease to glow (Broadley and Stringer, 2001). These eggs take 7-9 days to hatch (Merritt 
and Baker, 2001).  
 
Many other species use luminescence for mate attraction (Haddock et al., 2010), but direct evidence 
for this in Arachnocampa is lacking and males may be attracted by pheromone rather than visual 
signals. Males do have a peak in visual sensitivity at the wavelength that females emit, but this may 
be an adaptation to avoid the sticky larval snares commonly surrounding the female pupa (Gatenby, 
1959; Sivinski, 1998). This adaption would be unnecessary for females, because they do not often fly 
(Meyer-Rochow, 2007). Adult luminescence may not be adaptive but simply a by-product of juvenile 
luminescence, because the Malpighian tubes are relatively unaffected by metamorphosis (Broadley 
and Stringer, 2001). This would explain the weak bioluminescence of adult males (Richards, 1960).  
1.2.7.1.2 Diet 
Arachnocampa luminosa mostly prey upon small Diptera (Broadley and Stringer, 2001). Midges such 
as Anatynia debis make up the bulk of the diet of cave-dwelling glow-worms, while bush-dwelling 
glow-worms’ more varied diet includes stone flies, moths, caddis flies, sand flies, red ants, spiders, 
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millipedes, isopods and even small snails (Broadley and Stringer, 2001). Other glow-worms also form 
part of the glow-worm diet and newly-hatched glow-worms may be one of the few organisms small 
enough for a newly-hatched glow-worm to eat (Meyer-Rochow, 2007; Sivinski, 1998). This, 
combined with limited suitable web building spots, makes cannibalism rife among glow-worm 
populations (Meyer-Rochow, 2007; Sivinski, 1998). The speed of glow-worm growth depends on 
food availability: when food is common, glow-worms grow fast and pupate after a few months 
(Broadley and Stringer, 2001). In contrast, when food is rare they may take over a year to grow to 
pupation size (Broadley and Stringer, 2001). They seem adapted for times of famine and larval glow-
worms can survive without food for 78 days (Broadley and Stringer, 2001). The adults in comparison 
have very small mouth parts and do not eat (Harrison, 1961; Richards, 1960). Glow-worms recognize 
their prey through chemoreception and touch sensitivity and will bite into an inanimate object if it 
has been rubbed in crushed houseflies (Richards 1960). Active insects are dealt with more quickly 
than inactive ones, possibly to prevent damage to their fishing lines (Richards 1960).  
1.2.7.1.3 Web-building 
Each Arachnocampa larvae constructs a curtain-like web composed of up to 30 fishing lines studded 
with adhesive droplets (Walker et al., 2015). While most web-building organisms crawl down to their 
prey, Arachnocampa swallows its silk line to pull up the prey for consumption (Richards 1960). In 
other luminescent Diptera (Platyura and Ofelia), the web is coated with droplets of oxalic acid 
(Meyer-Rochow, 2007; Sivinski, 1998). Some think that Arachnocampa mucus may also contain toxic 
components because insects caught on a Arachnocampa line cease to struggle long before death 
(Meyer-Rochow, 2007; Sivinski, 1998). The fishing lines can be up to 50 cm long in caves, but are 
generally shorter in more exposed locations (Gatenby and Cotton, 1960). These webs can be 
constructed in less than 4 hours (Broadley and Stringer, 2001; Gatenby, 1959). Only the NZ glow-
worm builds vertical fishing lines; all Australian species hang their webs horizontally from a front and 
rear thread (Merritt and Baker, 2001). X-ray studies, infrared spectroscopy, and amino acid analysis 
have showed that the silk of Arachnocampa is composed of cross-linked silk proteins (M, 1962; 
Walker et al., 2015).  
1.2.7.1.4 Physiology of light production 
Light in Arachnocampa  is produced by light organs that are found at the posterior end of the body 
(Green, 1979). These light organs are derived from modified Malpighian tubules (Broadley and 
Stringer, 2001). While no other insects produces light from modified Malpighian tubules, it is not 
uncommon for these tubules to take on specialised synthetic roles (Broadley and Stringer, 2001). 
There are four malpighian tubules in A. luminosa, and the swollen distal tips of these tubules form 
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the light organ (Green, 1979). The light organ is well-supplied with oxygen from a surrounding 
network of tracheoles, and nerve endings (Green, 1979). The tracheal cup may also reflect light in a 
similar way to the tracheal tapetum of the insect eye enabling brighter luminescence (Green, 1979). 
The posterior region of the glow-worms that contains the light organs also contains the eggs (in 
females), the silk-producing organs and unmodified Malpighian tubules that perform kidney, liver 
and excretory functions (Gatenby, 1959).  
1.2.7.1.5 Regulation of luminescence and predation 
When startled, the NZ glow-worm will first glow brightly and then dim its light (Gatenby, 1959; 
Gatenby and Ganguly, 1956). There is some controversy as to how the light is dimmed. Some have 
suggested that the light is dimmed when the light organ is retracted back into the GW body, while 
others think that the light dims as the GW retreats into its burrow (Gatenby, 1959; Gatenby and 
Ganguly, 1956). GWs can also completely douse their lights, but this happens only slowly (Gatenby, 
1959). Such behaviours, combined with the glow-worm’s silk fortress must be successful, because 
Arachnocampa has few natural predators (Meyer-Rochow, 2007). The parasitic wasp Betyla fulva, 
the parasitic fungi Tolypocladium spp and Metarrhizium anisopliae and harvestmen (Opiliones) are 
the only known predators of Arachnocampa (Meyer-Rochow, 2007). Some troglobitic and 
troglophilic species of harvestmen, like Hendea myersi cavernicola and Megalopsalis tumida, have 
retained their eyesight seemingly just for the purpose of hunting glow-worms by light (Meyer-
Rochow, 2007). Spiders do not appear to attack glow-worms, although they often build webs in front 
of glow-worm traps (Broadley and Stringer, 2001; Gatenby, 1959). It could be that spiders take 
advantage of the glow-worm’s light to attract more insects into their webs (Broadley and Stringer, 
2001; Gatenby, 1959). Many insect predators may avoid glow-worms to avoid becoming trapped in 
their sticky nets (Broadley and Stringer, 2001; Gatenby, 1959).  
 
Glow-worms in bush habitats luminesce most brightly at night, and dim or quench their 
luminescence during the day (Merritt, 2009). Members of cave populations also show highly-
synchronised luminescence (Merritt and Clarke, 2011). However, the peak luminescence of cave 
populations occurs in mid-afternoon, which corresponds to peak insect flight time in caves and 
hence peak food availability (Merritt and Aotani, 2008). Luminescence is regulated by the internal 
circadian rhythm of Arachnocampa rather than by exogenous factors (Merritt and Aotani, 2008; 
Merritt and Clarke, 2011). Ligation experiments  showed that if the neural connection between the 
terminal abdominal ganglion and the light-emitting cells was broken, the glow-worms could not dim 
their lights (Gatenby, 1959). Gatenby speculated that nervous control prevents air diffusing from the 
tracheal reflector to the luminescent cells, limiting luminescence (Gatenby, 1959). More recently it 
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was shown that bioluminescence can be actively repressed through the action of the insect hormone 
octopamine (Rigby and Merritt, 2011). 
1.2.7.2 Previous biochemical studies  on Arachnocampa luminescence 
The first investigation into glow-worm luminescence biochemistry was by Lee, who found that a 
stable dry powder could be prepared by freeze-drying glow-worms then coarsely grinding up their 
lanterns (Lee, 1976). Addition of buffer and adenosine triphosphate (ATP) to this powder produced 
light. Lee found that the in vivo and in vitro GW  bioluminescent spectra were identical with a max: 
488 nm (Lee, 1976). A very small amount of light was obtained by the addition of buffer alone, 
probably due to bacterial contamination of buffer or to the ATP naturally found in the glow-worm 
light organs. Fine grinding of the dried powder caused activity to be lost. The powder could be 
stored at -5 °C for several months, but only 20% of the activity was preserved (Lee, 1976). Emission 
wavelength was not affected by pH, though pH 7.00 was found to be optimum for intensity. Oxygen 
was required for the reaction (Lee, 1976). 
 
Uridine diphosphate and adenosine diphosphate also stimulated the reaction, but not to the same 
extent as ATP, while other high-energy phosphates had no effect (Lee, 1976). 
Ethylenediaminetetraacetic acid (EDTA) was found to quench the reaction, indicating an Mg2+ 
requirement and at 10 mM ATP, light yields were doubled in the presence of Mg2+. Ethylene glycol 
tetraacetic acid (EGTA) did not quench the reaction, indicating that Ca2+ was not involved (Lee, 
1976). Ammonium sulfate was inhibitive, while sodium dodecyl sulfate (SDS), mannitol and -
mercaptoethanol had no effect on the reaction (Lee, 1976). Inorganic pyrophosphate quenched the 
reaction if added with ATP (like the firefly system), but did not stimulate the reaction if added after 
ATP (unlike the firefly system) (Fraga et al., 2005; Lee, 1976). 
 
Lee found that the decay of ATP-initiated luminescence was first order, and found no soluble 
inhibitors in the spent solution (Lee, 1976). In comparison, firefly luminescence was strongly 
inhibited by reaction products (da Silva, 2011). No reaction was found to occur between 
benzathiazole luciferin and glow-worm luciferase (Lee, 1976). Lee was unable to prove that a 
luciferin - luciferase type reaction existed by mixing of hot extracts and exhausted lysates, and was 
unable to extract a luciferin using methanol or DMSO (Figure 1.11). The specific light yields of these 
experiments showed considerable scatter (coefficient of variation of 50%) and the precision was not 




Shimomura and co-workers were also unable to prove that a luciferin-luciferase type reaction 
existed through the mixing of hot extracts and exhausted lysates (Figure 1.11) (Shimomura et al., 
1966). However, it was found that creatine and arginine phosphate, riboflavin 5’ phosphate, nicotine 
adenine dinucleotide and H2O2 did not have an effect on the luminescence reaction (Shimomura et 
al., 1966). 
 
Hastings and co-workers completed the most recent investigation of Arachnocampa luciferin (Viviani 
et al., 2002). They prepared aqueous glow-worm extracts from frozen glow-worm lanterns and 
found that luminescence of crude extracts was not enhanced by the antioxidants DTT or ascorbic 
acid but was enhanced by Mg2+ and ATP (Viviani et al., 2002). However, ascorbic acid was found to 
decrease the decay rate (Viviani et al., 2002). Luciferin-depleted extracts were produced by adding  1 
mM ATP to the crude extract and incubating the mixture on ice for 18 hours. A hot extract (HE) was 
prepared by heating crude extract at 98°C for 5 minutes and adding ATP-Mg2+. They then showed 
that luminescence was produced if the luciferin depleted extract and HE were combined with ATP 
and Mg2+. A luciferin extract was produced by extracting lanterns into hot citrate buffer, decreasing 
the pH to 2.5 – 3 and then extracting with ethyl acetate (Viviani et al., 2002). A protein fraction, 
having an estimated molecular mass of 36 kDa, was also isolated from crude extracts by gel filtration 
with Sephacryl S-400 (Viviani et al., 2002). 
 
The GW luciferase is believed to be a member of the ANL super-family of adenylating enzymes, with 





1.3 Reasons for studying the luminescence of Arachnocampa 
Arachnocampa is not closely related to any organism in which bioluminescence has already been 
studied in molecular detail; Arachnocampa luminosa is a fly (Diptera) whilst the other commonly 
studied luminescent insects are beetles (Coleoptera) (Viviani et al., 2002). All current evidence 
indicates that bioluminescence from Arachnocampa has a novel underlying mechanism (Viviani et 
al., 2002). Arachnocampa therefore provides a fascinating opportunity to understand a brand new 
luminescent system and such studies may also help to explain why and how Arachnocampa 
luminescence may have evolved. 
 
As well as general interest there is a possibility that the discovery of a new luminescent system may 
provide useful scientific tools. Fluorescent proteins are well-established tools in biochemical 
research (Dikici et al., 2009; Fan and Wood, 2007) and one may wonder why research into 
luminescent systems is necessary. Both fluorescent and luminescent systems can be used in assays, 
but until recently fluorescence was by far the more commonly-used technique (Dikici et al., 2009; 
Fan and Wood, 2007). Fluorescent assays tend to be brighter then luminescent assays, because 
photons can be introduced to an assay system far faster and far more easily than luciferin molecules 
(Rowe et al., 2010) and because luminescent quantum yields tend to be lower than fluorescent 
quantum yields (Fan and Wood, 2007). Also, while fluorescent systems have been modified to create 
a vast array of colors, pH stabilities, half-lives, aggregation tendencies, reduced cytotoxicities, and 
other desired properties, luminescent systems have yet to be developed to the same extent (Rowe 
et al., 2010). For example, bacterial luciferase does not currently express well in mammalian systems 
(Michelini et al., 2008). 
 
However, bioluminescence has its advantages and four bioluminescent systems have been widely 
adopted for biochemical research: firefly luciferase, Renilla luciferase, aequorin and Nanoluc  (Dikici 
et al., 2009; England et al., 2016; Fan and Wood, 2007). Luminescence studies suffer from less 
background light than fluorescence studies (Dikici et al., 2009; Fan and Wood, 2007). This is because 
the light detected in a fluorescence experiment may originate from the experimental light source, or 
from the fluorescence of compounds other than those studied (Dikici et al., 2009; Fan and Wood, 
2007). Also, although many compounds are fluorescent, very few are chemiluminescent (Dikici et al., 
2009; Fan and Wood, 2007). This makes luminescence often a more sensitive and specific method 
than fluorescence (Dikici et al., 2009; Fan and Wood, 2007). Some luminescent assays have 
approached attomolar detection limits (Rowe et al., 2010). Since luminescence assays require no 
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excitation wavelength, they are especially useful when working with photo-sensitive systems (Dikici 
et al., 2009; Fan and Wood, 2007). 
 
Luciferases are often used as genetic reporters (Fan and Wood, 2007; Loening et al., 2006). 
Generally, the luciferase gene is inserted next to the promoter or gene of interest and when the 
gene’s promoter is activated, the luciferase will be expressed (Fan and Wood, 2007; Loening et al., 
2006). If the luciferase is expressed and the necessary substrates are present, (e.g. benzathiazole 
luciferin, ATP, Mg2+ and O2 for firefly luciferase) luminescence will occur (Fan and Wood, 2007; 
Loening et al., 2006). This allows researchers to study under what causes certain genes to be 
switched on or switched off (Fan and Wood, 2007; Loening et al., 2006). Luciferases can also be 
fused to other proteins allowing protein transport, protein metabolism and protein – proteins 
interactions to be studied (Hall, 2012). For example Pholas luciferin is used for determining the 
concentration of horseradish peroxidise, or the concentration or location of molecules bound to 
horse radish peroxidise (Michelson, 1978).  
 
Luciferase and luciferin can also be added together to an assay, and the resulting luminescence can 
be used to determine the concentration of another compound necessary for the reaction (Fan and 
Wood, 2007). The firefly system, for example, is often used to detect ATP, while the bacterial system 
is used to detect NADH; and the Aequorea photoprotein system is used in Ca2+ assays (Fan and 
Wood, 2007; Greer and Szalay, 2002; Kricka and Thorpe, 1983). Most luminescent systems can also 
be used to determine oxygen concentrations (Fan and Wood, 2007).  
 
Chemically protected luciferins may also be added to assays, enabling the activity of  enzymes 
capable of deprotecting the luciferin to be measured (Fan and Wood, 2007). This technique is 
commonly used to measure the activity of monoamine oxidase (Fan and Wood, 2007). Luminescent 
bacteria are often used to detect the presence of cytotoxic compounds, because the light produced 
will be proportional to the number of living bacteria (Kricka and Thorpe, 1983). Assay systems have 
been produced that use several luciferases of different colours. This allows several variables to be 
tracked at the same time (Michelini et al., 2008). A new separate bioluminescent system could 
provide a useful addition to the current bioluminescent tool box especially if it does not interact with 




1.4 Previous luciferin discovery methods.  
In 1663, Robert Boyle proved the oxygen dependence of bioluminescence reactions by placing 
glowing organisms such as fungi into a vacuum pump and showing that they ceased to glow when 
oxygen was removed (Johnson and Shimomura, 1975; Lee, 2008).  In 1885, Dubois demonstrated  
that non luminescent hot and luciferin-exhausted extracts could be prepared from some 
luminescent organisms and that the recombination of the two produced luminescence (see Figure 
1.11) (Dubois, 1887). This showed that the bioluminescence of these organisms was produced by an 
enzyme-substrate reaction (Lee, 2008). In the early 20th century, Harvey  prepared similar hot and 
luciferin-exhausted extracts from a wide range of organisms and established that the recombination 
of these, with the addition of any necessary cofactors, also produced luminescence (see Figure 1.11) 
(Lee, 2008). This showed that the luminescence of many organisms may follow a similar enzyme-
substrate reaction. 
 
In the 1950s, McElroy and Bitler became the first to fully purify and elucidate any luciferin with their 
discovery of benzathiazole luciferin (Bitler and McElroy, 1957; McElroy and Coulombre, 1952). This 
was closely followed by Shimomura’s discovery of Cypridina luciferin, and Bode and Hastings’ 
discovery of dinoflagellate luciferin (Bode and Hastings, 1963; Shimomura, 1957). Since then, 
luciferins have been extracted and identified from many different organisms (Shimomura, 2006e).  
 
Luciferin purifications pose a unique isolation challenge, combining the difficulties of isolating small 
amounts of material from source organisms, working with unstable materials, and working with 
enzymatic assays. The challenges of luciferin purification and elucidation can be  broken down into 
seven parts: 
 
1. Source material collection 
2. Protection of luciferin against degradation  
3. Extraction of luciferin from the organism 
4. Separation of luciferin from active luciferase  
5. Detection of luciferin 
6. Luciferin isolation 
7. Luciferin structural elucidation 
 
The previous approaches used in the investigation of other bioluminescent systems for parts one to 
five are briefly reviewed below.  
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1.4.1 Source material collection  
In every luciferin purification, sufficient bioluminescent organisms must be collected to provide not 
only enough luciferin for purification, but also adequate luciferase for luciferin detection. Luciferin is 
generally a minor metabolite, with an unstable nature that leads to significant loss during 
purification (Shimomura, 2006i). Large quantities of source material are thus necessary to extract 
even small quantities of luciferin. In some cases the organism can be cultured to produce as much 
material as required, as can be done with bioluminescent bacteria and dinoflagellates (Bode and 
Hastings, 1963). In other cases, the luciferin can be extracted from sources more readily available 
than the luminescent organism. For example in the bacterial system, only the luciferase was 
extracted from source (Cormier, 1953). The bacterial luciferin; palmitic aldehyde was isolated from 
bovine kidney cortex (Cormier, 1953), while the bacterial emitter; reduced flavin mononucleotide, 
was bought commercially (Cormier, 1953; McElroy et al., 1953).  
 
However, in most cases luciferin had to be isolated from organisms collected from the wild. Bulk 
fishing provided Shimomura with 500 g of Cypridina and Inoue with 200 g of squid livers which 
enabled the isolation of 3 mg of Cypridina luciferin and 15 mg of squid luciferin respectively (Inoue, 
1975; Shimomura, 1957) whilst 40,000 sea pansies (Renilla reniformis), were required to obtain 
about 0.5 mg of pure Renilla luciferin (Hori and Cormier, 1973). 
 
Land creatures in contrast, had to be hand-collected at night, often in deeply unpleasant conditions. 
The collection of the 15,000 firefly lanterns used to produce 9 mg of benzathiazole luciferin (Bitler 
and McElroy, 1957) or the collection of 40 g of Fridericia heliota worms in Siberia (each worm is only 
2 cm), used to produce 0.005 mg of Fridericia luciferin (Dubinnyi et al., 2015a) were both massive 
collection efforts.  
1.4.2 Protection of luciferin against degradation 
Luciferins are notoriously sensitive to oxidation, so methods must be found to protect the luciferin 
during all stages of the purification. Almost all groups have achieved this by keeping the luciferin 
cool, and working with the compound only under anaerobic conditions. Firefly and dinoflagellates 
were isolated under nitrogen (Bitler and McElroy, 1957; Bode and Hastings, 1963); while Cypridina 
luciferin was isolated under hydrogen, which as a reducing gas was particularly effective against 
oxidation (Anderson, 1935; Mason, 1952; Tsuji, 1955). Many groups have also used reducing agents 
to protect their luciferins. Bode for example added -mercaptoethanol (ME to all solutions 
including chromatographic buffers (Bode and Hastings, 1963). Bode also protected dinoflagellate 
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luciferin by binding it to bovine serum albumin (Bode and Hastings, 1963), while the groups working 
with Cypridina luciferin protected it by forming the benzoyl derivative, which is more stable against 
oxidation (Anderson, 1935). 
1.4.3 Extraction of luciferin from the organism 
Luciferins have been successfully extracted from source material using a range of different solvents, 
depending on the solubility of the luciferin involved, and solvent availability. Bitler extracted 
benzathiazole luciferin from firefly lanterns using acetone (Bitler and McElroy, 1957), while 
dinoflagellate luciferin was extracted from Gonyaulax cells with hot water (Bode and Hastings, 
1963). Latia luciferin was extracted using ice-cold ethanol (Shimomura, 2006h), coelenterazine 
disulfate luciferin was extracted from squid livers using methanol (Inoue, 1975), and Cypridina 
luciferin was extracted using benzene (Anderson, 1935). Most groups simply pulverised the material 
into the solvent, but Cypridina luciferin was first extracted via Soxhlet (Anderson, 1935). Another 
approach was taken by Johnson and co-workers, who plunged live Cypridina into cold, oxygen-free 
methanol (Haneda et al., 1961) . This released most of the luciferin into the solution, but did not 
release cell metabolites as the cells were never broken (Haneda et al., 1961) . Several groups were 
able to pre-concentrate the luciferin, by only extracting from material containing high 
concentrations of luciferin. For example, luciferin is only found in the scintillons in dinoflagellates 
(Dunlap and Hastings, 1981; Schmitter, 1976). Isolation of these by density gradient centrifugation, 
followed by extraction of the luciferin, produced preparations that were free of many of the 
impurities found in the whole body or whole cell extracts (Dunlap and Hastings, 1981; Schmitter, 
1976). 
1.4.4 Separation of luciferin from active luciferase 
Active luciferase must be removed from luciferin preparations at an early stage to prevent luciferin 
loss though the luciferin – luciferase reaction and to allow luciferin detection via the same process. 
The luciferase can be denatured and deactivated by extracting the luciferin into an organic solvent as 
was carried out with Latia (Shimomura, 2006h), Cypridina (Anderson, 1935) and squid 
coelenterazine (Inoue, 1975) or by heat treatment, as was carried out with firefly (Bitler and 
McElroy, 1957) and Gonyaulax (Bode and Hastings, 1963). Luciferin can also be separated from the 
luciferase using dialysis, for example in fireflies (McElroy and Coulombre, 1952), or using 
chromatography, for example in Fridericia heliota (Dubinnyi et al., 2015a; Dubinnyi et al., 2015b; 
Petushkov et al., 2014). 
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1.4.5 Detection of luciferin 
For every luciferin purification, a method must be developed to allow the luciferin to be traced 
through the extraction procedure. Most groups have used a combination of fluorescence 
spectroscopy and luminescence assays (Bitler and McElroy, 1957; Bode and Hastings, 1963; Chase, 
1960; Inoue, 1975).  
 
Fluorescence is an attractive method of tracking luciferin, because the method is non-destructive 
and does not require a luciferase (Shimomura, 2006g). However many luciferins (e.g. Latia) are not 
fluorescent, while many other non-luminous compounds are fluorescent (Shimomura, 2006g). 
Sometimes the fluorescence of the luciferin can be increased by the addition of other materials; for 
example, Bode increased Gonyaulax luciferin fluorescence by binding it to bovine serum albumin 
(Bode and Hastings, 1963). Luminescence assays are more specific than fluorescence assays because 
few compounds display bio-luminescence or chemiluminescence and because the reactions 
generally require highly specific conditions and co-reactants (Fan and Wood, 2007). 
 
On the other hand, luminescent assays require some sample destruction and bioluminescent assays 
generally require specific luciferases and cofactors (Fan and Wood, 2007). Some luciferins may be 
traced by chemiluminescence as well as bio-luminescence.  For example, the clam system 
luminesces with the addition of ferrous ions (Michelson, 1978), while many other systems luminesce 
with hydrogen peroxide (Cormier et al., 2015; Oliveira and Stevani, 2009).  
 
However, for most luminescent systems, a luciferin-free luciferase extract must be produced in 
order to test for the presence of luciferin. This requires the extraction of an active luciferase, the 
development of an assay system, and a way of accurately detecting the light produced (Bitler and 
McElroy, 1957; Bode and Hastings, 1963; Chase, 1960; Inoue, 1975). In situations where neither the 
luciferin nor the luciferase are known, or are available, researchers have used the hot extract – 
exhausted lysate assay system (Figure 1.11) (Shimomura, 2006i). The assay requires two 
preparations made from the same light-producing tissue: one that contains the luciferase enzyme, 
but not the luciferin substrate (‘exhausted lysate’), and one that contains the luciferin but not the 
luciferase (‘hot extract’) (Shimomura, 2006i). On their own, the two preparations do not produce 
light, but when they are mixed (in the presence of required co-factors) light is produced 




The first step in producing both preparations is to homogenise light-producing tissue in buffer or 
water to produce a lysate. Luciferin-containing hot extract is then prepared by heating some of the 
lysate to denature all proteins, including the luciferase. This process produces an extract containing 
small-molecule metabolites, including the luciferin, but no active luciferase (Shimomura, 2006i). The 
exhausted lysate is prepared by inducing (with the addition of cofactors if necessary) the lysate to 
produce light until no more light is detected (Shimomura, 2006i). At this point all the available 
luciferin has been used by the bioluminescent reaction, but the preparation still contains luciferase. 
If the luciferin for a bioluminescent system is unknown, the exhausted lysate can be used in an assay 
to track the luciferin through the purification process (Shimomura, 2006i). Conversely, if the 
luciferase for a system is unknown, the hot extract can be used to assay for the luciferase 
throughout purification, even if the luciferin is unknown (Shimomura, 2006i).  
 
Newer techniques such as high performance liquid chromatography (HPLC) can be used to trace the 
luciferin through the purification process. This technique was used in the isolation of Fridericia 
hiliota earthworm luciferin (Dubinnyi et al., 2015a; Dubinnyi et al., 2015b; Petushkov et al., 2014). In 
HPLC, small molecules are separated, with high resolution, on a tightly packed column, that can be 
mechanically eluted, with mobile phase, at high pressure (Snyder et al., 2012). Molecules can then 
be identified by their retention time, fluorescence and UV-Vis absorbance (Snyder et al., 2012).  
 
However, before the luciferin can be quantified and traced by HPLC, a detectable and well resolved 
luciferin peak must be identified. This requires that the luciferin be present at concentrations 
detectable by HPLC, and that the luciferin peak is not hidden by larger co-eluting peaks. These things 
are often problematic in the early stages of luciferin purification and Dubinnyi’s group had to rely on 
the luminescent assay in combination with HPLC until the very end of the purification process, 
because the luciferin peak was not detectable until the final few purification steps (Dubinnyi et al., 





1.4.6 Luciferin purification 
All other characterised luciferins were purified by a combination of liquid - liquid extraction and 
column - chromatography (Dubinnyi et al., 2015b; Shimomura, 2006i). Most scientists have had to 
use several different orthogonal separation methods to produce pure luciferin, owing to the 
complexity of the biological material. The use of several orthogonal separation methods enables the 
luciferin to be separated from otherwise similar molecules, because it is unlikely that the same 
molecules would co-elute under different separation techniques (Figure 1.54) (Blunt et al., 1987; 
Yang et al., 2012). 
 
Figure 1.54. Different separation methods (e.g. silica and reverse phase chromatography) separate compounds (e.g. 
C1,C2 and C3)  based on different molecular features. Compounds that co-elute under one separation technique (e.g. C1 
and C2)  may not co-elute under a different separation technique.  
 A common method is to separate the luciferin under a variety of pHs (Bitler and McElroy, 1957; 
Bode and Hastings, 1963; Chase, 1960; Inoue, 1975). This works because most luciferins are more 
soluble in organic solutions when acidified, but more soluble in aqueous solutions under basic 
conditions (Figure 1.55) (Bitler and McElroy, 1957; Bode and Hastings, 1963; Chase, 1960; Inoue, 
1975). The solubility change of luciferins with pH is due to the almost universal presence of 
carboxylic acids in luciferins (Shimomura, 2006i). Separation of the luciferin containing mixtures 
under different pHs can therefore lead to the isolation of pure compound (Figure 1.55). 
 
Figure 1.55. Compounds may show different polarities and hence solvent solubilities at different pHs. Compounds (e.g. 
C1, C2 and C3) with different solubilities can be separated by liquid-liquid extraction or by chromatography. Separation 
of molecules at several different pH values can therefore separate molecules from complex mixtures. 
Another method, which was used to purify Cypridina luciferin, involved producing a luciferin benzoyl 
derivative whose solubility characteristics were quite different from the native compound 
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(Anderson, 1935). Separation in one form and then the other therefore resulted in a pure product 
(Figure 1.56). However to test for the presence of the luciferin fractions had to be deprotected since 
the benzoyl derivative was inactive (Anderson, 1935). 
 
Figure 1.56. Compounds (e.g. C1, C2 and C3) may show different polarities and hence solvent solubilities when 
derivatized compared to those of the native compound. Molecules with different solubilities can be separated by liquid-
liquid extraction or by chromatography. Separation of molecules both when derivatized and when not derivatized can 
therefore better separate the compounds from complex mixtures. 
 
There have been many advances in chromatography in the hundred years since the earliest attempts 
to isolate a luciferin (Nováková and Vlčková, 2009). A large array of column resins and designs are 
now available, as well as instrumentation such as semi-preparative liquid chromatography (SP-LC) 
which can resolve and separate very similar molecules (Provera et al., 2010; Xu et al., 2010; Zeng et 
al., 1998). SP-LC was recently used to successfully isolate Fridericia heliota luciferin (Dubinnyi et al., 
2015a; Dubinnyi et al., 2015b; Petushkov et al., 2014). 
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1.4.7 Structural elucidation  
Improving analytical techniques have made structural elucidation possible with less material than 
ever before (Cole, 2012; Kind and Fiehn, 2010; Melone et al., 2013; Provera et al., 2010; van der 
Hooft et al., 2012; Vukics and Guttman, 2010). The structure of Cypridina luciferin (Kishi et al., 1966) 
and benzathiazole luciferin (White et al., 1961) was solved by chemically altering the initial molecule 
then studying the initial molecule and its products by mass spectrometry and UV-Vis spectrometry. 
In the case of benzathiazole luciferin, this required at least 27 mg of pure compound (Kishi et al., 
1966). The structure of coelenterazine was solved by comparing the high resolution mass 
spectrometry, U.V, visible and IR  spectroscopy data of coelenterazine to that of Cypridina luciferin 
and proposing a structure based on the observed differences and similarities (Hori et al., 1977; Hori 
and Cormier, 1973). The structure of Latia was solved from 37 mg by 1H NMR, mass spectrometry 
and IR (Shimomura and Johnson, 1968c), while the structure of Fridericia heliota luciferin was solved 
by high resolution mass spectrometry, NMR spectroscopy with just 0.005 mg of pure compound 
(Dubinnyi et al., 2015a). In all six cases the proposed structure was confirmed and the 
stereochemistry found by synthesis (Hori et al., 1977; Hori and Cormier, 1973; Kishi et al., 1966; 
Nakatsubo et al., 1970; White et al., 1961) (Dubinnyi et al., 2015a). This synthetic step is important 
because natural products can be easily misassigned (Nicolaou and Snyder, 2005). 
 
 The small numbers of A. luminosa available and the small size of the GW LO meant that some of 
these methods were  impractical for studying the glow-worm (GW) luminescent system. In this 
thesis, the main structural elucidation tool used was mass spectrometry; the most sensitive tool 





2 Glow-worm collection, luciferin isolation and the 
development of a luminescence assay 
2.1 Introduction 
In order to isolate, and identify the glow-worm (GW) luciferin, it was essential to develop a 
glowworm luminescence assay that was capable of detecting the presence of luciferin throughout 
the purification process. Previous experiments (see section 1.2.7.2), had suggested that GW 
luminescence resulted from the reaction of a GW luciferin with a GW luciferase, oxygen, ATP and 
Mg2+ (see Figure 2.1) . Luminescence should therefore occur if GW luciferase, O2, Mg
2+ and ATP (2.3, 
Figure 2.2) were added to any fraction containing GW luciferin, in a suitable buffer system (Lee, 
1976; Viviani et al., 2002). If this luminescence can be measured, such an assay provides a method to 
detect GW luciferin.  
 
 
Figure 2.1. Schematic of the hypothesised glow-worm bioluminescent reaction (Lee, 1976; Viviani et al., 2002). 
 
In the early days of bioluminescence studies, light was detected either by eye, or using 
luminometers that were designed and built by the scientists who wished to use them (Berthold and 
Tarkkanen, 2013). Sensitivity was later improved by the developement of high-performance photon 
counting photomultipliers and commercial curvette luminometers became available in the 1970s 
(Berthold and Tarkkanen, 2013). Microplate instruments, that enabled the rapid screening of 
multiple samples,  were invented in the early 80s and developed the sensitivity and accuracy needed 
to become commercially successful in the early 90s (Berthold and Tarkkanen, 2013). Since then 
luminometers have become more accurate, and and more sensitive, and often measure 
luminescence, fluorescence and UV-Vis absorbance (Berthold and Tarkkanen, 2013). Some 
luminometers, such as the CLARIOstar can now also record complete emission or excitation spectra 
using high speed highly sensitive variable monochromators such as the  Linear Variable Filter (LVF) 
monochromator (Berthold and Tarkkanen, 2013; BMG-Labtech, 2016).  
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The research described in this thesis initially used a POLARstar luminometer from BMG Labtech 
(Durham, NC, USA). However, in 2014, the Otago University Biochemistry department purchased a 
CLARIOstar microplate luminometer which promised a sensitivity of < 0.4 pM (< 8 amol/well ATP, 
384 sv, 20 μL) which is better than most other commercial luminometers (BMG-Labtech, 2016)  and 
which was used in later experiments. 
 
Most luminometers, (including  the CLARIOstar and POLARstar luminometers used in this thesis), 
give luminescence in terms of relative luminescence units, because the sensitivity of luminometers is  
variable between instruments. Relative luminescence units can be converted into photons per 
second with the use of luminescence standards. However, this study only required the relative 
luminescence of different samples to be determined, and for this purpose relative luminescence 
units are adequate.  
 
This chapter therefore describes the development of an improved method for the detection of A. 
luminosa luciferin, based on the earlier work of Viviani et al, but adapted to use the new highly 
sensitive microwell plate luminometer technology.  
 
This chapter also describes the collection over four years, of 3000 glow-worms from eight different 
locations across New Zealand. These were collected  to provide the necessary luciferin and luciferase 
for the work described in this thesis.   
 
 
2.1. Reduced dithiothreitol (DTT) 
 
2.2. Oxidised DTT 
 
2.3.  Adenosine triphosphate 
Figure 2.2. Several molecules discussed in Chapter 2. 
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2.2 Results and discussion 
2.2.1 Glow-worm collection 
A supply of GWs was needed throughout this research, and since culturing GWs appeared unfeasible 
(no one had previously cultured them), collections were made across New Zealand (Figure 2.3). This 
was a major undertaking, because GWs had to be collected live, in the dark, in areas that were often 
difficult to work in and get to, such as caves, rivers and steep bush-covered cliffs. The aim of these 
collections was to get biomass for isolation work. Informal observations are recorded below for 
future reference. 
 
During collection I was able to observe Arachnocampa at all stages of its life cycle, including very 
small initial larval instars (1 mm -6 mm), later instars (6 mm – 2 cm), pupae (2 cm long) and adults 
(Green, 1979). The pupae had the appearance of tiny twigs but were identified due to the presence 
of a faint blue glow at one end. GWs begin to glow about 1-2 hours after dusk, so GW collections 
were collected between 10 and midnight. The Dunedin sites were visited multiple times (often not 
for collection) and it was noted that far more GWs were visible on rainy nights than dry nights. Most 
collections were therefore done in the rain. Possibly the GWs do not emerge from their burrows 
when conditions are too dry, because of the risk of desiccation, or because of reduced prey 
availability (Pugsley, 1983). GW larvae were located by their light and collected live, by picking each 
GW out of its web using a wooden cocktail skewer and placing it in a plastic tube. This procedure 
was executed with speed, because GWs hide in a matter of seconds when disturbed, and can move 
very fast, as documented previously (Gatenby, 1959; Mills et al., 2016; Sivinski, 1998). Only a few 
GWs were placed in each tube to prevent cannibalism (Richards, 1960). It was easier to collect from 
cave populations (than bush populations), because cave GWs could be collected in the day and 
because GWs from cave populations could not hide behind moss, ferns and soil. Full collection 




After collection, GWs were separated from plant material and dirt, and were snap-frozen on dry ice 
in a stretched out position, so that the light organs could easily be dissected (Figure 2.4). Frozen 
GWs were wrapped in the foil and stored at -80 °C until required for experiments. The GW larvae 
used in this chapter were found to weigh 31 mg on average (mean, SD: ± 12 mg) with the LO 
weighing on average 4 mg (mean, SD: ± 2) (see Table 2.1).  GW data for experiments completed in 
Chapter 2 are shown in section 2.3.1 while GW data for experiments completed in other chapters 

















A. Glow-worm collection sites around NZ. 
 
Takaka (1) 
One collection from a limestone cave population giving a 
total of 500 glow-worms. 
Kakahi (2), 
One collection from a railway cutting, giving a total of 
550 glow-worms. 
Piripiri (3) 
Four collections over four years from a gorge wall site, 
giving a total of 1105 glow-worms. 
Borland Valley (4), 
One collection from a limestone cave of 300 GW. 
West Auckland (5) – see B 
Dunedin (6) – see C 
Manuka Gorge (7) 
Two collections from a bush site outside an abandoned 




B. Location of Dunedin collection sites  
Nichols Falls Track (6.1) 
One collection from a bush site giving a total of 50 glow-
worms. 
Ross Creek Reservoir (6.2) 
Four collections from a rocky wall in the bush giving a total 
of 206 glow-worms. 
 
C. Location of West Auckland collection sites 
with estimated population size.  
Parau, stream site (5.1) 
Karamatua, stream site (5.2) 
Haultain Gully, stream site (5.3) 
Exhibition drive, road cutting (5.4) 
Glen Esk Stream (5.5) 












2.2.2 Lysate luminescence 
2.2.2.1 Initial luminescence 
For a luminescence assay to be developed for Arachnocampa luciferin, light must be produced from 
Arachnocampa lysate and measured in vivo. Light organs (LO, also known as lanterns) from frozen 
GWs, were dissected from bodies using a razor blade and tweezers. Tissue was kept frozen during 
dissection using dry ice. Dissection was difficult because LOs are small (1-4 mm) and because many 
GWs retract their light organs prior to freezing (Figure 2.4 A, B and C). The LOs were pulverised with 
buffer to produce a lysate. Initially Tricine buffer 1 (see section 2.3.2) was used as the lysis buffer, 
because it had previously been successfully used with the Arachnocampa  system (Viviani et al., 
2002). The lysate was then centrifuged to remove particulate matter, to produce a pale yellow, cell-







Figure 2.4. Photos of frozen glow-worms taken by Miriam Sharpe with an iPhone. A:  One large glow-worm (1.6 cm) on 
foil with light organ fully extended. B: One large glow-worm (2 cm) on foil with light organ semi-retracted. C: One large 











Assay buffer and a small amount of lysate (5 µl) were added to the wells of a 96 well plate. Initially 
0.1 M Tris assay buffer (pH 8) was used, because this had been previously successfully used as assay 
buffer with the Arachnocampa  system (Viviani et al., 2002). The well plates were kept at room 
temperature inside the luminometer  because no cooling function was available. The luminescence 
was then measured using the sequential method described below:  
Sequential method 
1. Measure the luminescence of well A for 5 s 
2. Add ATP-Mg2+ to well A using the POLARstar automatic injector  
3. Measure the luminescence of well A for a further 35 s 
4. Repeat for well B and well C etc. 
 
  
Figure 2.5. The ATP-Mg
2+
 dependence and the effect of storage at room temperature on glow-worm lysate 
luminescence. Each well was measured sequentially for 40 s with ATP-Mg
2+
 added (if required) after 5 s using the 
POLARstar automatic injector. No ATP-Mg
2+
 was added to every other sample as a control. Reaction mixtures were 
made with Tris buffer 1 and lysates were prepared in Tricine buffer 1. A: The light produced in luminescence units (LU) 
over time for selected reaction mixtures to which ATP- Mg 
2+
 had been added. B: The integrated (int) luminescence over 
40 s for reaction mixtures incubated in well plate wells at room temperature for various times previous to 
measurement.  
These results were plotted graphically to give luminescence traces like those shown in Figure 2.5A 
that showed both the magnitude and kinetics of the luminescence reaction. Figure 2.5A shows that 
the GW lysate produced no luminescence initially, but produced luminescence after the addition of 
ATP-Mg2+ (Figure 2.5A) which confirmed the findings of Lee and of Viviani (Lee, 1976; Viviani et al., 
2002). 
 
The luminescence was also integrated over the entire cycle time (40 s) using the trapezoidal 
integration method (Yeh and Kwan, 1978). This gave a single-value result for each reaction, which 








was chosen rather than a maximum luminescence, or the luminescence at a certain time, because an 
integration would be less affected by changes to the luminescence kinetics. Figure 2.5B shows that 
strong luminescence was only produced in wells to which ATP- Mg2+ had been added which 
confirmed the findings of Lee and of Viviani (Lee, 1976; Viviani et al., 2002). Figure 2.5B also shows 
that light production was highly unstable, and that reaction mixtures containing GW lysate, that 
were kept in 96 well plates at room temperature, rapidly (within minutes) lost the ability to 
luminesce with the addition of ATP-Mg2+. 
2.2.2.2 Protection of lysates by storage on ice and by the addition of reducing agents 
Cold temperatures had previously been used to preserve luminescent mixtures (see section 1.4.2). 
Lysates were therefore stored on ice (4 °C)  and added to the assay mix only immediately previous to 
the luminescent reaction (see method below). 
 
Sequential method with samples stored on ice before measurement 
1. Add buffer to all wells 
2. Add sample (e.g. lysate) to well A 
3. Measure the luminescence of well A for 5 s 
4. Add ATP-Mg2+ to well A using the POLARstar automatic injector  
5. Measure the luminescence of well A for 35 s 
6. Repeat steps 2 - 5 for the remaining wells 
 
Figures 2.6, 2.7 and 2.10 show that when the above method was used, lysates retained their 
capacity to luminesce with the addition of ATP-Mg2+ for much longer  than when lysates were left in 
the luminometer at room temperature (Figure 2.5).   
 
Reducing agents have also previously been used to preserve luminescent mixtures  (see section 
1.4.2).  mercaptoethanol (ME) and dithiothreitol (DTT) (2.1, Figure 2.2) were therefore added to 






Figure 2.6. The effect of adding  mercapto ethanol (ME) and dithiothreitol (DTT) to luminescent reaction mixtures 
containing glowworm lysate that had been stored on ice without reducing agent for varying lengths of time. Reaction 
mixtures contained either Tris assay buffer 1 only, or buffer containing 3 mM ME (A) or 2 mM DTT (B). Luminescence 
was measured for 40 s and ATP-Mg 
2+ 
added using the POLARstar automatic injector after 5 s. The integrated 
luminescence units over 40 s for each sample was then plotted against the time the lysate involved had been stored on 
ice (times since lysis). The lysates were prepared in Tricine buffer 1 
Figure 2.6 shows that the addition of ME and DTT to the well plate reaction mixture (and not to the 
stored lysate) had no effect on the luminescence. However, Figure 2.7 and Figure 2.10 show that the 
addition of DTT or ME to lysates stored on ice, strongly preserved lysate luminescent capacity.  In 
comparison the addition of non-reductants such as protease inhibitor cocktail, bovine serum 
albumin, and NaCl to stored lysate had no effect on GW lysate luminescent capacity (Figure 2.7B and 
Figure 2.10B). Lysates prepared with reducing agents displayed less browning than untreated lysates 
(Figure 2.9). It is important to note that lysates produced at different times from different GWs (e.g. 
the lysate in Figure 2.7 and the lysate in Figure 2.10) are not equivalent and that different lysates are 
not expected to show identical behavior.  
 
DTT was therefore added to assay and lysis buffers in most experiments. Other reducing agents were 






Figure 2.7. Additive experiment 1. The protective effect of adding various additives to glowworm lysate previous to 
storage on ice. Lysate was split into several parts, additives added, and the mixtures stored on ice. Subsamples of each 
lysate mixture were added to well plate reaction mixtures over a three hour period and luminescence initiated by the 
addition of ATP-Mg
2+
 at 5 s using the POLARstar automatic injector. X axis: the time the lysate mixture was stored on ice 
(time since lysis). Y axis: integrated (int) luminescence in luminescence units over 40 s (for each sample). Lysates were 
made in Tricine buffer 1 and tested in Tris assay buffer 1 containing dithiothreitol. Data is shown on two graphs (A and 
B) to aid understanding. Representative luminescence profiles are shown in Figure 2.8.  
 
 
Figure 2.8. The luminescence of glow-worm lysate stored on ice with dithiothreitol. 
Reaction mixtures contained Tris assay buffer 1 and ATP-Mg
2+
 was added at 5 s 
using the POLARstar automatic injector. Luminescence is shown immediately after 
lysis, and 1 hour after lysis. The lysate was made with tricine buffer containing 2 
mM dithiothreitol. 
 
Figure 2.9. Glow-worm lysates: 
on right with dithiothreitol, on 












Figure 2.10. Additive experiment 2. The protective effect of adding various additives to glowworm lysate previous to 
storage on ice. Lysate was split into several parts, additives added, and the mixtures stored on ice. Subsamples of each 
lysate mixture were added to well plate reaction mixtures over a three hour period and luminescence initiated by the 
addition of ATP-Mg
2+
 at 5 s using the POLARstar automatic injector. X axis: the time the lysate mixture was stored on ice 
(time since lysis). Y axis: integrated (int) luminescence in luminescence units over 40 s (for each sample). Lysates were 
made in Tricine buffer 1 and tested in Tris assay buffer 1 containing dithiothreitol. Data is shown on two graphs (A and 
B) to aid understanding.  
 
A 
Addition of dithiothreitol (DTT) to stored 
lysate improved lysate stability whereas 
adding protease inhibitor cocktail did not. 
Protease inhibitor cocktail + DTT (2 mM) 
DTT (2 mM) 
Lysate only 
B 
Addition of bovine serum albumin (BSA) or NaCl 








2.2.3  Inhibition of bioluminescence by non-light organ tissue 
Even with the addition of reducing agents to lysis buffers, many lysates failed to produce any 
luminescence. It was noted that far more non-luminous lysates were produced when a high number 
of very small GWs were used to prepare lysates. It was difficult to remove the LOs from these GWs, 
which led to the inclusion of more non-LO GW body material into the GW lysate. An experiment was 
therefore devised to discover the effect of non-LO GW body matter on the luminescent reaction. 
GW LOs were carefully separated from non-LO GW body tissue using a dissecting microscope, and 
lysates made from each separately. A portion of the non-LO GW body lysate was then heat-treated 
in the manner of the hot extract. The luminescence of the LO lysate was measured alone, and with 
the addition of non-LO tissue lysate or heat-treated non-luminescent tissue lysate (Figure 2.11).  
 
These experiments showed that reaction mixtures containing non-LO body material produced 
significantly less luminescence than reaction mixtures without (Figure 2.11A). The addition of heat-
treated non-LO body lysate did not produce a significantly different luminescence (Figure 2.11A) but  
the kinetics of this reaction were visibly different to the other reaction mixtures (Figure 2.11B). 
These experiments show that it is important to exclude as much of the non-LO GW body material as 
possible when removing the light organs, because the addition of even small amounts can inhibit 
luminescent activity. After this discovery there were no more problems with non-luminescent 
lysates.  
  
Figure 2.11. The inhibitory effect of non-LO body (Bod) material and heat treated non-LO body material (Hot Bod) on LO 
lysate (lysate) luminescence. ATP-Mg
2+ 
was added to all solutions
 
at 5 s using the POLARstar automatic injector. A: 
Integrated luminescence over 40 s for each reaction type. X axis: material added to reaction mixture buffer previous to 
ATP-Mg
2+
 addition. Y axis: luminescence (luminescence units, LU) of reaction mixtures integrated over 40 s. Data shows 
average of three replicates (analytical) with error bars showing one standard deviation above and below the mean. 
Lysate shows significantly higher luminescence than Lysate + Bod with P less than 0.00005, but Lysate + Hot Bod is not 
significantly different to either Lysate or Lysate + Bod using a student T test (two tailed, two sample unequal variance). 




Lee reported that their GW lantern extract was contaminated with 50% body material, and that 
contaminating body parts absorbed some of the light produced at the short wavelength end of the 
luminescent spectrum (Lee, 1976). Future research into this phenomenon could investigate whether 
the addition of non-lantern body material reduces luminescence across all wavelengths (presumably 
an overall inhibition effect) or whether it decreases luminescence at particular wavelengths (light 
decreases due to absorption). The addition of non-LO body material produces lysates that are very 
dark compared to pure LO lysates. GWs can quickly shut off their light production, and some have 
proposed that this is partly done by the GWs withdrawing their light organs into their bodies (see 
Figure 2.4 A, B and C) (Gatenby, 1959; Gatenby and Ganguly, 1956). If this were the case, it would 
make sense for the GW to develop pigmentation next to the light organ that could efficiently absorb 
the light produced. Incorporation of these pigments into in vitro assays may significantly decrease 




2.2.4 Optimisation of buffer components 
To determine whether any alternative buffers or alternative pH values increased the effectiveness of 
the assay, a variety of assay buffers from the Thermofluor Assay Screen (Ericsson et al., 2006) were 
trialled as assay buffers. These  experiments showed that lysates produced significantly greater 
levels of luminescence in 0.1 M MOPS at pH 7.5, than the initial Tris assay system at pH 8.00 (Figure 
2.12). The initial Tricine lysis buffer was therefore replaced by MOPS buffer 1, and the Tris assay 
buffer was replaced by MOPS buffer 2 for all subsequent lysate preparations and assays. Later, 
MOPS buffer 2 which contained no glycerol or EDTA was used as both the lysis and assay buffer. This 
was because high concentrations of glycerol in MOPS buffer 1 could cause problems with later LC-
MS and HPLC experiments. 
 
  
Figure 2.12. Replicate lysate luminescence in MOPS buffer 2 (pH 7.5) and Tris buffer 2 (pH 8.0). ATP-Mg
2+ 
was 
added at 5 s using the POLARstar automatic injector.  All buffers contained 2 mM DTT. Lysate was made in 
Tricine lysis buffer containing DTT. A shows luminescent trace. B shows average (MOPS n: 2, Tris n: 3) 
integrated luminescence over 40 s with error bars showing 1 standard deviation above and below the mean. 
Order of measurement Tris, MOPS, MOPS, MOPS, Tris with each being measured for 40 s. MOPS buffer 2 (pH 
7.5) shows significantly higher luminescence than Tris buffer 2 (pH 8.0), with P < 0.005 using a student T test 





2.2.5 Separation of glow-worm luciferin and glow-worm luciferase  
When isolating a luciferin, it is necessary to produce an extract containing luciferin but no active 
luciferase, and an extract containing luciferase but no active luciferin (section 1.4.4). The luciferase 
fraction can then be used to test for the presence of luciferin. 
  
To produce a GW extract containing luciferase but no luciferin, a desalting spin column, was used to 
separate lysate components. Desalting spin columns are essentially miniature centrifugally eluted 
size exclusion columns, that separate molecules based on size, which are usually used to separate 
proteins from small molecules (generally buffers) (Evans et al., 2009). Early eluting (F1 and F2), high 
mass fractions produced trace amounts of luminescence with the addition of ATP-Mg2+ (F1 much 
more so than F2), whereas later fractions showed no luminescence under the same conditions 
(Figure 2.13).  
 
  
Figure 2.13. Desalting chromatography of two separate glow-worm lysates produced fractions that were tested for 
luminescence with ATP-Mg
2+
  both with and without hot extract. A: Separation of ADE lysate, B: Separation of lysate BIE 
lysate (see Table 2.1 for further details).  Luciferase fraction (F1)  is slightly luminescent with ATP-Mg
2+
 but very 
luminescent with hot extract (HE) and ATP-Mg
2+
.  Later fractions show little luminescence with ATP-Mg
2+
 or with HE and 
ATP-Mg
2+
.  X axis: the desalting spin column fraction added to reaction mixture (F1 – F5). Each fraction was eluted to 
contain the same volume as the volume loaded. Y axis: the integrated (int) luminescence in luminescence units over 40 
s. Luminescence was measured using the POLARstar luminometer and ATP-Mg
2+ 
was added at 5 s using the POLARstar 
automatic injector. The initial lysates were made in, and the LF prepared in MOPS buffer 1 with DTT. Reaction mixtures 
contained MOPS buffer 2 with DTT.  
To produce an extract containing luciferin but no luciferase, GW lysate was heated at 95°C for 5 
minutes, then centrifuged to remove denatured proteinaceous material. The GW hot extract (HE) 
produced in this way showed no luminescence under assay conditions with ATP-Mg2+ (Figure 2.14).  
This demonstrated that the GW luciferase could be inactivated by heat, which confirmed previous 












Figure 2.14. Luminescence (in luminescence units, integrated over 40 s) of reaction mixtures containing MOPS buffer 2, 
ATP-Mg
2+
 and a mixture of glow-worm lysate (BIE), F1 produced from the lysate using a desalting spin column and 
glowworm hot extract. The luminescence of an empty well (blank) is also shown. Error bars show one standard 
deviation above and below the mean. Desalting chromatography of a lysate produced an F1 fraction that showed slight 
luminescence with ATP-Mg
2+
. The luminescence produced from the F1 fraction with ATP-Mg
2+
was significantly less 
luminescence than the initial lysate (P < 0.01) but significantly more luminescence than an empty well (P < 0.005). In 
contrast a HE produced from the same lysate produced no luminescence (not significantly different from empty well) 
with ATP-Mg
2+
 under the same conditions. The recombination of HE with the F1 fraction resulted in strong luminescence 
that was significantly greater that either the HE or the F1 luminescence (P < 0.005). Statistical significance was tested 
using a student T test (two tailed, two sample unequal variance).  
 
Addition of this GW hot extract (HE) as well as ATP-Mg2+ to the F1 and F2 desalting spin column 
fractions produced a strong luminescence much larger than the weak luminescence  of the F1 and F2 
fractions with ATP-Mg2+ with most of the activity was observed in F1 (Figure 2.13 and Figure 2.14). 
Later-eluting fractions (F3 – F5) produced no luminescence under assay conditions with ATP-Mg2+ 
alone, or in combination with HE (Figure 2.13). These later fractions therefore appeared to contain 
no active GW luciferase. The F1 fraction is hereafter referred to as luciferase fraction or LF. Further 
results using combinations of LF, HE and cofactors are shown in Figure 2.15. The weak luminescence 
of LF in the presence of ATP-Mg2+ without HE (Figures 2.13 and 2.14 and 2.15D), is probably due to 
the presence of small amounts of residual GW luciferin in the LF. It is important to note that 







Initial (HE + LF): no luminescence, 




Initial (buffer, HE, ATP and  Mg
2+
): no luminescence, 
A (addition of LF): luminescence. 
  
 
Initial (HE + LF): no luminescence,  




using the POLARstar 
automatic injector): luminescence,  
B (addition of HE): no extra luminescence. 
 
 
Initial (buffer only): no luminescence,  
A (addition of LF): no luminescence,  
B (addition of ATP and Mg
2+
): low luminescence,  
C: (addition of HE): high luminescence. 
  
Figure 2.15. Strong luminescence is only produced in reaction mixtures containing luciferase fraction (LF), hot extract 
(HE) and ATP-Mg
2+
. Y axis: Luminescence in luminescence units (LU) of reaction mixtures. X axis: time since initial 
luminescent measurement. The initial lysate was made in and the LF prepared in in MOPS buffer 1 with DTT. Reaction 
mixtures contained MOPS buffer 2 with DTT. Luminescence values are missing during the time periods where samples 
were added because luminescence measurements could not be taken while the luminometer was open. Luminescence 
was measured using the POLARstar luminometer.  
 
The fast (less than three minutes) desalting spin column method therefore produced  an  enzymatic 
fraction, that only strongly luminesced in the presence of luciferin and that could therefore be used  
to detect luciferin. However, the existence of weak LF luminescence in the presence of ATP-Mg2+ 
means that in every assay, sample luminescence with LF and ATP-Mg2+ had to be compared to the 
luminescence of the same LF with only ATP-Mg2+. This led to the formation of the general procedure 















2.2.6 Sequential and quasi-simultaneous luminescence measurements  
Luminescence had, until this stage, been measured using the sequential method described below: 
Sequential  method 
1. Add buffer to all wells 
2. Add sample (e.g. lysate) to well A 
3. Measure the luminescence of well A for 5 s 
4. Add ATP-Mg2+ to well A using the POLARstar automatic injector  
5. Measure the luminescence of well A for 35 s 
6. Repeat steps 2 - 5 for the remaining wells 
 
However the instability of the GW system meant that the same lysate tested three times could give 
variable luminescence data (Figure 2.16). This data was often variable in terms of kinetics, peak area 
and maximum peak height which made direct replication difficult.  
 
 
Figure 2.16. The luminescence kinetics observed for one lysate sample (BIE lysate) measured three times when tested in 
MOPS buffer 2 with ATP-Mg
2+ 
added at 5 s using the POLARstar automatic injector.  
Due to the above problem and because the POLARstar automatic injector  broke, a new quasi 
simultaneous method was designed (described below). 
Quasi-simultaneous method 
1. Add buffer to all wells 
2. Add samples to wells to be measured (e.g. wells A, B and C) 
3. Add ATP-Mg2+   to all wells simultaneously using an auto-pipette 
4. Measure the luminescence of A (0.5 s) 
5. Measure the luminescence of B (0.5 s) 
6. Measure the luminescence of C (0.5 s) 
7. Repeat 4, 5 and 6 until the luminescence from all samples has (mainly) disappeared 
 
 Injection by multi-pipette required the luminometer to be opened and this prevented the 
measurement of the initial few seconds of luminescence. This meant that the initial rise to maximum 
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luminescence could no longer be measured . However since GW luminescence is relatively long 
lasting, measurement of the later stages of luminescence (post the first 5 s) still gave a good 
indication of the overall luminescence. This is in contrast to fireflies, which show a flash profile 
where most luminescence disappears within the first few seconds, due to product inhibition (da 
Silva, 2011; Ribeiro and da Silva, 2008) (see section 1.2.5) but similar to the longer lasting Renilla 
system (Cormier, 1962).  
 
The new method meant that the luminescence of multiple wells could be measured almost 
simultaneously.  This in turn reduced the variability between replicates (see Figure 2.17A) which 
enabled the luminescence of different samples to be compared more easily.  The new method also 
greatly sped up the process of measuring multiple samples. The quasi simultaneous method was 
therefore used for all luminescence measurements described in the rest of this thesis. 
 
2.2.7 Luminescent kinetics 
Many of the GW reaction mixtures initially showed light emission profiles similar to those observed 
by Lee and Viviani (Lee, 1976; Viviani et al., 2002), where luminescence increased rapidly to a 
maximum within seconds after ATP addition, then decreased gradually over the next few minutes 
(Figure 2.17A). This profile shape was named L type, short for luciferin type, because this is the 
luminescent kinetics expected from a luciferin substrate that was ready to react with ATP-Mg2+. L 
type behavior was observed from both lysate and from LF and HE mixtures when combined under 
assay conditions with ATP-Mg2+ (Figure 2.17). 
 
However, some lysates, and some LF with HE mixtures did not show simple L type luminescence. 
Instead, these mixtures reached a luminescent maximum many minutes (and in some cases hours) 
after ATP-Mg2+ was added (Figure 2.17B). This kinetic behavior was called P type, short for precursor 
type. This was because this is the luminescent kinetics that might be expected if the substrate was 
first required to undergo a precursor step before being ready to luminesce. The reason for these 






Figure 2.17. L and P type luminescence kinetics of glow-worm lysates (red) and hot extract - luciferase fraction mixes 
(blue) when tested with ATP-Mg
2+
. The luciferase fraction and hot extracts in each figure were prepared from the lysate 
shown in the same figure. A: reaction mixtures showed L type kinetics. B: reaction mixtures showed P type kinetics. In 
both cases the luminescence of the luciferase fraction with ATP-Mg
2+ 
was negligible.  Both lysates and luciferase 
fractions were made in and tested in MOPS assay buffer 2 containing DTT.  Analytical replicates are shown in A to 
demonstrate the repeatability of the luminescent reaction when quasi simultaneous methods are used. 
The appearance of P type luminescence meant that samples had to be measured for much longer 
periods (between 3 minutes and several hours), because the initial 40 s period would not give a good 
indication of the overall luminescence produced. Since luminescence measurements were only 
compared within experiments, it did not matter if the luminescence was measured and integrated 
over different time periods in different experiments. It was however important to measure all 
samples that were to be compared in the same quasi simultaneous run, because samples could not 




P type luminescence kinetics 
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2.2.8 Dose dependence 
Reaction mixture luminescence was found to be dependent on the concentration of LF (Figure 2.18) 
and the concentration of HE (Figure 2.19) added to the reaction mixture initially. This shows that 
luminescence could be used as a qualitative measure of the amount of luciferin present. This 
indicates that these methods could enable the determination of the relative amount of luciferin in 
simultaneously analyzed samples. These methods therefore provide a method to track GW luciferase 
through the purification process. Interestingly, luminescence was not increased if further amounts of 
hot extract were added to reaction mixture after initial luminescence had started to decrease (Figure 




Figure 2.18.  The luminescence of reaction mixtures containing hot extract (HE), luciferase fraction (LF) and ATP-Mg
2+ 
is 
dose dependent on the amount of LF. Y axis: integrated (int) luminescence in luminescence units over 40 s for each 
reaction mixture. X axis: the volume of luciferase fraction (LF) added to reaction mixtures. MOPS buffer 2 with DTT was 
used to prepare the GW lysate, the LF, the HE and was used as the assay buffer. ATP-Mg
2+
 was added 5 s into each 




Figure 2.19. The luminescence of reaction mixtures containing hot extract (HE), luciferase fraction (LF) and ATP-Mg
2+ 
is 
dose dependent on the amount of HE. ATP and Mg
2+
 were added to all reaction mixtures at T- 5 s using a multi-pipette. 
A: The luminescence in luminescent units (LU) over time for 3 replicate well experiments completed using the same 
material at the same time (each data point shows mean, legend shows standard deviation). B: the average integrated 
(int) luminescence over 203 s of 3 replicate experiments as a factor of the relative amount of HE in the reaction mixture 
(% total volume). MOPS buffer 2 with DTT was used to prepare the GW lysate, the LF and HE and as the assay buffer. All 





2.2.9 Comparison of developed assay techniques to those used previously 
As described section 1.4.5, luciferins have almost always been isolated via luminescence-guided 
assays, and the development of this GW bioluminescence assay owes a lot to assays developed for 
other systems and to the previous work on Arachnocampa performed by Lee and by Viviani (Lee, 
1976; Viviani et al., 2002).  
 
Both Lee and Viviani et al. showed that the luminescent reactions of the glow-worms A. flava and A. 
richardsae shared many requirements with the firefly system, including Mg2+, oxygen and ATP 
dependence (Lee, 1976; Viviani et al., 2002). This led both groups to develop assays based on the 
firefly assay. Using these techniques, Viviani et al. were able to show that the hot and exhausted 
lysate extract techniques were applicable to the glow-worm system, proving that glow-worms did 
indeed contain an ATP dependent luciferase – luciferin system.  
 
The methods used in this chapter were built upon those used by Viviani and Lee, and upon those 
used in the isolation of benzathiazole luciferin (Lee, 1976; Viviani et al., 2002). However, several 
major improvements have been made. These experiments used highly sensitive multi-plate 
luminometers (POLARstar and CLARIOstar) which provided many advantages over earlier studies 
which used (often lab made) cuvette based luminometers (Berthold and Tarkkanen, 2013). For 
example the assay of Viviani et al. employed  cuvette-based techniques which were unsuitable for 
the analysis of multiple small luminescent samples. The microplate luminometers used in this 
project displayed great sensitivity and allowed for the quasi-simultaneous measurement of multiple 
small volume assays.  
 
Another improvement was the ability to quickly make luciferase fractions using desalting spin 
columns. Viviani et al. made their luciferin-free luciferase fraction using an luciferin exhaustion 
method where ATP-Mg2+ was added to crude lysate and the mixture left to incubate for 18 hours on 
ice (Viviani et al., 2002). The desalting spin column method is faster than that developed by Viviani 
et al. taking only minutes. This reduces the exposure of enzymatic mixture to oxidising 
environmental conditions. Viviani’s luciferin-exhausted lysate also contained high concentrations of 
ATP and other small molecules (including reaction products such as oxidized luciferin). With such a 
luciferin-exhausted lysate it is not possible to initiate luminescence by the addition of ATP-Mg2+ 
because ATP-Mg2+ would already be present. Most importantly, the LFs produced using the desalting 
spin column method were often capable of detecting both L and P type luminescence, whereas all 





This chapter described the collection over four years of 3000 glow-worms from eight different 
locations across New Zealand. This chapter also described the development of a GW luciferin assay 
method that could detect both P and L type luminescence.  These methods enabled the fast 
production of a GW enzyme containing fraction (luciferase fraction, LF) that produced luminescence 
when tested with GW samples containing luminescent material and ATP-Mg2+. Only the L type 
luminescence had previously been reported in the literature (Lee, 1976; Viviani et al., 2002). These 
methods also used modern micro plate luminometer technology which enabled the rapid, sensitive 
and simultaneous analysis of multiple samples for the presence of luciferin. This allowed the relative 
amount of luciferin in simultaneously analyzed samples to be determined, and enabled the tracking 





2.3.1 Collection and processing of glow worms 
Larvae were located at night by their bioluminescence and collected live in Falcon tubes. Glow-
worms were taken offsite, then snap frozen with dry ice and stored at – 80 °C. Ideally only larvae 
greater than 1 cm were collected. Voucher specimens were stored in 75% ethanol in the PERU 
herbarium. Specific collection details are shown in Appendix 2. 1. 
2.3.2 Solutions used for glow-worm lysate production and in luminescence assay 
Tricine buffer 1: 27 mM Tricine pH 7.4, 7 mM MgSO4, 0.2 mM ethylene-diamine-tetra-acetic acid 
(EDTA), 10% glycerol, 1% Triton X-100 
Tricine buffer 2: 27 mM Tricine pH 7.4 
Tris assay buffer 1: 0.1 M Tris pH 8.0 
MOPS buffer 1: 100 mM 3-(N-morpholino)propanesulfonic acid (MOPS) pH 7.4, 7 mM MgSO4, 
0.2 mM EDTA, 10% glycerol, 1% Triton X-100 
MOPS buffer 2: 100 mM MOPS pH 7.4  
NH₄HCO₂ buffer: 93 mM NH₄HCO₂ pH 7.5 
ATP-Mg2+ solution: 40 mM ATP mM, 80 mM MgSO4 0.1 M MOPS, pH 7.4, 2 mM dithiothreitol 
(DTT) mM 
 
The pH of all buffers (at room temperature) was adjusted using HCl or NaOH during the production 
of 1 M stock solutions and the pH of all buffers was tested previous to use. 
2.3.3 Production of glow-worm lysate and hot extract (HE) 
Light organs (LO, 20 to 200) were dissected from GWs on dry ice and stored at – 80 °C. Care was 
taken to exclude non-LO body material when preparing the lysate, to prevent inhibition of 
luminescent activity. Lysates were prepared by the pulverisation of frozen LO in a B type douncer 
(Thermofisher) with cold buffer (1- 4 ml) for a minute while kept on ice. The lysed solution was 
centrifuged at 15800 RCF for 5 min at 4 °C and the supernatant removed and kept as the GW lysate. 
GW lysate was kept on ice or stored at – 80 °C. Hot extract (HE) was produced by heating GW lysate 
at 94 °C for 5 min, then centrifuging the denatured lysate at 15800 RCF for 5 min at 4 °C and 
decanting the supernatant as the HE. MOPS buffer 2 with 2 mM DTT was most often used for GW 
extraction. HE was kept on ice or stored at – 80 °C. The details of specific lysates and HEs produced 
for work described in this chapter, including buffers used, are shown in Table 2.1. Details of specific 
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lysates and HEs produced for work described in other chapters, including buffers used, are shown in 
the method sections of those chapters. 
2.3.4 Production of luciferase fraction (LF) for luciferin detection  
The storage liquid was removed from a Thermo Fisher ZebaTM spin 2 ml desalting column by 
centrifugation at 1000 RCF for 2 min. The column was equilibrated by the elution (by centrifugation) 
of 3 x 1 ml MOPS buffer 2 containing 2 mM DTT. Lysate (0.3 to 1 ml) was loaded onto the spin 
column and the column re-centrifuged for 1 min to give a luciferase fraction (LF) with the same 
volume as the initial added lysate. LF subsamples were stored at – 80 °C and gently thawed on ice 
before use. Details of specific LFs produced are shown in Table 2.1.  
Table 2.1 Methods used for making various lysates, LFs and HEs. All glow-worms used for these experiments were 
collected from Piripiri or Kakahi on 3.5.12 or 18.6.12. All lysates were made in air. Buffers used: Tricine buffer 1 (TB1), 





of LO (g) 
Weight of non-
LO body (g) 
Lysis buffer HE and LFs made 
Additive experiment 1 
(AE1) 
40 0.1619 0.9322 TB1 (1 ml) AE1 Lysate 
Additive experiment 2 
(AE2) 
37 0.1747 1.472 TB1 (1 ml) AE2 Lysate 
Additive experiment 3 
(AE3) 
37 0.1676 1.6403 TB1 (1 ml) AE3 Lysate 
Body inhibition 
experiment (BIE) 
15 0.0743 0.2286 
TB1 with 2 mM DTT 
(1 ml for LO, 1 ml 
for non LO body) 
BIE LO lysate 
BIE LO LF 
BIE body lysate 
BIE Heat treated body lysate 
Assay buffer experiment 
(ABE) 
30 0.0478 1.2101 





19 0.1069 0.4097 
MOPS 1 with 2 mM 




2.3.5 Luminescence assay method to detect the presence of luciferin (LAM). 
The luminescence assay was completed using either the POLARstar (work described up until section 
3.2.9) or CLARIOstar (work described after section 3.2.9) microplate luminometers and 
Nunc© MicroWell 96 well plates (white, flat bottomed). Typically, wells were filled with 50 µl MOPS 
buffer 2 containing DTT (2 mM), 5 µl of LF, and 5 µl of sample being assayed. Other buffers and 
volumes were used as described. Initially ATP-Mg2+ solution (30 µl; freshly made) was added to well 
plates using the POLARstar automatic injector and sample luminescence measured for 40 s. The 




In later experiments (Figure 2.19 and onwards) ATP-Mg2+ solution (30 µl; freshly made) was added to 
all wells simultaneously using a multi-channel pipette, and the luminescence of each well was 
measured in the luminometer. Samples that were to be directly compared were analysed quasi-
simultaneously; i.e. the luminometer measured the luminescence of all wells over several seconds, 
then the cycle was repeated.  
POLARstar luminometer sequential settings: luminescence mode,  well mode, no filter, Gain: 4095, 
cycle time: 40 s, each data point measured for 1 s, injection of ATP-Mg2+ after 5 s followed by 
shaking for 2 s.   
POLARstar luminometer quasi-simultaneous settings: luminescence mode, plate mode, no filter, no 
shaking, Gain: 4095, measurement time for each well for each cycle: 0.58 s with an overall cycle time 
of 7 s for the measurement of 12 wells.  
CLARIOstar luminometer settings: luminescence mode, plate mode, no filter, no shaking, Gain: 
3500, Focal height: 11 mm, rapid speed function, measurement time for each well for each cycle: 
0.42 s with an overall cycle time of 5 s for the measurement of 12 wells.  
 
Variations to this method are noted in individual experiments. Results were analysed using Microsoft 
Excel: luminescence units were integrated for every cycle over time using the trapezoid method: 
(time A – time B) * (height A + height B)/2 and the cycle areas summed over the time of interest (40 
s – 4 hours).  
2.3.6 General procedure for tracking luminescent components 
During the purification of luminescent components from GW lysate, the following procedure was 
used to track the luminescent activity and therefore luminescent components. 
1. Test lysate, LF and LF + HE for luminescent activity with ATP-Mg2+ in triplicate 
2. Fractionate lysate  
3. Test LF + fractions, LF and LF + HE for luminescent activity with ATP-Mg2+. Replicate samples 
were measured depending on sample and LF availability. Samples to be compared were 
measured in the same luminescence run (the quasi-simultaneous measurement of a number 
of wells after the simultaneous addition of ATP-Mg2+ into all aforesaid wells). Each 
luminescent run also included reaction mixtures containing (HE and LF) and (LF alone). 
Addition of ATP-Mg2+ to these reaction mixtures gave an indication of LF luciferase activity in 
the first case and of residual luciferin activity in the second. If samples contained potential 
assay inhibitors (e.g. organic solvents or NaCl), the LF control was tested with the same 
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concentration of inhibitor to provide an indication of the inhibitory effects experienced by 
the sample. 
4. Step 3 was repeated with different samples until the LF lost activity.  
5. Samples were considered luminescent if the integrated luminescence was at least five times 
greater than the background noise. This generally meant that samples were luminescent if 
they gave a signal above 1000 LU using the POLARstar, or above 200 LU using the 
CLARIOstar. 
6. Samples were considered to contain luminescent compounds if integrated luminescence 
was at least three times that of the LF control, tested at the same time under the same 
conditions. 
2.3.7 Additive experiments  
Two GW lysates were prepared (see Table 2.1) and split into portions, and additives added as 
described in Table 2.2. These portions were kept on ice and subsamples were tested for luminescent 
activity over a period of three hours with Tricine assay buffer 2 as the luminescence assay buffer.  
Table 2.2. Additives added to lysate subsamples.  
Tube Additive experiment 1 Additive experiment 2 
1 None (lysate only) None (lysate only) 
2 DTT, 2 mM 
DTT, 2 mM + Complete
TM
 protease inhibitor cocktail tablets 
(Roche), 1 tablet dissolved in 0.5 ml assay buffer, 1/200 
dilution 
3 ME, 2 mM DTT, 2 mM 
4 
Protease inhibitor cocktail, 
1/200 dilution 
BSA, 1 mg/ml 
5  NaCl, 150 mM 
2.3.8 Body inhibition experiments 
GW LOs were carefully separated from GW bodies under a dissecting microscope, on a metal tray 
over dry ice using tweezers and a razor blade. Great care was taken not to include non-LO body 
material. The LOs were used to prepare a LO-only lysate (LOL) and the bodies were used to prepare 
a non-LO body lysate (BOL) (Table 2.1). A portion of BOL was heat treated as described in section 
2.3.3 to produce a non-LO body hot extract (BHE) (Table 2.1).  Reaction mixtures containing LOL 
(5 µl), BOL (5 µl), LOL + BOL (5 µl of each) or LOL + BHE and Tris buffer 1 (to a total well volume of 
70 µl) were measured by luminescence assay in triplicate.  
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2.3.9 Bioluminescent assay buffer screen 
Lysate (5 µl) was added to wells containing 50 µl of the assay buffer to be tested.  ATP-Mg2+ was 
added to initiate luminescence. The activity of lysate in each buffer was measured in triplicate and 
compared with the activity of the lysate in Tris pH 8.0 tested at the same time. 
2.3.10 Luminescent reactions involving luciferase fractions and hot extracts  
In these experiments ADE lysate and BIE lysate (300 µl each) (Table 2.1) were applied to a Zebaspin 
desalting spin columns as described in section 2.3.4, and eluted using MOPS Buffer 2 with 2 mM DTT 
to produce an approximately 300 µl F1 fraction. 300 µl of MOPS Buffer 2 with 2 mM DTT were then 
loaded and another (approximately 300 µl) fraction eluted. This process was repeated until five 
fractions were produced. Each fraction was tested for luminescence with ATP-Mg2+ in MOPS buffer 2 
both with and without HE. The luminescence’s of various mixtures of HE, ATP-Mg2+ and enzymatic 
fraction 1 (LF) were also measured both initially and after further additions of HE, ATP-Mg2+ and LF. 
LF was then assayed with different concentrations of HE, and HE assayed with varying 




3 The purification of compounds responsible for glow-
worm luminescence 
3.1 Introduction 
The research completed for this thesis required both the GW luciferin and the GW luciferase to be 
extracted from GWs. Since a limited number of GW were available and because GWs are small, such 
a process poses many problems to a researcher. This is further complicated by the fact that neither 
the GW  luciferin nor the GW luciferase are likely to be major metabolites and because both 
molecules are likely to face stability issues. This chapter explains how the difficulties involved in such 
a process were overcome. This chapter describes the isolation by reverse phase (RP) bench 
chromatography and semi preparative HPLC of two compounds that gave P type luminescence (slow 
rise and a slow fall) with luciferase fraction (LF) and ATP-Mg2+ (Figure 3.1). These molecules were 
identified as L-tyrosine (Tyr) and xanthurenic acid (XA) (Figure 3.1). These molecules are thought to 
be precursors to the glow-worm luciferin. A separate fraction that gave L type luminescence (sharp 
decrease followed by a slow decrease) was also produced, but the molecule responsible could not 
be isolated (Figure 3.1). This molecule is thought to be the GW luciferin. 
  





3.1. L-Tyrosine**  
 














3.9. Glutamyl leucine* 
 
3.10.  Glutamyl valine*  







3.14. Hydroxy tryptophan* 
 
3.15. Valine** 
Figure 3.20. Compounds found in glow-worm light organ lysate discussed in this chapter. ** indicates that the 
compound was identical to a purchased standard by HPLC retention time, MS, MS
2
 and UV-Vis spectra. * indicates that 
the compound MS and MS
2






3.16. Reduced glutathione** 
 
3.17. Oxidised glutathione** 
 
Figure 3.2. Compounds found in glow-worm light organ lysate discussed in this chapter. ** indicates that the compound 
was identical to a purchased standard by HPLC retention time, MS, MS
2
 and UV-Vis spectra. * indicates that the 
compound MS and MS
2
 spectra match those found in the literature. 
 
3.18. Anthranilic acid glucosyl ester 
 
 
3.19. Anthranilic acid  





3.22. N-carbamyl tyrosine 
 
3.23. Phenol-O-carbamyl tyrosine 




3.2 Results and discussion 
3.2.1 Methods of producing a luciferase free, luciferin rich glow-worm extract 
It was hoped that both the active luciferin and active luciferase could be purified from the same 
active GW lysate, because this would maximize the amount of luciferase and luciferin produced from 
each batch of collected A.luminosa , and minimize the number of GWs required. Furthermore, the 
Siberian Laboratory of Photobiology had successfully used this approach in the isolation of a luciferin 
from bioluminescent earthworm Fridericia heliota (Marques et al., 2011). Their first purification step 
was to separate earth worm lysate via ion exchange chromatography, to give both luciferase and 
luciferin fractions. The luciferase fractions were then used to follow the earthworm luciferin through 
the purification process.  
 
GW lysate was fractionated on multiple occasions by size exclusion chromatography and ion 
exchange chromatography but no fractions were produced that gave luminescence with luciferase 
fraction (LF) and ATP-Mg2+,  even when reducing agents such as dithiothreitol were added to the 
elution buffers. These techniques were therefore not useful to produce luciferin fractions. A luciferin 
rich starting material was therefore produced by heating cell-free GW lysate to produce a hot 
extract (HE) (see Chapter 2). 
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3.2.2 General reverse phase chromatography procedure 
At the start of each purification process, the luminescent activity of the initial HE was measured 
using the luminescent assay. If the HE showed greater activity than the control (see section 2.3.6), it 
was separated by reverse phase (C18) bench chromatography (Blunt et al., 1987). C18 reverse phase 
(RP) chromatography was chosen as the separation technique, due to its good separation ability and 
its compatibility with RP HPLC and LC-MS (Euerby and Petersson, 2003). The bench column (BC) 
fractions and the initial HE starting material were then assayed for luminescence (see section 2.3.6). 
Fractions with luminescent activity above the control were combined, concentrated, and then 
further separated using semi-preparative reverse phase HPLC (SP-LC). Resultant semi-preparative 
(SP) fractions were concentrated, then assayed for luminescence along with the subsamples of the 
initial HE and concentrated BC fraction (see section 2.3.6). A summary of the process of tracking 
luminescent compounds using the GW luminescent assay is shown in Figure 3.4. In this and the 
following chapters luminescent activity will often simply be referred to as “activity” and 
bioluminescent fractions as active. 
 
Figure 3.4. Summary of process of tracking luminescent compounds through several sequential separation procedures 




Due to the large number of lysate separations completed for  this research, data has been given for 
most separations in terms of percentage luminescence yield with luminescence traces only shown 
for important findings. Mass yields are not given since fraction mass was often less than 1 mg and 
because much of the measured mass was added buffer or reductant rather than GW related 
compounds.  
 
Sample luminescence and luminescence yields were calculated as follows:  
 
Integrated (int) luminescence = The number of luminescence units (LU) produced by a reaction 
mixture integrated over a chosen time frame. 
 
Integrated sample luminescence =  
Integrated# luminescence of sample – integrated luminescence of control  
(when both are tested concurrently under with LF and ATP-Mg2+ ) 
 
#Luminescence was intgrated over 203 s unless stated othewise 
 
Luminescence yield = 
100 * (Int fraction luminescence * total volume of fraction produced at concentration tested#) 
(Int column input luminescence * volume of column input added to column) 
 
#With the effect of subsampling taken into account. 
  
Luminescence of samples tested non-concurrently or with different LFs could not be compared, 
because LF activity was highly variable between LF preparations, and because the activity of any LF 
preparation reduced over time (see Chapter 2). This luminescence yield is only an approximate 




3.2.3 Separation of hot extracts in air, analysis by HPLC and concentration 
Hot extracts were initially separated on prepacked C18 columns in air, using water – organic phase 
gradients. Fractions were eluted with pressurized nitrogen and collected on ice to minimize luciferin 
degradation. However these initial reverse phase separations gave fractions that showed no 
luminescence when assayed with LF and ATP-Mg2+ despite the strong luminescence of the original 
HE, under the same luminescent assay conditions, with the same LF. 
 
 
Figure 3.5. Luminescent fractions produced from the separation of several glow-worm light organ (LO) hot extracts (total 
LO frozen mass shown), by bench reverse phase (C18) chromatography in air, using water – organic phase gradients. 
Bench column (BC) separations are numbered BC(number) and semi-preparative separations are numbered SP(number).  
Elution buffers contained 5 mM DTT. Figure shows the percent organic solvent (in the water: organic solvent mixture) 
that caused the elution of the luminescent fraction. Figure also shows the luminescent kinetics (P or L type) of each 
luminescent fraction and the luminescence yield. 
 
This was rectified by the addition of the reducing agent dithiothreitol (DTT) to the elution buffer. 
With DTT present, fractions were eluted that gave L type luminescence when assayed with LF and 
ATP-Mg2+ (Figure 3.5). These fractions were eluted with 13% or more of ethanol or acetonitrile 
(MeCN). All separations from BC4 onwards used MeCN rather than ethanol as the organic phase, to 
allow easy comparison between the bench column system and the HPLC set-up. 
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The initial concentration of active samples by freeze-drying gave samples that showed no 
luminescence when assayed (Figure 3.5). However, if fractions were handled only in nitrogen 
(including when dry), concentrated by freeze drying using the desiccator method (Figure 3.52), and 
only re-solubilized with degassed solvents, luminescence ability could be retained with yields of 99% 
(Figure 3.5). Concentration enabled the detection by luminescence of much smaller amounts of 
luciferin, and enabled samples to be studied by HPLC. Concentration also removed organic solvent 
which could otherwise inhibit the luminescent enzymes (Griebenow and Klibanov, 1996; Mozhaev et 
al., 1989). 
 
Analysis of concentrated active samples by HPLC-UV-Vis showed the presence of a large number of 
poorly-retained polar peaks. These peaks could not be well-retained or well-resolved on C18, even 
after HPLC method optimization. Analysis by thin layer chromatography (TLC) showed that the active 
samples contained many polar compounds that could be visualized using anisaldehyde or with 
ninhydrin. These compounds produced purple spots with ninhydrin, indicating that the main 
components of the fractions were amino acid based (McCaldin, 1960).  
 
An aqueous stable Synergi 4 µM hydro-RP C18 column was purchased, because these columns can 
be initially eluted with 100% water, which enables the better retention and separation of polar 
compounds (Layne, 2002). Even very polar molecules like uracil and ATP were well-retained using 
this column (tested as part of this research). An optimized hydro C18 method was produced to 
separate the polar peaks observed in GW active fractions (see section 3.4.1). Formic acid (FA) was 
not used as an acidity modifier in the HPLC mobile phase because it gave a large very broad peak in 
the area of interest, with a strong UV-absorption that extended up to 230 nm. This peak would 
therefore prevent the accurate visualization of non-aromatic molecules (such as amino acids) that 
elute around this retention time (Meek, 1980). FA is only problematic on hydro C18 columns 
because it is non-retained on regular C18 columns. Separation of concentrated active samples by 




3.2.4 Separation of hot extracts under N2 to give fractions showing L type kinetics 
Luminescence yields were increased by separating the GW HE under nitrogen rather than air 
(compare yields in Figure 3.5 to those in Figure 3.6). This demonstrated the importance of anaerobic 
technique. A nitrogen-filled glove bag and degassed solvents were therefore used for most 
chromatographic and handling steps post this point. When this was not possible, for example during 
the luminescence assay or HPLC analysis, only subsamples were exposed to air. Alternatively, 
samples were stored in air tight vials with gas-tight membranes. This setup enables subsamples to 
be extracted with a Hamilton syringe or HPLC automatic injection needle without exposing the bulk 
sample to oxygen. Punctured membranes were replaced as soon as possible under nitrogen. 
Samples were stored at – 80 °C or on dry ice whenever possible.  
 
 
Figure 3.6. Luminescent fractions produced from the separation of glow-worm hot extract (HE) by RP (C18) 
chromatography under nitrogen using water – acetonitrile (MeCN) gradients. Bench column (BC) separations are 
numbered BC(number) and semi-preparative separations are numbered SP(number). Bench chromatography elution 
buffers contained 5 mM DTT. Figure shows the percentage MeCN that caused the elution of the luminescent fraction, 




In these separations it was found that L type luminescent fractions could be eluted from the C18 by 
the addition of 5% or more acetonitrile (MeCN) and that they could be eluted under neutral or acidic 
conditions (Figure 3.6). These active fractions, when analyzed by HPLC (method 1) gave several 
peaks with retention times (RT) between 2 and 28 minutes (Figure 3.7). The concentrated active 
fractions were then separated by semi-preparative HPLC (SP-LC) under a nitrogen atmosphere. The 
oxygen free nitrogen atmosphere was produced by placing the SP-LC instrument inside a nitrogen-
filled glove bag, by using degassed solvents, and by stringently excluding oxygen. No activity was 
initially detected from any of the fractions collected (Figure 3.6) even though the column input 
showed high levels of luminescence with the same LF under the same conditions.  
 
Figure 3.7. HPLC chromatogram of an active fraction from bench column 5 showing UV-Vis absorption at 210 nm. 
Assignments were made based on the reinjection of standard samples of tryptophan, glutamyl tyrosine, phenylalanine, 





Figure 3.8. Luminescent activity of hot extract (HE) and 
an active fraction (F6) from bench column nine (BC9) 
with the addition of luciferase fraction (LF) and ATP-
Mg
2+
. All luminescent samples showed only L type 
luminescence. Replicates showed very similar 
luminescent traces. Luminescence was measured in 
luminescence units (LU). *Desiccated HE when 
rehydrated to the same volume gave the same 
luminescence if treated using the desiccator method 
(Figure 3.52). 
 
Figure 3.9. Luminescent activity of hot extract (HE) and an 
active fraction from semi-prep column six (SP6) with the 
addition of luciferase factions and ATP-Mg
2+
. All 
luminescent samples showed only L type luminescence. 
Replicates showed very similar luminescent traces. 
Luminescence was measured in luminescence units (LU). 
However, when DTT was added to the collecting vials in SP6, a semi-prep fraction was collected that 
showed strong L type luminescence (Figure 3.6, Figure 3.8 and Figure 3.9). This fraction was 
collected just after the tryptophan peak at 22.8 – 24.8 minutes (Figure 3.10). No UV-Vis peak could 
be detected in this area (apart from residual DTT), but a very small broad fluorescent peak was 
observed in the region. This small broad peak was also observed in the concentrated bench column 
fractions (Figure 3.10) but at variable retention times. Not enough material was collected to get a 
mass. Appendix 3. 1 shows the luminescent yields at each stage of this purification, and 
representative luminescence traces are shown in Figure 3.8 and Figure 3.9. It is not known why SP5 




Figure 3.10. HPLC chromatogram (Fluorescence A, see HPLC methods) of active fractions from BC9 and SP6. From bottom 
to top: BC9-F6, BC9-F7, BC9-F8, reinjected SP-LC active fraction collected from region (A) and SP6 SP-LC separation 
leading to the production of an active fraction collected at region (A). The material observed eluting at 14 minutes in the 
collected SP-LC active fraction could not have been collected in region (A). This indicated that this material was formed 
from the degradation of the material collected at (A).  
 
(A) Region isolated to 




Reinjected SP6 active fraction 
collected from region (A) 








3.2.5 Separation of hot extracts to give fractions showing both P and L type 
kinetics  
At this stage of the research HEs and lysates were first produced that showed both L and P type 
kinetics when assayed. The reason why such HE and lysates were not previously observed is not 
known. These HE could be separated by reverse phase (RP) bench chromatography to produce early 
eluting fractions that displayed P type luminescence and late eluting fractions that displayed L type 
luminescence (Figures 3.11, 3.12 and 3.13). A detailed summary of these purifications is given in 
Appendix 3. 2. Concentrated L and P type fractions were further separated by SP-LC but no SP 
fractions were produced that showed any luminescent activity with LF and ATP-Mg2+ even when DTT 
was put in the collecting vials. A detailed summary of these purifications is given in Appendix 3. 2. 
 
 Figure 3.11. Luminescent fractions produced from the separation of hot extracts showing L+P type luminescence by 
reverse phase chromatography under a nitrogen atmosphere and using water – acetonitrile gradients. Bench column 
(BC) separations are numbered BC(number) and semi-preparative separations are numbered SP(number).  Bench 
chromatography elution buffers contained 5 mM DTT. Figure shows percent acetonitrile that caused the elution of the 





Figure 3.12. The luminescent activity of hot extract (HE) 
and active fractions from BC9 with the addition of 
luciferase fraction (LF) and ATP-Mg
2+
. HE shows L type 
character by showing a high initial luminescence but 
shows P type character by the fact that this 
luminescence slowly increases then slowly decreases. 
This gives HE a mixed L+P character. Late eluting 
fractions F5 and F6 in contrast show typical P type 
luminescence while early eluting fraction F1 shows 
typical L type luminescence. Luminescence was 
measured in luminescence units (LU).  
 
 
Figure 3.13. Integrated luminescence over 203 s of hot extract 
(HE) and concentrated fractions from BC10 with the addition 
of luciferase fraction and ATP-Mg
2+
. The luminescence kinetics 









3.2.6 Separation of fractions showing both P and L type kinetics 
In BC12 (Figure 3.14) all luminescent components were eluted into one fraction using 55% 
acetonitrile. This fraction, which showed strong L + P luminescence, was concentrated, then 
separated by SP-LC into a few broad fractions. A fraction collected between 0 and 14 minutes, 
showed very weak P type luminescence activity. This fraction could not be analyzed by LC-MS due to 
the high concentrations of MOPS buffer present in the sample. However, concentration and further 
semi-prep separation of this fraction resulted in no luminescent  semi-prep fractions (Figure 3.14). 
 
 
Figure 3.14. Luminescent fractions produced from the separation of hot extracts by bench reverse phase 
chromatography under nitrogen using water – acetonitrile (MeCN) gradients. Bench column (BC) separations are 
numbered BC(number) and semi-preparative separations are numbered SP(number). Figure shows percent organics that 
caused the elution of the  luminescent fraction, the luminescence kinetics (P or L type) of each luminescent fraction, and 
the luminescence yield (from  input).  
In BC13 (Figure 3.14) an NH4HCO3 buffer was used instead of MOPS to produce the GW lysate 
because NH4HCO3 could be removed by vacuum, to produce an sample free of buffer, that could 
more easily be studied by LC-MS. In BC13 (Figure 3.14), HE was separated by bench column 
chromatography into many small fractions using a very shallow water – MeCN gradient. These 
fractions were assayed, then analyzed by HPLC and Orbitrap nanoflow LC-MS. Formic acid was added 
to the bench column assay buffers to increase compound retention and separation. The reducing 
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agent TCEP (tris(2-carboxyethyl)phosphine) was added to the column buffers because it is a much 
stronger reducing agent than DTT under acidic conditions (Burns et al., 1991). BC13 gave early 
eluting fractions with P type luminescence (Figure 3.15), and late eluting fractions with L type 
luminescence (Figure 3.16). This was consistent with what had previously been observed in BC9 and 
BC10.  
 
Figure 3.15. The representative luminescence activity of 
early eluting active column fractions from BC13 with the 
addition of luciferase fraction (LF) and ATP-Mg
2+
. The 
luminescent fractions show P type luminescence. Brackets 
show percent luminescent yield from hot extract.  Some 
P+L character may be observed but this is due to the 
background L character of the LF. Luminescence was 
measured in luminescence units (LU). 
 
Figure 3.16. The luminescence activity of several late 
eluting active column fractions from BC13 with the 
addition of luciferase fraction (LF) and ATP-Mg
2+
. The 
luminescent fractions show L type luminescence. Brackets 
show percent luminescent yield from hot extract. 
Luminescence was measured in luminescence units (LU). 
 
Concentrated active fraction 8 (the most active L type fraction, see Figure 3.16) was then twice 
separated by SP-LC. In the first instance, 500 µl of concentrated material was added (Figure 3.20). 
This separation did not show good chromatography and  displayed early component elution and 
poor compound resolution compared to that observed from smaller injections of the same mixture 
(Figure 3.20). This probably occurred because the injected mixture contained too much acetonitrile 
for the volume injected. Full details of this purification are given in Appendix 3. 4. Fractions 11 – 15 
of this SP separation showed low levels of L type luminescence activity when assayed (Figure 3.17 
and Figure 3.18).  
 
Fractions 11 – 15 were combined and reseparated by SP-LC (SP13) (Figure 3.14). This separation 
showed good chromatography but no active fractions were produced (Figure 3.14). BC12 fraction 8 
was therefore further concentrated to remove any remaining MeCN, and then re-separated by SP-LC 
(SP14). This separation again showed good chromatography but no active fractions were produced 




Figure 3.17. The luminescence activity of several active 
column fractions from SP12 with the addition of 
luciferase fraction and ATP-Mg
2+
. Luminescent fractions 
showed L type luminescence. Luminescence was 
measured in luminescence units (LU). 
 
Figure 3.18. The integrated (over 200 s) luminescence 
activity of initial injected material and active column 
fractions from SP12 with the addition of luciferase 
fraction (LF) and ATP-Mg
2+
. Fractions showed L type 
luminescence. Error bars show one standard deviation 
above and below the mean (n= 2). Luminescence was 
measured in luminescence units (LU). 
 
 
Figure 3.19. HPLC chromatogram (220 nm) of several active fractions from SP12.  
Each BC13 and SP12 fraction was then analysed by HPLC-UV-Vis and by high resolution 
Orbitrap nanoflow LC-MS. Active bench column fractions, were found to mainly contain tris(2-
carboxyethyl)phosphine (TCEP), while active SP fractions were found to mainly contain tryptophan. 
However, higher concentrations of tryptophan were found in fractions that eluted previous to the 
active fractions showing that tryptophan was not the luminescent molecule. HPLC-UV-Vis analysis 
(Figure 3.19) also showed that the active semi-prep fraction contained mainly tryptophan. This 
indicated that the luciferin peak eluted close to tryptophan on C18. Several other minor components 




Figure 3.20. HPLC chromatogram (FlA) of separation SP6 and SP12 and the active fractions resulting from these 
separations. 
Several difficulties were encountered during LC-MS analysis. The first was that the bench column 
fractions contained much more TCEP than any GW compound. It was therefore difficult to add 
enough material to allow the compounds of GW origin to be analysed, without overloading the 
column. Furthermore TCEP, which was un-retained under this system, tended to swamp the signals 
of all other polar components. A similar problem was encountered in the analysis of the active SP 
fractions, which were hugely dominated by the tryptophan peak. Many of the highly polar materials 
found in early eluting P type fractions were also un-retained on the nanoflow C18 column indicating 
that this set up may be  unsuitable for the analysis of early eluting P type fractions. The nanoflow LC-
MS system also lacked UV-Vis detection making it difficult to compare UV-Vis peaks between HPLC-
UV-Vis and LC-MS. 
 
SP12 Fractions 11 – 15 were combined, concentrated then re-separated by SP-LC (300 µl injection; 
SP13) (Figure 3.14). The chromatography of this separation was good, giving a range of peaks 
between 15 and 26 minutes, but no luminescent active fractions were produced.  
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3.2.7 Tyrosine isolation 
In BC separations 14 and 15, the purification was scaled up to increase the likelihood of producing a 
strongly active SP-LC fraction (Figure 3.21). Reducing agent and buffer was not added to the column 
mobile phases, because the concentration of reducing agent would be vastly greater than that of the 
luciferin, making LC-MS difficult. 
 
Figure 3.21. Luminescent fractions produced from the separation of hot extracts (produced under N2 with no reducing 
agent) by bench C18 chromatography under N2, using water – acetonitrile gradients. Bench column (BC) separations are 
numbered BC(number) and semi-preparative separations are numbered SP(number). Figure shows percent acetonitrile 
(MeCN) that caused the elution of the luminescent fraction, the luminescence kinetics (P or L type) of each luminescent 
fraction, and the luminescence yield (from input). 
It was hoped that the stringent use of anaerobic conditions would allow the luciferin’s survival. 
However, BC separations 14 and 15 showed only early eluting P type luminescent fractions, with no 
sign of the late eluting L type fractions (Figure 3.21 and Figure 3.22). These active P type fractions 
were concentrated and separated by SP-LC under nitrogen (SP11, SP12). In both cases, a fraction 
was collected at 8.19 – 8.68 minutes (fraction 17), that when concentrated and tested using the 
luminescence assay showed a weak P type luminescence (Figure 3.23). A detailed summary of these 




Figure 3.22. Luminescence of hot extract (HE) and concentrated active fractions from BC15 (F1, F2) and SP16 (F17) with 
the addition of a luciferase fraction (LF) and ATP-Mg
2+
. Luminescence was measured in luminescence units (LU) using the 
POLARstar. 
 
Fractions from SP15 were rehydrated with MOPS buffer 2 containing 2 mM DTT and then 
immediately tested by luminescence assay, in order to best preserve what was possibly a highly 
unstable compound. This active fraction could not be analyzed by LC-MS, due to the high 
concentrations of MOPS buffer and reducing agent. SP16 in contrast was rehydrated with water, and 
back injection of the SP16 P type luminescent fraction showed a good quantity of one relatively pure 
compound (95% pure at 210 nm). 
 
This sample (F17) was therefore taken to Lincoln New Zealand (frozen in a dry shipper), where it was 
analyzed by milli-flow Ion-trap LC-MS and MS2. Samples were analysed by milli-flow Ion-trap because 
the Orbitrap Nano flow LC-MS had proved unsuitable for the analysis of highly polar materials. The 
Ion-trap LC-MS in contrast could be used with the milli flow HPLC methods which had been 
optimized for polar resolution. However, the ion trap MS only gave low resolution mass data. The 
Ion-trap LC-MS set up also contained a photodiode array which could take UV-Vis spectra. F17 was 
analysed in negative ion mode because no peaks were initially observed in positive ion mode. All 
remaining F17 material was used to get a good LC-MS chromatogram because the ion-trap milli flow 
system was far less sensitive and required far larger sample injections than the Orbitrap system (20 




 Figure 3.23. HPLC-UV (210 nm) chromatogram of the 
separation of BC15 F1 (red). Green horizontal line shows 
peak collection of F17 from F1.  
 
Figure 3.24. LC-MS and LC–UV-Vis (210 nm) 
chromatogram of SP F17 when analysed by Ion-trap LC-
MS (0.1% FA). Blue: Total ion curent, Red: UV-Vis (210 
nm). Leucine (7.9 minutes, no UV- vis absorption) X (8.87 
minutes, 232, 267 nm), tyrosine (9.04 minutes 231, 274 
nm). 
 
Milli-flow Ion-trap LC-MS and MS2 analysis showed  F17 to contain tyrosine, leucine, and an 
unknown compound X which was later identified as 3-OH kynurenine (3.2, Figure 3.23, Figure 3.24). 
Only one major peak was observed by HPLC because tyrosine and 3-OH kynurenine co-elute whilst 
leucine has no chromophore. The identities of leucine and tyrosine was confirmed by the injection of 
commercial standards. Analysis of GW HE by Orbitrap Nanoflow LC-MS and LC-MS2, then provided 
high resolution MS and MS2 data for tyrosine, leucine, and unknown compound X (Table 3.1).  
 
3.1. L-Tyrosine** (active component) 
 




Figure 3.25. Compounds found in purified early eluting P type luminescent fraction. 
 





 fragmentation spectra (MS
2
) of the major components in F17 as analysed by milli-flow Ion-trap in 
negative mode and nanoflow Orbitrap, in positive mode. 
Compound 3-OH kynurenine (X) 
UV-Vis max: 232, 267 nm 
Tyrosine 













































































































































Compound Leucine, UV-Vis max: 232, 274 
LC-MS 
Ion-trap, 
negative ion mode 
Orbitrap, positive ion mode 
Retention time 7.93 min 5.00 min 













113: [M - H2O]
-
 - 
103: [M- NH3 - H]
-
 105.0698: [M- NH3 + H]
+
 






Fractions used in production of F17 were also examined by milli-flow Ion-trap LC-MS. F1, the P type 
BC fraction, contained mainly valine, phenylalanine, leucine, tyrosine, 3-OH kynurenine, and a range 
of glutamyl amino acids (glutamyl valine, glutamyl tyrosine and glutamyl leucine) (Figure 3.26). F5, 
the fraction that in other purifications displayed L type luminescence, was found to contain only the 
aromatic amino acids, phenylalanine and tryptophan. These fractions were analysed in positive and 
negative mode, and compounds were identified by comparing low resolution MS and MS2 spectra to 
the literature (Horai et al., 2012). These molecules are discussed in more detail in section 3.2.12 
where they are characterised by high resolutions MS and MS2 and in some cases compared to 
commercial standards. 
 
3.9. Glutamyl leucine* 
 
 
3.10.  Glutamyl valine*  












3.2.8 3-OH kynurenine identification 
Compound X showed a similar UV – Vis spectrum to tyrosine, and had a m/z [M-H]- of 223 Da. When 
analysed by LC-MS2 the X [M-H]- ion was found to initially lose NH3 to form a m/z: 206 Da ion, which 
then fragmented to give the same two major peaks as tyrosine: the m/z 93 negative ion which 
indicated a [C6H5O]
- phenol fragment, and the m/z 163 negative ion which in tyrosine represents [M 
– (NH3 + H)]
- (Table 3.1). This suggested that X was a tyrosine derivative.  
 
Analysis of GW HE by high resolution LC-MS (Orbitrap nanoflow LC-MS, positive mode) gave high 
resolution data which showed that X had a [M+H]+ of 225.0867, which indicated a molecular formula 
of C10H12N2O4 (Table 3.1). C10H12N2O4 suggested 4823 compounds in the Chemical Abstracts 
(27/12/15). Of these N-carbamyl tyrosine (3.22) was initially investigated, because it was a tyrosine 
derivative and a known natural product (see Chapter 6). However, neither N-carbamyl tyrosine 
(3.22) nor its isomer phenol-O-carbamyl tyrosine (3. 23) proved to be X (see Chapter 6). Compound X 
was later found to be 3-OH kynurenine (3.2), and commercial 3.2 was found to be identical to X by 
MS and MS2, UV-Vis absorbance and LC retention time (i.e. just previous to tyrosine on the ion trap 




3.22. L-N-carbamyl tyrosine 
 
3.23. L-Phenol-O-carbamyl tyrosine 
Figure 3.27. N-carbamyl tyrosine and O-carbamyl tyrosine 
3-OH kynurenine (3.2) is a metabolite of the kynurenine pathway (Guilbault, 1990). The kynurenine 
pathway begins with tryptophan and generates a variety of important molecules, many of which also 
show blue fluorescence e.g. NADH (3.20): λem: 460 nm (Guilbault, 1990),  kynurenine (3.21) λem: 480 
nm (Chang et al., 1990) and the molecule responsible for the blue death fluorescence observed in 
the nematode C. elegans; anthranilic acid glucosyl ester (3.18);  λem : 430 nm (Coburn et al., 2013; 
Coburn and Gems, 2013).  




3-OH kynurenine (3.2) in contrast is not initially fluorescent, but it forms a variety of blue fluorescent 
substances after reactions with peptides (λem: 465 nm on excitation at 370 nm) (Chang et al., 1990; 
Dillon et al., 1999). This was interesting as a complex range of over 40 different blue fluorescence 
substances (BFS) with similar absorbance and fluorescence spectra were generated in the reaction 
mixtures over several days, if peptidic material was not removed. If peptidic material was 
immediately removed from the reaction mixtures (by heat treatment and centrifugation or RP 
chromatography) following the reaction, no BFS were produced. These reaction products were 
formed regardless of whether luminescence had occurred. Several of these substances were 
partially purified and analysed by LC-MS. However, structural elucidation has proved difficult, and 
since the molecules do not appear to be directly related to luminescence they have not been 
discussed in this thesis. 
 
 
3.18 Anthranilic acid glucosyl ester 
 
 
3.19 Anthranilic acid 




Figure 3.28. Several kynurenine pathway metabolites. 
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3.2.9 Tyrosine luminescence 
Pure commercial samples of L-tyrosine was found to produce P type luminescence with LF and ATP-
Mg2+ in a dose dependent manner (Figure 3.29) and the light emitted was found to have the same 
luminescence spectra as live GW (Figure 3.30). These experiments showed that L-tyrosine was 
responsible for the luminescent activity of luminescent SP fraction F17, and for the P type 
luminescence in early eluting fractions. These findings were presented at the 18th International 
Symposium on Bioluminescence and Chemiluminescence (Watkins et al., 2014). The dip in the 
luminescence spectra at 522 nm is possibly caused by the presence of other absorbing compounds in 
the luciferase fraction (Figure 3.30). The addition of tyrosine to fractions showing L type 
luminescence produced L+P type kinetics (Figure 3.31) which suggested that tyrosine caused P but 
not L type luminescence. D–tyrosine, leucine and 3-OH kynurenine produced no luminescence above 
the control when tested with LF and ATP-Mg2+.  
 
Figure 3.29. Luminescence of L-tyrosine at varying concentrations with luciferase fraction and ATP-Mg
2+
. Addition of 
tyrosine at concentrations above 0.05 mmol/L caused a dose dependent increase in luminescence. Each data point 
on each trace is an average of three replicate samples. The average standard deviation between replicate data 




Figure 3.30. Luminescence emission spectra of tyrosine 
and BC15 hot extract (HE) with luciferase fraction (LF) and 
ATP-Mg
2+
. The luminescence intensity of tyrosine has 
been doubled for better comparison.  
 
Figure 3.31. Luminescence of a fraction showing L type 
luminescence (BC13, F9) with the addition of BC13 LF 
and ATP-Mg
2+
, and the conversion of this luminescence 
to L+P type caused by the addition of tyrosine (5 µl, 








L + P 
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luminescence units (LU) using the Clariostar.  
However, some LFs that produced good amounts of L type  luminesecnce with HE and ATP-Mg2+ 
produced no or very weak luminesecence with tyrosine (Figure 3.32).   
 

























“L+ P type” kinetics 
“L+ P type” kinetics but with 
an extremely reduced P 
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 This LF appears to strongly 
catalyse the proceses that 
cause P type kinetics and 
those that cause L type 
kinetics. 
This LF appears appears to 
weakly catalyse the proceses 
that cause P type kinetics 
and strongly catalyse those 
that cause L type kinetics. 
This LF appears to only 
catalyse the proceses that 
cause L type kinetics  
Figure 3.32. Luminescence of hot extract (HE) 3.2.2 or tyrosine (Tyr) with three different luciferase fractions (LFs) and 
ATP-Mg
2+
. Each data point: sample average (mean n=3) – control average (mean n=3).  Reaction mixtures contained LF in 
MOPS buffer 2 with DTT and 5 µl of either sample (HE or 0.25 µg /mL Tyr) or water (control). Luminescence initiated by 
the addition of ATP-Mg
2+
 solution (30 µl). Luminescence was measured in luminescence units (LU) using the Clariostar. 
Tyrosine luminesced well with LFs that showed good P type ability with HE, luminesced less well with 
LFs with a reduced P type ability with HE, and produced no luminescence with LFs that did not show 
P type activity with HE (Figure 3.32). This suggested that tyrosine was not the limiting factor in the 
luminescent reaction of tyrosine and LF and indicated that other component/s may be added with 




LFs that did not produce light with tyrosine and ATP-Mg2+ still produced L type luminescence with 
active HE and ATP-Mg2+. In contrast, any LF that could produce P type luminescence with tyrosine 
and ATP-Mg2+ also produced L type luminescence with an active HE and ATP-Mg2+. This indicated 
that the step that produced L type luminescence could be taken without the step necessary for P 
type luminescence. 
 
It was also found that over time lysates that initially showed both P and L type kinetic behavior lost 
their ability to show P type behavior and showed only L type (Figure 3.33). Furthermore LFs that 
initially showed both P and L type kinetic behavior with HE lost their ability to show P type behavior 
and showed only L type, even when the HE was protected from degradation by being stored as 
subsamples on dry ice (Figure 3.34). This indicated that the factor in LF that enabled P type 
luminescence decreased over time.  
 
 
Figure 3.33. The luminescent reaction of lysate (3.2.7) with 
ATP-Mg
2+
. Lysate luminescence initially (red) and after 20 
minutes stored on ice (blue). LF with ATP-Mg
2+
 in this case 
produced no luminescence. Luminescence was measured 




Figure 3.34. The luminescent reaction of a luciferase 
fraction initially (red) and after 20 minutes on ice (blue) 
with hot extract and ATP-Mg
2+
. Samples used: hot extract 
3.2.2 (two subsamples, both kept on dry ice until required) 
and luciferase fraction 3.2.2 (one sample, kept on ice for 
duration of experiment). LF with ATP-Mg
2+
 in this case 
produced no luminescence. Luminescence was measured 
in luminescence units (LU) using the Clariostar 
luminometer. 
These findings led to the suggestion that tyrosine could be a luciferin precursor that was converted 
into GW luciferin (the molecule responsible for L type luminescence) by an unknown process under 
assay conditions (Figure 3.35). It was hypothesized that LFs capable of showing P type activity 
contained a component/s that enabled the conversion of tyrosine to GW luciferin, while other LFs 
lacked this component/s. This component, rather than tyrosine, would be the limiting factor in the P 
type reaction. It was not known whether the missing component was an enzyme that catalysed the 
Initial: L+P 
After 20 min: 
 L+P with reduced 
P 
After 20 min: 




conversion of tyrosine to luciferin, the availability of another luciferin precursor, or an enzymatic 
cofactor, or even a mixture of components. 
 
 
Figure 3.35. The proposed synthesis of glow-worm luciferin from tyrosine and the reaction of glow-worm luciferin with 
ATP-Mg
2+
, O2 and luciferase to produce light. 
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3.2.10 Xanthurenic acid isolation 
Research into tyrosine luminescence had suggested that tyrosine required a second component to 
produce P type luminescence. A lysate showing strong P type luminescence was therefore separated 
by RP chromatography using column buffers containing the reducing agents: tris(2-
carboxyethyl)phosphine (TCEP) and  mecaptoethanol (BME) and 0.1% formic acid (BC16, see Figure 
3.36). A fraction that showed strong luminescent activity (P type) was found to elute with 20% MeCN 
(0.1% formic acid) (Figure 3.37).  
 
Figure 3.36. Luminescent fractions produced from the separation of hot extracts by bench C18 chromatography under 
nitrogen using a water – acetonitrile (MeCN) gradient. Bench reverse phase chromatography elution buffers contained 
TCEP and β mercaptoethanol. Semipreparative chromatography elution buffers contained β mercaptoethanol. Figure 
shows the percent acetonitrile that caused elution of luminescent fraction, luminescent kinetics, and percentage 
luminescent yield (from column input not from hot extract and without the addition of tyrosine). Luminescent 
percentage yields are not a useful way of determining XA extraction yields since sample luminescence also depends on 
the concentration of tyrosine and of inhibiting compounds.  
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This fraction was separated by SP-LC under nitrogen (SP17, Figure 3.36). Fractions were collected by 
hand rather than by using the automatic fraction collector that was used in previous separations. 
This enabled fractions to be frozen and sealed immediately on dry ice, reducing sample degradation 
(see below).  
 
Automatic collection under N2 
Samples are left in solution at room temperature possibly for up to 40 minutes because samples 
cannot be removed until run is stopped. 
 
Hand collection under nitrogen: 
Samples can be immediately frozen on dry ice. 
 
BME was also added to the HPLC buffers to preserve unstable components. BME was chosen as the 
reducing agent because it could be removed from samples by vacuum. No acid was used in the LC 
buffers, because BME only acts as a reducing agent under neutral conditions. However, FA was 
added to the initial injected material (to a concentration of 0.1%) so that all compounds were 
retained on the column. The semi-prep fractions produced were assayed for luminescent activity. 
 
Two fractions that eluted with 80% MeCN (collected 34.0 - 34.5 (F53) and 34.5 - 35.0 (F54) minutes  
showed a strong P type luminescence when assayed with LF and ATP-Mg2+ (Figure 3.37), and a very 

















Figure 3.37. The luminesence of hot extract (HE) and concentrated bench semi-preparative column fractions (BC16 and 
SP17) with luciferase fraction (LF) and ATP-Mg
2+
. Luminescence was measured in luminescence units (LU) on the 
Clariostar luminometer. All luminescent samples showed P type luminescence. (A) Representative luminesent traces of 
the hot extract and luminescent bench column fraction containing reaction mixtures. (B) Representative luminesent 
traces luminescent semi-prep fraction containing reaction mixtures. (C) Integrated (Int) luminescence (over 2000 s/ µl 









Figure 3.38. The luminesence of hot extract (HE) and concentrated semi-preparative column fractions (SP17) with 
luciferase fraction (LF) and ATP-Mg
2+
 and the effect on luminescence caused by the addition of tyrosine. Luminescence 
was measured in luminescence units (LU) on the Clariostar luminometer. All luminescent samples showed P type 
luminescence. (A) Representative luminesent traces of SP16 fractions with the addition of LF and ATP-Mg
2+ 
with and 
without tyrosine. (B) Representative luminesent traces of LF and ATP-Mg
2+ 
(ATP) with and without tyrosine. (C) 
Integrated (Int) luminescence (over 2000 s/ µl sample) of SP16 fractions with the addition of LF and ATP-Mg
2+  
(ATP) with 
and without tyrosine. (D) Integrated (Int) luminescence (over 2000 s/ µl sample) of of LF and ATP-Mg
2+ 
(ATP) with and 
without tyrosine.  
The most active semipreparative fraction (F54) was found by LC-MS (Orbitrap) to contain mainly 
xanthurenic acid (XA) and a small amount of riboflavin (Figure 3.42). These compounds were 
identified by high resolution MS and MS2 fragmentation analysis. These identities were confirmed by 
comparison to pure purchased standards (MS, MS2, UV-Vis spectra and LC retention time). The main 








Figure 3.39 Compounds found in late eluting P type luminescent fraction. All isolated compounds were identical to 
purchased standards by LC retention time, MS, MS
2
 and UV-Vis spectra (shown by Compound**). 
RT: 0.00 - 29.96
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Figure 3.40. Total ion current (TIC) and extracted ion current (EIC) chromatograms of SP13 F54 by Orbitrap nanoflow LC-
MS. XA EIC m/z: 206.04- 206.05 Da, Riboflavin EIC m/z: 377.14-377.15 Da. 
 









P2_9_15_SP_54_BA6_01_2410.d: UV Chromatogram, 270 nm xatharenic_acid_BA6_01_2479.d: UV Chromatogram, 270 nm
Riboflavin_BB1_01_2484.d: UV Chromatogram, 270 nm
 
Figure 3.41. HPLC-UV-Vis (met 1 with 0.1%, 350 nm)  FA chromatogram of SP13 F54 (green), pure xanthurenic acid 









Figure 3.42. Ions found to be concentrated in SP17 F54 and their relative amounts in the surrounding fractions and in 
BC16, F2. MS
2
 spectra for these compounds are shown in Appendix 3. 4. 
Riboflavin did not boost LF and ATP-Mg2+ luminescence either with or without tyrosine (Figure 3.43). 
XA produced weak P type luminescence with LF and ATP-Mg2+ (increased compared to control), but a 
strong P type luminescence with tyrosine, LF and ATP-Mg2+  (very increased compared to 
control)(Figures 3.43 and 3.44). The intensity of light produced by synthetic XA was similar to that 
produced from isolated fractions containing a similar concentration of XA (Figure 3.35).  
 
In the replicated experiment described in Figure 3.44, the addition of ATP-Mg2+ led to a five times 
increase in luminescence above LF alone, while addition of XA or tyrosine led to five times 
luminescence increase above ATP-Mg2+ and LF. Addition of both XA and tyrosine led to luminescence 
112 times ATP-Mg2+ alone (Figure 3.44). This indicated that LF, tyrosine, XA and ATP-Mg2+ were all 
















Figure 3.43. The luminesence of xanthurenic acid (XA, 2.8 nMol added), riboflavin (Rib, 2 nmol added), tyrosine (Tyr, 2 
nmol added) and fraction SP17-F54 (estimated 1.43 nmol XA added), with luciferase fraction (E) and ATP-Mg
2+
 (ATP). 
Addition of similar amounts of synthetic and isolated XA to the assay gave similar luminescent intensities. Luminescence 
was measured in luminescence units (LU) on the Clariostar luminometer and graph shows integrated (int) luminescence 
over 2000 s/ µl sample). All luminescent samples showed P type luminescence. Note: the reaction mixtures shown here 
were completed as part of the same experiment as those shown in Figure 3.38 using the same LF. 
 
Figure 3.44. The addition of xanthurenic acid (X) or tyrosine (T) to reaction mixtures containing luciferase fraction BC16 LF 
(E) and ATP-Mg
2+
 (ATP) boosted luminescence. However the addition of both XA and tyrosine boosted luminescence to a 
much greater extent. Luminescence is expressed as integrated (int) luminescence units over five hours thirty minutes. 
Luminescence was measured on the Clariostar luminometer. Error bars show 1 standard deviation above and below the 





Figure 3.45. The proposed synthesis of glow-worm luciferin from tyrosine (Tyr) and xanthurenic acid (XA) followed by the 
reaction of glow-worm luciferin with ATP-Mg
2+
 O2 and luciferase to produce light. 
Tyrosine and XA displayed P type luminescent kinetics with LF and ATP-Mg2+. This suggests that 
tyrosine and XA do not immediately react with GW luciferase and ATP-Mg2+. Instead the slow rise to 
a maximum suggests that tyrosine and XA must be converted into luciferin by another process, 
producing a coupled reaction (Yang and Schulz, 1987) as shown in Figure 3.45. If reaction 2 is fast 
compared to reaction 1, the reaction of luciferin by 2 will reach a luminescent maxima much more 
quickly than the reaction of XA and Tyr by 1 and 2. This would cause the reaction of XA and Tyr by 1 
and 2 to produce P type luminescence, but the reaction of luciferin by 2 to cause L type 
luminescence. The kinetics of both processes are described below. When both processes occur, L+P 
type luminescence kinetics would be produced. These findings indicated that that both XA and 
tyrosine were precursors to GW luciferin (Figure 3.45).  
P type kinetics 
 Initially no luciferin is present, so no luminescence is produced 
 The luminescence increase depends on luciferin formation (reaction 1, slow), resulting in a 
slow increase in luminescence, until a maximum is reached, in which the formation of 
luciferin is equal to its destruction via enzymatic and oxidative pathways. 
 The luminescence then falls, due to luciferase degradation, product inhibition or decrease in 
luciferin concentrations, depending on which first becomes limiting. A decrease in luciferin 




L type kinetics 
 Initially luciferin is present, so the luminescence increases depends on reaction 2 (fast), 
resulting in a fast increase in luminescence until a maximum is produced in which the 
formation of luminescent intermediate (of the slowest luminescent step) is equal to its 
disappearance. This appears to take a few seconds. 
 Luminescence then falls as the GW LUC becomes less active, or the luciferin supply decreases 
depending on which is the limiting factor. 
Figure 3.46 shows the luminescence at 10 °C of a large scale reaction mixture containing GW lysate, 
XA, tyrosine and ATP-Mg2+, as measured by a Cary luminometer over 61 hours.  The luminescence 
spectrum of the reaction matched that of both lysate and GW luminescence (Figure 3.46). This 
experiment also showed that the luminescent reaction could continue for several days if the reaction 
mixture is kept at 10°C. 
 
 
Figure 3.46. The luminescence of xanthurenic acid (XA) and tyrosine (Tyr)  with glow-worm lysate and ATP-Mg
2+  
at 10 °C 
as measured by a Cary luminometer. A: Luminescence emission spectrum of the reaction of tyrosine and xanthurenic 
acid with lysate and ATP-Mg
2+
 taken 30 minutes after the reaction was initiated. Luminescence was measured in 
luminescence units (LU). max: 480 nm. B: Representative luminescence time courses over 61 hours. The initial addition 
of XA and Tyr to lysate and ATP-Mg
2+
 increased luminescence above the initial baseline luminescence of lysate with ATP-
Mg
2+
 (D). Luminescence rose slowly until it reached a maximum after 1 hour (A).  Addition of further ATP, Mg
2+
, XA or 
Tyr in the first 4 hours did not further increase luminescence. Addition of ATP-Mg
2+
 at 19 hours (B) caused the 
luminescence to increase and reach a second maximum at 21 hours (C). Luminescence was not detectable after 61 
hours, and addition of further ATP, XA or Tyr after this point did not recover luminescence. 
If the proposal described in Figure 3.45 is correct, any LF that displays P type luminescence must 
contain both active LSE and LUC. The pre-incubation of XA and tyrosine with such an LF should 
therefore cause GW luciferin to be built up in the reaction mixture. When ATP-Mg2+ is added to such 
a solution some L type kinetic behaviour should be observed due to the presence of some 





type luminescence even after the incubation of XA and Tyr with LF for over an hour. This suggested 
that the process that coverts XA and tyrosine into the luciferin requires the addition of ATP-Mg2+ 
which suggested that LSE, like GW luciferase, may require ATP. These results also show that for this 
reaction even replicate samples tested at the same time can produce variable amounts of 
luminescence (Figure 3.47). The reason for this is not known. 
 
Blue: LF incubated with tyrosine (Tyr) and xanthurenic acid 
(XA) with ATP-Mg
2+
 added after 20 minutes (n=3). 
Red: LF incubated without Tyr and XA, with Tyr, XA, Mg
2+
 
and ATP added after 20 minutes (n=3). 
 
Blue LF incubated with tyrosine (Tyr) and xanthurenic acid 
(XA), with ATP-Mg
2+
 added after 8 minutes (n=3). 
Orange: LF incubated without Tyr and XA with Tyr,  XA, Mg
2+
 
and ATP added after 81 minutes (n=3). 
Figure 3.47. Reaction mixture luminescence after incubation with or without xanthurenic acid (XA) and tyrosine (Tyr). 
Reaction mixtures initially contained luciferase fraction (LF), MOPS buffer 2 with DTT and in some cases XA and Tyr.  
Samples were incubated in a 96 well plate, for (A) 20 minutes and (B) 81 minutes at room temperature. Luminescence 
was then initiated by the addition of ATP-Mg
2+   
and (if not previously added) XA and Tyr. Luminescence was measured in 
luminescence units (LU). 
3.2.11 A discussion on why P type luminescence was sometimes not observed 
If the luminescence process described in Figure 3.45 is correct, luminescence depends on the 
concentration of tyrosine and XA and on the activity of GW LSE and GW LUC. For a GW lysate to 
display P type activity, tyrosine, XA, active LSE and active LUC must all be extracted into aqueous 
buffer. The early L type lysates may therefore have lacked either tyrosine, XA, or active LSE, but 
contained both active luciferin and GW LUC. Later L + P type lysates, in contrast, must have allowed 
for the extraction and preservation of all components. 
 
Tyrosine has limited solubility in water at neutral pH (0.45 mg/ml at 25°C (Brown, 1991)) while XA is 
nearly insoluble in acidic or neutral water solutions, but soluble in alkaline aqueous solutions (10 
mg/ml) (Lepkovsky et al., 1943). It is therefore likely that in many extractions, tyrosine or XA were 
not extracted into the lysate. Both molecules also precipitate easily in neutral or acidic solutions at 
cooler temperatures (my observation). Tyrosine and XA may therefore have been lost via 




Tyrosine is substantially more polar than XA and the two molecules elute separately on C18 with 
tyrosine eluting with water and XA eluting with 20% MeCN. Crude bench column separations are 
likely to incompletely resolve XA from tyrosine, resulting in fractions that still show P type 
luminescence. In contrast, semi-preparative HPLC fractions are likely to contain either XA or tyrosine 
but not both. These samples will only luminesce when tested with LFs that contain enough residual 
tyrosine or XA as well as containing active LSE and active LUC. This explains why purified semi-
preparative fractions containing tyrosine often produced no luminescence, even when tested with 
LFs that showed strong L type luminesce with HE (i.e. containing a strongly active GW LUC). 
 
Column fractions may also lack XA and tyrosine due to losses during the purification procedure. 
Since XA is highly insoluble in water, it would be lost by precipitation when kept on ice and during 
concentration. XA is also extremely difficult to re-solubilise once precipitated and XA solutions 
produced for these experiments were produced by dissolving XA into sodium carbonate solutions. It 
is thus likely that much XA was lost when dried fractions were resoluabilised in water. 
 
Chromatography would have also changed the solubility of XA and Tyr, separating them away from 
some pH and ionic strength modifiers that may increase their solubility while concentrating them 
with other modifiers that may decrease their solubility. Both compounds are more soluble under 
basic aqueous conditions than acidic aqueous conditions and so would be less soluble with DTT 
which makes solutions acidic, and are likely to be more soluble with metabolites like glycine that 
make the solution more “hydrophobic like” (Carta and Tola, 1996). Given that XA is insoluble in 
water and tyrosine has very low water solubility, it is quite likely that the GW luciferin and the GW 
luminescent reaction product (LRP) may also have low solubilities in water. For this reason, when 








LF F1 shows very weak residual L type luminescence with 
ATP-Mg
2+
. This is increased to a weak P type 
luminescence by the addition of XA and tyrosine. 
 
LF F2 shows very weak residual L type luminescence with ATP-
Mg
2+
. This is increased to a strong P type luminescence by the 
addition of XA and tyrosine. 
Figure 3.48. The luminescence of xanthurenic acid (XA), tyrosine (Tyr) and ATP-Mg
2+
 with two different luciferase 
fractions (LFs). These LFs were produced from the first (A) and second (B) fractions that eluted from the desalting spin 
column (LF 3.2.8 F1 and F2) after the addition of a glow-worm lysate. Reaction mixtures contained MOPS buffer 2, LF 
and ATP-Mg
2+
 with tyrosine and XA (5 µl, 2 mg/ ml of each) added in some instances. Luminescence was measured in 
luminescence units (LU). 
 
Figure 3.48 shows the reaction of XA, tyrosine and ATP-Mg2+ with two different enzymatic fractions. 
These two fractions were the first (F1) and second (F2) fractions to be eluted from a desalting spin 
column after the addition of a GW lysate, and were treated identically. Fraction one should contain 
higher molecular weight components than fraction two (Bora et al., 2012) (see section 2.2.5). F2 
showed a much greater P type luminescent response than F1 upon addition of tyrosine, XA and ATP-
Mg2+, indicating that F2 had a much greater ability to react with XA and tyrosine than did F1. This 
would suggest that that F2 contained a greater amount of LSE than F1.  
 
In contrast the F1 fraction had previously consistently showed a stronger reaction with fractions that 
caused L type luminescence (see section 2.2.5). This would suggest that LUC, elutes to a greater 
extent in F1 and would imply that LSE and LUC are different enzymes that could be separated by 
chromatography. The LFs used in this experiment were not tested with HE because none was 
available. Both enzymatic  fractions showed residual luciferin activity probably due to the presence 
of residual  luciferin. If the described hypothesis  (Figure 3.45) is correct, then for a HE or sample to 
show P type luminescence, the LF must contain both LSE and LUC. It seems likely that, in producing 
many of the LFs, very little LSE eluted with the LF into F1, giving fractions that showed L type 




3.2.9. It is also possible that LSE may be more unstable than GW LUC. LFs exposed to oxygen over 
time may therefore have lost LSE activity while retaining LUC activity which would also explain the 
findings in section 3.2.9. 
 
It is proposed that for a reaction mixture to show P type luminescence with an LF containing both 
LSE and LUC, the reaction mixture must contain both tyrosine and XA. Both the tyrosine and the XA 
may come from either the LF or from the sample. However, since the LF is mainly depleted of small 
molecules by the desalting column, the luminescence resulting from a sample that lacks either XA or 
tyrosine will always be low or absent no matter the concentration of the non-missing compound in 
the sample. This could explain the low amount of P type luminescence observed when either 
tyrosine or XA (synthetic or isolated) are analyzed without the addition of the other. HEs may lack XA 
or tyrosine if the molecules were not initially extracted into the lysate, or if either molecule 




3.2.12 Other metabolites of the glow-worm light organ 
As well as identifying two luminescent precursors to GW luciferin, LC-MS analyses enabled the 
identification of the main metabolites of GW light organs (Figure 3.49 and Table 3.2). These 
metabolites were identified by high resolution MS and MS2 spectra, and their identity confirmed in 
some cases by comparison to a pure standard (see Table 3.2 and Figure 3.2). MS2 spectra for 
unknown compounds are shown in Appendix 3. 6. The concentrations described in Table 3.2 are only 
estimates, because the lysates studied were made from many different larvae of different sizes and 
presumably different instars. Insect larva often have very different chemistries in their different 
instars (Junnikkala, 1976; Kramer and Hopkins, 1987), and so the concentrations given may not be 
representative of any individual GW. Furthermore, different amounts of ice and body material would 
have been incorporated in different lysates, further affecting component concentrations.  
 








3.10  Glutamyl valine* 
 












3.16. Reduced Glutathione** 
 
3.17. Oxidised glutathione** 
Figure 3.49 The major components found in glow-worm light organ lysate. ** shows that the compound was identical to 
a purchased standard by HPLC retention time, MS, MS
2
 and UV-Vis spectra. * shows that the compound MS and MS
2
 
spectra match those found in the literature. 
Most small molecules were found in lower concentrations in the LF than the lysate (Table 3.2) which 
was expected because the LF should be depleted in small molecules (see section 2.2.5). However, 
phenylalanine, tryptophan and XA were found to be more concentrated in the LF than the lysate 
(Table 3.2). The increase in these aromatic amino acids and of XA may be because these hydrophobic 
molecules bind strongly to peptides in aqueous solution. Xanthurenic acid and its derivatives may 
even be stored bound to a protein matrix in intracellular granules (Needham, 1974; Umebachi and 
Katayama, 1966). 
RT: 0.00 - 30.00
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Figure 3.50. Total ion curent LC-MS chromatogram of glow-worm lysate 3.22 (after preparation for LC-MS) by Orbitrap 
nanoflow LC-MS.  
149 
 
Table 3.2. Concentration (conc, nMol/mg of frozen light organs) of major components found in GW lysates and 
luciferase fractions (LFs), as estimated by LC-MS nanoflow Orbitrap using the no second pass conversion factors 
described in Table 3.4 or using an estimate calibration factor of 2*10
7
. Three subsamples of each sample were prepared 
for nanoflow Orbitrap LC-MS as described in section 3.4.9, then analysed. Table shows average of these three replicates. 
Standard deviation was 20% between replicates for major compounds shown. The variance was not decreased when 
peak areas were normalised to any of the major compounds (which should act as natural internal standards). An extra 
internal standard was not added because it was not known what regions would be important for analysis or at what 
concentrations the compounds of interest might be found at. RT: retention time. 
Major components 
* Matches 
Literature MS and 
MS
2
 (Horai et al., 













Concentration (nMol/mg of 












Leucine** 132.1019 5.0 7.5 1.79 2.00 1.34 - 
3 OH kynurenine** 225.0867 6.0 7.8 Trace Trace Trace - 
Tyrosine** 182.0811 6.3 10.4 1.11 1.25 0.63 - 
Inosine 
monophosphate** 







10.2 Trace Trace Trace - 
Guanosine** 284.0991 7.5 11.4 1.48 0.59 0.68 - 
Inosine** 269.0880 7.7 11.5 6.17 2.34 Trace - 
phenyl alanine** 166.0863 7.7 14.1 0.44 0.21 1.30 + 
glutamyl valine* 247.1288 7.9 13.3 4.70 1.87 Trace - 
glutamyl tyr** 311.1237 9.3 18.5 5.46 2.09 Trace - 
Tryptophan** 205.0972 10.3 28.2 0.35 0.15 0.75 + 
Hydroxy 
tryptophan* 
221.092 10.3 29 2.82 1.07 Trace - 
Unknown A 237.0869 10.4 29 4.04 1.48 Trace - 
glutamyl leucine* 261.1444 12.9 30 8.79 3.49 1.41 - 
Xanthurenic acid** 206.0404 14.4 33.6 0.61 0.23 1.31 + 
Unknown B 261.0869 16.6 30.8 1.13 0.36 0.30 - 
Riboflavin** 377.1451 18.0 36 0.99 0.38 0.15 - 
 
 
GW LO are derived from Malpighian tubules (Green, 1979). In insects, Malpighian tubules remove 
waste products by producing urine and solid nitrogenous waste, which are then excreted (O’Donnell, 
2008). Malpighian tubules are also the site of synthesis for many insect secondary metabolites (Dow, 
150 
 
2009; Dow and Davies, 2006; Wigglesworth, 1961). The metabolomic makeup of GW light organs 
(previously unreported) reflected both these factors.  
3.2.12.1 Tryptophan metabolites 
Many of the major light organ components are tryptophan metabolites. For example, the light 
organs contained 5-hydroxy tryptophan (3.14) which is an important insect hormone and tryptophan 
oxidation product (Barreteau et al., 1993; Hirashima and Eto, 1993; Sloley and Downer, 1990; Ureshi 
et al., 2002; White et al., 2012). The light organs also contain the tryptophan metabolites 3-OH 
kynurenine and XA. Both these molecules have been found in the Malpighian tubules of other 
insects (Sloley and Downer, 1990; Ureshi et al., 2002), and both are members of the kynurenine 
pathway which synthesizes NAD and many important insect pigments (Billker et al., 1998; Brunet, 
1963; Han et al., 2007; Thomas and Stocker, 1999). Several of these processes are localised to the 
Malpighian tubules (Sullivan et al., 1974; Tearle, 1991). The kynurenine pathways are also thought to 
be important for the excretion of excess tryptophan, a process that also occurs in the Malpighian 
tubules (Mullins and Cochran, 1973).  
 
The GW light organ also contained an unknown molecule (unknown A) which high resolution mass 
spectrometry showed to have a molecular formula of C11H12N2O4 (Table 3.2). This suggested an 
oxidised tryptophan derivative such as dihydroxy tryptophan (3.25), tryptophan hydroperoxide 





3.25 (5, 6)-di hydroxy tryptophan 
 
3.26 Tryptophan hydroperoxide 
Figure 3.51 Possible structures for Unknown A (C11H12N2O4). 
N′-formylkynurenine is a common insect metabolite made from tryptophan by tryptophan 2,3-
dioxygenase (TDO) as part of the kynurenine pathway (Paglino et al., 2008; Rizki, 1961). Since many 
other kynureneine pathway metabolites have already been found in GW light organs (3 OH 
kynurenine, xanthurenic acid), this compound seemed the most likely candidate. However, literature 
MS2 data showed MS2 results quite different from the unknown compound (Ronsein et al., 2009) 
(Appendix 3. 6). However a purchased standard would have to be tested under the same conditons 




5, 6 Di-hydroxy-tryptophan is also formed from the oxidation of tryptophan and is known to have 
hormonal activity in several organisms (Savchenko et al., 1983; Segawa et al., 1975; White et al., 
2012). However, the molecule is little studied and has not been found in insects. A literature MS or 
MS2 spectra could not be found for comparison. 
 
Tryptophan hydroperoxide is the major intermediate of tryptophan photo oxidation and 
chemiluminescence (see section 4.1.1.4) (Ronsein et al., 2008). The molecule was stable enough to 
be isolated and completely characterized by HPLC, mass spectrometry and NMR analyses (Ronsein et 
al., 2009), but was found to convert into N′-formylkynurenine over time. The fragmentation data 
provided by Ronsein et al. (2009) matches that found for unknown A (Appendix 3. 6). However, 
authentic standards would be needed to determine the identity of unknown A. 
 
3.2.12.2 Glutamyl amino acids 
Many of the compounds found in the GW light organs were glutamyl amino acids. This is not 
surprising, because the gamma-glutamyl cycle is an essential and common metabolic process for the 
transport and metabolism of amino acids (Allison and Meister, 1981). In insects, glutamyl derivatives 
can act as storage forms for otherwise relatively insoluble amino acids such as tyrosine, valine and 
phenylalanine (Bodnaryk, 1970; Junnikkala, 1976; Kramer and Hopkins, 1987). The identity of the 
gamma-glutamyl tyrosine peak was confirmed by the LC-MS analysis of a commercial sample.  
 
The presence of gamma-glutamyl tyrosine is intriguing, given that tyrosine is involved in the 
luminescent process. SIL tyrosine (see Chapter 4) was therefore incubated for several hours with GW 
lysate, and either ATP-Mg2+ or water and the resulting mixture analysed by LC-MS (see Appendix 3. 
7). LC-MS analysis showed the presence of both SIL and UL gamma glutamyl tyrosine (3.11) in 
reaction mixtures to which SIL tyrosine had been added regardless of whether ATP-Mg2 was added 
(Table 3.3). In contrast only UL glutamyl tyrosine was observed in reaction mixtures to which SIL 
tyrosine had not been added. This showed that GWs could enzymatically convert tyrosine to gamma-
glutamyl tyrosine.  No other SIL product was observed in this experiment. The appearance of labeled 
gamma glutamyl tyrosine is likely due to a non-luminescent related pathway, because glutamyl 
tyrosine showed no luminescence by bioluminescent assay with LF and ATP-Mg2+ either with or 
without XA under conditions, where tyrosine showed luminescence. 3.11 was synthesised in the 
absence of ATP-Mg2+  indicating that ATP-Mg2+  was not required for the reaction. This is not 
surprising, considering that γ-glutamylphenylalanine in Musca domestica is synthesised by 
γ-glutamyl transpeptidase; an enzyme that does not require ATP (Bodnaryk and Skillings, 1971). 
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Table 3.3. MS and MS
2
 data (nanoflow Orbitrap) for stable isotope labeled (SIL) and unlabeled gamma glutamyl tyrosine. 
Unlabeled gamma glutamyl tyrosine SIL-labeled gamma glutamyl tyrosine 
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C9H9O3 [Tyr+H–NH3]
+













































 127.0761 127.0754 
 
Tyrosine is a vital amino acid in insects, and all insects have to store large quantities during their 
larval phase so that tyrosine is available for cuticle formation during pupation (Andersen, 2010). 
Gamma-glutamyltyrosine has been found as the main tyrosine storage molecule in Musca 
domestica, but other Diptera derivatise tyrosine with other small polar molecules (O-phospho 
tyrosine in Drosophila and β-alanyl-L-tyrosine in Sarcophaga) (Bodnaryk, 1970; Junnikkala, 1976; 
Kramer and Hopkins, 1987). Other insects store tyrosine as glucopyranosyl-O-L-tyrosine (Kramer and 
Hopkins, 1987) or in storage proteins known as arylphorins and tyrostaurins (Delobel et al., 1993). In 
each case, when large amounts of tyrosine are required (e.g. for moulting or metamorphosis), 
tyrosine is cleaved from the large molecule and quickly released (Andersen, 2010; Delobel et al., 
1993; Kramer and Hopkins, 1987). It seems likely that A. luminosa, like Musca domestica, uses 
gamma-glutamyl tyrosine as a storage form for tyrosine. One could speculate that Arachnocampa 




GW light organs were found to contain large amounts of purines and phosphopurines. This seems 
reasonable, as  Malpighian tubules are known to import these common and important biomolecules 
as starting materials for pteridine and flavin biosynthesis (Price, 1973; Sullivan et al., 1979). Such 
processes would also explain the presence of large amounts of riboflavin in GW light organs (Sullivan 
et al., 1979). 
 
3.3 Conclusion 
The research reported in this Chapter showed that synthetic L - tyrosine and XA produced strong and 
long-lasting P type luminescence when mixed with LF and ATP-Mg2+ under assay conditions, and that 
the light produced had the same spectrum as the light produced by GWs. Both individually produced 
only small amounts of P type luminescence, but produced far greater luminescence when both were 
tested together. This luminescence was found to have the same spectral and kinetic qualities as P 
type fractions prepared from GW lysate. This indicated that neither molecule is the GW luciferin, but 
suggested that XA may react with tyrosine to form the true GW luciferin. This would make tyrosine 
and XA biosynthetic precursors to GW luciferin. This represents an important new discovery in the 
field of bioluminescence, because previously nothing was known about the chemistry of GW 
luminescence. 
 
This work relied on the fortunate fact that the LFs used for this research showed luminescence with 
tyrosine and XA as well as the GW luciferin. Previous GW studies in contrast had only reported L type 
luminescence (Lee, 1976; Viviani et al., 2002). This indicated that previous luminescence assay 
methods were not capable of detecting the luminescence of tyrosine and XA. The new assay 
methods developed in Chapter 2 were therefore essential for the discovery that XA and Tyr were 
precursors to the GW luciferin. If these methods had not been developed it is likely that the two GW 
luciferin precursors could not have been isolated. This work also relied on LC-MS, which allowed the 
structures of tyrosine and xanthurenic acid to be elucidated at concentrations that it would have 




3.4.1 HPLC Methods 
Instrumentation:  Agilent 1100 with photodiode array and Agilent 1260 infinity with fluorescence 
detector, UV-Vis detector and automatic fraction collection unit. Columns: Phenomenex Synergi 4 
µM Hydro RP 80 Å: analytical (150 x 4.6 mm) and semi-preparative (150 x 10 mm). Mobile phase A: 
Grade I Water. Mobile phase B: MeCN (HPLC grade, LiChrosolv LC grade solvents, Merck). HPLC 
method 1: 0% B – 6% B over 5 min, 6% B for 23 minutes, 6 - 25% B in 14 minutes, 25 – 100 B in 10 
minutes, 4 minutes of 100% B, 100 - 0% B in 1 minutes, 5 minutes 0%. HPLC method 2: 0% B – 6% B 
over 5 min, 6 - 100% B in 10 minutes, 7 minutes of 100% B, 100 - 0% B in 1 minutes, 5 minutes 0% B. 
Flowrate hydro C18 analytical column: 0.5 ml/ min, flowrate hydro C18 semi-prep column: 2.3 ml/ 
min. Fluorescence detection: Excitation 280 nm, Emission FlA: 415 nm, FlB – 500 nm, FlC – 550 nm. 
UV Detection: 210, 250, 280, 300, 320, 350, 380 and 400 nm. 
 
3.4.2 LTQ ion-trap LC-MS  
This LC-MS system consisted of a Thermo Electron Corporation (San Jose, CA, USA) Finnigan Surveyor 
MS pump, Thermo Accela Open Auto sampler (PAL HTC-xt with DLW), Finnigan Surveyor PDA plus 
detector and a ThermaSphere TS-130 column heater (Phenomenex, Torrance, CA, USA). Aliquots (20 
µl) of each prepared sample were separated with a mobile phase consisting of 0.1% formic acid in 
water (A) and 0.1% formic acid in acetonitrile (B) by reverse phase chromatography (Aqua guard 
cartridge 4 x 2 mm, 10 μ and Synergi-HydroRP C18, 4 μ, 80 Å, 250 x 2.1 mm, Phenomenex, Torrance, 
CA, USA) maintained at 30°C with a flow rate of 200 µl/min. HPLC method 1 was applied with both 
mobile phase A and B containing 0.1% formic acid. The eluent was scanned by photodiode array 
(200-600 nm) and API-MS (LTQ, 2D linear ion-trap, Thermo-Finnigan, San Jose, CA, USA), with 
electrospray ionisation (ESI) in the negative or positive ion mode. Data were acquired for parent 
masses from m/z 145–2000 Daltons with MS3. Data were processed with the aid of Xcalibur®2.2 







3.4.3 Orbitrap nanoflow LC-MS 
LC: Ultimate 3000 RSLC nano System (DIONEX), Column temperature: 30 °C. Column: C18, 
DrawSpeed: 200 [nl/s], DrawDelay: 5000 [ms], DispSpeed: 2000 [nl/s], DispenseDelay: 2000 [ms], 
Pump Flow: 0.500 [µl/min]. Buffer A: 5% milli Q, 95% MeCN, 0.1% FA, Buffer B: MeCN, 0.1% FA. 
Injection volume (1 µl), Gradient elution: 0 - 3 min (0% B), 3 - 18 min (0 – 15% B), 18 - 20 ( 15 – 60% 
B) 20 -22 (60 - 99%B), 22 – 24 (99%B) 24 – 25 (99 – 0% B) and 25- 32 (0% B). Mass spectrometry: 
ThermoScientific LTQ Orbitrap XL MS: Scan range: 105-800, Act type: CID, Iso width (m/z): 1, 
Normalized collision energy: 35, Resolution, 100000. Data type: profile, Analyser FT-MS, Polarity: 
positive, MS2: Act type: HCD, Iso width (m/z): 1, Normalized collision energy: 45. Activation time: 30 
ms (take MS of 4 most intense ion). Concentrations were calculated with the conversion factors 
shown in Table 3.4. 
Table 3.4. Conversion factors used for calculating concentration from peak area on the Orbitrap nanoflow system. 
Second pass integration was not used because it did not work well for the tryptophan peak. Conversion factors: peak 
area / concentration (µm). The concentrations of other compounds were calculated using an adaption factor: 2 * 10
7
. 
Compound RT Ion m/z 
No second pass 
integration 
Second pass integration 
Factor R2 Factor R2 
3-OH 
Kynurenine 
4.58 225.0867 2.78* 107 0.975 1.77* 107 0.918 
UL Tyr 4.59 182.0811 1.88* 107 0.971 1.18 * 107 0.814 
SIL Tyr 4.66 192.1084 1.45* 107 0.945 1.44* 107 0.873 
Guanosine 7.44 284.099 1.02* 107 0.882 1.22 * 107 0.775 
Phenylalanine 6.71 166.0862 1.68* 107 0.783 7.58 * 107 2.91 
Tryptophan 10.19 205.0972 1.37* 107 0.946 1.90 * 107 0.927 
Riboflavin 18.38 377.1457 2.42* 107 0.932 4.92 * 107 0.879 
XA 14.45 206.0448 1.63* 107 0.963 1.67 * 107 0.945 
Glut tyr 9.2 311.1229 1.35* 107 0.931 2.09* 106 0.933 
3.4.4 QTOF ESI LC-MS methods 
Instrumentation: Brucker Micro QTOF, Electrospray ionisation with Dionex Ultimate 3000 HPLC 
system. MS settings: Endplate offset; 500 V, Caillary: 4500 V, Nebulizer: 0.5 bar, Dry gas: 5 ml/ min, 
Temp 180°C. Column and gradient methods were used as described in section 3.4.1 with all mobile 
phases containing 0.1% formic acid. 
3.4.5 Lysate and hot extract sample production 
Lysates and HE were made as described in Chapter 2. Specific details are shown in Figures 3.5 and  





Table 3.5. Methods used for making lysates, luciferase fractions (LFs) and hot extracts (HEs) used for the 
chromatography experiments described in this chapter. Buffers used: MOPS buffer 1 (MOPS1): MOPS buffer 2 (MOPS2) 






LO (g) Body (g) Buffer 
Atmosphere 
used 






MOPS 1 + 2 
mM DTT  
(2.5 ml) 
N2 









MOPS 1 + 2 
mM DTT  
(2.4 ml) 
N2 




Lysate3.1.3 70 Nichols creek 0.2617 2.3954 
MOPS 2 + 2 
mM DTT  
(2 ml) 
N2 
BC10 LF  
(1 ml) 
Lysate 3.1.4 62 Te Anau 0.3114 4.0194 
MOPS 2 + 2 
mM DTT  
(2 ml) 
N2 
BC10 HE  
(1.4 ml) 
Lysate 3.1.5 64 Te Anau 0.3030 3.079 
MOPS 2 + 2 





BC11 LF  
(800 µl) 




NH₄HCO₂ + 46 
mM DTT (2ml) 
N2 
BC13 HE  
(1 ml) 
LF (1 ml) 




MOPs 1 + 5 
mM DTT  
(2 ml) 
N2 
BC13 LF  
(2 ml) 
Lysate 3.1.8 30 Te Anau 0.1001 1.7463 Water (1 ml) N2 
BC HE 14 
(800 µl) 
 
Lysate 3.1.9 60 Te Anau 0.0918 1.17 
MOPS 2 + 2 
mM DTT  
(1.2 ml) 
air 
BC (14 + 15) 
LF (800 µl) 




MOPS 2 + 2 
mM DTT  
(1.2 ml) 
air 
SP15 LF  
(200 µl) 
Lysate 3.1.11 127 Auckland 0.3525 2.6086 Water (1.3 ml) N2 
BC HE 15 
(1.3 ml) 




MOPs 2 + 5 
mM TCEP  
(2 ml) 
N2 
BC16 LF  
(2 ml) 
 




MOPs 2 + 5 
mM TCEP  
(4 ml) 
N2 





Table 3.6. Methods used for making lysates, luciferase fractions (LFs) and hot extracts (HEs) used for other experiments 
described in this chapter. Buffers used: MOPS buffer 1 (MOPS1): MOPS buffer 2 (MOPS2) and NH₄-HCO₂ buffer (93 mM) 
pH 7.5. See section 2.3.2 for buffer compositions. LFs were split up into separate fractions (approximately 100 µl) 













HE and LFs made 
Lysate 
3.2.1 
30 Ross Creek 0.0746 0.4270 
MOPS 2  
+ 2 mM DTT  
(1 ml) 
air LF 3.2.1 (1 ml) 
Lysate 
3.2.2 
30 Ross creek 0.0603 0.8930 
MOPS 2  
+ 2 mM DTT  
(2 ml) 
air 
LF 3.2.2 (1 ml) 
HE 3.2.2 (1ml) 
Lysate 
3.2.3 
20 Ross creek 0.0401 0.6512 
MOPS 2  
+ 2 mM DTT  
(2 ml) 
air 
LF 3.2.3 (1 ml) 
HE 3.2.3 (1 ml) 
Lysate 
3.2.4 
23 Ross creek 0.0299 0.4457 
MOPS  
+ 2 mM DTT 
(1.5 ml) 
N2 LF 3.2.4 (1 ml) 
Lysate 
3.2.5 
70 Ross creek 0.1058 0.9119 
Water  
+ 2 mM DTT 
(2.7 ml) 
air Lysate only 
Lysate 
3.2.6 
100 Ross creek 0.1500 1.5447 
Water  
+ 2 mM DTT  
(5 ml) 
N2 
HE 3.2.6 (1.5ml) 
LF 3.2.6 (1.5ml) 
Lysate 
3.2.7 
43 Ross creek 0.058 0.677 
Water  
+ 2 mM DTT  
(2 ml) 







MOPs 2  
+ 5 mM DTT  
(3 ml) 
N2 
LF 3.2.8 (F1) (500 µl) 




3.4.6 General reverse phase chromatographic bench column methods 
HE was loaded onto a pre-equilibrated 0.5 g (or larger as described) isolute C18 column and under a 
N2 atmosphere, eluted with a water (grade 1) to MeCN (LiChrosolv LC grade solvents, Merck) 
gradient. Fractions were eluted under positive N2 pressure and the entire separation was completed 
inside a N2 filled glove bag. Details of specific separations of interest are described in Table 3.7. 
Samples were frozen at – 80 °C immediately after collection and freeze-dried using the desiccator 
freeze-drying technique (Figure 3.52). Samples were rehydrated under N2 with water (100 µl – 1 ml). 
Subsamples were tested by luminescence assay in MOPS buffer 2 (containing 2 mM DTT) using the 
methods described in sections 2.3.5 and 2.3.6. Table 3.5 describes the LFs used for each purification 
protocol. Changes made to the general method  have been noted with the experimental details or 
result. Concentrated fraction subsamples were analysed by HPLC using Method 1. Concentrated 
luminescent fractions were then separated under N2 by semi-preparative HPLC using HPLC Method 1 
(section 3.4.1). Specifics of the isolation of tyrosine are described in section 3.4.7 and for the 
isolation of xanthurenic acid in section 3.4.8.  
 
 




Table 3.7. Specific details for several bench column separations of glow-worm hot extract (HE) including the luciferase 
fractions (LF) they were tested with. Elution buffer additives marked in bold. Further details regarding these separations 
are given in Appendix 3. 1 - Appendix 3. 3. 
Separation HE Water (type 1) - acetonitrile gradient 





F1 – F4 (2 ml water each),  
F5 - F8 (1 ml, 20% MeCN each). 





F1 – F4 (2 ml water each),  
F5 - F8 (1 ml, 20% MeCN each). 





F1 – F3 (4 ml water each), F4 (2 ml water),  
F5 - F9 (1 ml, 5% MeCN each). 
with 5 mM DTT 
BC10 LF 
BC11 
BC11 HE (600 
µl) 
F1 (4 ml water each), F2 - F4 (2 ml water each), F5 - 
F9 (1 ml, 5% MeCN each). 
with 5 mM DTT 
BC11 LF 
BC13 
BC13 HE (400 
µl) 
F1 (4 ml water), F2 – F3 (2 ml water each),  
F4- F6 (2 ml, 5% MeCN), F7 (4 ml, 10% Me CN), 
 F7 (4 ml, 10% MeCN), F8 (4 ml, 25% MeCN),  
F9 (4 ml, 50% MeCN), F10 (4 ml, 100% MeCN). 







F1 - F4 (2 ml water each), F5 - F9 (2 ml 5% MeCN 
each). 






F1 (5 ml Water), F2 – F4 (1 ml water each), F5 (5 ml 
5% MeCN), F6 (5 ml 100% MeCN). 





F1 (5 ml 5%), F2 (10 ml 20%), F3 (10 ml 50% MeCN), 
F4 (10 ml 100% Me CN) 
with 0.1% FA, 3 mm ME and 2 mM TCEP 
BC16 LF 
 
3.4.7 Isolation of tyrosine by semi-preparative chromatography 
Portions (100 µl each, stored in HPLC vials under N2) of concentrated F1 from BC14 and 15 (produced 
as described in Table 3.7) were taken (in HPLC vials under N2) and injected onto the semi-preparative 
Hydro C18 column, then separated by HPLC Method 1. Samples were collected every 30 seconds 
under N2. After the entire collection was complete, fractions were frozen, freeze-dried, then 
rehydrated under N2 with: SP15 100 µl MOPS (pH 7.4, 0.1 M), DTT (2 mM) or SP16 200 µl degassed 
grade I water. A fraction collected between 8.19 and 8.68 minutes (F17) after the injection of BC14 
was found to be luminescent when tested by luminescent assay with BC14 + 15 LF and ATP-Mg2+. 





Note: Fractions from BC15 were initially tested with BC14 + 15 LF and ATP -Mg2+ but no 
luminescence was produced even though the same LF produced good L type luminescence with HE. 
Fractions from BC15 were therefore retested with SP15 LF which led to the detection of 
luminescence in F17. 
Table 3.8. The purification of tyrosine by following P type luminescence through bench columns 14 and 15, and semi-
prep columns 15 and 16 showing the luminescent yields at each stage. Mass yields were not calculated because DTT 
made up the majority of the mass recovered. Tyrosine concentrations were estimated from LC peak area (210 nm). 
These concentrations may be overestimates due to the presence of the co-eluting minor component 3-OH kynurenine. 



























BC14 HE 0.8 24 9306 
 
18 
100 L+P 100 
0.139 
 




11824 6 16 P 18 0.004 
Conc SP15, F17 0.1 
 
11711 15 15 P 10 0.056 






1062 5 9.89 P 12 0.129 
F2 0.2 
 
71 2 0.65 P - 0.008 
Conc SP16, F17 0.2 
 
326 7 3.00 P 12 0.342 
 
3.4.8 Isolation of xanthurenic acid 
F3 from BC16 was concentrated to a volume of 600 µl and this material added to an air tight HPLC 
vial. FA was added (to a concentration of 0.1%), and 500 µl of the solution injected onto the semi-
prep Hydro C18 column and separated by HPLC Method 1. Mercaptoethanol was added to the 
HPLC buffers at 5 mM, and to collecting vials (100 µl, 100 mM). 
 
Fractions were collected under N2 by hand rather than by using the automatic collector. FA was 
added to the initial injected material (to a concentration of 0.1%), in order that all compounds were 
retained on the column. The semi-prep fractions produced were dried and then stored under 
nitrogen and on dry ice. Samples were then taken to the luminometer, and rehydrated immediately 
previous to assay analysis by the injection of 50 µl of degassed water into the HPLC vial using a 
Hamilton syringe, taking care not to introduce any air to the sample. A portion of each solution (20 
µl) was immediately injected using a Hamilton syringe into an assay well containing MOPS Assay 
buffer 2 (100 µl) with 2 mM DTT and luciferase fraction. The remaining fraction was then frozen on 
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dry ice. ATP-Mg2+ solution (20 µl) was added simultaneously to all wells, and the luminescence of 




Figure 3.53. SP-LC collection of late eluting active P type fraction containing XA (34 – 34.5 minutes).  
Two fractions that eluted with 80% MeCN (collected 34.0 – 34.5 (F53) and 34.5- 35.0 (F54) minutes; 
see Figure 3.22) showed P type luminescence when assayed with LF and ATP-Mg2+. Wells contained 
MOPS  buffer 2 with 2 mM DTT (100 – 140 µl), 5 µl LF (BC16 LF) and either HE (20 µl), F2 (10 µl) or SP 
fractions (50 µl). Luminescence was generated by the addition of 30 µl ATP-Mg2+ solution. 
 
F54 and F55 and XA were then tested by luminescence assay with and without the addition of 
tyrosine by the following method: Wells contained 5 µl LF (BC16 LF) and or SP fractions (10 µl), and 
or SIL tyrosine solutions (13C9H11
15NO3, 0.2101 mg/ ml, 10 µl) and/ or XA ( 58 µg /ml, 10 µl) and MOPS 
buffer 2 with DTT (100 – 140 µl, enough to keep well volumes the same). The initial tyrosine and XA 
solutions were made up in NaHCO3 solution in order to propally disolve both components (1.2 mg/ 
ml). Luminescence was initiated by the addition of 30 µl ATP-Mg2+ solution. 
 
Active fractions F54 and F55 and the surrounding fractions were then analyzed by nanoflow Orbitrap 
LC-MS and HPLC. F54 was found to contain approximately 0.143 mmol XA, 0.027 mmol riboflavin in 






3.4.9 Luminescence of commercial xanthurenic acid with commercial tyrosine 
The luminescence of LF, LF + Tyr, LF + XA and LF + XA + Tyr were then measured simultaneously in 
triplicate both with and without ATP-Mg2+ solution. Wells contained MOPS assay buffer with 2 mM 
DTT (100 µl), LF 3.2.8 (10 µl), and either 50 µl  tyrosine solution (1:1, SIL:UL) and/ or XA solution 
and/or enough water so that wells contained identical volumes (Figure 3.54). 
 
Tyrosine solution (1:1, SIL:UL) 
Unlabeled tyrosine (UL, C9H11NO3): 0.94 µg/ ml and stable isotope labeled tyrosine (SIL, 
13C9H11
15NO3):  0.94 µg/ ml, in 1.2 mg/ ml NaHCO3 solution 
 
XA solution 
58 µl /ml in 1.2 mg/ ml NaHCO3 solution 
 
 









H2O Tyr XA XA + Tyr Initially 
Row 
B 
H2O Tyr XA XA + Tyr Never 
Row 
C 
XA + Tyr (added 
initially) 
XA + Tyr (Added 
with ATP-Mg2+) 
  After 20 min 
Row 
D 
XA + Tyr (added 
initially) 
XA + Tyr (Added 
with ATP-Mg2+) 
  After 81 min 
Figure 3.54. Layout of experiment in 96 well plate 
After the reaction, all reaction mixtures were added to pre-equilibrated Sorenson Bioscience 
Multiguard II Filter tips containing 30 mg C18. The filter tips were placed through holes drilled 
through the lids of Eppendorfs and the lids placed back on Eppendorfs. Centrifugation was then used 
to elute the material through the C18. The C18-filled tips were then further eluted with six 200 µl 
volumes of MeCN (0.1% FA). All eluents for each sample were combined and the resulting solutions 
dried under vacuum, then stored at - 80°C.  
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3.4.10 Large scale luminescence assay of xanthurenic acid and tyrosine 
Four solutions containing lysate 3.2.8 (500 µl) and MOPS buffer 2 with 2 mM DTT (500 µl) were 
placed into 4 cuvettes (1 ml total in each). These were placed in the Cary luminometer and kept at 
10 °C. Luminescence was initiated by the addition of 100 µl ATP-Mg2+ solution, and luminescence 
measured as described in section 3.4.11 at 490 nm and 541 nm. Luminescence was then increased 
by the addition of L tyrosine (50 µl, 2 mg/ ml in 3.74 mg/ ml NaHCO3) and XA (50 µl, 2 mg/ ml in 3.74 
mg/ ml Na2CO3). A luminescence spectrum was then taken as described in section 3.4.11.2. More L-
Tyr, XA and ATP-Mg2+ solutions were added at intervals over the first few hours, but were found to 
have no further effect on luminescence. However, luminescence was increased when ATP was added 
after 19 hours. Addition of further ATP after this time did not produce more luminescence. A total of 
0.3 mg (tyr and XA) and 4 mg (ATP) was added to each cuvette over the course of the experiment. 
After 4 days, all four solutions were combined then separated on a 10 g C18 Isolute column using a 
water- MeCN gradient in which all mobile phases contained 0.1% formic acid: water (5 x 7 ml), 5% 
MeCN (5 x 7 ml), 50% MeCN (5 x 7 ml), 100% MeCN (20 ml). All fractions were dried by speed vac. 
3.4.11 Cary Eclipse luminometer methods 
3.4.11.1 Spectral measurements of the reaction of tyrosine with a luciferase fraction  
Measurements were taken in a 100 µl cuvette containing 20 µl ATP-Mg2+ solution, 20 µl MOPS buffer 
2, 20 µl GW LF 3.2.1, and 40 µl HE 3.2.2. Instrument: Cary Eclipse, Data mode; 
Bio/Chemiluminescence, Gate time (ms): 200, Scan mode, Emission Start (nm) 400 Stop (nm), 600 
Em. Slit (nm): 20, Data interval (nm) 0.1500, Emission filter; Open, PMT voltage (V) High, Filter size: 
101, Temp: 10 °C. 
 
3.4.11.2 Spectral measurements of the reaction of tyrosine and xanthurenic acid with a 
luciferase fraction  
The luminescent reaction of tyrosine with XA produced far more luminescence than the reaction of 
Tyr with XA so a slit of 20 nm, and a PMT voltage: medium were used. The luminescence spectra of 
the mixture described in section 3.4.10 was taken 30 minutes after ATP had been added to the 
mixture, when the luminescence was presumed to be mainly due to tyrosine and XA P type 





4 Glow-worm luciferin and related molecules 
4.1 Introduction  
Chapter 3 described how xanthurenic acid (XA) and tyrosine (Tyr) produced luminescence with GW 
enzyme mix (LF), and ATP-Mg+2 to produce P type luminescence. Chapter 3 also suggested that XA 
and tyrosine were precursors to the GW luciferin (Figure 4.1). This Chapter describes the analysis of 
GW luminescent reaction mixtures, augmented with XA and tyrosine, by LC-MS and HPLC-UV-Vis-
fluorescence and explains how this led to the discovery of one major luminescence related product 
A (LRPA). A scaled up amount of LRPA was then synthesised using the GW enzymatic reaction. LRPA 
was then purified and characterised by LC-MS, 1H NMR spectroscopy and UV-Vis spectroscopy, 
which enabled partial structural elucidation. When tested in the luminescence assay with LF and 
ATP-Mg2+, LRPA luminesced with strong L type luminescence identical to that of the L type fractions. 
This suggests that LRPA is either the glow-worm luciferin or a closely related molecule.  
 
 
Figure 4.1. The proposed biosynthesis of GW luciferin from xanthurenic acid and tyrosine and its reaction to give 
luminescence and luminescence related products (LRP) including the luciferin enzymatic product (LEP). 
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4.1.1 Literature on tyrosine and xanthurenic acid 
4.1.1.1 Luminescence and fluorescence of tyrosine and related molecules 
Many known luciferins and fluorescent chromophores are partially derived from tyrosine (see 
Chapter 1 and Figure 4.2) and tyrosine displays many qualities that make it a good luciferin 
precursor. 
 
1.1. Coelenterazine was shown by Oba to be biosynthesised 
partially from tyrosine (Oba et al., 2009). 
  
1.3. Earthworm Fridericia heliota luciferin. 
 
 
1.5. Green fluorescent protein (GFP) chromophore 
Figure 4.2. A selection of tyrosine derived luciferins and luminescence chromophores. The segment originating from 
tyrosine is in bold. 
 
Under neutral conditions tyrosine fluoresces poorly with a max: 300 nm. However, under basic 
conditions it displays a strong blue fluorescence with max: 340 nm due to the deprotonation of the 
tyrosine phenol as shown in Figure 4.3 (Imai et al., 2001; Lakowicz, 2013; Szabo et al., 1978). This is 
important because the GW emitter molecule (not the luciferin) should also show strong blue 





Figure 4.3. Protonated and deprotonated forms of L-tyrosine Isoelectric point: 5.7 (Hu, 2015; Liu et al., 
2011)  
Tyrosine is also the starting material for many other molecules that display a strong blue 
fluorescence. For example in many insects, tyrosine metabolism leads to the formation of 
catecholamines (Gardner and Brady, 1977; Raabe, 1984). Two catecholamines (dopamine, 4.1 and 
noradrenaline, 4.2) are shown in Figure 4.4. Catecholamines are weakly fluorescent but may react 
with formaldehyde via a Pictet-Spengler condensation followed by oxidative dehydrogenation to 
form highly fluorescent dihydroisoquinolines (4.3) (emission 400 – 650 nm when excited at 400 nm) 
(Björklund et al., 1968). Some dihydroquinolines show chemiluminescence with base addition  
(Papadopoulos et al., 2000). Isoquinolines are also synthesised from tyrosine enzymatically (Nagatsu, 
1997) although most are formed from tryptophan via the kynurenine pathway as shown in Figure 4.5 
(Botting, 1995). Catecholamines also form a large variety of melanin type pigments and exoskeleton 
compounds and many of these also show strong fluorescence (Brunet, 1963; Gallas and Eisner, 1987; 









Figure 4.4. Fluorescent molecules related to tyrosine 
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Oxidation of tyrosine and tyrosine derivatives can lead to the formation of covalent Tyr-Tyr cross-
links and the formation of dityrosine (4.4, see Figure 4.4) and its polymers (Ali, 2006; Malencik et al., 
1996). Tyr-Tyr linkages can also be formed by ultraviolet irradiation, radical exposure or 
enzymatically by enzymes such as horse-radish peroxidase (Malencik et al., 1996).  
Dityrosine displays intense fluorescence (max: 400 nm) on excitation at 315 nm (alkaline) or 284 nm 
(acidic) (Aeschbach et al., 1976; Malencik et al., 1996) and it is the tyrosine-tyrosine crosslink  that 
gives lipofuscin (produced from the oxidation of proteins during cell death), insect elastin and 
collagen their strong blue fluorescence (Coburn and Gems, 2013; Malencik et al., 1996). Tyrosine 
also has interesting electrochemistry and can undergo a number of radical, redox and charge 
transfer processes (Harriman, 1987; Sjödin et al., 2000; Whittaker et al., 1989; Zhang et al., 2004). 
Tyrosine therefore has many properties that would make it a good GW luciferin precursor. 
4.1.1.2 Xanthurenic acid biochemistry 
Xanthurenic acid (XA) was first isolated in 1938 by Musajo from the urine of rats fed on fibrin, and 
was shown to be 4, 8-dihydroxyquinoline-2-carboxylic acid (3.4, Figure 4.5) (Dalgliesh, 1951). In 
common with other 8-hydroxyquinoline derivatives, XA easily forms metal complexes (Dalgliesh, 
1951). For example XA forms an intensely coloured green complex with Fe2+  (Dalgliesh, 1951). XA is 
a well-studied insect metabolite and is synthesised from 3-OH kynurenine by kynurenine 
transaminase (see Figure 4.5) (Hardeland et al., 1999). Kynurenine transaminase was upregulated in 
the GW LO compared to the GW body (Sharpe et al., 2015) which is interesting given the role of 
xanthurenic acid as a GW luciferin precursor and the presence of 3-OH kynurenine in the GW lysate. 
3-OH kynurenine is synthesised from kynurenine by kynurenine hydroxylases while kynurenine is 
synthesised from tryptophan by tryptophan dioxygenase as part of the kynurenic pathway (see 




 4.5. Kynurenic acid 4.6. 3-OH anthranilic acid  
 
3.13. Tryptophan 4.7. Kynurenine 3.2. 3-OH kynurenine 3.4. Xanthurenic acid 
Figure 4.5. Biosynthesis of xanthurenic acid from tryptophan via the kynurenic pathway 
XA is a highly effective antioxidant and free radical scavenger, so may be produced by some insects 
to prevent reactive oxidative substance (ROS) damage (Hardeland et al., 1999). For example it is 
found in large concentrations in mosquitoes, where it may prevent the heme catalysed oxidative 
damage associated with a blood diet (Lima et al., 2012). XA may act as a stable storage form of 3-OH 
kynurenine (3.2) preventing free 3.2 from reacting with proteins to form the blue fluorescent 
chromophore 4.8 (Figure 4.6) or as a way to dispose of excess tryptophan (Aquilina et al., 1999; 




Figure 4.6. The blue fluorescent chromophore produced by the reaction of 3-OH kynurenine with peptides (Aquilina 




1.1.1.3 Metabolites biosynthesised from xanthurenic acid 
Several xanthurenic acid derivatives also known in nature. Bacteria, for example produce 
siderophores such as quinolobactin (4.9) (du Moulinet d'Hardemare et al., 2004; Matthijs et al., 
2004) while insects produce the highly fluorescent xanthurenic acidmono and diglucosides (4.11 
and 4.10) (Ishiguro and Ikeno, 1974; Real and Ferre, 1989; Real and Ferré, 1990). Mammals use 4.11 
and xanthurenic acid 8-O-sulfate (4.12) as natriuretic hormones (Cain et al., 2007) while 4.11 is also 
found in mammal eyes (Shirao et al., 2001; Thiagarajan et al., 2002). 
 
 
4.9. 2-Quinolinecarboxylic acid, 8-hydroxy-4-methoxy 
(Quinolobactin) 
CAS registry number: 28027-14-7 
NMR data by (du Moulinet d'Hardemare et al., 2004) 
 
4.10. 2-Quinolinecarboxylic acid, 4,8-bis(β-D-
glucopyranosyloxy)- (xanthurenic acid 4,8-
diglucoside) 
CAS registry number: 51532-25-3 
(Ishiguro and Ikeno, 1974) 
 
4.11. 2-Quinolinecarboxylic acid, 8-(β-D-glucopyranosyloxy)-
1,4-dihydro-4-oxo (xanthurenic acid 8-O- beta-D-glucoside) 
CAS registry number: 121691-37-0 
UV-Vis absorbance max: 338 nm 




4.12. 2-Quinolinecarboxylic acid, 4-hydroxy-8-
sulfoxy (xanthurenic acid 8-O-sulfate) 
CAS registry number: 114187-86-9 
UV-Vis absorbancemax: 338 nm (Cain et al., 2007) 
 
Figure 4.7. A selection of known  xanthurenic acid based natural products.  
Xanthurenic acid in insects is also further metabolised into the ommochrome pigment 
xanthommatin (4.13), (Le Roes-Hill et al., 2009; Seligy, 1972; Smânia et al., 2003). Ommochrome 
pigments are interesting from a luciferin perspective because  they contain a redox sensitive 
chromophore (Fuzeau-Braesch, 1963). Ommochrome colour is strongly affected by redox state with 
the reduced form being more bathochromic (red) than the oxidised form (yellow) (Needham, 1974). 
The oxidation or reduction of ommochrome pigments is  often responsible for colour change in 
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insects (Futahashi et al., 2012; Needham, 1974). It is for example the reason why dragonflies turn 
from yellow to red upon maturation (Futahashi et al., 2012). Xanthommatin (4.13) and reduced 
xanthommatin (4.14) are shown in Figure 4.8 (Fuzeau-Braesch, 1963). 
 
 
4.13. Oxidised xanthommatin 4.14. Reduced xanthommatin 




4.15. Cinnabarinic acid  4.16. Cinnabarin 4.17. Tramesanguin 
Figure 4.9. The structure of some more ommatins. 
 
Xanthommatin belongs to the simplest class of ommochromes: the ommatins. Ommatins tend to be 
gold in colour and tend to oxidise in air (Needham, 1974). Xanthommatin (4.13) is biosynthesised 
from XA but  other ommatins  such as cinnabarinic acid  (4.15), cinnabarin (4.16) and tramesanguin 
(4.17) can be formed by the condensation of other kynurenic pathway derivatives (Figure 4.8 and 
4.9)(Fuzeau-Braesch, 1972; Smânia et al., 2003). Further oligomerisation and the incorporation of  
either cysteine or methionine to form a thiazine ring, produces the large molecular weight and ill-
defined ommidines and ommins which range in colour from violet to black (Fuzeau-Braesch, 1972). 
Ommins are generally found in the reduced form and do not oxidise readily (Needham, 1974). 
Ommochrome glucosides (rodammatin a) and 2 sulphuric esters (ommatin S) also exist (Fuzeau-
Braesch, 1972). Due to their low solubility, ommochrome pigments are normally found bound to a 
protein matrix in intracellular granules from which they can be released with acid (Needham, 1974; 
Umebachi and Katayama, 1966). None of this class is strongly fluorescent except in strong acid 
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(Needham, 1974). Given the diversity of the molecules made from XA, it would not be surprising if 
GWs could further metabolise XA to form GW luciferin. 
 
4.1.1.3 Xanthurenic acid tautomerization and oxidation 
In aprotic solvents, XA exists in a mix of the enol and monoketo forms, while in alkaline aqueous, or 
in 90% ethanol solutions, XA exists in a mix of the enol and diketo forms (Figure 4.10) (Yanshole et 
al., 2010). The diketo form is far more fluorescent than the enol form, but the diketo form is also 
readily oxidised at room temperature to the highly fluorescent di oxo xanthurenic acid (DOXA, 4.18) 
(Malina and Martin, 1996; Yanshole et al., 2010). DOXA covalently binds to proteins to produce blue 
fluorescent peptides  and likely induces oxidative stress in biological systems by generating oxygen 
radicals, hydrogen peroxide, and hydroxyl radicals (Malina and Martin, 1996). 
  
3.4. XA 4.18 DOXA 
Figure 4.10. The tautomerisation of xanthurenic acid from the keto form (XAK) to the enol form (XAe) to the diketo form 
(XAdK) and the oxidation of XAdk to di-oxo xanthuerenic acid (DOXA).  
 
 
Figure 4.11. Protonated and deprotonated forms of xanthurenic acid (XA). pkas are estimates because there is some 
uncertainty in the literature. pka data: Ferre suggested pKa (NH): 1.8, pKa (XA 4-OH): 7.3 and pKa (XA 8-OH):  12.3 (Ferre 
et al., 1985) whereas Lima suggested that pKa (XA 8-OH):  7.5 (Lima et al., 2012) and Yanshole suggested a pKa (COOH): 




4.1.1.4 Chemiluminescence of xanthurenic acid. 
The quinoline xanthurenic acid, like many indoles and quinolines, produces chemiluminescence 
when oxidised by free radicals, for example after exposure to a heme catalyzed hydrogen peroxide 
system or to UV light (Hardeland et al., 1999; Slawiński et al., 1980). Chemiluminescence is also 
produced if quinolines are reduced into dihydroquinolines using radiolysis then activated with base 
(Papadopoulos et al., 2000). 
 
The chemiluminescence most likely results from the oxidative cleavage of the indole derivative 
resulting in the formation of a kynuramine (Hardeland et al., 1995; Slawiński et al., 1980). For 
example the chemiluminescent oxidation of melatonin leads to the formation of  N1 -acetyl-N -
formyl-5-methoxykynuramine (AFMK) which further degrades into N1 -acetyl-5-methoxykynuramine 
(AMK) (Figure 4.12) (Hardeland et al., 1995). In a similar fashion tryptophan reacts to form N-formyl 
kynurenine which then degrades to form kynurenine (emission max: 436 nm (Figure 4.13) (Ronsein 
et al., 2009).  
      
4.19. Melatonin 4.20. AMFK 4.21. AMK 
       
Figure 4.12. The chemiluminescent reaction of melatonin resulting in the formation of N1-acetyl-N -formyl-5-
methoxykynuramine (AFMK) and N1 -acetyl-5-methoxykynuramine (AMK).  
 
3.13. Tryptophan 4.22. FMK 4.7. Kynurenine 
          




The tryptophan chemiluminescent reaction is thought to proceed via a tryptophan hydroperoxide 
and dioxetane mechanism as shown in Figure 4.14 (Ronsein et al., 2009). The tryptophan 
hydroperoxide is unstable and it further reacts to form FMK and chemiluminescence (Figure 4.14). 
Despite this instability, a tryptophan hydroperoxide (3.26) has been isolated from the reaction 
mixture and characterized by MS and NMR and this gives credence to the mechanism (Ronsein et al., 
2008). A GW luciferin based on XA  could follow a similar chemiluminescent mechanism. 
3.13. Tryptophan 4.23. Tryptophan hydroperoxide (I)  4.22. FMK 
 
 3.26. Tryptophan hydroperoxide (II) 4.7. Kynurenine 
Figure 4.14. The chemiluminescent oxidation of tryptophan by singlet oxygen (1g) (Ronsein et al., 2008).  
Kynuramines are thought to undergo further chemiluminescent oxidative processes resulting in the 
formation of many different photoproducts (Slawiński et al., 1980). Unfortunately  the search for 
these products has been difficult, since both kynuramines and the secondary kynuramine products 
are highly reactive and form a large variety of decomposition and oligomerization products 
(Hardeland et al., 2009). Many products were particularly unstable on LC and most could not be 
isolated by HPLC or studied by LC-MS (Hardeland et al., 1995).  
 
Xanthurenic  acid chemiluminescence takes a long  time to reach  its maximum (more than 24 hours) 
(Hardeland et al., 1999). In contrast the luminescence of indole-3-pyruvic acid (4.24) dropped to 12% 
after less than 2 hours (Hardeland et al., 1999). XA is less luminescent than kynurenic acid, possibly 
due to the ability of the hydroxy group to form an intramolecular hydrogen bond (Figure 4.16) 





Figure 4.15. Indole-3-pyruvic acid 
 
Figure 4.16. Potential intramolecular hydrogen bonds of 
xanthurenic acid 
 
Papadopoulos et al., suggested that dihydroquinolines produce chemiluminescence via a peroxide 
dioxetane mechanism based on absorption, fluorescence and NMR spectroscopy of unseparated 
reaction mixtures (Papadopoulos et al., 2000). However, the chemiluminescence products of this 
reaction and the reaction intermediates could not be isolated (Papadopoulos et al., 2000) making 
this mechanism less certain than that sugested by Ronsein (Ronsein et al., 2008). 
 
4.1.2 The planned identification of luminescence related products (LRP) 
Since both GW luciferin precursors (XA and tyrosine) were commercially  available, and because the 
GW enzyme mix contained both luciferin synthetic enzyme and GW luciferase, it was thought that 
other GW luminescence related products (LRP) could be generated by the reaction of commercial 
tyrosine and xanthurenic acid with GW enzymes.  
 
Similar reactions had previously been used to deduce the structure of the fungal luciferin 3-hydroxy 
hispidin (1.17) (see section 1.2.6.4) (Purtov et al., 2015). A commercially available fungal luciferin 
precursor (hispidin, 1.36) had been isolated from the fungus using chromatography and a 
bioluminescence assay that, like the GW assay, luminesced  with luciferin precursors as well as with 
luciferin (Purtov et al., 2015). The soluble fungal luciferin synthetic enzyme could be separated from 
the insoluble fungal luciferase so hispidin was reacted with the luciferin synthetic enzyme to 
produce the luciferin. The fungal luciferin,  which was found to luminesce with the fungal luciferase 
was then isolated and was characterised by  1H NMR and high resolution MS (Purtov et al., 2015). 
This enabled the fungal luciferin to be identified as 3-hydroxy hispidin (1.17) (Purtov et al., 2015).  
 
Such a method could not be used on the GW system because a GW luciferin synthetic enzyme 
separate from the GW luciferase was not available. This research therefore aimed  to produce a 
large amount of luciferin enzymatic product (LEP) by the reaction of commercial tyrosine and 
xanthurenic acid with both luciferin synthetic enzyme and GW luciferase (Figure 4.18). However, 
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since LEP would not  be luminescent with the GW luminescence assay, another detection method 
would be necessary to discover and isolate it.  
 
The structure of papiliochromes II (4.25, Figure 4.17), found in the wings of the swallowtail butterfly 
was also determined by the enzymatic reaction of commerically available precursors with an 
extracted crude enzyme mix (Rembold et al., 1978; Umebachi and Yoshida, 1970; Yago, 1989).  Like 
the GW luciferin, papiliochromes derivative 2 is made from the condensation of a tyrosine derivative 
(in this case L-DOPA) with kynurenine pathway molecules (in this case tryptophan) (Rembold et al., 
1978; Umebachi and Yoshida, 1970; Yago, 1989). Isotopically labeled tryptophan and dopa were 
therefore reacted with a crude enzyme fraction which enabled the generation of large amounts of 
material for NMR and structural elucidation (Yago, 1989). This compound could be identified as a 
reaction product by isotope labeling.  It could not be detected by the luminescence assay, 
because it could not react with the luciferase. 
 
4.25 
Figure 4.17. Papiliochrome II with  stacking shown between benzene rings. 
 
It was therefore  hypothesised that if a mixture of commercially available stable isotope labeled (SIL) 
tyrosine (13C9H11
15NO2) and unlabeled (UL) tyrosine (C9H11NO2) were mixed and reacted with XA, ATP-
Mg2+ and either GW LF or lysate, luminescence related products incorporating either SIL or UL Tyr 




Figure 4.18 Production of luciferin enzymatic product (LEP) and luminescence related products (LRP)  that are either 
stable isotope labeled (SIL) or unlabeled (UL). 
These LRPs could be detected in the reaction mixtures in several ways: 
1. HPLC and LC-MS differential analysis 
LRP peaks should increase in reaction mixtures displaying luminescence. However if these 
peaks are small compared to other reaction mixture components, these may be hard to 
detect. 
2. Chromophore analysis 
LRP peaks may have (but not necessarily) a similar UV-Vis absorbance spectra to XA or to the 
fluorescent emission spectra of glow-worm luminescence. 
3. LC-MS fragmentation analysis. 
LRP peaks might (but might not) display fragment ion peaks similar to those seen for 
tyrosine and/or XA. 
4. Stable isotope analysis 
LRP LC-MS peaks should show the incorporation of either labeled or unlabeled tyrosine.  
These could be detected by searching for co-eluting peaks with the expected UL vs SIL mass 
differences shown in Table 4.1. This can be done using Thermofisher  SieveTM  LC-MS perfect 
pair analysis (Thermofisher, 2014). The nanoflow orbitrap LC-MS is accurate to 0.001 Da and 
can therefore distinguish between 13C9 and  
13C8
15N. 
Table 4.1. Expected mass differences between compounds containing one stable isotope labeled (SIL) and unlabeled (UL) 
tyrosine.  
Elements incorporated 
Mass difference between UL and SIL 
compounds (Daltons) 
13C9
15N – incorporation of all tyrosine C and N 10.027 
13C9  - loss of tyrosine nitrogen
 9.030 
13C8




 Reaction mixture samples from the experiments described in section 3.4.9 were therefore analysed  
using HPLC-UV and LC-MS. 
 
4.2 Results and discussion  
4.2.1 Discovery of major luminescence related product A (LRPA) 
 
Samples from the reaction of XA and tyrosine with LF and ATP-Mg2+ (see section 3.4.9) were 
transfered from their 96 well plates, and within an hour of the assay, eluted through filter tip pipette 
tips containing C18, with a water to MeCN gradient (see section 3.4.9). This step removed material 
unsuitable for C18 chromatography, such as precipitated peptides. These filtered mixtures were 
dried, redissolved, then separated by SP-LC into broad fraction bands (in air). The chromatograms 
resulting from this separation were inspected for differences. The fractions resulting from this 
separation were then studied by LC-MS and the LC-MS data were analysed using Thermo 
Scientific™ SIEVE software (Thermofisher, 2014). 
 
It was necessary to separate the reaction mixtures into fractions to remove reaction mixture 
components such as ATP, ADP, AMP and MOPS, that were orders of magnitude more concentrated 
than the compounds of interest. This enabled the detection, and analysis of very low concentration 
reaction mixture components by LC-MS. SP-LC provided a repeatable way of separating the reaction 
mixtures, and enabled simultaneous HPLC chromatographic analysis of the reaction mixture 
samples. Samples were separated using a new HPLC gradient method (Method 2) which gave good 
separation and resolution of hydrophobic components. 
4.2.1.1 Discovery of LRPA by HPLC-UV analysis 
Inspection of HPLC chromatograms showed a distinctive peak at 13.3 minutes that displayed a UV-
Vis absorbance spectrum similar to XA (Figures 4.22 and 4.19). This peak appeared only in reaction 
mixtures to which LF, ATP-Mg+2, tyrosine and XA were added. The absence of any of these factors 
caused the loss of strong luminescence and the loss of this peak (Figures 4.20 and 4.21). This 
suggests that this peak was directly related to the GW luminescent reaction, and not to an unrelated 
process, because few other reactions are likely to require LF, ATP, Mg+2, tyrosine and XA. This 
compound was therefore named luminescence related product A (LRPA). As noted above, LRPA 
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showed a similar absorbance spectra to XA (LRPA UV-Vis finding 1, Figure 4.22). However it showed 
no detectable fluorescence when excited with 290 – 350 nm light (LRPA fluorescence finding 1).  
Minutes
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Figure 4.19.  Chromatograms detected at 270 nm of several example SP-LC reaction mixture separations. Reaction 
mixtures all contained luciferase fraction (LF) and ATP-Mg
2+
 while some contained tyrosine, xanthurenic acid (XA) or 
glow-worm light-organ isolated fractions F54 and F55 (which themselves contained XA). The production of these 
reaction mixtures is described in 3.4.9. The LRPA peak only appeared in reaction mixtures where LF, tyrosine, XA and 
ATP-Mg
2+



















Figure 4.20. The increase in luminescence and LRPA peak 
area (HPLC-UV) caused by the addition of SIL tyrosine to 
reaction mixtures that contained luciferase fraction (LF), 
ATP-Mg
2+
 and xanthurenic acid (XA). Both commercial 
and glow-worm isolated (F54) xanthurenic acid were 
tested. Production of these reaction mixtures is described 
in section 3.4.9. 
Figure 4.21. The increase in luminescence and LRPA peak 
area (HPLC-UV) caused by the addition of tyrosine (SIL and 
UL), xanthurenic acid (XA) and ATP-Mg
2+
 to reaction mixtures 
that contained luciferase fraction (LF). Error bars show one 
standard deviation above and below the mean of three 
seperate replicate reaction mixtures. Production of these 
reaction mixtures is described in section 3.4.9. 
 
Figure 4.22. UV-Vis spectra of xanthurenic acid (XA, 12.2 minutes) (blue) and the 13.3 minute LRPA peak (green) taken 






4.2.2 LRPA syntheses and isolation 
LRPA synthesis was scaled-up  by the reaction of larger amounts of XA (2 mg total), unlabeled 
tyrosine (2 mg total) and ATP-Mg2+ (24 mg total) with GW lysate (2 ml made from 30 GW LO) over a 
period of 3 days at 10 °C (see section 3.4.10). LRPA was isolated by SP-LC to produce approximately 
10 µg of material that was 99% pure by HPLC-UV and LC-MS (see section 4.4.1). This was a good 
amount considering that this material was generated from only 30 GW larvae whose light organs 
weighed only 23 mg in total. This showed the advantage of generating material enzymatically from 
added precursors  as opposed to isolating the material initially present. In comparison the Siberian 
bioluminescence research group used 9 g of wet Fridericia heliota earthworms to gain 0.005 mg of 
earthworm luciferin (Marques et al., 2011). LRPA was analysed by 1H NMR and UV-Vis spectroscopy 
and by LC-MS.  
4.2.3 Mass spectrometry and stable isotope labelling of LRPA 
High resolution MS of the purified LRPA indicated a [M+H]+ of m/z 369.1080 Da (Table 4.2). LC-MS 
analysis of stable isotope experiment SP-LC fractions showed the presence of co-eluting stable 
isotope labeled LRPA with [M+H]+ of m/z 379.1350 Da (Figure 4.24 and Table 4.2). The Δm/z 
between these ions was 10.027 Da; consistent with the incorporation of 13C9
15N  rather than  12C9
14N 
into SIL LRPA (Table 4.1). Strong luminescence and high concentrations of LRPA (both SIL and UL by 
LC-MS) were only observed in reaction mixtures to which LF, ATP-Mg+2, tyrosine (UL + SIL) and XA 
were added (Figure 4.23). This was consistent with the HPLC-UV findings (Figure 4.23).  
 
Figure 4.23. The luminescence and LRPA content (by LC-MS and HPLC-UV) of LF containing reaction mixtures was boosted by 
the addition of xanthurenic acid (XA), tyrosine (SIL:UL, 1:1) and ATP-Mg
2+




XA and tyrosine. Reactions were completed as described in section 3.4.9. Luminescence was measured with the 
Clariostar luminometer and LRPA concentration measured by Orbitrap nano-flow LC-MS. Error bars show one standard 
deviation above and below the mean for three separate replicate reaction mixtures analysed for  each sample type. 
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Figure 4.24. LC-MS chromatogram expansions (13 – 30 min) of total ion current (TIC) and extracted ion currents (EIC) of 
XA, UL-LRPA and SIL-LRPA for semi-preparative fraction F5 of a reaction mixture that contained luciferase fraction, SIL 
and UL tyrosine, XA and ATP-Mg
2+
. All LC-MS mobile phases contained 0.1% formic acid. 
 
Figure 4.25 shows the change in reaction mixture luminescence and LRPA concentration that 
resulted from the addition of SIL tyrosine (rather than 1:1 SIL: UL Tyr) to reaction mixtures 
containing LF and ATP-Mg2+ and either XA, XA containing solutions or water. Tyrosine and XA 
separately produced both luminescence with LF and ATP-Mg2+, but in much smaller amounts than if 
both XA and tyrosine were added together. This presumably occurred due to the presence of a small 
amount of native tyrosine and native XA in the luciferase fraction (LF).  
 
Figure 4.23 shows that when a 1:1 mixture of SIL: UL tyrosine was added to the reaction, the 
concentration of SIL LRPA and UL LRPA (by MS) both increased.  However Figure 4.25 shows that 
when only SIL tyrosine was added to reaction mixtures (Figure 4.25) the concentration (by MS) of SIL 
LRPA increased but that the concentration of UL LRPA did not change. This further supports the 
conclusion that LRPA was made from the tyrosine added to the reaction mixture. 
Total ion current 
XA  
UL LRPA 
SIL LRPA  
(379.13-369.14) 
RT: 0.00 - 29.97
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206.04-206.05 F: FTMS + 




Base Peak m/z= 
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The reaction mixtures of this experiment (made using LFs) were far more easily studied than those 
involving the reaction of GW crude lysates because the reaction contained only added molecules 
such as XA, Tyr, ATP and Mg2+ as major components. The LFs used did contain a range of small 
molecules. However, because only a small amounts (10 µl) of LF were necessary to catalyse the 
reaction, the concentration of these molecules was low: 3-OH kyn (less than 1 nM), Tyr (58 nM ± 20),  
Phe (196 nM ± 100), glutamyl tyrosine(80 nM ± 30), riboflavin (12 nM ± 8), as measured by LC-MS 
(see section 3.4.3).  
 
 
The luminescence and LRPA 
content of LF containing reaction 
mixtures were: 
A1 compared to A2:  
boosted with the addition of  ATP-
Mg2+ 
 A1 compared to A3:  
not boosted by the addition of 
tyrosine  
A2 compared to A4 and A3 
compared to A4:  
strongly boosted by the addition of 
ATP-Mg2+  and tyrosine    
 
 
The luminescence and LRPA 
content of LF, ATP-Mg2+ containing 
reaction mixtures were:  
A2 compared to B1 and A2 
compared to B3:  
boosted with the addition of XA 
containing mixtures (synthetic XA 
or F54 isolated from GW LO) 
B1 compared to B2 and B3 
compared to B4:  
Strongly boosted with the addition 
of tyrosine and XA containing 
reaction mixtures 
 
Figure 4.25.  The increase in luminescence and LRPA content caused by the addition of SIL tyrosine, xanthurenic acid 
(XA), glow-worm fractions containing XA (F54) and ATP-Mg
2+
 to reaction mixtures containing luciferase fraction (LF).  
Luminescence was measured by Clariostar luminometer and concentration by Orbitrap nano-flow LC-MS. Samples in A 
and B were tested concurrently but A is shown separately as luminescence and LRPA concentrations of these samples 
were much lower. Three separate replicate reaction mixtures were analysed for each sample type in A and error bars 
show one standard deviation above and below the mean. Samples in B were not replicated due to lack of material.   
A 
B 1 2 3 4 




4.2.3.1 MS fragmentation of LRPA 
The high resolution mass indicated that UL LRPA was C19H16N2O6 and that SIL LRPA was 
C10
13C9H16N
15NO6 while the MS fragmentation data of LRPA (Table 4.2, Figure 4.26 and Figure 4.27) 
indicated a molecule that contained tyrosine and XA residues. Such data would indicate that LRPA is 
consistent with Tyr + XA – H2O (LRPA MS finding 1) because Tyr is C9H11NO2 and  XA is C10H7NO4. The 
high resolution of the MS data clearly differentiates between 13C labeling and 15N labeling. For 
example, the m/z 219.0611 ion represents C10
13CH9N
15NO3
+ rather than C9
13C2H9N2O3
+ (Table 4.2). The 
production of both SIL and UL LRPA greatly helped the study of LRPA and related molecules. 
 
Table 4.2. MS and MS
2














































































































































160.0393 160.0399 XA fragment 













































































































RT: 13.80-14.81  AV: 35 T: 




2_151028103436#725  RT: 
21.72  AV: 1 F: FTMS + p NSI 




2_151028103436#679  RT: 
21.74  AV: 1 F: FTMS + p NSI 
d Full ms2 379.13@hcd45.00 
[50.00-390.00] 
 




















































379.1354303.1152285.1045272.1053248.0587 266.0696 342.4335 351.7134294.3286 330.4113 365.2636 371.8055
332.1263
314.1157
379.1351303.1149286.1079272.1054248.0587 293.4906 323.5786 356.9307264.0350
NL: 1.29E6
15077_P9_10_15_E3_F5
MS2#1034  RT: 21.83  AV: 





MS2#1035  RT: 21.86  AV: 





MS2#707  RT: 15.68  AV: 1 




Figure 4.26.  Expanded (m/z 300 – 375 Da) MS
2
 spectra of unlabeled (top) and stable isotope labeled LRPA (below) 
(Orbitrap nanoflow LC-MS). Full spectra shown in Appendix 4. 2. 





































































127.0759 219.0611160.0393 332.1266114.0726 188.0342145.0995
174.0848 198.9557




RT: 13.80-14.81  AV: 35 T: 




2_151028103436#725  RT: 
21.72  AV: 1 F: FTMS + p NSI 




2_151028103436#679  RT: 
21.74  AV: 1 F: FTMS + p NSI 
d Full ms2 379.13@hcd45.00 
[50.00-390.00] 
 
Figure 4.27. Expanded (m/z 100 – 270 Da) MS
2
 spectra of unlabeled (top) and stable isotope labeled LRPA (below) 
(Orbitrap nanoflow LC-MS). Fragments labeled as originating from tyrosine (Tyr) or xanthurenic acid (XA). XA and Tyr 
fragments occur in similar ratios to those seen in the fragmentation of XA and Tyr. Full spectra shown in Appendix 4. 2. 
Loss of CO2H2 (46.005 Da) 
379.108 
MS2 spectrum  Loss of
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15021_P3_11_15_1_F21 #723 RT: 16.14 AV: 1 NL: 7.07E6
T: FTMS + p NSI d Full ms2 206.01@hcd45.00 [100.00-425.00]



































Figure 4.28.  MS
2
 spectrum of XA (Orbitrap nanoflow LC-MS). This shows that the major m/z 178 Da signal observed in 
the MS
2 
of LRPA can be observed in the MS
2
 of XA.  
 
SIL-LRPA showed an initial neutral loss of 13CO2H2 (SIL formic acid) while UL-LRPA showed an initial 
neutral loss of CO2H2 (UL formic acid) (Figure 4.26). This suggested the loss of the tyrosine carboxyl 
carbon (LRPA MS finding 2). The loss of formic acid was also observed for tyrosine (UL and SIL) 
causing the formation of the immonium ion (UL and SIL) (Ronsein et al., 2009). This result is 
consistent and indeed characteristic of the fragmentation patterns of the majority of amino acids, 
which show an initial protonation at the amino group, followed by proton transfer to the carboxylic 
acid moiety and fragmentation (Ronsein et al., 2009). If the XA was bound to Tyr by only the 
carboxylic acid carbon then cleavage of the carboxyclic acid carbon would cause the Tyr residue to 
be cleaved from the XA residue. LRPA MS finding 2 therefore suggests that in LRPA, tyrosine was 
attached to XA at a position other than the tyrosine carboxylic acid carbon. 
 
The loss of formic acid also indicated that the tyrosine carboxylic acid carbon was lost with two 
oxygens and two protons. LRPA MS finding 2 therefore suggests that in LRPA, the tyrosine carboxylic 
acid carbon remained attached to two oxygens. This would suggest that tyrosine carboxylic acid 
carbon was not converted into an amide or aldehyde.  
 
All the fragments observed from tyrosine itself [Tyr+H]+ except for the [Tyr + H]+ ion were observed 
from the fragmentation of LRPA with SIL tyrosine fragments originating from the m/z 379 ion and UL 
fragments originating from the m/z 369 ion (LRPA MS finding 3) (Table 4.2 and Figures 4.26 and 
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4.27). These fragments included the C8H10NO
+  and C8H7O
+  ions  which are characteristic of an intact 
tyrosine residue.  LRPA MS finding 3 therefore suggested that the tyrosine residue in LRPA was very 
similar to that of tyrosine.  
 
Both UL and SIL LRPA fragmented to give a m/z 206 ion corresponding to the parent ion of XA 
[XA+H]+ and all the fragments observed from the fragmentation of XA itself ([XA+H]+) were observed 
from the fragmentation of LRPA (LRPA MS finding 4, Table 4.2 and Figures 4.26, 4.27 and 4.28). This 
suggested a LRPA fragmentation pathway that enabled the regeneration of [XA+H]+ and that the XA 
residue of LRPA was very similar to that of XA. It also suggested that the XA residue was attached to 
tyrosine via C-O or C-N bonds rather than C-C bond, because C-C bonds would not be easily cleaved 
to give a major m/z 206 Da ion.  
 
The m/z 217 ion (UL-LRPA) and the m/z 219 ion (SIL-LRPA) (Figure 4.27) represented the [XA - O + (13 
or 12)CH + (15 or 14) NH3 ]
+ ion (LRPA MS finding 5). This sugested that LRPA underwent a fragmentation 
process that resulted in a molecule containing either: 
 
XA - TyrN -TyrC    or  TyrC -XA - TyrN 
 
       (XA bound to TyrN which is bound to TyrC)                                 (XA bound separately to TyrN and TyrC)        
 
This indicated that either XA was attached to the tyrosine via the tyrosine amine, or that 
fragmentation and rearrangement resulted in an ion for which this was true.   
 
4.2.3.2 Deuterium labelling of exchangeable protons  
The addition of heavy water (D2O) to a sample, enables protons that would rapidly undergo proton-
proton exchange, to undergo proton-deuterium exchange (Andrieu et al., 2006). If such mixtures are 
analysed by MS, this process causes the appearance of ions that have higher m/z values due to the 
incorporation of deuterium rather than hydrogen (Andrieu et al., 2006; Budzikiewicz et al., 1964). 
The maximum number of deuteriums that can be exchanged for hydrogens shows how many readily 
exchangeable protons the compound has (Garcia et al., 2004; Price, 2006). LRPA, tyrosine and XA 
were dissolved in 50% D2O and 50% d3-MeCN with 0.1% formic acid (FA) to label the acid 
exchangeable protons with deuterium. Under these acidic conditions, LRPA was found to contain 
three exchangeable protons while tyrosine had four and XA had two rapidly exchanging protons and 
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one slowly exchanging proton (minor) (LRPA MS finding 6, Tables 4.3, 4.4 and 4.5). The acid 
exchangable protons of tyrosine and XA are shown in Figure 4.29.  
It is important to note that one of the exchangeable protons in each case will generally be due to the 
proton that provides the MS ionisation charge (i.e.[M+H]+). Since only one proton or deuterium is 
necessary for ionisation, LRPA would be expected to have 5 (4 + 2 – 1) rapidly exchanging protons 
under acidic conditions if no rapidly exchanging protons had been lost during LRPA formation. The 
fact that LRPA has three exchangeable protons showed that two rapidly exchangeable protons had 
been lost in the formation of LRPA. This would be consistent with the loss of H2O which supports 




Figure 4.29. Xanthurenic acid and tyrosine. Acid exchangeable protons are shown by a. Protonated XA contains two 
protons that rapidly exchange under acid conditions (Figure 4.11 shows the ionisation of XA under different pH). 
Protonated tyrosine contains four protons that rapidly exchange under acid conditions (Figure 4.3 shows the ionisation 
of tyrosine under different pH). 
 
Table 4.3. UL LRPA ions in 50% d3-MeCN and 50% D2O with 0.1% formic acid. LRPA had three exchangeable protons 
under acidic conditions. The m/z 369 Da [LRPA + H]
 + 
peak was not observed because the LRPA sample had previously 
been kept in D2O:D3-MeCN (1:1) for several days for NMR studies before being dried for storage. Therefore when LRPA 
was redissolved in D2O: D3-MeCN (1:1) previous to this experiment, it had already undergone deuterium exchange. LRPA 
therefore underwent a far more complete exchange than XA or tyrosine which had only been dissolved in D2O: d3-MeCN 
(1:1) once. Spectra are shown in Appendix 4. 5. 
Ion Experimental m/z Calculated m/z % of pattern 
[LRPA + D] + 370.1140 370.1144 20 
[LRPA – H + 2D] + 371.1203 371.1207 47 




Table 4.4. Tyrosine ions in D2O: d3-MeCN (1:1) with 0.1% formic acid.  Tyrosine had four exchangeable protons under 
acidic conditions, likely the three amino protons and the carboxylic alcohol proton. Spectra are shown in Appendix 4. 3. 
Ion Experimental m/z Calculated m/z % of pattern 
[Tyr + H] + 182.0811 182.0812 29 
[Tyr + D] + 183.0870 183.0874 18 
[Tyr – H + 2D] + 184.0934 184.0937 11 
[Tyr – 2H + 3D] + 185.0998 185.1000 29 
[Tyr – 3H + 4D] + 186.1058 186.1063 12 
 
Table 4.5. XA ions in D2O: d3-MeCN (1:1) with 0.1% formic acid.  XA had two rapidly exchangeable protons under acidic 
conditions (carboxylic acid and N-H). The molecule also contained one slowly exchangeable proton (less than 5% of the 
pattern, probably phenol exchange). Spectra are shown in Appendix 4. 4. 
Ion Experimental 
m/z 
Calculated m/z % of pattern 
[XA + H]+ 206.0447 206.0448 39 
[XA + D]+ 207.0506 207.0448 42 
[XA - H + 2D]+ 208.0565 208.0573 16 
[XA - 2H + 3D]+ 209.0634 209.0636 3 
4.2.4 1H NMR spectroscopy of LRPA 
An 1H NMR spectrum was taken of LRPA in 50% d3-MeCN and 50% D2O and this spectrum was 
compared to the spectra of XA and tyrosine under the same conditions (Figures 4.30 and 4.33 and  
Table 4.6). Spectra were taken in this solvent mix because LRPA did not dissolve in water, chloroform 
or MeCN under neutral conditions. 2D spectra could not be collected due to lack of material (150 μg 
is needed for HMQC or HMBC even for micro NMR (Marques et al., 2011). The 1H NMR spectrum of 
LRPA was found to be similar to that of the combined spectra of XA and tyrosine with signals similar 
to the 5, 6 and 7 protons of XA and the 2, 3 and  protons of tyrosine (LRPA NMR finding 1). This 
indicated that these regions of the LRPA molecule were unchanged. 
 
 The disappearance of the one proton singlet XA-3 proton peak at 7.8 ppm and the appearance of a 
new one proton singlet peak at 9.1 ppm (LRPA NMR finding 2) and a shift of the one proton double 
doublet tyrosine  proton from 4.5 to 5.4 ppm  (LRPA NMR finding 3) indicated that changes had 





These new peaks are unlikely to represent NH or OH protons because the spectrum was taken in 
50% D2O which would lead to proton exchange. These new peaks are unlikely to represent protons 
unrelated to LRPA because they show the same integrated peak area and coupling as the peaks that 
disappeared.  
 
Figure 4.30. Expanded (3.5 – 6.0 ppm) 
1
H NMR spectra (with water suppression) of LRPA (red), tyrosine (Tyr, green) and 
xanthurenic acid (XA, blue) in D2O: d3-MeCN (1:1) (500 MHz referenced to 1.94 ppm MeCN peak). Arrows show peak 
assignments. Full spectra are shown in Appendix 4. 6. HOD peak is larger in the LRPA spectrum due to the low 
concentrations of LRPA (50 µg/ml). 
 
Figure 4.31. The numbering of xanthurenic acid moiety 
 
 








Figure 4.33. Expanded (6.9 – 9.3 ppm) 
1
H NMR (with water suppression) of LRPA (red), tyrosine (Tyr, green) and 
xanthurenic acid (XA, blue) in D2O: d3-MeCN (1:1) (500 MHz referenced to 1.94 ppm MeCN peak). Arrows show peak 
assignments. Full spectra are shown in Appendix 4. 6. The unknown broad peak shown has an integration less than one 
proton and was not observed when the spectra of LRPA was taken a few weeks later after desiccation and re-
solubilisation. The unknown broad peak is therefore not thought to be due to the dominant tautomer of LRPA and likely 











H NMR spectra for XA, Tyr and LRPA in 1:1 D2O: d3-MeCN. 
Assignment 
Tyrosine 
(assignments own work 
described in Chapter 6 and 
(Laws et al., 1986)) 
XA (assignments from 
Yanshole (Yanshole et 
al., 2010)) 
LRPA 
LRPA new peak - - 9.09 (s, 1H) 
XA 7 -  8.45 (d, 8.4 Hz, 1H), 8.39 (d, 8.3 Hz, 1H) 
XA 6 - 8.13 (t, 8.1 Hz, 1H), 8.10 (t, 8.0 Hz, 1H) 
XA 5 - 8.01 (d, 7.8 Hz, 1H), 7.95 (d, 7.7 Hz, 1H) 
XA 3 - 7.79 (s, 1H). - 
Tyr 2 7.86 (d, 8.5 Hz, 1H) - 7.85 (d, 8.0 Hz, 2H) 
Tyr 3 7.54 (d, 8.5, 1H) - 7.45 (d, 8.1 Hz, 2H) 
Tyr  4.52  
(dd, 8.4, 4.8 Hz, 1H) 
- 
5.36 
 (dd, 9.2, 4.6 Hz, 1H) 
Tyr 1 3.88 (dd, 14.4, 4.8 Hz, 1H) - 
3.96  
(dd, 14.1, 4.6 Hz, 1H) 
Tyr 2 3.66 
(dd, 14.5, 8.4 Hz, 1H) 
- 
3.68  
(dd, 14.1, 9.2 Hz, 1H) 
 
4.2.5 Conversion of LRPA into Oxy LRPA 
Several days after the 1H NMR spectrum of LRPA was taken, the solution was dried and redissolved 
in d3-MeCN: D2O (1: 1) and a small amount reanalysed by HPLC and LC-MS (nanoflow Orbitrap  and 
milli flow micro TOFQ). LC-MS showed that most LRPA remained unchanged but also showed several 
new LC-MS peaks which appeared to be oxidation products of LRPA (Figure 4.34, Table 4.7). These 
molecules showed fragmentation similar to LRPA and gave fragment ions that were oxidised 
versions of LRPA fragments (Table 4.7).  
 
Oxy LRPA 1 shows two possible parent ions: Oxy LRPA  1.1 and Oxy LRPA 1.2. These two ions show a 
mass difference of H2O and it is not known which is the [M+H]
+ ion. The extra H2O could be caused 
by residual solvent attachment or may be incorporated into the structure (Wyttenbach et al., 2005). 
 
Oxy LRPA 2 shows a [M+H ]+ and a [M+H -2H]+ ion by MS. Since other quinones undergo 2H MS 
reduction (Das et al., 1965; Oliver and Rashman, 1971; Ukai et al., 1967), the [M+H -2H]+ ion is 






Figure 4.34. The increase in LRPA degradation products as a proportion of LRPA after a month storage in d3-MeCN:D2O 
1:1 with 0.1% formic acid. Relative compound concentrations were determined by LC-MS (Orbitrap, nano-flow). For the 
coeluting m/z 417.0929 and 399.0823 Da only the higher mass (presumed to be parent) ion was plotted. 
 
Table 4.7. MS and MS
2














Oxy LRPA 1 + H2O (1.1) 
 [LRPA + H + O2 + H2O – H2]
+ 







Oxy LRPA 1 (1.2) 





Both these ions co-elute 














































[M +H - CO2H2 - CO2H2]
 + 






















Oxy LRPA 2 (2.1) 
[LRPA + H + H2O – H2]
+ 








Oxy LRPA 2 – 2H (2.2) 
[LRPA + H + H2O – (2 H2]
+ 






Both these ions co-elute 































































4.2.6 Discovery of minor luminescence related products LRPB and LRPC 
Thermofisher Sieve™ Perfect Pair analysis was used to search SP-LC fraction LC-MS spectra for 
co-eluting compounds that showed the expected UL - SIL differences shown in Table 4.1. As well as 
detecting the UL-LRPA_SIL-LRPA and UL-Tyr_SIL-Tyr perfect pairs, this analysis also detected two 
more Perfect Pairs (Table 4.8). These were named luminescence related products B (LRPB) and 
luminescence related product C (LRPC). These were present at MS TIC intensities one hundred times 
less than LRPA, so their discovery shows the power of SIL analysis when studying minor compounds 
found at very low concentrations. 
 
LRPA (SIL and UL), LRPB (SIL and UL) and LRPC (SIL only) were found at significantly larger (P < 0.05 
by Sieve differential analysis) concentrations in reaction mixtures that contained LF +  ATP-Mg2+ + XA 
+ Tyr (1:1, SIL: UL)  compared to those than contained  LF +  ATP-Mg2+ (Figure 4.35, LRPA data 
included for comparison). This suggested that these compounds were connected with the 
luminescence reaction. UL LRPC was not found to be significantly larger because the variation 
between samples was larger than the increase in UL LRPC which was probably due to the low 
concentration of UL LRPC. 
 
Table 4.8. Minor luciferin enzymatic product candidates discovered by Perfect Pair analysis. Table shows estimated 
compound concentration (conc, by LC-MS) in reaction mixtures that contained luciferase fraction (LF), ATP-Mg
2+
, XA and 
Tyr (stable isotope labeled (SIL): unlabeled (UL), 1:1) (see section 3.4.9). Percentage standard deviation: % stan dev.  Not 
observed: NO. Table also shows the relative amounts of these compounds in reaction mixtures that contained LF, ATP-
Mg
2+




LRPB and LRPC (Figure 4.35, Table 4.8) showed the incorporation of all tyrosine carbons and 













Conc (µM)  
LF +  ATP-
Mg
2+
   
+ XA + Tyr 
(% stan dev) 
Relative 
amount 
(LF +  ATP-Mg
2+
,   
+ XA + Tyr)/   















 386.1155 386.1179 0.10, (40) 
NO  in 
 LF +  ATP-Mg
2+
,   












 384.0998 384.1022 0.03, (44) 
NO  in 
 LF +  ATP-Mg
2+
,   
+ XA + Tyr 
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LRPB and LRPC contained two less XA carbons compared to LRPA. MS2 fragmentation data of LRPB 
and LRPC were not collected. LRPB C17H16O8N2
+ and LRPC C17H14O8N2
+
 have an even number of 
nitrogens but an [M+H]+ ion containing two nitrogens would be expected to have an odd nominal 
mass (Kind and Fiehn, 2007; McLafferty and Tureček, 1993). This indicated that these ions were not  
[M+H]+ ions. If these ions were not [M+H]+ ions they were likely either [M]+ ions formed by one 
electron oxidation of M or by the loss of H from the [M+H]+ ion, or fragments of larger structures.  
However, no larger parent ion peaks that showed stable isotope labeling were observed.  
 
  
Figure 4.35. Luminescence related product (LRP) ions found by SIL analysis. Xanthurenic acid (XA) is also shown. Graphs 
show the change in ion peak area between reaction mixtures that contained luciferase fraction (LF) and ATP-Mg
2+
 and 
those containing LF, ATP-Mg
2+
, XA, stable isotope labeled (SIL) tyrosine and unlabeled (UL) tyrosine in the semi-
preparative fraction F5 of each reaction mixture. Error bars show one standard deviation above and below the mean for 
three separate replicate reaction mixtures. 
 
LF + ATP-Mg2+ 




RT: 0.00 - 29.98

























































































Figure 4.36. LC-MS total ion current (TIC) and extracted ion chromatograms for stable isotope labeled (SIL) and 
unlabeled (UL) LRPB and LRPC. Spectra were taken from a F5 semi-preparative fraction derived from a reaction mixture 
that contained luciferase fraction, ATP-Mg
2+
, xanthurenic acid and tyrosine (UL and SIL). The reason for the two peaks of 
LRPC is not known, and both peaks appear identical by MS and MS
2
. Both peaks were integrated together. 
4.2.7 Discovery of LRPD 
Fraction 54 from which XA was extracted contained a minor compound with a high resolution mass 
that suggested the formula C19H14N2O6; the mass of LRPA after the loss of two protons (an oxidation) 
(Table 4.9).  Furthermore, the MS2 spectra showed a fragmentation pattern similar to that expected 
of LRPA after the loss of two protons (Table 4.9). It seems likely that this compound is related to 
LRPA and is therefore named luminescence related product D (LRPD). The presence of C8H8NO
+ 
fragments rather than C8H10NO
+ and fragments suggested that the two protons were lost from the 











Table 4.9. MS and MS
2






Experimental m/z of 
same fragment in LRPA 









 321.0862 321.0870 323.1028 
XA, C10H8NO4
+
 206.0443 206.0453 206.0448 
XA fragment, C9H8NO3
+
  178.0443 178.0504 178.0499 
XA – (H + CO2), C9H7NO2
+
 
161.0468 161.0471 160.0393 




 134.0597 134.0600 136.0757 
 
4.2.8 LRPA luminescence 
LRPA was the major new component formed by the GW extract catalysed luminescent reaction of 
tyrosine and XA with LF and ATP-Mg2+, and it was not formed if one of these components was 
absent. It was therefore thought that LRPA was most likely the GW luciferin enzymatic product (LEP) 
i.e. the final product of the luminescent reaction (Figure 4.37). However, the MS and 1H NMR data 
for LRPA suggested a structure that had undergone neither oxidation nor decarboxylation when 
compared to XA plus tyrosine. Such a structure seemed unlikely to be LEP given that all known 
luminescence reactions involve oxidation and generally involve oxidative decarboxylation (see 
Chapter 1).  Since ATP-Mg2+ seems to be required to form GW luciferin, as well as for the 
luminescent luciferase reaction (see section 3.2.11) the addition of ATP-Mg2+ will increase both the 
luciferin synthesis reaction as well as the luciferase reaction. LRPA could therefore also be a luciferin 







Figure 4.37. The production of luminescence related products from tyrosine and xanthurenic acid.  
It was not considered likely that LRPA would be the luciferin because previous experiments had 
shown the GW luciferin to be quite unstable while LRPA appeared stable under similar conditions 
(Chapter 3). It was also thought that any active luciferin would have been consumed in the 
luminescent reaction. However, since LRPA might be a luciferin precursor it was tested by 
luminescence assay with LF and ATP-Mg2+ (Figure 4.38). All remaining LRPA was used up in this 






Figure 4.38. The luminescence (luminescence units, LU) of LRPA, XA and Tyr with LF and ATP-Mg
2+
 (measured in 
triplicate). A: 83 ng LRPA added to reaction mixture. B: 16 ng LRPA added to reaction mixture. C. XA and Tyr added to 
reaction mixture. Details are described in section 3.4.9. Note differences in scales between A, B and C. 
 
Figure 4.38 shows that LRPA produced a very strong luminescence when mixed with LF and ATP-
Mg2+. This luminescence was 1000 times stronger than that of XA and tyrosine under the same 
conditions with the same LF. Figure 4.38 also shows that LRPA produced luciferin type (L type) 
kinetics rather than precursor type (P type) kinetics. Since L type luminescence was also produced by 
glow-worm fractions believed to contain luciferin (Chapter 3), this showed that the LRPA solution 






4.2.9 Structural elucidation of LRPA  
The experimental findings from above are summarised below. This is followed by a discussion on 
possible LRPA structures. 
4.2.9.1 MS findings 
MS summary of section 4.2.3. 
LRPA MS finding 1. The molecular formula of LRPA is consistent with Tyr + XA – H2O. 
This suggested that: 
- Either XA was attached to tyrosine via an ester. 
- Or that XA was attached to tyrosine via an amide. 
- Or that a phenol alcohol had been removed. 
- Or that the XA-Tyr conjugate contained an aldehyde at a position that tyrosine or XA had 
contained a carboxylic acid. 
LRPA MS finding 2. SIL-LRPA showed an initial neutral loss of 13CO2 H2 (SIL formic acid) while UL-LRPA 
showed an initial neutral CO2 H2 (UL formic acid).  
This suggested that: 
- The Tyrcarboxylic acid carbon was lost as formic acid without the cleavage of XA residue from  
the tyrosine residue. 
- The Tyrcarboxylic acid carbon remained attached to two oxygens which suggested that the 
Tyrcarboxylic acid had not undergone amide derivatisation. 
LRPA MS finding 3. All the tyrosine fragments observed in the fragmentation of [Tyr+H]+ were also 
observed from the fragmentation of LRPA including C8H10NO
+  and C8H7O
+. SIL tyrosine fragments 
were produced from the SIL LRPA m/z 379 positive ion and unlabeled fragments from the unlabeled 
LRPA m/z positive 369 ion. However an intact [Tyr + H]+ fragment was not observed from LRPA. 
This suggested that: 




LRPA MS finding 4. Both SIL- and UL-LRPA fragmented to give a m/z 206 positive ion identical to 
[XA+H]+ and to give all the XA fragments that were observed from the fragmentation of [XA+H]+. 
 This suggested that: 
- LRPA underwent a MS fragmentation and rearrangement process that regenerated [XA+H]+. 
LRPA MS finding 5. UL-LRPA fragmented to give an m/z 217 positive ion while SIL-LRPA fragmented 
to give a m/z 219 positive ion. High resolution mass data shows that these represent [XA + H4 - O + 
(13 
or 12)C + (15 or 14) N]+ ions which shows that LRPA can fragment to produce a [XA + H4 - O +
TyrC + Tyr N]+ ion. 
This suggested that: 
- Either LRPA contains a Tyrnitrogen-XA attachment. 
- Or that such an attachment is formed during the rearrangement and fragmentation of the 
LRPA ion. 
LRPA MS finding 6. Under acidic conditions (0.1% formic acid, pH 2.8), LRPA contained three rapidly 
acid exchangeable protons while tyrosine had four and XA had two. 
This suggested that 
- LRPA had lost two previously acid exchangeable protons, which was consistent with the loss 
of H2O. 
4.2.9.2 1H NMR findings 
1H NMR summary of section 4.2.4. 
 
LRPA NMR finding 1. The 1H NMR spectrum of LRPA was similar to the combined spectra of XA and 
tyrosine with signals similar to the 5, 6 and 7 protons of XA and the 2, 3 and  protons of tyrosine. 
- This suggested that these regions were unaffected by LRPA formation. 
LRPA NMR finding 2. The one proton singlet XA-3 proton peak at 7.8 ppm was observed in the 
spectra of XA but was not present in the spectra of LRPA, while a one proton singlet peak at 9.1 ppm 
was observed in the spectra of LRPA but not in the spectra of tyrosine or XA. 
This suggested that: 
- The region around the XA-3 proton was affected by LRPA formation. 
- LRPA contains a highly de-shielded proton that results in a 1H NMR singlet peak. 
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LRPA NMR finding 3.  
The formation of LRPA caused the tyrosine  proton to be shifted from 4.5 ppm (in tyrosine) to 5.4 
ppm in LRPA. However the coupling patterns of the and tyrosine protons did not change 
between LRPA and tyrosine. 
This suggested that: 
- This region around the tyrosine  proton was affected by LRPA formation. 
- But that the change did not include adding protons to the and  carbons or to the carbons 
attached to the and  carbons. 
4.2.9.3 Other evidence 
Summary of section 4.2.1.1. 
LRPA UV-Vis finding 1. LRPA showed a similar absorbance spectrum to XA in MeCN containing 0.1% 
formic acid. 
- This suggested that the XA chromophore was not affected by the attachment of the tyrosine 
residue during the formation of LRPA. 




4.2.9.4 Ester or amide linked candidates 
LRPA MS finding 1 suggested that tyrosine might be attached to XA via an ester or an amide linkage 
while LRPA NMR finding 1 and LRPA NMR finding 2 suggested that derivatisation occurred close to 
the XA 3 proton. This would suggest structures 4.26, 4.27, 4.28 or 4.29 as possible candidates (Figure 
4.39 and Figure 4.40). None of these structures break the conjugation of the XA chromophore in 




Figure 4.39. Candidate LRPA in which the xanthurenic acid moiety is attached to the tyrosine moiety by the formation of 
a simple ester. a: acid exchangeable protons including the ionising proton which has not been attached to any specific 




Figure 4.40. Candidate LRPA in which the xanthurenic acid moiety is attached to the tyrosine moiety by the formation of 
a simple amide. a: acid exchangeable protons including the ionising proton which has not been attached to any specific 
position. s: Proton possibly responsible for one proton singlet peak. 
A Chemical Abstracts search for molecules similar to 4.26 (1/4/16) showed that there are many XA 
based natural products in which the XA phenol is derivatized including the bacterial produced 
quinolobactin (4.9) (du Moulinet d'Hardemare et al., 2004; Matthijs et al., 2004) and the insect 
produced xanthurenic acid 4,8-diglucoside (4.10) (Ishiguro and Ikeno, 1974; Ishiguro et al., 1974) as 
well as other examples previously discussed in section 4.1.1.2.  No natural product was found in 
which the XA phenol was ester derivatized.  The search showed that the ester derivatisation of 
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phenols in related synthetic  compounds such as 4.30 and 4.31 caused the neighbouring proton to 
be more deshielded than the XA-3 proton (Figure 4.41) which is consistent with LRPA NMR finding 2. 
However neither 4.30 or 4.31 show a chemical shift as high as the 9.10 ppm shift observed for LRPA 
(LRPA NMR finding 2).  Furthermore the loss of tyrosine derived formic acid is unlikely to be a major 
fragmentation process for compound 4.26 which is contrary to LRPA MS finding 2. Structure 4.26 
also shows 4 exchangeable protons under acid conditions which is contrary to LRPA MS finding 6. 
Compound 4.26 is therefore unlikely to be LRPA. 
 
 






NMR provided by (Clarke et al., 1985) 
Figure 4.41. Xanthurenic acid (XA) containing molecules in which an XA  4 or 8 like phenol is derivatized. 
1
H NMR data is 
given for the XA 3 proton. 
Amide linkages like those of  4.28 and 4.29 are extremely common in nature (Newman et al., 2003) 
while anhydride linkages like those found in 4.27 are not found as natural products because the 
anhydride linkage is unstable in water (Johnson, 1999). No natural products similar to structures 
4.27, 4.28 and 4.29 were found in the Chemical Abstracts (searched 1/4/16). Full search details are 
shown in Appendix 4. 8. Since compounds 4.27, 4.28 and 4.29 appear to contain no protons that 
could cause the observed 3-H chemical shift of 9.10 ppm these compounds were unlikely to be LRPA. 
4.2.9.5 Cyclised candidates 
LRPA MS finding 2 suggested that in LRPA, XA was bound to the tyrosine with at least one non-ester 
connection while LRPA MS finding 5 suggested that XA was bound to Tyr by a TyrN - C link.  
If the TyrN – C link is not an amide bond, then H2O must be lost from another position in order to fulfil 
LRPA MS finding 1. One possibility is that the tyrosine carboxylic acid was also attached to XA 
alcohol via an ester.  Since the XA 5, 6 and 7 region is unchanged between LRPA and XA (LRPA NMR 
finding 1 and LRPA NMR finding 2) structures 4.32 - 4.37 were suggested as candidates. Candidates 
4.32 - 4.37 could all fragment to produce [XA+H]+ and [XA – O + H3 + 
TyrCH + TyrN]+ ions  and could all 
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fragment to produce TyrFormic acid which is consistent with LRPA MS finding 4, LRPA MS finding 5. 





Figure 4.42.  Cyclic LRPA candidates which show full xanthurenic acid (XA) conjugation. a: acid exchangeable protons 
including the ionising proton which has not been attached to any specific position. s: Proton possibly responsible for one 






4.34 4.35 4.36  4.37 
Figure 4.43. Cyclic LRPA candidates in which xanthurenic acid  XA is reduced. a: acid exchangeable protons including the 
ionising proton which has not been attached to any specific position. s: Proton possibly responsible for one proton 
singlet peak. 
Candidates 4.34 - 4.37 (Figure 4.43) all show a reduced XA ring. A Chemical Abstracts similarity 
search for reduced XA  (4.38) (1/4/16) showed similarity with dihydroquinoline 4.39 (Table 4.10). 
This was interesting, because dihydroquinoline 4.39 (produced in vitro by reductive radiolysis from 
the sister carboxyquinoline) produced chemiluminescence when base was added (Papadopoulos et 
al., 2000).  
 
However, compound 4.39 shows a 3 proton shift of 5.8 ppm and a UV-Vis max:  290 nm (see Table 
4.10) (Papadopoulos et al., 2000). This shows that reduction of the quinoline leads to the 3 proton 
becoming far more shielded and the max becoming shifted to a shorter wavelength. Candidates 4.34 
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- 4.37  would therefore not have ring protons capable of giving a chemical shift of 9.10 ppm or a UV-
Vis spectrum similar to XA. This would contradict both LRPA UV-Vis finding 1 and LRPA NMR finding 
2. 
Table 4.10. Compound identified by Chemical Abstract search for molecules similar to reduced XA (1/4/16)  
Fragment searched for  Compounds identified by search (
1
H NMR of 
important positions shown if available) 
 
4.38. A reduced XA fragment similarity search 
 
4.39. 2-Quinolinecarboxylic acid, 1,4-dihydro-4-hydroxy- 
CAS registry number: 265653-12-1 
NMR data from (Papadopoulos et al., 2000) 
 
A search of the Chemical Abstracts (1/4/16) showed no molecules similar to structures 4.33 and 4.36 
(Appendix 4. 7) but 4.32 and 4.37 showed similarity with the anti-cancer drug 4.40 (Gorohovsky and 
Bittner, 2001) and to the bacterial product 4.41 (Komagata et al., 1992). This showed that the six 
membered lactonic ring observed for 4.32 and 4.37 was possible in natural products. 
 
4.40.  2H-Naphth[1,2-b]-1,4-oxazin-2-one, 5-chloro-3,4-
dihydro-6-hydroxy-3-[(4-hydroxyphenyl)methyl]-, (3S)- 
CAS registry number: 359766-05-5 
NMR from (Gorohovsky and Bittner, 2001) 
 
4.41. 2H-1,4-Benzoxazine-5-carboxylic acid, 3,4-dihydro-2-
oxo-3-(phenylmethylene)-, (3Z) (TA-3037A (I)) 
CAS registry number: 143651-44-9 
(Komagata et al., 1992) 
Figure 4.44. Molecules similar to 4.32 and 4.37. 
 
Refinement of the search to molecules involved in biological processes showed that  4.33 and 4.36 
were somewhat similar to phenoxazinone class natural products such actinomycin (4.42) (Barry et 
al., 1989), rifamycin (4.43) (Figure 4.45) (Yamane et al., 1991) and insect produced ommochromes 
such as xanthommatin (4.13) (Le Roes-Hill et al., 2009). This was interesting because these 
molecules are formed from the oxidative coupling of kynurenine pathway molecules such as 3-OH 
anthranilic acid (4.6), 3-hydroxy kynurenine (3.2) and in the case of the insect metabolite 
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xanthommatin (4.13) from XA (4.13) (see section 4.1.1.2) (Le Roes-Hill et al., 2009; Seligy, 1972; 





CAS registry number: 1402-38-6 




benzofuro[4,5-a]phenoxazine (Rifamycin VIII) 
CAS registry number: 135778-74-4 
(Yamane et al., 1991) 
 
Figure 4.45. Phenoxazinone class natural products. 
Of all the cyclised candidates, only candidates  4.32, 4.33 and 4.36 showed three acid exchangeable 
protons (LRPA MS finding 6) and only candidates  4.32, 4.33 retained the XA chromophore, 
consistent with (LRPA UV-Vis finding 1). Since neither 4.32 or  4.33 contain protons that could 
represent a one proton singlet peak at 9.10 ppm (LRPA NMR finding 2) none of these cyclised 
candidates (4.32 - 4.37) was likely to be LRPA. 
4.2.9.6 Candidates in which the 4-OH is removed 
LRPA MS finding 1 suggested the loss of H2O which could be partially caused by removing a phenolic 
group. Since 1H NMR data had suggested that the XA 8-OH and the tyrosine phenol had remained 
unchanged, structures 4.44 and 4.45 were suggested (Figure 4.46). A Chemical Abstracts, search (on 
1/4/16), showed no molecules that were similar to either 4.44 or 4.45 (Appendix 4. 9). Candidates 
4.44 and 4.45 could both lose Tyrformic acid without XA-Tyr cleavage in keeping with LRPA MS 
finding 2. However neither of these molecules could easily fragment to form the [XA+H]+ peak which 
is contrary to LRPA MS finding 4 and neither molecule shows three acid exchangeable protons which 
is contrary to LRPA MS finding 6. Furthermore none of these structure can explain the one proton 







Figure 4.46 LRPA candidates containing the loss of the xanthurenic acid (XA) 4 phenol and one 
Tyrosine
N-XA link. a: acid 
exchangeable protons including the ionising proton which has not been attached to any specific position. s: Proton 
possibly responsible for one proton singlet peak  
 
4.2.9.7 Aldehyde and formate candidates 
LRPA MS finding 1 suggested that the loss of H2O could be partially caused by the reduction of a 
carboxylic acid to an aldehyde or a formate.  Since LRPA MS finding 5 and LRPA MS finding 2 had 
suggested that LRPA may be attached to XA via a XA-TyrN link and because LRPA NMR finding 2 had 
shown the disappearance of the XA-3 proton signal structures 4.46, 4.47 and 4.48 were suggested 
(Figure 4.47).  
  
 
4.46 4.47  4.48 
Figure 4.47. LRPA candidates containing one 
Tyrosine
N-Xanthurenic acid link and an aldehyde. a: acid exchangeable 
protons including the ionising proton which has not been attached to any specific position. s: Proton possibly 
responsible for one proton singlet peak  
 
These structures could all explain the LRPA low field 9.10 ppm peak since similar aldehyde protons 
also show very low field chemical shifts (Figure 4.48). Furthermore all these structures show three 
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exchangeable protons  and would likely show a UV-Vis spectra similar to XA (consistent with LRPA 
MS finding 6 and LRPA UV-Vis finding 1). 
 
4.49. Acetamide, N-[1-formyl-2-(4-hydroxyphenyl)ethyl]-, 
(S)- (9CI) 
CAS registry number: 85483-56-3 








CAS registry number: 1283742-08-4 
NMR data provided by (Xue et al., 2011) 
Figure 4.48. Molecules containing aldehydes similar to the proposed 4.46 and 4.48. 
However, the aldehyde proton in compound 4.46 would couple to the tyrosine  proton which was 
not observed (LRPA NMR finding 3) while 4.47 would have two protons and more complex  -
coupling, neither of which was observed (LRPA NMR finding 3). Structure 4.48 in contrast fits all 
observed NMR results. 
 
 Structure 4.48 would also fragment in MS to give tyrosine derived formic acid and tyrosine 
fragments  consistent with  LRPA MS finding 2 and LRPA MS finding 3. Structure 4.48 cannot form 
[XA+H]+ ions by simple fragmentation which is contrary to LRPA MS finding 4. However peptidic 
materials can undergo a range of cyclisation and rearrangement processes during the MS2 
fragmentation process (Bythell et al., 2010; Yagüe et al., 2003). Since alcohols can attack aldehydes 
to form hemiacetals under protonating conditions (Hart et al., 2011) it is possible that candidate 
4.48 could undergo the rearrangement shown in Figure 4.49 to give an [XA+H]+ ion. 





If candidate 4.48 can undergo such a MS rearrangement, 4.48 would give analytical data entirely 




4.2.10  LRPD candidate based on LRPA candidate 4.48 
LRPD appears to be LRPA – 2H with the oxidation occurring at the tyrosine residue (see section 
4.2.7). If structure 4.48 is correct for LRPA, LRPD might be represented by a molecule such as 4. 4.51. 
 
4.48. Possible LRPA candidate 4. 4.51. Possible LRPD candidate  
Figure 4.50. Possible structures of LRPA and LRPD 
 
4.2.11  Oxy LRPA candidates based on LRPA candidate 4.48  
LC-MS analysis showed that some LRPA degraded to form two new molecules that appeared to be 
oxidised LRPA compounds (see section 4.2.5 and Table 4.7). These molecules were known as Oxy 
LRPA 1 and Oxy LRPA 2.   
 
Tyrosine fragments of  Oxy LRPA 1 and 2 (see section 4.2.5 and Table 4.7) do not show extra 
oxidation compared to tyrosine (C8H9NO
+, C8H7O
+ and C7H7O
+ remain unchanged in Oxy LRPA 1 and 2) 
but XA fragments do show extra oxidation (e.g. C9H8NO4
+ in Oxy LRPA 2 but C9H8NO3
+ in XA). This 
indicated that oxidation occurred on the XA moiety rather than the tyrosine moiety.  If the XA 
moiety of LRPA oxidises in a similar fashion to XA (Yanshole et al., 2010) then Oxy LRPA 2 (with 2.1 as 
the [M+H]+ parent ion and 2.2 as the [M+H-2H]+  ion) may be represented by structure 4.52 (Figure 
4.51). However LRPA  also contains an aldehyde that could be oxidised to give candidate 4.53 (Figure 
4.51).  
 
Oxy LRPA 2 only shows one carboxylic derived loss (the loss of formic acid to give the (C18H13N2O5]
+ 
peak (Table 4.7) which would be more consistent with 4.52  than 4.53. Furthermore, Oxy LRPA 2.1 
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shows a similar retention time to LRPA which would also suggest 4.52 as a better candidate, because 
LRPA and 4.52 should have similar polarities. In contrast  4.53 should be much more polar than LRPA 
due to the extra carboxylic acid and should therefore elute much earlier than LRPA by LCMS. 
 
Oxy LRPA 2 (with ion 2.2 as the [M+H]+ parent ion and 2.1 as the [M+H+H2O]
+ ion) seems likely to be 
candidate 4.54 in which both the XA ring and the aldehyde have undergone oxidation. The presence 
of two carboxylic acid groups in Oxy LRPA 2.2 is shown by the loss of two formic acids to produce the 
C17H11N2O4
+
 signal (Table 4.7).  
 
 4.52. Oxy LRPA 2 candidate structure 1  
 
 4.53. Oxy LRPA 2 candidate structure 2 4.54.  Oxy LRPA 1 candidate structure 




4.2.12 Discussion on LRPA formation and luminescence  
4.2.12.1 Is LRPA the glow-worm luciferin 
LRPA solution produced a strong L type luminescence with LF and ATP-Mg2+ (see section 4.2.8). LRPA 
is therefore either the glow-worm luciferin or is converted into the GW luciferin. It does not seem 
likely that LRPA is the GW luciferin described in Chapter 3, because in that work, the GW luciferin 
appeared unstable in air. LRPA in contrast was mostly stable in solution for over two months. The 
GW luciferin described in Chapter 3 also appeared to be more polar than LRPA eluting at 22 minutes 
(just after tryptophan) by HPLC method 1, 5% MeCN. LRPA in contrast eluted at 35.2 minutes by 
HPLC-UV-Vis method 1, 100% MeCN). Furthermore, fractions that showed L type luminescence 
showed no trace of LRPA by LC-MS.  
 
If LRPA is different from GW luciferin, the conversion process either occurred non enzymatically 
during LRPA storage or via an extremely fast process that occurred in the GW assay. Proposed 
transformations  are shown in Figure 4.52. The GW luciferin described in Chapter 3 could not be the 
adenylated luciferin because that GW luciferin still required ATP-Mg2+ to give luminescence (see 
Chapter 3).  The conversion process seems unlikely to be an enzymatically catalysed reaction (e.g. 
LRPA derivatisation as shown in Figure 4.50), since such a process would likely change the 
luminescence kinetics away from L type toward something more similar to P type since unless the 
enzymatic reaction was very fast compared to the luciferase reaction. 
 
In contrast oxidised LRPA molecules were already present in the LRPA solution (see section 4.2.5). 
Therefore if an oxidised LRPA was the GW luciferin it could react as soon as LF and ATP-Mg2+ were 





Figure 4.52. Proposed conversion reactions between the LRPA candidate 4.48 and possible glow-worm luciferins. 
Compound 4.53 is suggested as a likely GW luciferin despite not being the main oxidised product 
found in the LRPA solution because 4.53 could undergo adenylation at the XA carboxylic acid which 
could enable ATP catalysed reactions to occur on the XA chromophore residue (the presumed 
bioluminescence emitter) producing bioluminescence (see next section). Compounds 4.48 and 4.52 
in contrast could only be adenylated at the tyrosine carboxyl residue; a position more distant from 
the XA chromophore residue. Compound 4.53 would also likely be more polar than LRPA (due to the 
carboxylic acid) and could elute in a similar fashion to tryptophan which would agree with the 
findings of Chapter 3. 4.53 could also be further oxidised in solution to produce 4.54 (see section 
4.2.11). This could explain why GW luciferin was so sensitive to oxidation.  Compound 4.53 is 
therefore suggested as a candidate GW luciferin.  
4.2.12.2 LRPB, LRPC and possible luminescence reaction mechanisms 
Figures 4.53 and 4.54 propose the ATP dependent luminescent reaction of compounds 4.48 and 4.53 
if the bioluminescence mechanism followed a similar pathway to that observed in fireflies (Vieira et 
al., 2012) while  Figure 4.55 shows the luminescent reaction of compounds 4.48 if the 
bioluminescence mechanism followed a similar pathway to that observed in coelenterazine 
(Shimomura and Johnson, 1979).  
 







No molecule was found in the GW reaction mixtures by LC-MS with a mass that matched the 
products of these hypothesized reactions. Neither was any molecule found that matched the mass 
of any expected oxidation products of the products of these hypothesized reactions. It therefore 
seems unlikely the GW luminescence reaction progresses by either of these mechanisms.  
 
 
Figure 4.53. The bioluminescence mechanism of LRPA candidate 4.48 if the reaction followed a  bioluminescence 
mechanism similar to that of the firefly system.  
 
Figure 4.54. The bioluminescence mechanisms of possible glow-worm luciferin candidate 4.53 if the reaction followed a 




Figure 4.55. The bioluminescence mechanisms of possible glow-worm luciferin candidate 4.48 if the reaction followed a 
bioluminescence mechanism similar to that of the coelenterazine system (Shimomura and Johnson, 1979).  
 
The use of stable isotope labelling enabled the detection of not only LRPA, but also two other stable 
isotope labeled molecules (LRPB and LRPC) (see section 4.2.6). The highest observed m/z ions of 
LRPB were m/z 376.0883 Da (UL-LRPB) and m/z 386.1155 Da (SIL-LRPB) while the highest observed 
ions of LRPC were m/z  374.0727 Da (UL-LRPC) and m/z  384.0998 Da (SIL-LRPC). These ions 
suggested a molecular formula of C17H16O8N2
+ for UL LRPB, C8
13C9H16N
15NO8
+ for SIL LRPB, C17H14 
N2O8
+ for UL LRPC and C8
13C9H14N
15NO8
+ for SIL LRPC.  
 
These ions have an even nominal mass but an [M+H]+ ion containing two nitrogens would be 
expected to have an odd nominal mass (Kind and Fiehn, 2007; McLafferty and Tureček, 1993). This 
indicated that either the molecular formulae were wrong, which seemed unlikely due to the good 
high resolution mass and lack of other molecular formula that could possibly fit, or that these ions 
are not [M+H]+ ions. These ions seem unlikely to be fragments of larger structures since no larger 
labeled parent ion peaks were observed. It therefore seemed likely that these ions represented [M]+ 
ions formed by one electron oxidation of M or by the loss of H from the [M+H]+ ion. The production 
of an M+ ion by a one electron oxidation of M is not implausible, since quinones are known to 
undergo one electron reductions and oxidations (Ashnagar et al., 1984; Iyanagi and Yamazaki, 1970).   
 
LRPB and LRPC, like LRPA, were only formed in the presence of LF, tyrosine, XA and ATP-Mg2+ (see 
section 4.2.6). LRPB and LRPC have two less carbons than LRPA. However, the SIL molecules still 
contain all the 13C labeled tyrosine carbons. The missing carbons must therefore have been lost from 
the XA moiety. LRPB and LRPC therefore appear to have lost two XA carbons and undergone a 




The chemiluminescence of indoles and quinolines also involves oxidation and the loss of two ring 
carbons (see section 4.1.1.4).  Since enzyme catalysed bioluminescent mechanisms are often similar 
to chemiluminescent mechanisms of the luciferin (Schramm et al., 2015) it would not be unexpected 
if the bioluminescence of XA follows a similar process producing LRPB and LRPC as products. A 
possible mechanism, similar to the chemiluminescence mechanisms of indoles and quinolines but 
involving GW luciferin candidate 4.53 is described in Figure 4.56. A mechanism  is not described for 
possible LRPA candidate 4.48 because 4.48 lacks a carboxylic acid on the quinoline ring and thus 







Figure 4.56. A possible bioluminescence mechanism based of the chemiluminescence mechanism of indoles and 
quinolines (see section 4.1.1.4) involving candidate 4.53 that leads to the production of molecules that have the correct 




If this type of mechanism were true, LRPB and LRPC and any other LEP would be kynuramines. These 
molecules are notoriously unstable and are known to undergo a range of oxidative, decomposition 
and oligomerization processes that result in highly complex product mixtures (Hardeland et al., 
2009; Slawiński et al., 1980). Kynuramines for example bind to aromatic compounds and peptides via 
tyrosyl and tryptophanyl residues as shown in Figure 4.57 and Figure 4.58 (Hardeland et al., 2009). 
These oxidation, decomposition and oligomerization products are generally unstable in LC and  
therefore cannot be isolated or studied by HPLC-UV or LC-MS (Hardeland et al., 1995).  
 
Figure 4.57 Structure of a putative N1-Acetyl-5-methoxykynuramine (AMK) - tyrosyl adduct. (Hardeland et al., 





Figure 4.58. Structures of several N1-Acetyl-5-methoxykynuramine (AMK) oligomers (Hardeland et al., 2009).  
R= CO-CH2-CH2NH-CO-CH3 
Any kynuranine product present in a complex mixture like the GW assay reaction mixture would 
therefore likely react to form a large variety of low concentration, high molecular weight products. 
These would likely be lost in the reaction-mixture processing step when denatured peptidic material 
was removed causing little kynuranine to remain in the reaction mixture. This could explain why 




4.2.12.3 The formation of LRPA and glow-worm luciferin. 
The stable isotope labelling reaction of XA and tyrosine with lysate and ATP-Mg2+ caused light to be 
produced for several hours. It was expected that the reaction would cause a substantial build-up of 
stable isotope labeled luminescent enzymatic product (LEP). It was therefore odd that the major SIL 
product was the luminescent molecule LRPA. However a build-up of LRPA could be explained if 
process 1 is fast compared to process 2 or 3 (Figure 4.59) or if process 1 is active for longer than 
process 2 or 3 (see section 3.2.10).  
 
 
Figure 4.59. Reaction of xanthurenic acid and tyrosine to form LRPA (via 1), the reaction of LRPA to form glow-worm 
luciferin (via 2) and the luminescence reaction of GW luciferin (via 3). 
 
If LRPA is 4.48 and GW luciferin is 4.53 then process 1 and process 2 would proceed as described in 




 4.48. LRPA candidate 4.53. glow-worm luciferin candidate  
 
Figure 4.60. Reaction of xanthurenic acid and tyrosine to form LRPA candidate 4.48 (via 1), the reaction of LRPA to form 




However, if LRPA is 4.48 and luciferin is 4.53 the question becomes why would GW form an XA 
aldehyde only to reoxidise it in the luciferin. One possibility is that the tyrosine amine attaches to the 
XA via a 1,4 addition and a reduction to give the aldehyde  4.53 (Figure 4.61). Oxidation of this 
molecule then may produce the active luciferin 4.53 (Figure 4.61). Such a coupling reaction could be 
catalysed by many different oxidoreductase enzymes including peroxidases, laccases, oxidases, and 
oxygenases (although the mechanism involved may be quite different from that shown in Figure 
4.61) (Kobayashi and Higashimura, 2003).  
 
 
Figure 4.61. Proposed enzyme catalysed nucleophilic attachment of the tyrosine amine on the XA 3 carbon via a 1,4 
addition (Michael addition) followed by enzymatic reduction to form LRPA candidate 4.48. 4.48 is then oxidised into the 
candidate luciferin 4.53. 
Tramesanguin (4.17) and and cinnabarinic acid (4.15) are found in the bracket fungus Pycnoporus 
cinnabarinus and 4.17 is the aldehyde form of 4.15 (Figure 4.62). Cinnabarinic acid (4.15) is formed 
from 3-hydroxyanthranilic acid (4.6) via oxidative dimerization, by a laccase enzyme, in a 6-electron 
oxidation reaction (Eggert, 1997; Eggert et al., 1995). The biosynthesis of tramesanguin and 
cinnabarinic acid (like the proposed synthesis of 4.48 and 4.53) therefore involves amine attachment 
4.48. LRPA candidate 
4.53. glow-worm luciferin candidate  
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to the phenolic carbon ortho to the carboxylic acid group (Dias and Urban, 2009; Gripenberg, 1963; 
Sullivan and Henry, 1971). 4.48 and 4.53 may therefore be synthesised by a similar laccase type 
enzyme. 
  
4.17. Tramesanguin 4.15. Cinnabarinic acid  
Figure 4.62. Tramesanguin and cinnabarinic acid are both found in the bracket fungus Pycnoporus cinnabarinus  
Laccases  catalyse the oxidative coupling of phenolic substances and over 60 laccases have been 
detected from various plant, insect, bacterial, and fungal sources. These enzymes are important, 
because they are involved in the synthesis of humic substances, lignins, tannins, melanins, and 
alkaloids (Gianfreda et al., 1999). Laccase catalysed oxidative coupling involves substrate reduction 
(Gianfreda et al., 1999; Kobayashi and Higashimura, 2003). If the luciferin synthetic reaction was a 
laccase this  could explain the formation of the aldehyde LRPA. However, this is speculation and 
more work needs to be done to determine the identity of the luciferin synthetic enzyme. 
4.3 Conclusions 
This Chapter describes how XA, tyrosine and GW enzymes and stable isotope labeling techniques 
were used to identify the HPLC-UV and LC-MS peaks of luminescence related molecule LRPA. These 
techniques were then used to synthesise LRPA which was isolated (10 µg) then characterised by 1H 
NMR and UV-Vis spectroscopy and mass spectrometry. A LRPA solution was then tested with glow-
worm enzymatic mix and ATP-Mg2+ and was found to produce strong luminescence with L type 
kinetics. Characterisation led to compound 4.48 being proposed as a LRPA candidate structure and 
4.53 to be suggested as a possible GW luciferin candidate. Stable isotope labeling studies enabled 
the identification two other LC-MS peaks LRPB and LRPC that also appeared to be connected to the 
luminescent reaction. The molecular formulae of these molecules suggested that the glow-worm 
bioluminescent reaction may proceed in a similar way to that of indole or quinoline 
chemiluminescence. Such a mechanism would be quite different to all known bioluminescent 
mechanisms, the closest being the coelenterazine mechanism which also involves heterocylic ring 




4.4.1 Semi-preparative separation of luminescent reaction mixtures  
Reaction mixtures (from experiments described in section 3.4.9) that had previously been filtered 
through C18 and dried (see section 3.4.9) were dissolved in 50% MeCN, 50% water and 0.1% FA (100 
µl). 80 µl of this mixture was injected onto the hydro C18 semi-preparative column and eluted using 
HPLC gradient method two with 0.1% FA (see section 3.4.1). The following fractions were collected; 
F1: 0 – 3.06 min, F2: 3.06 – 6.05 min, F3: 6.05 – 9.05 min, F4: 9.05 – 12.05 min, F5: 12.05 - 15.05 min 
and F6: 15.05 – 18.05 min. Fractions 3 and 4 were combined and all fractions were dried by vacuum. 
Fractions 3 + 4 and F5 were analysed by Orbitrap LC-MS (section 3.4.3). 
 
The LRPA component was separated from the reaction mixture by bench chromatography as 
described in section 3.4.1. The bench column fraction that eluted with 50% MeCN was dried then 
redissolved with 50% MeCN, 50% water and 0.1% FA. Injections of 1 x 5 µl, 1 x 50 µl and 2 x 100 µl of 
this material were made onto the Phenomenex Synergi 4 µM Hydro RP 80 Å semi-preparative (150 x 
10 mm) column and the material eluted using HPLC gradient method two with 0.1% FA (see section 
3.4.1). Each fractions was collected for 0.2 minutes. Fractions were dried under vacuum. XA, a yellow 
powder (visible but  < 0.1 mg), was found in fraction 21: (12.05 – 12.24 min 72% MeCN). LRPA, a 
yellow powder (visible but  < 0.1 mg), was mainly found in fraction 28 (13.46 - 13.64 min 86% 
MeCN).  
 
4.4.2 LRPA characterisation 
F28 from above was dissolved in 50% MeCN, 50% water and 0.1% FA (200 µl) then analysed by HPLC-
UV and LC-MS (Biochem Orbitrap nanoflow  see section 3.4.3).  Initial HPLC-UV analysis (Method 2) 
showed F28 to contain 99% LRPA when detected at 210 nm. UV-Vis spectra were taken using the 
HPLC photodiode array. This data is summarised in Section 4.2.3. F28 was then dried and re-
dissolved in 200 µl of 50% d3-MeCN and 50% D2O and placed into a D2O Shigimi tube for analysis on 
a 500 MHz  Varian NMR spectrophotometer using 1H Presat (D2O) settings for 12 hours at 25 °C.  
Tyrosine (0.2 mg/ml), and XA (0.2 mg/ml) were analysed under the same conditions. Chemical shifts 
were referenced to the residual solvent signal for MeCN at 1.94 ppm.  1H NMR data are shown in 
section 4.2.4. By comparing the integrated compound peaks of tyrosine and LRPA to the integrated 
d3-MeCN solvent peak and by using the orbitrap nanoflow LCMS method (see section 3.4.3) it was 
estimated that 10 µg of LRPA was collected.   F28 was then dried and re-dissolved in 200 µl of 50% 
223 
 
d3-MeCN and 50% D2O with 0.1 % FA. Tyr and XA were also dissolved in 50% d3-MeCN and 50% D2O 
with 0.1% FA.  These solutions were then injected without a column into the Orbitrap MS so the 
number of exchangeable protons could be studied. This data is summarised in section 4.2.3. The 
LRPA solution was then reanalysed by LC-MS (milli flow micro TOFQ and nanoflow orbitrap) and 
HPLC (see section 3.4.1) to determine the amount of LRPA degradation. Luminescence assays were 
carried out as previously described in section 3.4.9 using MOPS buffer 2 (100 µl), LF (F1, 5 µl), LRPA 
solution (5 µl containing 83 or 16 ng) and ATP-Mg2+ solution (30 µl). 
4.4.3 Analysis of LC-MS data 
Thermo Scientific Sieve software (Thermofisher, 2014) was used to analyze LC-MS data and analysed 
data were exported into Microsoft Excel. Sieve software was used to identify labeled LRP by 
searching for co-eluting perfect pairs with the expected mass differences (Table 4.1). Perfect pairs 
were discarded if the SIL partner (the stable isotope labeled half of the perfect pair) showed a peak 
area more than 3 x the blank in reaction mixtures not containing SIL tyrosine because SIL partners 
should not be present in reaction mixtures not containing SIL tyrosine. Perfect pairs were also 
discarded if the SIL partner was more than 150% larger than the UL partner in the experiments in 
which SIL and UL tyrosine were added in a 1:1 ratio. In these experiments UL LRP should be observed 
in equal larger concentrations due to the presence of native UL Tyr. Larger concentrations of SIL LEP 
would indicate that this perfect pair is not due to tyrosine labeling. Perfect pairs were also discarded 
if either partner was found to be significantly larger in the non-luminescent reaction mixtures and 
both partners were discarded if the SIL partner was not found to be significantly larger in the 




5 Syntheses of N-carbamyl tyrosine and phenol-O-
carbamyl tyrosine 
5.1 Introduction  
This chapter describes the synthesis and characterization of N-carbamyl tyrosine (3. 22) and phenol-
O-carbamyl tyrosine (3. 23) (Figure 5.1). Chapter 3 previously described the separation of a semi-
preparative HPLC fraction from glow-worm lysate, that luminesced with LF and ATP-Mg2+ (see 
section 3.2.7). This fraction was found to contain leucine, tyrosine and an unknown compound X, 
that was later found to be 3-OH kynurenine (see section 3.2.8). Compound X showed a similar UV – 
Vis spectrum to tyrosine under LC conditions (0.1% formic acid, 6% MeCN) and had an [M-H]- m/z of 
223 Da. When analysed by LC-MS2, the X [M-H]- ion initially lost NH3 to form a m/z 206 Da negative 
ion. This then fragmented to give two major negative ions with m/z 93 Da and m/z 163 Da. These 
ions were also formed from the MS2 fragmentation of tyrosine where they represented a [C6H5O]
- 
phenol fragment and [M – (NH3 + H)]
-  respectively (see section 3.2.7) This suggested that X could be 
a tyrosine derivative. Analysis of GW hot extract (HE) by high resolution Orbi-trap nano-flow LC-MS 
in positive mode showed that X had a [M+H]+ m/z of 225.0867 Da, which indicated the molecular 
formula C10H12N2O4. 
 
The initial negative fragmentation of this molecule did not match that of any molecule stored in the 
Mass Bank fragmentation library (Horai et al., 2012) but the molecular formula C10H12N2O4 matched 
4823 compounds in the Chemical Abstracts (searched on 27/12/15). This selection was further 
refined to include only tyrosine derivatives. This gave structures 3.22, 5.5 and 5.6. Compound 5.5 
was detected in the essential oil of Cortex Moutan (tree peony) (Liu et al., 2010) and has been 
synthesised (Arnold, 1983) while compound 5.6 has been synthesised (Rakhshinda and Khan, 1979). 
However neither molecule seemed likely to give the give the same MS2 fragmentation as compound 
X fragments.The natural product N-carbamyl tyrosine (3. 22, Figure 5.1) and the undescribed isomer; 
phenol-O-carbamyl tyrosine (3. 23, Figure 5.1) were therefore investigated as candidate molecules 
(Kanno and Oyama, 1963; Koshiishi and Imanari, 1989; Kraus and Kraus, 2001; Thoai et al., 1956). 
Carboxyl-O-carbamyl tyrosine was not known and was not investigated because the anhydride 




This chapter therefore describes the synthesis and characterization of candidates 3.22 and 3.23 and 
shows that neither are X. It is to be noted that the name carbamoyl is often used interchangeably 
with carbamyl in the chemical literature (Meisters, 1975; Smyth, 1967; Wilson et al., 1961). The term 
carbamyl has been used here since it was the term used for N- carbamyl tyrosine in the synthetic 
procedure used for  N-carbamyl tyrosine (Verardo et al., 2007).  
 
3.22. L-N-carbamyl tyrosine 
 
3.23. L-phenol-O-carbamyl tyrosine 
 
 
5.1. L-N,O-di-carbamyl tyrosine 
 
5.2.  L-Tyrosine hydantoin 
 
  




5.5. L-Tyrosine, 3-[(E)-(hydroxyimino)methyl]  
5.6. 1,3-Benzodioxole-5-propanoic acid, α,β-diamino- 
Figure 5.1. Some molecules discussed in this chapter. 
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5.1.1 Literature on N-carbamyl tyrosine  
N-Carbamyl-tyrosine (NCT, 3.22) (CAS registry number 90899-85-7) has been known since 1909 
(Lippich, 1909), yet has only 19 references in the Chemical Abstracts (as of 27/4/16). Other 
carbamylated amino acids are far better studied e.g. ala (54 references), asp (69), cys (81) met (59), 
ser (50)and val (43). Carbamyl amino acids (including N-carbamyl tyrosine) are used by bacteria to 
stereo-specifically produce D amino acids from L amino acids (Altenbuchner et al., 1999; Bommarius 
et al., 2002; Ishikawa et al., 1996; Miyoshi et al., 1985; Pozo-Dengra et al., 2010). Such processes 
have been adopted by chemists to commercially produce D-amino acids via the hydantoinase 
process (Nozaki et al., 2005).  
 
Carbamylation of amino acids (including tyrosine) and proteins is also known to occur during cyanide 
metabolism, particularly in disease states such as uremia, or under oxidative stress (Kanno and 
Oyama, 1963; Koshiishi and Imanari, 1989; Kraus and Kraus, 2001; Thoai et al., 1956). Carbamyl 
amino acids including NCT have been extracted from the urine of rats, and from patients with 
chronic renal failure (Kanno and Oyama, 1963; Kraus and Kraus, 2001; Thoai et al., 1956). However, 
there is some concern that these compounds may be artefacts caused by the reaction of urea with 
amino acids during sample processing (Kollipara and Zahedi, 2013). Several carbamyl amino acids 
have been detected in wines, but the presence or absence of NCT in wine was not investigated 
(Huang and Ough, 1993). The carbamyl group can act as an amine protecting group in the production 
of peptides, but it is rarely used (Bommarius et al., 1997; Krix et al., 1997). Several N-carbamyl-L-
amino acid analogues have antibacterial properties (Sykes et al., 1988; Verardo et al., 2007) whilst 
others have been used as synthetic entry points for N-carboxy-anhydrides (Lagrille et al., 2007), 
chiral pyrimidin-2(1H)-ones (Egorov et al., 2013) and fluorescent β-cyclodextrins (Corradini et al., 
2003).  
 
N-Carbamyl amino acids are most often produced through the conversion of 5-substituted 
hydantoins into carbamyl amino acids using hydantoinases (Drauz et al., 2004; Durham and Weber, 
1995 ; Nishi et al., 2006). Bacterially synthesised enzymes are expensive, but reaction yields are 
often high (90 - 99 % in Wagner et al., 1996) (Drauz et al., 2004; Durham and Weber, 1995 ; Nishi et 
al., 2006; Wagner et al., 1996). Carbamyl amino acids are also produced via the reaction of amino 
acids with cyanate salts (Lagrille et al., 2007) but these methods are slow  (10 – 70 hours at 50 – 60 
°C), involve the formation of the volatile and poisonous isocyanic acid (Taillades et al., 2001) and 
require pH and temperature to be careful controlled (De Luca et al., 2010). Carbamyl amino acids 
may also be synthesised by the reaction of amino acids with urea and Ba(OH)2 (Goodson et al., 1960; 
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Lippich, 1909; Pechenkin et al., 1974; Takeuchi et al., 1989; Ware, 1950). However most urea based 
methods require long reaction times and high temperatures (100 °C). These reactions also require 
toxic Ba(OH)2 to convert the major side product hydantoin back to NCT (Lippich, 1909; Phillips, 
1954). A microwave driven variation of this reaction was described by Verardo in 2007 that appears 
to be a vast improvement on previous methods (Verardo et al., 2007). The reaction proceeds in a 
urea melt, removing both tyrosine solubility problems and the need for organic solvents. The 
reaction time was short (10 min) and did not require Ba(OH)2 (Figure 5.2). This method was 
therefore chosen to synthesise NCT. 
 
 
Figure 5.2. The microwave driven production of N-carbamyl tyrosine from tyrosine and urea. 
 
5.1.2 Literature on phenol-O-carbamyl tyrosine  
Phenol-O-Carbamyl tyrosine (OCT, 3.23) is not described in the literature, but a range of similar 
molecules have been studied. L-tyrosine, methylcarbamate (5.7) was detected with LC-MS when 
human globin was treated with methylisocyanates, then broken into component amino acids (Mraz 
et al., 2004). 
 
5.7. L-tyrosine, methylcarbamate. CAS registry number: 848640-66-4 
 
Several prodrugs have also been synthesised in which pharmaceuticals were attached to tyrosine via 
phenol derived urethane bonds. These drugs were released into the body when the urethane bonds 
were cleaved by plasma or liver esterases (Flamme et al., 2013; Huryn et al., 2004; Kahns and 
Bundgaard, 1991; Nortcliffe et al., 2013). The urethane bond can also act as an amide bond mimetic 
in the design of pseudo-peptides (Parkinson et al., 1994; Wu and Kohn, 1991). A tyrosine based 
urethane nitrogen mustard was also produced (Suciu, 1966). It has been suggested that the phenol 
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derived carbamate group may be a useful protecting group because it is easily removed under 
neutral or basic conditions but in general it has been ignored in favour of other protecting groups 
(Jaeger et al., 1968). However the similar Boc-N-methyl-N-[2-(methylamino)ethyl]carbamyl group 
(Boc-Nmec) has recently become popular (Wahlstroem et al., 2008).  
 
As noted above, a synthetic method for phenol-O-carbamyl tyrosine was not found in the chemical 
literature (Chemical Abstracts search on 12/4/15). However a method of forming the related N,O-
dicarbamyl tyrosine (5.1) was described by Smyth (Smyth, 1967). The reaction involved the 
nucleophilic addition of the amino and phenoxide groups to the molecular form of cyanic acid. As 
part of this thesis research, the same reaction was used on N-BOC tyrosine (5.3) instead of tyrosine 
enabling the formation of compound 5.4 rather than 5.1 (Figure 5.3). Low pH (6.5) was used in the 
reaction to minimise the hydrolysis of the phenol carbamyl because this functionality is only stable in 
acid (Smyth, 1967). Compound 5.4 could then be deprotected with TFA to produce 3.23. 
 




5.2 Results and discussion 
5.2.1 Synthesis of N-carbamyl tyrosine 
The microwave catalysed reaction of tyrosine and urea proved both fast and simple and gave a 10% 
NCT  yield. HPLC and 1H NMR analysis of the initial filtered product produced by the microwaved 
catalysed reaction of tyrosine and urea, showed the filtered product to contain tyrosine, NCT and 
tyrosine hydantoin. Reverse phase separation of this initial filtered material using a water-organic 
phase gradient gave early eluting fractions that contained tyrosine (eluted with H2O) and later 
eluting fractions (eluted with 10% MeCN) that contained NCT and tyrosine hydantoin (by LC-MS). 
NCT was separated from tyrosine hydantoin by further bench reverse phase C18 chromatography to 
give NCT (93% pure). This material was characterised by NMR, IR and MS. 
 
 













C NMR data of N-carbamyl tyrosine in d6-DMSO. Referenced to solvent signals at 
1





H proton signals were linked to 
13
C by HMBC, HSQC and COSY spectra. NO = Not observed. 


























174.1 - HH -
CONH2 159.0 
- 
158.1 - NO - 
4 156.8 
- 
155.9 - 3H, 2H - 
2 131.0  






6.90, 2H, d, 8.0 Hz 3H, H 3H 
1 129.0 - 127.5 - 3H, 2H, H - 
3 115.8.  




114.9 6.60, 2H, d, 8.0 Hz 2H 2H 
 54.8 
4.26, 1H, ABX syst 
5.5, 8.0 Hz 
54.0 
 




2.8, 2H, ABX syst,  




2.84, 1H, dd 14.0, 
5.0 Hz  
 
2.71, 1H, dd 14.0, 
8.0 Hz 
2HH H, 2H
Phenol-OH - 9.23, 1H, s - NO NO - 
NHa - 5.65, 2H, s - 5.60, 2H, s NO - 
NHb - 
6.08, 1H, d, 8.0 Hz 
- 
6.00 (d), 1H, 8.2 
Hz 
NO H








C NMR data of N-carbamyl tyrosine in basic D2O. In this work D2O was made basic by the addition of 
NH4OH (0.2 %). In Verardo’s work D2O was made basic by the addition of an unknown quantity of NaOH.  Spectra were 
referenced to the Trimethylsilylpropanoic acid peak at 0.0 ppm. 
1
H proton signals were linked to 
13
C by HMBC and HSQC 
and COSY spectra. NO = Not observed.  
13
C (ppm),  
1
H, chemical shift (ppm), intensity, coupling 
 Verardo This work 
Assignment 
















175.9 - 169.1 - 
CONH2 
186.0  
- - 155.2 - 
4 
NO  
158.0 - 154.0 - 
2 
133.7 6.86, 2H, d, 
8.3 Hz 
129.2 7.00, 2H, d, 8.0 Hz 130.6 




123.5  129.6 - 
3 
121.7 6.45, 2H, d, 
8.3 Hz 
118.9 
6.70, 2H, d, 8.0 
Hz, 
115.2 




3.28, 1 H, 
dd, 7.3, 5.4 
Hz 
58.21 
3.98, 1H, dd, 7.7, 
5.4 Hz, 1H 
51.9 4.23, 1H, m 

42.9 
2.54, 1 H 
13.7, 7.3, 5.4 
Hz 
2.72, 1H, 
13.7, 7.3, 5.4 
Hz 
38.12 
3.12, 1H, dd, 14.8, 
5.2 Hz 
 
2.98, 1H, dd, 14.7, 
7.7 Hz 
37.3 
3.05, 1H, dd, 
5.1, 14.0 Hz 
 
2.86, 1H, dd, 
7.7, 14.0 Hz 
OH   - - - NO 
NHa   - - - NO 
NHb   - - - NO 





Table 5.3. MS and MS
2
 data for N-carbamyl tyrosine taken using the ion trap LC-MS and the same conditions used to 
analyse extracted unknown X.  
Positive ion mode Negative ion mode 






















































































































































































Table 5.4.  LC-MS
2 
of tyrosine hydantoin (5.2) by ion trap LC-MS analysis. 
Negative ion mode Positive ion mode 






















The NMR data for the NCT synthesised in this research was not consistent with those reported by 
Verardo in basic D2O (Verardo et al., 2007). In particular Verardo reported an  proton shift of 3.28 
ppm (Table 5.2). This is much more sheilded than any NCT  proton shift recorded in this research 
and is more consistent with the  chemical shift of tyrosine (Table 5.5). Verardo also observed a 
peak at 186.0 ppm by 13C NMR but did not observe a 4 carbon signal at 154.0 or a CONH2 signal at 
155.2 ppm. Therefore the NCT prepared in this work was fully characterised to confirm its structure. 
 
Tables 5.1 and 5.2 show the NMR data for the purified N-carbamyl tyrosine (NCT, 93% pure). The 1H 
and 13C NMR data of NCT in d6-DMSO matched those reported by Lagrille (Table 5.1) (Lagrille et al., 
2007).  The 1H , 13C and 2D spectra (COSY, HMBC and HSQC) were almost identical to those of 
tyrosine with a few important differences (Table 5.2). The  proton of NCT had a higher chemical 
shift than tyrosine showing that derivatization had occurred on the amine or the carboxylic acid 
(Table 5.5). In tyrosine, only one NHx proton signal was seen whilst for NCT in d6-DMSO two NHx 
proton signals were present: a two proton singlet and a one proton doublet which was coupled to 
the -H (Table 5.1). This showed the presence of a second NHx (probably CONH2) and showed that 
the tyrosine amine had undergone derivatization.  
 
The 13C spectra showed little change between the chemical shifts of the tyrosine carboxyl and the 
NCT carboxyl, which also indicated that the NCT carboxyl remained underivatized (Table 5.2). The 13C 
spectra of NCT showed a 155.2 ppm signal which was absent in tyrosine. This indicated the presence 




The high resolution MS data of the product matched the calculated for structure 3.22 (see section 
5.4.3). When fragmented by ion trap MS in negative ion mode, NCT lost a carbamyl moiety to leave a 
tyrosine ion (Table 5.3). This resultant ion then showed identical fragmentation to tyrosine (Table 
5.3). When fragmented by ion trap MS in positive ion mode, NCT first lost either water, the carbamyl 
moiety or formic acid (Table 5.3). These fragmentation patterns are all consistent with structure 
3.22. 
 
The NCT produced in this study had a similar IR spectrum to tyrosine, but with extra peaks in the 
1716 – 1612 cm-1 region including a peak at 1691 cm-1. The 1691 cm-1 peak is consistent with the 
carbamyl C=O stretch of the nine other N-carbamyl amino acids synthesised by Verardo using the 
same procedure which showed peaks between 1680 - 1690 cm-1 (Verardo et al., 2007). This signal is 
also consistent with other N-carbamyl derivatized  molecules (Arcuri et al., 2000; Navarrete et al., 
1994). The NCT IR spectrum reported by Verardo et al. in contrast appears identical to that of 
tyrosine (Barth, 2000; Verardo et al., 2007) and showed no peaks between 1607 and 2200 cm-1. 
 
The lack of peaks in the 1760 – 1800 cm-1 and 1720–1760 cm-1 regions in the IR spectrum of the N-
carbamyl synthesised in this research showed that the molecule had not cyclised to form a 
hydantoin (Kleinpeter et al., 2003). The UV – Vis spectra of NCT synthesised in this study was 
identical to that of tyrosine. This was consistent with structure 3.22 because the carbamyl group 
would not be expected to change the phenol chromophore.  
Table 5.5.  Proton 
1




H chemical shift (ppm), coupling (Hz)
D2O+ 0.2 % FA D2O + 0.2 % NH4OH d6-DMSO
Tyrosine 
4.20 
dd, 7.5, 5.3 
3.77 
dd, 7.8, 5.2 








3.74 - 4.29, 





dd, 7.8, 5.1 
4.49, 
dd, 8.1, 5.5 
4.22 - 4.79, 
t, 6.4 
 
High resolution mass spectrometry indicated that the minor side product of the tyrosine urea 
reaction had a molecular formula of C10H10N2O3  which indicated that the molecule had lost H2O 
compared to NCT (see section 5.4.3). This molecule was not purified. The 1H NMR spectrum of the 
initial filtered product showed NCT peaks, tyrosine peaks and another peak at 4.49 ppm that showed 
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similar coupling to the  peaks of NCT and tyrosine (Table 5.5). This suggested that the unknown 
compound was very similar to NCT but that it had a modification at a position close to the  proton. 
Together this suggested that the minor side product was tyrosine hydantoin (5.2). Tyrosine 
hydantoin and phenylalanine hydantoin have been reported to have an  proton shift of 4.24 ppm 
and 4.34 ppm respectively in d6-DMSO which were consistent with the 
1H NMR data of 5.2 (Table 
5.5) (Huang and Ough, 1991). 
 
Tyrosine hydantoin (5.2, CAS registry number: 98819-07-9) is well known and is used commercially in 
the production of chirally pure D or L tyrosine (Cao et al., 2004; Nozaki and Watanabe, 2005; Suzuki 
and Tuzimura, 1976; Ware, 1950).  It is also used in the cosmetics industry for skin whitening creams 
(Kitayama et al., 1993) and as an intermediate in producing a wide range of agrochemicals, 
pharmaceuticals and food additives (Sato et al., 1988). Previous studies had shown hydantoins to be 
major by-products of the urea-amino acid reactions (Lippich, 1909; Phillips, 1954). Compound 5.2 
was stable under acidic, neutral and weakly basic conditions by LC-MS, 1H NMR and HPLC but was 
converted into tyrosine under strongly basic conditions which was consistent with the known 
literature on hydantoins (Lippich, 1909; Smyth, 1967). This suggests that a better method of NCT 
purification would have been to add strong base to the initial tyrosine, tyrosine hydantoin, NCT 
mixture to convert all 3.22 into tyrosine. NCT could then have been easily separated from tyrosine 
by bench column chromatography. 
 
The  proton chemical shifts of tyrosine and the reaction products in D2O or DMSO were highly 
variable with pH (Table 5.5). This meant that any trace amount of acid or base that remained from 
synthesis or chromatography could strongly affect the chemical shift of these molecules. Since the 
 proton chemical shift was important for differentiating between tyrosine, NCT and tyrosine 
hydantoin, only spectra taken under the same pH and in the same solvent should be compared. 
It is difficult to measure or control the pH of a DMSO solution and tyrosine is known to undergo 
oxidation reactions with DMSO under non neutral conditions (Kipton and Bodwell, 1973; Savige and 
Fontana, 1980). Tyrosine is also only very slightly soluble in DMSO and its  peak is often obscured 
by water. This means that although d6-DMSO is a useful solvent for studying purified NCT, it is not 
suitable for studying the composition of product mixtures.  In contrast the pH of D2O is easily 
measured and pH can be adjusted by the addition of acid or base. Reaction components were 
studied in basic D2O since all components were soluble under such conditions and because tyrosine 
has a much higher solubility in basic aqueous solution than acidic aqueous solution (at 25°C; 2.62 
mmol/L, pH 5.1, 7.06 mmol/L at pH 9.2 and 35.8 mmol/L at pH 9.9 (Hitchcock, 1924).  
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NH4OH rather that NaOH was used to increase pH since NH4OH could be removed by vacuum. 
Reaction mixture compositions (percentage (molar) of each component) were estimated by 
comparing the NMR  peak area of each component.  This method and HPLC-UV was used to 
determine that the initial precipitate of the urea-tyrosine reaction contained NCT (3. 22, 38 – 72% by 
1H NMR), tyrosine (0 – 61 % by 1H NMR) and tyrosine hydantoin (5.2, 0 – 50 % by 1H NMR) (yields 
variable across several syntheses). The use of microwave methodology therefore did not prevent the 
low yield and side product production encountered by earlier chemists using the urea-tyrosine 
method (Goodson et al., 1960; Lippich, 1909; Pechenkin et al., 1974; Takeuchi et al., 1989; Ware, 
1950).   
 
This synthesis method consistently gave NCT yields of around 10% (NCT present in filtrate), while 
80% yields were recorded by Verardo (Verardo et al., 2007). Verardo reported that the precipitate 
was mainly NCT (by 13C NMR and microanalysis) (Verardo et al., 2007) but it seems likely that the 
precipitate also contained tyrosine and tyrosine hydantoin  which could have led that group to 
overestimate the percentage yield of NCT. 
5.2.2 Synthesis of phenol-O-carbamyl-N-BOC tyrosine and phenol-O-carbamyl 
tyrosine. 
The method of Smyth, (1967) was used on N-BOC tyrosine (5.3) to produce the new compound 
phenol-O-carbamyl-N-BOC tyrosine (N-BOC-OCT, 5.4). Acidic conditions were used in the reaction 
and during purification to protect the phenol-O-carbamyl moiety from hydrolysis. 5.4 was purified by 
chromatography then de-protected with TFA to produce the new compound 3.23. The general 
procedure and yields are outlined in Figure 5.5. This led to the successful synthesis and isolation of 6 





     
Figure 5.5. Synthesis and purification of OCT  
The limited solubility of N-BOC tyrosine (5.3 in water) required that the carbamylation reaction be 
done at low concentrations (0.4 g /L, 2.2 mM). This was problematic as the reaction produced 
various cyanate derived salts on a multigram scale under the acidic conditions necessary to prevent 
Ph-O-CONH2 hydrolysis (Redemann et al., 1958; Smyth, 1967). Tyrosine derivatives were found to 
make up less than 17% of the dried ethyl acetate extract with the remainder being cyanate derived 
salts. These cyanate products were not visible by 1H NMR spectroscopy but were found by high 
resolution MS to include C3H3N3O3 (probably cyanuric acid), and C5H4N4O3 (probably uric acid), as well 
as a range of unidentified cyanate salts. The BOC group of 5.4 was found to undergo partial 
hydrolysis under the selected reaction conditions, leading to the formation of carbamyl tyrosine, 
dicarbamyl tyrosine (5.1) and tyrosine (all identified by high resolution MS) as well as the desired 
product N-BOC OCT (5.4).  Concentrations of N-BOC OCT (5.4) reached a maximum after one hour of 
reaction, as measured by TLC or HPLC consistent with Smyth’s findings (Smyth, 1967).  
 
Purified 5.4 was found to slowly form OCT (3.23) in an aqueous solution containing 0.2 % FA; a 




N-BOC tyrosine products were separated from the cyanate derivatives and from unprotected 
tyrosine derivatives by bench RP (C18) chromatography. Neither bench RP (C18), nor silica 
chromatography were able to separate 5.3 from 5.4 so 5.3 was separated from 5.4 by semi-
preparative C18 HPLC to give 10.4 mg of 5.4 (99% pure see Figure 5.6). This was cleanly deprotected 
with TFA to give 3.23 (100% conversion by 1H NMR and HPLC see Figure 5.7). Neither 5.4 or 3.23 had 
previously been reported.  
Minutes















Figure 5.6. Isolation of 5.4 (99% pure) by semi-preparative C18 HPLC (39.95% MeCN, 59.95% H2O and 0.1% FA). Red 
chromatogram: column input, Green chromatogram: back injection of isolated 5.4.  
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Figure 5.7. Deprotection of purified 5.4 gave  3.23 (red chromatogram). Addition of base to purified 3.23 gave tyrosine 
(pink chromatogram). The green chromatogram shows an unpurified mix of 5.4 and 5.3 for contrast. Samples were 
analysed by HPLC method 1.  
 
High resolution MS of purified OCT and N-BOC-OCT showed molecular ions consistent with those 
calculated (see section 5.2.2). MS2 fragmentation of the [M-H]- and [M+H]+ ions of OCT (3.23) by ion 
trap MS caused the loss of a carbamyl group and the formation of a tyrosine ion which then 









+ ions (Table 5.7) while fragmentation of [M-H]- formed 
[M-H-H2O]
- (Table 5.7).  
 
The 1H NMR spectra of OCT and N-BOC-OCT showed aromatic 2H and 3H signals that were downfield 
shifted compared to those of tyrosine but with similar coupling (Table 5.6). This indicated that the 
phenol OH of these molecules was derivatized (Table 5.6). This was consistent with structure 3.23. 
The chemical shifts of the  and  proton signals of OCT were similar to those of tyrosine which 
indicated that no derivatization had occurred to either the carboxyl or the amino group (Table 5.6). 
 
These molecules were studied in D2O + 0.1 % formic acid rather than D2O or DMSO because the 
phenol-carbamyl derivative was known to be stable under these conditions (Smyth, 1967). Exposure 
of either molecule to neutral or basic aqueous solutions caused all of 5.4 to be converted to 5.3 and 
all of 3.23 to be converted to tyrosine (by HPLC and 1H NMR). This was consistent with the findings 
of (Smyth, 1967) who reported that addition of base caused N,O-dicarbamyl tyrosine (5.1) to be 
converted to NCT (3.22).  
 
The IR spectrum of OCT was similar to that of tyrosine. However, in OCT the 1242 and 1266 cm-1 
phenol C-O signals were absent which indicated phenol derivatisation. New large peaks were also 
present at 1761, 1731 cm-1 (carbamyl C=O) and at 1648 cm-1  (carbamyl amine) which indicated 








C NMR data of selected tyrosine products in acidic D2O with 0.2 % formic acid. Spectra were 
referenced to the Trimethylsilylpropanoic acid peak at 0.0 ppm. Assignments by HMBC and HSQC and COSY spectra.  
Assignment 











































7.31, 2H, d, 
8.2 Hz
 130.6 
7.4, 1H, d, 8.6 
Hz 











7.16, 2 H, d, 
8.3 Hz
 122.6 
7.17, 1H, d, 
8.6 Hz 
115.8 6.85 – 6.56 
1H, m 
 51.2 
4.17, 1 H, dd 
9.1, 5.2 Hz
 54.0 
4.35, 1H, dd, 
7.8, 5.5 Hz
 54.6 
4.04, 1H, dd, 




3.2, 1H, dd, 
14.1, 5.0 Hz,  
 




3.39, 1H, dd, 
14.7, 5.6 Hz 
 




3.10, 1H, dd, 
14.7, 5.5 Hz 
 
2.97, 1 H, 














 of phenol-O-carbamyl tyrosine by ion trap LC-MS methods used to discover 3-hydroxy kynurenine (see 
section 3.4.2) 





 Fragment identity Fragmented ion MS
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5.2.3 Non-identity of NCT and OCT with X  
OCT (3.23) and NCT (3.22) were synthesised because they both had the same molecular formula as X 
(Table 5.8). However both molecules showed MS2 fragmentations different from those of X under 
the same conditions (see section 3.4.2). Furthermore both NCT and OCT had later LC retention times 
than unknown X (Table 5.8) (see section 3.2.7).  This showed that neither candidate was natural 




Table 5.8 LC-MS retention times of various tyrosine derivatives using HPLC method 1 with 0.1% FA. 
 
 
No luminescence was seen when pure (99%) NCT was tested with LF and ATP-Mg2+.  Luminescence 
was however observed from less pure samples. These samples were therefore further separated and 
the luminescence-producing compound isolated but no compound other than tyrosine (see section 
3.2.9) was found to be luminescent. This showed that the luminescence of less pure NCT was due to 
tyrosine. Purified OCT was found to weakly luminesce with LF and ATP-Mg2+ but it produced less 
luminescence than a similar amount of tyrosine tested under the same conditions. It is thought that 




Three tyrosine derivatives (3.22, 3.23 and 5.4) were synthesised, purified and characterised.  Phenol-
O-carbamyl-N-BOC tyrosine (3.23, N-BOC-OCT) and phenol-O-carbamyl tyrosine (5.4  OCT) had not 
previously been described in the literature. Neither OCT nor NCT were unknown X.  




Tyrosine C9H11NO3 8.4 – 9.0 (variable) 
OCT (3.23) C10H12N2O4 9.8 








5.4.1 General methods 
NMR spectra were recorded at 25 °C on 500 MHz or 400 MHz Varian instruments with d6-DMSO or 
D2O as the solvent. Chemical shifts are given in ppm on the  scale. Samples in d6-DMSO were 
referenced to the residual solvent signals for 1H and 13C at 2.50 ppm and 40.80 ppm respectively. 
Samples in D2O were referenced to the Trimethylsilylpropanoic acid peak at 0 ppm for both 
1H and 
13C. PRESAT spectra were taken to minimise the H2O signal. IR spectra were recorded using a Brucker 
ATR platinum Diamond FTIR on powder samples.  HPLC data were collected using an Agilent 1100 
instrument with photodiode array detector and an Agilent 1260 instrument with a fluorescence 
detector, UV-Vis detector and automatic fraction collection unit. HPLC method 1 was used as 
described in section 3.4.1 with a Phenomenex Synergi 4 µM Hydro RP 80 Å Analytical (150 x 4.6 mm) 
and semi-preparative (150 x 10 mm) columns. LC-MS data were collected using a Thermo-Finnigan 
LTQ, 2D linear ion-trap, with electrospray ionisation (ESI) as described in sections 3.4.2. High 
resolution mass data (MS only not LC-MS) were collected with a Brucker Micro TOFQ, ESI with 
Dionex Ultimate 3000 HPLC system. MS settings: Endplate offset; 500 V, Capillary: 4500 V, Nebulizer: 
0.5 bar, Dry gas: 5 ml/ in, Temp 180. Amino acids were purchased from Sigma and used without 
further purification and LiChrosolv LC grade solvents were purchased from Merck. All other solvents 
were distilled before use. TLC conditions: butanol: acetic acid: H2O (14:1:1), Dip: ninhydrin (0.75 g), 
EtOH (95%, 250 ml), glacial acetic acid (2.5 ml). Plates were developed with heat exposure for 5 min. 
5.3 Rf: 0.85,  
5.4.2 Microwave method for the synthesis of N-carbamyl tyrosine (NCT)  
A solution containing H2O (3.6 ml), NaOH (0.48 g), and tyrosine (1 g, 5.5 mmol) was stirred on ice 
until the mixture became clear, then urea (0.62 g, 10 mmol) was added. The mixture was 
microwaved in a domestic microwave (1000 watts) for 5 minutes, along with a beaker containing 
H2O (200 ml), to produce a dry yellowish crystalline material. Aqueous HCl (2 ml, 6 M) was added, 
the mixture cooled on ice, filtered, then dried to give a white solid containing a few yellow crystals 
(0.620 g, 50% NCT (3.22) as measured in DMSO by 1H NMR). This filtered material also contained 
tyrosine (25 % by 1H NMR) and tyrosine hydantoin (5.2, 25% by 1H NMR).  The filtrated solution 
(from which the filtered material had been removed) contained mainly tyrosine. 
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Caution: This reaction produces ammonia and potentially toxic Biuret type compounds (Redemann 
1958).  
5.4.3 Purification of N-carbamyl tyrosine (NCT) 
NCT was purified from the filtered material by reverse phase chromatography (C18, 5 g Isolute) with 
a H2O – MeCN gradient. All mobile phases contained 0.1% formic acid because compounds were not 
retained on C18 under neutral conditions. Tyrosine eluted with H2O, while NCT (3.22) and 5.2 eluted 
with 10% MeCN with 5.2 eluting slightly later than 3.22. After two bench column separations, NCT 
was isolated with 93% purity, 26% mass recovery (3 mg of 3.22 from 40.5 mg filtered material 
containing 22 mg NCT).  This material was analysed by IR, 1H NMR, LC-MS and FTIR. NCT was also 
further purified by semi-preparative HPLC (HPLC method 1, 0.1 % FA, see Chapter 3). 4 x 100 µl 
injections containing 3.2 mg /ml material (88% NCT, 10% 5.2, 2% tyrosine). NCT eluted at 23.6 
minutes  to give 1 mg NCT (99 % pure) with an 87 % yield. This material was tested using the LF and 
ATP-Mg2+ using the luminescence assay described in section 2.3.5.  
 
N-Carbamyl tyrosine (3.22) 
CAS Registry Number: 90899-85-7. White powder. MP: had decomposed to a brown substance by 
the time the sample had been heated to 300 °C. 1H and 13C NMR: Table 5.1 and Table 5.2. ESI MS 
(Micro TOFQ) m/z [C10H13N2O4]
+ exp m/z: 225.0860, calc m/z: 225.0870 m/z. [C10H12N2O4Na]
+ exp 
m/z: 247.0677, calc m/z: 247.0695. m/z [C10H11N2O4]
- exp: 223.0711, calc: 223.0724. FTIR: 3500 – 
2500 (broad multiple peaks) 3335, 3200, 1716, 1637, 1591, 1558, 1512, 1443, 1399, 1236, 1173, 
1015, 827, 777, 585, 491, 431 cm-1.  UV-Vis (NH4OH, 0.2 %) max (log  295 nm (3.31).  
 
Tyrosine hydantoin (5.2) 
CAS Registry Number: 40856-79-9. ESI MS (Micro TOFQ): [C10H11N2O3]
+ exp m/z: 207.0766, calc m/z: 
207.0764. [C10H9N2O3]
- exp: 205.0594, calc 205.0619. 
 
5.4.4 Synthesis of N-BOC-phenol-O-carbamyl tyrosine 
N-BOC-tyrosine purchased from Sigma (0.4 g, 1.42 mmol, 5.3) was dissolved in H2O (1 L) and mixed 
with sodium cyanate (30 g, 46 mmol). Aqueous acetic acid (5 M) was added until the solution was at 
pH 6.5. This solution was stirred at 30° C for 2.5 hours and acetic acid (5 M) was continually added to 
keep the pH between 6.5 and 7.0. The pH was measured using indicator paper. Without the 
continuous addition of acid the pH of the solution increased due to the reaction of sodium cyanate 
with water and acid. The product was extracted with EtOAc (3 x 200 ml) and DCM (2 x 200 ml). These 
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organic extracts were combined, and H2O was removed with MgSO4. The solution was then dried 
under vacuum at 40 °C to give 2.87 g of a white powder. This material contained cyanate salts, 
carbamyl tyrosine (3.22 or 3.23), 5.1, 5.3, 5.4 and tyrosine by high resolution MS. Addition of base to 
a subsample of this material gave a solution that contained 3.22, 5.3 and tyrosine by high resolution 
MS.  
 
The filtered product (2.87 g) was adsorbed onto 3.2 g of C18 then loaded onto a H2O pre-
equilibrated isolute C18 10 g column. This was eluted as follows. Mobile phase A: H2O + 0.1% acetic 
acid, Mobile phase B: MeCN + 0.1% acetic acid. F1 and F2 (10 ml, MP A each), F3 and F4 (10 ml, 25% 
MP B each), F4 – F9 (10 ml, 50% MP B each), F10 (20 ml, 100% MP B). Starting material 5.3 and 
product 5.4 co-eluted with 50% MeCN (Table 5.9). Fractions 8 and 9 were combined as were 
fractions 10, 11 and 12. The combined fractions were dried under vacuum (Table 5.9).  The results of 
this separation are shown in Table 5.9.  
Table 5.9. Separation of ethyl acetate extract by bench RP chromatography.  
Sample 
Composition HPLC  
(210 nm) 











F5  1:4  1:8 101 18 3.9 
F6 1:2 1:4 97 29 6.3 




22 4 0.9 




18 2 0.3 F11  - 
F12  - 
    Total 202 59 12.4 
 
Fractions containing 5.4 and 5.3 were injected onto the semi-preparative HPLC and eluted with 
39.95% MeCN, 59.95% H2O and 0.1% FA, 5 ml/ min. 5.4 was collected between 2.95 and 3.31 min 
(F1) and 5.3 collected between 3.34 and 3.83 min (F2) (Table 5.10). The results of this separation are 
shown in Table 5.10. 5.4 was produced with a 5% yield from N-BOC-tyrosine (syntheses, and 


























A F6 7.5 1.2 5.4 88 54 
B F6 16 1.3 10.9 76 27 
C F6 16 2.9 11.3 89 61 
D F6 25 1.4 19.7 84 19 
E F8 - F9 25 2.6 19.5 88 58 
F F10 -F12 25 1.0 18.2 77 48 
 
Total 114.5 10.4 85.0 83 40 
 
N-BOC-phenol-O-Carbamyl tyrosine (5.4) 
White powder (10.4 mg), ESI MS (Micro TOFQ): [C15H20N2O6Na]
+ exp m/z: 347.1220 calc m/z: 
347.1214, [C15H19N2O6 Na2]
+  exp: 369.1056, calc: 369.1044. 1H and 13C NMR see table Table 5.6. 
Silica TLC Rf: 0.9. 
5.4.5 Synthesis of phenol-OCT (3.23) from N-BOC-phenol-OCT (5.4 ) 
TFA (700 µl) was mixed with the N-BOC-phenol-OCT (9.2 mg in 0.9 ml of 1:1 MeCN:water with 0.1% 
formic acid). TLC analysis showed the disappearance of N-BOC OCT: Rf 0.62 (pink yellow spot) and 
the appearance of OCT Rf: 0 (purple spot). The solution was freeze dried to remove TFA and solvent. 
The de-protection was also monitored by HPLC and MS (100% conversion). The dried material was 
dissolved in D2O + 0.2 % formic acid (700 µl) and the remaining impurities were removed by 
extraction with 100 µl ethyl acetate. The aqueous fraction contained 6 mg 99% OCT (3.23) and a very 
small amount of tyrosine by NMR, MS and LC-MS. The organic fraction was found to contain OCT 
(3.23) and phenol-O-carbamyl-N-BOC-tyrosine (5.4) by high resolution MS. 
 
Phenol-O-carbamyl tyrosine (3.23) 
White powder (6 mg). 1H NMR see table Table 5.6, IR: 3452, 3347, 2894, 2581, 1760, 1732, 1648.2, 
1596.0, 1407, 1159, 1128, 1038, 1021, 1002, 972, 948.3, 890, 853, 815, 798, 775, 751, 727, 705, 666, 
636, 599, 575, 511, 436, 408 cm-1. ESI MS (Micro TOFQ): [C10H13N2O4]
+: exp m/z 225.0881, calc m/z: 
225.0870, m/z [C10H12N2NaO4]
+ exp: 247.0702, calc: 247.0689, UV Vis (6% MeCN  inwater with 0.1% 
formic acid). max (log  265 nm (3.3). Silica TLC Rf: 0.25. 
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6 An LC-MS investigation into the origin of tutin glucosides 
found in New Zealand toxic honeys  
6.1 Introduction 
It was recently reported that honeys contaminated with the neurotoxin tutin (6.1) and 4-hydroxy 
tutin (6.2) (hyenanchin/mellitoxin) also contained tutin glucosides 6.3 and 6.4 (Larsen et al., 2015). 
These molecules are shown in Figure 6.1. 
 
 
6.1. Tutin 6.2. Hyenanchin  
 
 
6.3. Tutin monoglycoside 6.4. Tutin diglycoside 
Figure 6.1. Tutin and derivatives.  
The tutin in such contaminated honey is derived from tutu plants of the genus Coriaria L. (family 
Coriariaceae), which are native to New Zealand (Allan, 1961). Tutin contaminates honey  when 
honeybees, Apis mellifera L. (Hymenoptera) collect the honeydew (gut waste product) excreted by 
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passionvine hoppers, Scolypopa australis Walker (Hemiptera) that are feeding on tutu sap 
(Easterfield and Aston, 1901; Fields et al., 2014; Goodwin, 2013; Palmer-Jones et al., 1947; 
Sutherland, 1992). Tutin is readily extracted from tutu leaves and has been found in Scolypopa 
honeydew and in contaminated honey (Palmer-Jones et al., 1947; Palmer-Jones and White, 1949; 
Sutherland, 1992). 
 
A related compound, hyenanchin (6.2) has been found in the honey and honeydew, but not in tutu 
leaves, young shoots or stems (Hodges and White, 1966; Palmer-Jones et al., 1947; Palmer-Jones 
and White, 1949; Porter, 1967). It was thought that hyenanchin was probably synthesised from tutin 
in the gut of the hopper (Palmer-Jones et al., 1947; Palmer-Jones and White, 1949). However it was 
also possible that hyenanchin was more concentrated in the phloem (which is fed upon by the 
passionvine hoppers), than other plant parts. 
 
The tutin glucosides 6.3 and 6.4 have so far only been confidently identified in honey (Larsen et al., 
2015) and it was suggested that bees or Scolypopa, rather than the plant, may be responsible for the 
glycosylation of tutin. Glycosylation can act as a detoxification mechanism (Maag et al., 2014) and as 
a method to prevent insect honeydew from provoking a plant defensive response (VanDoorn et al., 
2015). However, tutin and hyenanchin were not fatal to bees at 2000 ppm (Palmer-Jones et al., 
1947). Since previous analyses by this research group showed maximum concentrations of 50 ppm 
for tutin and 400 ppm for hyenanchin in honeys, the bees have no need for specific defences against 
tutin (Larsen et al., 2015). However the glycosylation pathway may have evolved to protect the bees 
against other, more toxic compounds. This study investigates the origins of tutin derivatives,  6.2 – 
6.4 by measuring the concentrations of these compounds (by LC-MS) in S. australis honeydew and in 
different parts of the Coriaria plant including phloem.  
 
Despite the worldwide interest in the picrotoxanes of Coriaria (Gössinger, 2010; Yokoyama et al., 
2000), few quantitative investigations of toxin content of different plant parts have been reported. 
Animal dosing studies showed that young tutu leaves were more toxic than mature leaves, and that 
stems, root cortex and root core were not toxic at the maximum dose tested (Palmer-Jones and 
White, 1949). Gas chromatography (GC) analyses of five Coriaria species native to New Zealand 
showed that tutin concentrations were greater in leaves than in stems (Lowe and White, 1972). 
Stems of Dendrobium nobile (Orchidaceae) were the source of the only picrotoxane glucosides 
reported before this work (Gössinger, 2010). However traces of monoglycoside 6.3 had been found 




Honeydew analysis played a vital part in the discovery that tutu was responsible for the pircrotoxin 
contamination of New Zealand honey (Easterfield and Aston, 1901; Fields et al., 2014; Goodwin, 
2013; Palmer-Jones et al., 1947; Sutherland, 1992). However up until now, it has never been 
analysed using modern methods. Insect honeydews were first studied as a method to analyse the 
transport of plant secondary metabolites by the phloem when direct analysis options were 
unavailable (Byrne and Miller, 1990; Molyneux et al., 1990). For example the honeydew based 
studies on the alkaloid swainsonine in the honeydew of pea aphids Acyrthosiphon pisum feeding on 
Astragalus (Leguminosae) species, established that swainsonine was biosynthesized in the leaves 
and transported in the phloem (Harris et al., 1988; Molyneux et al., 1985).  
 
Most early studies focussed on a few important plant defence compounds such as pinitol, which was 
detected in the honeydew of pea aphids feeding on alfalfa (Campbell and Binder, 1984), and 
quaternary furanoquinoline alkaloids, which were detected in the honeydew of leafhoppers feeding 
on Ptelea (Rutaceae) (Kiss, 1984). Glucosinolates were studied in the honeydew of cabbage and 
peach aphids feeding on rape Brassica napus (Weber et al., 1986).  
 
However, the advancement of insect stylectomy techniques  has meant that honeydew is no longer 
used as a method to sample phloem (Dinant and Lemoine, 2010; Guelette et al., 2012). Instead more 
recent studies have focused on saccharide markers that could be used to determine whether honeys 
are of nectar or honeydew origin (Sanz et al., 2005; Tuberoso et al., 2011). These studies led to the 
discovery of several new saccharides (Hendrix and Wei, 1994; Wei et al., 1997; Wei et al., 1996). One 
honeydew study also measured the amino acid content of aphid honeydews to determine  the roles 
played by intracellular symbionts in the nitrogen metabolism of aphids (Sasaki et al., 1990). Another 
discovered that  whiteflies glycosylate salicylic acid before excreting it as honeydew and posited that 
this was done to prevent the whitefly honeydew form setting off and plant defense response 
(VanDoorn et al., 2015). 
 
Despite Tutu phloem being essential to the toxic honey story, no reports of sap analyses in a Coriaria 
species were published previous to this study. Phloem sap is complex and carries a large array of 
small molecules, including sugars, hormones, defence compounds, proteins, lipids and RNA (van Bel 
and Hess, 2008). It is possible to directly sample sap by removing the insect body from the insect 
mouth-parts after the insect has begun to feed. Sap can then be collected from the end of the insect 
mouth-part; a method known as insect stylectomy (Dinant and Lemoine, 2010; Guelette et al., 
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2012). This method enables the collection of relatively pure phloem sap. However, it is technically 
difficult, time consuming, and the sap collected this way can be affected by insect metabolism 
(Palmer et al., 2013). Incision into the phloem of some plants (e.g. Cucurbita species) can provide 
large volumes of sap by spontaneous exudation. Unfortunately most plants quickly stop phloem 
leakage through callose deposition and P protein accumulation, and there is some controversy over 
whether this phloem is representative of the major fascicular phloem (Tetyuk et al., 2013; Zhang, 
2006). Therefore, in this research phloem was collected by a third method: ethylene diamine tetra 
acetic acid (EDTA) facilitated exudation. EDTA prevents wound healing through the chelation of Ca2+ 
ions (Tetyuk et al., 2013). This method is a relatively quick and easy, but it not does give absolute 
phloem component concentrations (Tetyuk et al., 2013). Furthermore, the collected phloem may be 
contaminated by leakage from the cut petiole, a process worsened by the presence of EDTA (Tetyuk 
et al., 2013). This chapter now reports the LC-MS analyses of tutin (6.1) and derivatives 6.2– 6.4 
along the pre-bee food chain to picrotoxane-contaminated honey. As part of this study these 
molecules were measured in S. australis honeydew, S. australis adults and larvae, and in Coriaria 
phloem, leaves, stems and roots.  
 
6.2 Results and discussion 
Three C. arborea trees (Allan, 1961) at Te Puke, North Island, New Zealand, infested with S. australis 
were used in this study. Honeydew samples were collected by wrapping plastic bags around 
branches upon which S. australis were feeding, and collecting the drips of honeydew. A small sample 
of honeydew was also collected by washing older honeydew off leaves.  Larval and adult S. australis 
were collected by hand. Phloem was collected by EDTA facilitated exudation (Tetyuk et al., 2013) 
from mature photosynthesising leaves (source phloem) and from the stems leading to young leaves 
(sink phloem). Phloem samples were also collected into water without EDTA to show the degree of 
spontaneous exudation. Leaves and woody stems were collected from all three trees and a root 
sample was collected from one tree. 
 
Samples were prepared for LC-MS by eluting the material though C18 using a water – acetonitrile 
(MeCN) gradient. This removed any material unsuitable for LC-MS. Previous researchers (Larsen et 
al., 2015) had separated the toxic honeys into sub fractions which were analysed separately. In this 
study, all tutin and tutin derivatives were eluted into the same fraction. This meant that only one 
fraction had to be studied by LC-MS for sample analysis and that relative concentrations of each 
picrotoxin could easily be compared.  Sample complexity was not a problem due to the use of 
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multireaction monitoring (MRM) methods. The quantitative LC-MS analysis method was adapted 
from a previously published method (Larsen et al., 2015) and calibrated using previously isolated 
picrotoxanes (compounds 6.1– 6.4) and sucrose. 
 
Table 6.2 shows the concentration of tutin, tutin derivatives and sucrose in honey, honeydew and 
phloem sap according to LC-MS analysis. Honeydew (bag samples), phloem samples and leaves were 
compared by non-parametric statistics due to the high sample variation and the large data skew.  
 
EDTA facilitated exudation does not give consistent amounts of phloem and most researchers use it 
to study only the relative amounts of different components (Tetyuk et al., 2013). To provide some 
degree of quantitative measurement, the phloem samples and honeydew samples were dried and 
tutin derivative concentrations given as µg/mg of dry material. However due to the low amounts of 
phloem and honeydew collected (Table 6.1), the presence of EDTA in some samples and the 
presence of variable amounts of cut petiole leakage, these values are only semi-quantitative and are 
expected to have a large standard deviation and spread. They are therefore only useful for studying 
large differences between samples.  Slight changes between samples can only be determined by 
studying the relative amounts of each compound. 
Table 6.1. Mass of phloem and honeydew collected. Scale error was ±0.3. 
 Number of 





Source phloem (EDTA) 24 4.7 2.7 6.5 
Source phloem (water) 11 1.6 0.5 1.9 
Sink phloem (EDTA) 6 3.2 3.7 1.0 
Honeydew 10 3.2 2.2 3.0 
  
Only one sample of honeydew could be collected by washing leaves (as opposed to bag method) and 
only one sample of toxic honey was available. Table 6.3 shows the concentration of tutin, tutin 
derivatives and sucrose in leaf, stem, root and insects. Samples were compared by parametric 
statistics because not enough samples were available for non-parametric analysis. In both tables 
both the median and the mean concentrations are provided because the data was highly skewed 




Table 6.2. Concentration of tutin, tutin derivatives and sucrose in honey, honeydew and phloem sap according to LC-MS 
analysis (given as µg/g of dried sample, except for honey which was not dried). Superscript
AB
 shows the significant 
difference by non-parametric statistical analysis (P≤ 0.05).  e.g. Sample
A




















Honey (1) 8 3 8 8 7873 
Honeydew by 
leaf wash (1) 
214 9 1 0 186 
Honeydew by 
bag method (9) 










































































































Table 6.3. Concentration of tutin, tutin derivatives and sucrose in leaf, stem, root and insects according to LC-MS 
analysis (given as µg/g of dried sample except for insect samples which were not dried). Superscript
WZ
 shows the 
significant difference by parametric statistical analysis (P≤ 0.05).  e.g. Sample
W
 is significantly to sample
Z
 but a sample
WZ
 






Number of biological replicates. 
b
Three samples taken from one 
root and prepared separately. 
Concentration (µg/g): mean (standard deviation), median. 




























































































































6.2.1 Honey and phloem 
A sample of toxic honey (unrelated to the sampling area in this study) was analyzed and was found 
to contain compounds 6.1– 6.4 (Table 6.2 and Figure 6.2) which was consistent with the previous 
analysis of this sample (Larsen et al., 2015). 
 
Compound Results of non-parametric statistical analysis 
6.1 NA A NA A A A A 
6.2 NA A NA A B A B 
6.3 NA A NA A A A B 
6.4 NA A NA A B A B 
  
Figure 6.2. Mean relative concentrations of compounds 6.2, 6.3 and 6.4 for phloems, honeydew, honey and tutu leaf by 
percentage concentration relative to 6.1, 6.2, 6.3 and 6.4 (%1). Graph shows percentage 6.2, 6.3 and 6.4 for samples 
where at least one of these compounds is detectable. The remaining percentage represents tutin. Brackets show 
number of samples in each sample type. Error bars below show one standard error below the mean. Abbreviations: HD: 
Honeydew. EDTA: ethylene diamine tetra acetic acid. Samples showing different letters were significantly different by 
non-parametric statistical analysis (P≤ 0.05).  
  
Honeydew (HD) collected as part of this study via the bag method also contained compounds 6.1– 
6.4 but was found to contain 100 times more tutin, and 30 times more of compounds 6.2 - 6.4 than 




This could be due to the toxic honey being diluted with nectar from other plants. However, the 
relative amounts of each tutin derivative in the honey were within the range measured for 
honeydew (Figure 6.2). Since the honey tested was not related to the honeydew tested, detailed 
conclusions cannot be drawn. However since 6.1– 6.4 are present in both honeydew and honey it 
appears that bees are not responsible for the synthesis of 6.2 – 6.4. 
 
A small sample of honeydew (30 mg) was also collected by the method of Palmer, who washed 
honeydew off leaves with water (Palmer-Jones and White, 1949). This honeydew appeared quite 
different from the honeydew collected by the bag method and was found to contain 96% 6.1 , 4% 
6.2, and 0.5% 6.3 (Table 6.2 and Figure 6.2). This is consistent with the results of Palmer who only 
reported (but possibly only searched for) 6.1 and 6.2 from honeydew collected in this manner 
(Palmer-Jones and White, 1949). It may be that 6.3 and 6.4 are converted into 6.1 on the leaf 
surface; possibly by bacteria or fungi feeding upon the honeydew (sooty mold heavily infested most 
leaves). For example both bacteria and fungi are known to deglycosylate the ginsing glycosides 
known as ginsenosides (Hasegawa, 2004; Zhao et al., 2012) 
 
6.2.2 Phloem and honeydew. 
In this experiment, sink phloem (phloem flowing into new leaves) and source phloem (phloem 
flowing out of photosynthesizing leaves) were collected via the EDTA method from three trees and  
phloem water controls taken for each (King and Zeevaart, 1974).  
 
The absolute and relative concentrations of tutin derivatives were compared between each type of 
phloem and the honeydew (Table 6.2 and Figures 6.2 and 6.3). This showed that compounds 6.1, 
6.2, 6.3 and 6.4 were present in all analysed phloem samples at concentrations that were not 
significantly different to those in honeydew by absolute or relative concentrations. The presence of 
6.2 – 6.4 in phloem indicated that these tutin derivatives are of plant, not insect origin. 
 
The absolute concentrations of compounds 6.1 - 6.4 in phloem samples were highly variable, with 
medians that were often less than 60% of the mean. This was expected because the EDTA method of 
phloem collection does not give good quantitative data as discussed in section 6.1.  Linear regression 
was therefore used to determine the relationship between the absolute concentrations of the 




Table 6.4. Relationship (linear regression) between the concentrations of 6.2, 6.3 and 6.4 for different phloems and for 
honeydew. All correlations were significant with P <0.005. Sample types that showed significantly different gradients (P 
< 0.05) are marked. The relationship between 6.2, 6.3 and 6.4 with sucrose is shown in Appendix 6. 1. 
 
 
The absolute concentrations of compounds 6.2, 6.3 and 6.4 were strongly correlated with each other 
in phloem and moderately correlated in honeydew (Table 6.4). Tutin concentrations, in contrast, 
were not correlated to the concentrations of any other molecule in either phloem or honeydew. This 
indicated that the tutin in the phloem samples may have a different origin than compounds 6.2, 6.3 
and 6.4. The relative tutin metabolite concentrations excluding tutin (percentage 2) are therefore  
shown in Figure 6.3. 
 
 
Correlation (linear regression) between 6.3 and 6.4  (X) and 6.2 (Y) 
Sample type: Gradient (A) for Y=AX, (St Dev), R
2
. 

















All phloems and honeydew: 1.34 (0.08), 87% 
Source phloem (EDTA): 1.39 (0.02), 94% 
Sink phloem (EDTA): 1.48 (0.07), 99 % 
The source phloem (water 
control) contained 
significantly less 6.3 
compared to 6.2 than other 
phloem samples (P <0.001) Strong correlation 
Source phloem (Water control): 0.54 (0.01), 99.9% 
Moderate correlation 
Honeydew: 0.91 (0.02), 45% 
6.4 
Strong correlation 
All phloems and honeydew: 2.2 (0.1), 81% 
Source phloem (EDTA): 2.2 (0.2), 84% 
Sink phloem (EDTA): 2.4 (0.4), 90% 
Source phloem (Water control): 1.5 (0.1), 95% 
Moderate correlation 
Honeydew: 1.7 (0.7), 39% 
Correlation (linear regression) between 6.3 (X) and 6.4 (Y) 
Sample type: Gradient (A) for Y=AX, (St Dev), R
2
. 

















All phloems and honeydew:0.53 (0.04), 80% 
Source phloem (EDTA): 0.54 (0.08), 84% 
Sink phloem (EDTA): 0.6 (0.2), 83% 
Source phloem (Water control): 0.35 (0.04), 95% 
Moderate correlation 





Compound Results of non-parametric statistical analysis 
6.2 A A A B 







     
 
Figure 6.3. Mean relative concentrations of 6.2, 6.3 and 6.4 for phloems and honeydew by percentage concentration 
relative to 6.2, 6.3 and 6.4 (%2) for samples where at least one of these compounds is detectable. Error bars below show 
one standard error below the mean. Abbreviations: HD: Honeydew, EDTA: ethylene diamine tetra acetic acid. Samples 
showing different letters were significantly different by non-parametric statistical analysis (P≤ 0.05).  
 
Absolute tutin concentrations were found to be significantly higher in the phloem imported into the 
young leaves (Sink phloem EDTA), than in all other phloem and honeydew samples (P< 0.001). This is 
consistent with the toxicology results of Palmer, who reported that the young leaves were far more 
toxic to guinea pigs than old leaves (Palmer-Jones et al., 1947). Possibly fresh young leaves require 
more defence from herbivores than older leaves because young leaves are physically weaker and 
more valuable to the plant (Karageorgou and Manetas, 2006; McKey, 1974). 
 
Rather unexpectedly, the phloem collected from the water control (rather than using EDTA) did not 
contain significantly different absolute amounts of any compound, including sucrose, to either the 
phloem or honeydew samples (Table 6.2). These water controls should theoretically contain only 
“cell leakage”, because without EDTA, the plants wound healing response should quickly block the 
phloem tubes (Tetyuk et al., 2013). This indicated that some phloem exudation occurred even in the 
absence of EDTA. The water phloem samples did contain significantly less of compounds 6.2 and 6.4 
(by Percentage 1, Figure 6.2) and less of compounds 6.3 and 6.4 (by Percentage 2, Figure 6.3) than 
the EDTA phloem samples showing that EDTA did have an effect. However the lack of a significant 
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difference between the absolute phloem and water control data means that the water control 
cannot be subtracted from the EDTA data to give an indication of the phloem content without the 
effects of cell leakage. 
6.2.3 Comparison of leaves to honeydew and phloem (all types). 
Absolute tutin (6.1) concentrations were higher in the honeydew and phloem samples, than in the 
leaves (Table 6.2, Figure 6.2). In contrast absolute sucrose concentrations were found to be higher in 
the leaves (Table 6.2). This is not surprising because sucrose does not appear to be the main 
transport sugar in tutu (see Appendix 6. 8). Compounds 6.2 and 6.4 were found at significantly 
higher concentrations in the honeydew and phloem than leaves (Percentage 1), whilst the 
monoglucoside (6.3) showed significantly higher concentrations (percentage 1) in the leaves than 
the phloem (Figure 6.2). The leaves were well washed before extraction so the presence of these 
molecules cannot be due to honeydew contamination.  
 
Previous research had found only tutin (6.1) in Coriaria leaves, although compound 6.2 had 
previously been isolated from the leaves of Hyaenanche globosa (Momtaz et al., 2010). This had led 
researchers to believe that only tutin (6.1) was produced by the plant (Hodges and White, 1966; 
Palmer-Jones et al., 1947; Palmer-Jones and White, 1949; Porter, 1967). These results show that 
previous researchers were correct in the statement that compound 6.1 is the main tutin derivative in 
leaves (Sutherland, 1992). However the conclusion that tutin is the only picrotoxin in the plant is 
wrong, because compounds 6.2, 6.3 and 6.4 were present in high concentrations in the phloem 
(Table 6.2). Compounds 6.2 and 6.3 were likely not previously detected because they occurred at 
much lower concentrations than 6.1 in the leaves and because the phloem had not previously been 
analysed. 
 
6.2.4 Plant parts 
Leaf, root and woody stem samples contained mainly tutin (6.1), with some hyenanchin (6.2) and 
monoglucoside (6.3) (Table 6.3 and Figure 6.3). Root and stem samples showed detectable 
diglucoside 6.4 but in very low amounts (less than 0.01% by percentage 1). The absolute and relative 
concentrations of each plant part were compared by ANOVA and leaf samples were found to contain 
significantly more monoglucoside 6.3 (absolute concentration) than root or woody stem samples. 
Woody stem samples contained significantly more tutin (absolute concentration) than root samples. 
The leaves contained much higher total amounts of picrotoxanes than other plant parts which may 
explain the finding of Palmer who reported that roots and stems were less toxic than the leaves 
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(Palmer-Jones et al., 1947). However while the toxicity of tutin and hyenanchin has been studied 




Compound Results of parametric statistical analysis 
6.2 A A A A A 
6.3 A A A A A 
6.4 A A A A A 
 
Figure 6.4. Mean relative concentrations of 6.2, 6.3 and 6.4 for tutu plant parts (leaf stem and root) and for adult and 
larval Scolypopa by percentage concentration relative to 6.1, 6.2, 6.3 and 6.4 (%1). Graph shows percentage 6.2, 6.3 and 
6.4 with the remaining percentage representing tutin. Error bars below shows one standard error below the mean. 
Abbreviations: HD: Honeydew. EDTA: ethylene diamine tetra acetic acid. Samples showing the different letters were 
significantly different by non-parametric statistical analysis (P≤ 0.05).  
 
6.2.5 Other 
The adult and larval Scolypopa were found to contain very small amounts of compounds 6.1 - 6.4 
and the relative amounts found were not significantly different (by ANOVA) from the phloem they 
fed upon, or the honeydew that they produced (Table 6.3 and Figure 6.3). Thus Scolypopa do not 
appear to store any tutin or tutin metabolites preferentially. However this is a very small study.  
The collected phloem and honeydew samples contained mainly fructose when measured by LC-MS 
and 1H NMR (see Appendix 6. 8 for the composition of various phloem samples). Samples also 





6.2.6 A proposal on the distribution of tutin and its derivatives within the plant.  
Phloem, unlike xylem, is not a unidirectional transporter (Turgeon and Oparka, 2010). It travels from 
metabolite source to sink, but the source may be roots or photosynthesizing leaves, while the sink 
could be any plant part that cannot photosynthetically support itself (Turgeon et al., 2001). Phloem 
is complex, variable, and difficult to sample (Dinant and Lemoine, 2010; Guelette et al., 2012; Tetyuk 
et al., 2013; Zhang, 2006).  
 
The physiology of C. arborea has not been closely studied but Coriaria myrtifolia is known to have 
both symplastic open minor veins and closed apoplastic minor veins (Gamalei, 1989). Closed minor 
veins cells contain no plasmodesmata and rely on active apoplastic transport to pump sucrose into 
the vein against a concentration gradient (Gamalei, 1989; Haritatos et al., 1996; Turgeon et al., 
2001). In contrast the cells of open minor veins contain high numbers of openings called 
plasmodesmata through which sucrose can pass (symplastic transport). In some plants sucrose is 
then converted by intermediary cells into the polysaccharides raffinose (i.e. sucrose monoglucoside) 
and stachyose (i.e. sucrose diglucoside) (Haritatos et al., 1996). Once the polysaccharide is made, it 
cannot leak out of the vein (Gaupels and Ghirardo, 2013; Haritatos et al., 1996). When the phloem 
transported molecule reaches its destination, the polysaccharides are converted back into sucrose 
and symplasticly unloaded from the vein though the plasmodesmata (Haritatos et al., 1996). This 
process is known as polymer trapping (Haritatos et al., 1996). Since the collected tutu phloem shows 
stachyose, raffinose and sucrose (Appendix 6. 8), it seems plausible that C. arborea may use polymer 
trapping to transport sucrose.  
 
The closed minor veins therefore carry mainly sucrose, while open minor veins generally carry more 
complex polysaccharides (Haritatos et al., 1996). There may also be further large differences in the 
metabolites transported by these veins types (Dinant and Lemoine, 2010; Thompson and Schulz, 
1999). Phloem may also undergo further modification when the minor vein phloem reaches the 
major stem phloem (Turgeon et al., 2001). It seems plausible that several types of phloem are 
encountered by feeding Scolypopa. The honeydew collected therefore may be produced from a 
variable mix of these phloems. This could explain the high absolute and relative concentration 




Tutin diglucoside (6.4) is present in high proportions in the phloem, but virtually absent in the rest of 
the plant while the monoglucoside (6.3) is present mainly in the leaves (in minor amounts) (Table 6.2 
and Table 6.3). It seems likely that tutin (6.1) is converted into monoglucoside (6.3) in the minor leaf 
veins and that some is then further converted into diglucoside (6.4) for transport out of the leaves. 
This would explain why the monoglucoside (6.3) is found in leaves and phloem while diglucoside 
(6.4) was mainly found in the phloem. The root samples contain only very low levels of compounds 
6.3 and 6.4 compared to the phloem (Table 6.2 and Table 6.3). It is therefore likely that once the 
phloem reaches a sink (such as the roots) the diglucoside (6.4) is converted back into tutin (6.1).  
 
One could therefore liken the 6.1 - 6.3 - 6.4 transport process to that of the sucrose – raffinose – 
stachyose polymer trap system (Gaupels and Ghirardo, 2013). Since tutu phloem contains raffinose 
and stachyose, it is likely that tutu to some extent uses a polymer trap system to transport sugars. It 
may be that tutu is able to transport tutin via the same process (Figure 6.5). This would be exciting if 
it were true, because although such a mechanism been suggested in Cucurbitaceae for the transport 
of l-ascorbic acid via ascorbate glycosides (Hancock et al., 2008) there has yet to be strong proof that 
polymer trap loading can be used to transport molecules containing non saccharide moieties.  
 
 
Figure 6.5. A comparison of the possible tutin transport process with the raffinose-stachyose transport system. 
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The concentrations of hyenanchin (6.2), monoglucoside (6.3), diglucoside (6.4) and sucrose are all 
strongly correlated with one another in phloem samples (Table 6.4 and Appendix 6. 1) which 
indicates that these molecules were carried together in the phloem. In contrast, the concentrations 
of tutin were not at all correlated with the concentrations of sucrose or compounds 6.2 - 6.4. 
Furthermore samples with little or no sucrose or compounds 6.2 - 6.4 contained similar 
concentrations of tutin to those with high levels of sucrose or compounds 6.2 - 6.4. This implied that 
tutin does not originate from the same source as sucrose and compounds 6.2 - 6.4.  
 
The main sugar in the collected phloem was fructose (Appendix 6. 8). Hexoses are commonly found 
in phloem collected by the EDTA method but are usually thought to be caused by “cell leakage” from 
the cut petiole surface (Rothe et al., 1999; van Bel and Hess, 2008). The presence of large amounts 
of fructose could indicate that phloem samples contain high levels of this cell leakage (Pickard, 
2008). Tutin could have entered the phloem sample via this process. This would explain why tutin 
does not appear to originate from the same source as sucrose and compounds 6.2 - 6.4. Variation in 
the ratio of phloem to cell leakage in the phloem sample, would explain the variation in the relative 
amounts of 6.1 compared to 6.2 - 6.4. The effect of cell leakage could not be easily studied because 
the water controls, which theoretically should have contained just cell leakage, contained similar 
absolute amounts of phloem metabolites as the EDTA sampled phloem (Figure 6.2, Figure 6.3 and 
Table 6.4). 
 
However, the presence of high concentrations of fructose could also be explained if tutu had both 
fascicular and extra-fascicular phloem like that observed in Cucurbitaceae (Zhang, 2006). In such a 
system the central fascicular phloem contains raffinose and sucrose, and acts as the main long 
distance nutrient transporter while the extra-fascicular phloem, contains monosaccharides such as 
fructose and defence molecules and forms a complex net-like structure in between and around the 
central phloem (Gaupels and Ghirardo, 2013; van Bel and Hess, 2008; Zhang, 2006).The extra-
fascicular phloem is thought to provide protection to the fascicular phloem, as well as providing 
nutrients to the surrounding area (Gaupels and Ghirardo, 2013; Zhang, 2006). The extra-fascicular 
phloem exudes even in the absence of EDTA (Gaupels and Ghirardo, 2013; Zhang, 2006). 
Extrafasticular phloem has not been studied outside Cucurbitaceae but Coriariaceae, the family 
containing tutu is related to Cucurbitaceae and both fit within the order Cucurbitales (Turgeon and 




The presence of large amounts of fructose, along with the observed spontaneous exudation in the 
absence of EDTA may suggest that tutu stems also contain both fascicular phloem and extra-
fascicular phloem. If this were the case it seems likely that sucrose and compounds 5.2, 6.3, and 6.4 
would be transported in the fascicular phloem. The more fascicular phloem that was collected, the 
higher the concentration of these compounds in the collected phloem. This would explain why the 
concentrations of these molecules are strongly correlated. In contrast tutin would likely originate 
from the extra fascicular phloem. Since the amount of extra fascicular phloem collected would not 
be related to the amount of fascicular phloem, the concentration of tutin in phloem samples would 
not be correlated to the concentration of compounds 5.2, 6.3, and 6.4. It would be very interesting if 
tutin was found in the extra fascicular phloem and not in fascicular the because this would fit with 
the idea that extra-fascicular phloem fulfils a defensive purpose (Gaupels and Ghirardo, 2013).  
 
6.3 Conclusions 
This research showed that hyenanchin (6.2), tutin monoglycoside (6.3) and tutin diglycoside (6.4) in 
toxic honeys were all plant derived. This is in contrast to the earlier hypothesis which suggested that 
these molecules were insect metabolites (Larsen et al., 2015). This was based on the assumption 
that the composition of phloem sap was similar to that of the leaf. However this research showed 
that the leaf and phloem  display strongly contrasting compositions.  This is a good reminder that 
plants have complex defence mechanisms and that it is important to study the transport of 
molecules around the plant rather than relying on material that is easily sampled such as leaves. 
Plant and Food Research intends to extend this approach to study secondary metabolites in the 
phloem of other plant species. With the exception of the phloem transport  of some important 
defence compounds such as the  glucosinolates (Chen and Andreasson, 2001) cyanogenic glycosides 
(Calatayud et al., 1994), quinolizidine alkaloids (Wink and Witte) and the alkaloids of Solanaceae and 
in the opium poppy (Yazaki, 2005) the transport process of most secondary metabolites has not 





6.4.1 General  
All reagents and solvents were purchased from commercial suppliers and were used without further 
purification. Tutin, tutin glucosides and hyenanchin were provided by Lesley Larson (Larsen et al., 
2015).  
6.4.2 Sample collection 
Samples were collected on 16/2/15 from three trees on Number 4 road in Te Puke with the help of 
Nick Gould, Nicky Haisman and David Logan. All trees were found on the east side of the road.  Sap 
collection on day one began at 1.30 pm (tree one) and 3.30 pm (tree two) and continued for 24 
hours.  Sap collection on day two began at 11.00 am and continued for 24 hours.  Trees were heavily 
infested with leaf hoppers and sooty black mold (between 2 and 28 adult Scolyopopa on each 
pinnate leaf). Geniostroma ligustrifolium (hangehange) was also found growing upon the tutu. Many 
steel blue ladybirds Halmus chalybeus were also observed. These likely prey upon Scolyopopa. Trees 
one and two were very brown and looked infected with some disease. Sooty mould was observed on 
most leaves. A root sample 60 cm long was dug from under tree one. Voucher specimens have been 
lodged in the Peru Herbarium (Codes P15.02.17.1 - P15.02.17.5) 
 
6.4.3 Phloem 
Phloem was collected by EDTA facilitated exudation with the assistance of Nick Gould (King and 
Zeevaart, 1974). Pinnate leaf segments of five to nine leaves were cut from each tree with a razor, 
either under EDTA (5 mM, pH 7.0) or water. Individual leaves (source phloem) or the new growth 
stem still attached to the tree (sink phloem) were placed in an Eppendorf containing EDTA (5 mM, 
pH 7.0) or water. Stems were placed in the solution that they had been cut under, and the solutions 
were sealed with Blue-tack™. Exudates were collected for 24 hours, stored at room temperature for 
two days then at – 20 °C for a week.  
 
6.4.4 Honeydew 
Honeydew was collected by placing plastic bags over entire pinnate leaf sections for four hours.  
Bags were stored at room temperature for a day, then at -20 °C for a week. Bags were rinsed with 
water (50 ml), the resulting solution filtered through cotton wool, then dried under vacuum. An 
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empty plastic bag was used as a control and was found to yeild no detectable tutin derivatives. 
Honeydew was also washed off the collected leaves using cold water.  
 
6.4.5 Tutu sap and honeydew sample preparation.  
The water used to wash the honeydew from the bags was filtered through cotton wool, then freeze 
dried to give 30 mg of material. Samples of sap or honeydew solution (washed off leaves or bag 
collected) (1 ml in H2O) were loaded onto a prepacked C18 column (0.5 g Isolute, Biotage) and the 
column eluted with MeCN (50%, 1 ml, 100%, 2 ml). The resulting solution was dried under vacuum to 
give between 0.1 and 15 mg of material. Samples containing more than 0.1 mg of material were 
rehydrated to a concentration of 2.4 mg/ ml in 50% MeOH 50% water. All other samples were 
rehydrated with 50% MeOH 50% water (1 ml).  
 
6.4.6 Tutu leaf, wood and root and insect extract preparation 
Leaves were well washed to remove all honeydew from their surfaces, then air dried for five days. 
Leaves were removed from woody stems and ground in a mortar and pestle (three leaf samples, 
made up of six to nine leaves each were taken from each tree). Ethanol (40 ml) was added to each 
sample (2 g).  Woody stem samples (one from each tree) were ground in a coffee grinder and 
ethanol (10 ml) added to each sample (1 g). The root sample, from tree one, was cut into three parts 
and each part ground into sawdust using a coffee grinder. Subsamples of each part (22 g) were each 
added to 220 ml ethanol. Samples were shaken for 24 hours. The ethanol extracts were filtered 
through cotton wool then dried under vacuum. The solid material was re-extracted into water to 
check that all tutin derivatives had been extracted. This showed that 99% of the tutin derivatives had 
been extracted in the first ethanol extract. The collected S. australis were killed by freezing and split 
into six subsamples each containing 20 insects. The first three samples contained adult insects only 
while the second three samples contained larval insects only. These samples were each ground into 
3 ml 1:1 MeCN:water in a  douncer. Each solution was centrifuged to remove insolubles then dried 
under vacuum.  
 
A portion (250 mg leaf extract, 200 mg root extract, 15 mg woody stem extract) of each of the dried 
ethanol extracts (dark oily green) was adsorbed to C18 (250 mg) by evaporation. The coated material 
was loaded onto a prepacked C18 column (0.5 g Isolute, Biotage). The column was eluted with H2O 
(2 CV) followed by two column volumes each of 10%, 20%, 30%, 40%, 50% and 100% MeCN in H2O.  
Fractions eluted with 0 - 30% MeCN were combined to give F1 and fractions eluted with 40 – 50 % 
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MeCN were combined to give F4. A large amount of black tarry matter similar to that reported by 
(Easterfield and Aston, 1901) remained stuck to the column and could not be removed even with 
cyclohexane. Leaf, root and stem samples were made into solutions with a concentration of 2.4 
mg/ml with 1:1 MeOH:water. Insect fractions were rehydrated with 2 ml 1:1 MeOH:water (F1) and 
300 µl MeOH:water (F4, F7) giving approximately 2.4 mg/ml. The majority (99%) of the tutin 
derivatives were found in F1. 
 
6.4.7 LC-MS method  
An MRM LC-MS method was developed that gave the shortest analysis time and best sensitivity for 
the tutin derivatives. It was based on the setup of Larsen et al. but used an Agilent 6430 triple quad 
LC-MS with a 1200 Infinity HPLC (Larsen et al., 2015). Chromatography: 0.2 ml/min water – methanol 
gradient (0.1% ammonium formate), Phenomenex Luna  3 µm C18 (2)100 Å 100 x 2 mm. Time (% 
methanol): 0 min (10%), 3 min (30%), 8 min (100%), 13 min (100%) 14 min (10%), 30° C.  Injection 
volume: 5 µl. MS conditions in Appendix 6. 6. 
 
Stock standards of tutin, hyenanchin, tutin mono glucoside (6.3) and tutin diglucoside (6.4) at 500 
µg/mL were prepared in MeOH. These were used to prepare calibration standards containing 50, 
100, 500, 1000, and 2000 ng/mL each of tutin and hyenanchin tutin monoglucoside (6.3) and tutin 
diglucoside (6.4). These were analysed as described above and used to produce a standard curve for 
compound quantitation. One standard was used as a check sample and run with a blank after every 
15 (approx.) samples.  Rehydrated samples were filtered with filter tip pipettes and analysed over a 
three day period. The percent standard deviation of the reinjected standard (compounds 6.1 - 6.4, 
1000 ng/mL each) was 6.4% (average). Total analytical percent standard deviation of analytical 
results samples used for compound calibration: 15%. Samples were also analysed using the MRM 
method in scanning mode. This showed that the major components in phloem and honeydew were 
sugars. Several samples were therefore analysed by LCMS using a standard sugar method as 
described in Appendix 6. 7. 
6.4.8 LC-MS analysis 
Data was analysed using Mass Hunter Quantitative Analysis Software and the results were exported 
into an Excel spreadsheet. Conversion factors produced using standard curves were used to 
calculate concentrations in ng/ml (see Appendix 6. 6). These were used to calculate the 
concentration of tutin derivatives in dried fractionated extracts (ng/mg matter). The concentration 
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of tutin derivatives in leaf, stem, wood (air dried) and insect samples (fresh frozen) were calculated 
using the mass yields for the ethanol extraction and chromatography steps.  Peak areas that were 
below the Limit of Blank (LoB) = meanblank (n=22) + 1.645 (StDevblank) were considered missing values. 
LOB sucrose 111 ng/ml; Hyn 8 ng/ml; tutin diglycoside 0.5 ng/ml; tutin monoglycoside 2.3 ng/ml; 
and tutin: 497 ng/ ml.  
 
Concentrations relative to the total of compounds 6.1, 6.2, 6.3 and 6.4 (%1) and relative to 
compounds 6.2, 6.3 and 6.4 (%2) were also calculated. Absolute concentrations were only calculated 
when more than 0.1 mg of extract was collected. Statistical analysis was conducted using Genstat. 
Kruskal-Wallis One Way ANOVA on Ranks followed by Mann-Whitney U were used to determine 
statistical difference between phloem leaf and honeydew samples. ANOVA was used to determine 
statistical differences between tutu leaves, roots, stem and insects because there were not enough 
replicates to perform non parametric data analysis. By ANOVA, leaves from tree 3 (notably greener) 
showed significantly more sucrose and compound 6.3 (absolute concentration) than leaves from 
tree one and two but showed no other difference. The leaves from all three trees were therefore 
analysed together because this enabled the more suitable non-parametric analysis to be performed.  
Correlations were analysed by simple linear regression and differences between correlations were 




7 Future work and conclusions 
7.1 Glow-worm work 
The aim of this research was to discover the luciferin responsible for bioluminescence in 
Arachnocampa luminosa. Luminescence is an interesting area of research because humans have 
always been fascinated by organisms that can bring light to dark places. It is an important area of 
research both scientifically and commercially, because the discovery of a new bioluminescent 
system could be a useful addition to the current bioluminescent tool box (Dikici et al., 2009; England 
et al., 2016; Fan and Wood, 2007). 
 
Bioluminescence is found in a great number of different species and many different luciferins are 
utilised by different groups  and the known literature on luciferins is reveiwed in Chapter 1. This 
chapter also reviewed how other luciferins were discovered. This review highlighted that the 
discovery of a new luciferin poses a unique isolation challenge. Such research combines the 
difficulties of isolating material from source organisms, working with unstable materials, and 
working with enzymatic assays and therefore requires a creative multi-disciplinary approach.  
 
Previous to this research, little was known about the chemistry of glow-worm luminescence. Studies 
by Lee and by  Viviani et al. had indicated that Arachnocampa bioluminescence had a novel 
underlying mechanism, which was not unexpected since Arachnocampa is not closely related to any 
well studied bioluminescent organism (Lee, 1976; Viviani et al., 2002). Previous investigations had 
also indicated the existence of an ATP-Mg2+ dependent luciferin-luciferase reaction but the GW 
luciferin had remained unidentified (Viviani et al., 2002).  
 
Since neither the GW luciferin nor the GW luciferase were available from other sources, both had to 
be purified from GWs. Therefore, as part of this research, a total of 3000 glow-worms were collected 
from across New Zealand (see  Chapter 2). GW luciferin assay methods capable of detecting GW 
luciferin were then developed to enable GW luciferin to be tracked through the purification process 
(Chapter 2) (Figure 3.1). These methods included the fast production of a GW enzyme containing 
fraction (LF) that produced luminescence with ATP-Mg2+ and any sample containing GW luciferin or 
GW luciferin precursors (Chapters 2 and 3). These assay methods also used modern plate 
luminometers rather than the cuvette luminometers of previous research (Lee, 1976; Viviani et al., 
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2002). These plate luminometers enabled the rapid, sensitive and simultaneous analysis of multiple 
samples and were essential for the success of this research.  
 
Crude GW lysate was then separated by reverse phase (RP) chromatography and the luminescence 
assay was used to track luminescent compounds throughout the separation process (Figure 7.1 and 
Chapter 3). These separations resulted in production of three separately eluting fractions that 
displayed luminescence with glowworm enzyme mix (LF) and ATP-Mg2+ by luminescence assay 
(Figure 7.1). Two of these fractions displayed luminescence with precursor type kinetics (P type), 
while the other gave luminescence with luciferin type kinetics (L type) (Figure 7.1). Only the L type 
luminescence had previously been documented in the literature (Lee, 1976; Viviani et al., 2002). 
  
Figure 7.1. Summary of the sequential chromatographic steps used to obtain luminescent fractions from Arachnocampa 
luminosa. Separations resulted in the purification of tyrosine and xanthurenic acid which both showed P type 
luminescence with luciferase fraction (LF) and ATP-Mg
2+
. Separation also produced a fraction that showed L type 
luminescence with LF and ATP-Mg
2+ 
but the compound responsible could not be purified.  
Both synthetic  L-tyrosine and XA produced small amounts of P type luminescence when each was 
separately mixed with LF and ATP-Mg2+ under assay conditions (Chapter 3). The discovery that 
tyrosine produced luminescence was reported at the  International Society for Bioluminescence and 
Chemiluminescence Conference in 2014 (Watkins et al., 2014). However, over twenty times more 
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luminescence was produced when both xanthurenic acid and tyrosine were tested together with LF 
and ATP-Mg2+. This suggested that XA may react with tyrosine to form GW luciferin, and that 
tyrosine and XA were GW luciferin biosynthetic precursors (Chapter 3). The light produced in these 
reactions had the same spectrum as the light produced by GWs (Chapter 3). 
 
This was exciting because it was the first time that any GW luminescent compound had been 
identified and because it gave information about the glowworm luciferin biosynthetic pathway.  
Precursors to benzathiazole luciferin and coelenterazine had been proposed based on retrosynthetic 
analysis  and confirmed using stable isotope labeling techniques (see section 1.2.2.1 and 1.2.5) and 
luciferin precursors had previously been isolated from luminescent mushrooms (see section 1.2.6.4). 
However, the biosynthesis pathways of most luciferins were poorly known (see Chapter 1). 
 
Another fraction that gave L type luminescence was also separated (Figure 7.1). The compound 
responsible was not isolated, but the compound appeared to elute with tryptophan on RP 




Figure 7.2. The proposed synthesis of glow-worm (GW) luciferin from tyrosine (Tyr) and xanthurenic acid (XA) and the 
reaction of GW luciferin with ATP-Mg
2+
 and luciferase to produce light.  
P type luminescence had not been reported in previous GW luminescence methods  (Lee, 1976; 
Viviani et al., 2002) and it is possible that the enzymatic mixes used by previous groups were only 
able to catalyse reaction 2 and not reaction 1 (Figure 7.2). In contrast, the enzymatic mixes used in 
this research could detect both L and P type luminescence, and could therefore presumably catalyse 
both reaction 1 and reaction 2.  The development of new methods of producing GW enzymatic 
fractions that could react with the GW luciferin precursors and with the GW luciferin was therefore 
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essential to the success of this research. Without such methods the two GW luciferin precursors 
could not have been isolated.  
 
The fraction containing purified tyrosine also contained small amounts of leucine, tyrosine and an 
unknown compound X, that was later found to be 3-OH kynurenine (3.2, Figure 7.3, Chapter 3). 
Compound X (C10H12N2O4) displayed a similar UV – Vis spectrum and MS fragmentation to tyrosine 
which suggested that X could be a tyrosine derivative. It was suggested that X might be N-carbamyl 
tyrosine (3. 22) or its isomer phenol-O-carbamyl tyrosine (3. 23, Figure 7.3). These were synthesised 
but were found not to match the natural product data (3.2, Figure 7.3) (Chapter 5). OCT (3.23) had 




3.22 L-N-carbamyl tyrosine 
 
3.23 L-phenol-O-carbamyl tyrosine 
Figure 7.3. 3-OH kynurenine (3.23) and candidate unknown X molecules: N-carbamyl tyrosine (3. 22) or its isomer 
phenol-O-carbamyl tyrosine (3. 23). 
It was hypothesised that if stable isotope labeled (SIL) tyrosine (13C9H11
15NO2) and unlabeled (UL) 
tyrosine (C9H11NO2) were mixed and reacted with XA, ATP-Mg
2+ and LF, luminescence related 
products incorporating SIL and UL Tyr residues would be produced. Such reactions were completed 
and SIL labeled luminescence related products detected using LC-MS and  Sieve (TM) Perfect Pair 
analysis (Thermofisher, 2014) (Chapter 4). Reaction mixture compositions were also compared by 
HPLC-UV-Vis (chapter 4). This led to the discovery of luminescence related product A (LRPA); a 
molecule that only appeared in reaction mixtures to which LF, ATP-Mg+2, tyrosine and XA were 
added, i.e. the same reaction conditions that produced luminescence (Chapter 4). Both UL and SIL 
LRPA  were found in reaction mixtures to which both SIL and UL tyrosine had been added but only 
UL LRPA was found in reactions where only UL tyrosine had been added (Chapter 4). The Δm/z 
between these ions was 10.027 Da which is consistent with the incorporation of 13C9
15N  rather than  
12C9
14N into SIL LRPA (Chapter 4). This showed that all the carbons and nitrogens present in tyrosine 




UL LRPA (10 µg) was then synthesised by the large scale reaction of XA, UL tyrosine and GW enzymes 
and the molecule isolated and studied by 1H NMR  and UV-Vis spectroscopy (Chapter 4).  These 
techniques showed 4.48 (Figure 7.4) to be the most likely LRPA candidate structure. LRPA partially 
oxidised in solution to form two oxidised products. The LRPA solution containing LRPA and oxidised 
LRPA was then tested with glow-worm enzymatic mix and ATP-Mg2+ and was found to produce 
strong luminescence with luciferin type (L type) kinetics (Chapter 4). This showed that LRPA (possibly 
candidate 4.48), or a molecule also present in the LRPA solution, was the glow-worm luciferin.  
This was the first time that a purified molecule (and its oxidation productions) had produced the 
luminescence profile expected for the GW luciferin.  
 
It is rare for structural elucidation to be possible with such a small amount of natural product and in 
this case elucidation was only possible because xanthurenic acid and tyrosine were known to be 
precursors to LRPA and the GW luciferin.  This emphasises how much this work relied on the 
identification of tyrosine and xanthurenic acid as GW luciferin precursors. 
 
Since the GW bioluminescent reaction is ATP dependent,  4.53 was suggested as a possible GW 
luciferin candidate because it contains an carboxylic acid (that could undergo adenylation) next to 
the quinoline ring (the presumed bioluminescent chromophore). Candidate 4.48 in contrast only 
contains a carboxylic acid on the tyrosine moiety, a position several positions away from the 
quinoline chromophore.  
 
 
Tyrosine and xanthurenic acid  4.48. Candidate LRPA 4.53. Candidate GW luciferin 
Figure 7.4. The proposed conversion of tyrosine and xanthurenic acid into LRPA candidate 4.48 and the oxidation of 4.48 
into glow-worm luciferin candidate 4.53. 
Stable isotope labeling studies also enabled the identification two molecules LRPB and LRPC that 
showed stable isotope labeling, and that like LRPA, only appeared with the addition of LF, ATP-Mg+2, 
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tyrosine and XA (i.e. the reaction conditions that produced luminescence). The molecular formulae 
of these molecules indicated oxidised LRPA-like molecules in which the carboxyl quinoline moiety 
had lost two carbons. If these molecules are products of the luminescence reaction, this may 
indicate that the glow-worm bioluminescent reaction proceeds in a similar way to quinoline or 
indole chemiluminescence (Chapter 4). Such a mechanism would be exciting because it would be 
quite different to other bioluminescent mechanisms (Chapter 1). Such a mechanism, if ATP 
catalysed, could only proceed from 4.53 rather than 4.48 making 4.53 the likely GW luciferin and 
making 4.48 a likely luciferin precursor.   
7.2 Insect – plant interactions 
The research on the New Zealand glow-worm required the intensive use of LC-MS  techniques. Since 
the GW research was often slowed by a shortage of glow-worms, these techniques were used to 
investigate another New Zealand natural products problem involving insect metabolites: the origins 
of the tutin glucosides found in New Zealand toxic honeys (Chapter 6).  New Zealand toxic honeys 
derive their toxicity from the neurotoxin tutin, which is introduced to honey when honey bees (Apis 
mellifera) collect honeydew from passionvine hoppers (Scolypopa australis) that are feeding on sap 
of the poisonous shrub tutu (Coriaria spp.) (Chapter 6). Two tutin glucosides had recently been 
discovered in toxic honeys, but it was not known if these were produced by the tutu tree, by the 
Scolypopa, or by the bees (Chapter 6). Therefore as part of this research, the concentrations of tutin, 
tutin glucosides and the related molecule hyenanchin were measured in tutu leaves, stem, phloem 
sap and roots, in Scolypopa honeydew, in the Scolypopa insect (when feeding on tutu phloem), and 
in tutin contaminated toxic honey, were measured by LC-MS. These measurements showed that 
tutin, hyenanchin and the tutin glucosides are all present in tutu phloem sap, which showed that 
these metabolites were of plant, not insect origin (Chapter 6). The tutin glucosides were mainly 
found in the phloem and very little of either of the tutin glucosides  was found in the leaves or roots. 
This may indicate that the tutu shrub glycosylates tutin in order to transport it through the phloem 
via a polymer trap mechanism (Chapter 6). Such a mechanism has been suggested in Cucurbitaceae 
for the transport of L-ascorbic acid via ascorbate glycosides (Hancock et al., 2008) but there has yet 
to be strong proof that polymer trap loading can be used to transport molecules that are not only 
saccharides.  A paper on this research is currently being prepared. 
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7.3 Future work  
7.3.1 Synthesis of and further research into LRPA and glow-worm luciferin 
candidates 
The next step in this research, would be the synthesis and analysis of the proposed LRPA candidate 
4.48 and the proposed GW luciferin candidate 4.53 to determine whether the candidate structures 
are correct. These molecules should also be tested with the bioluminescence assay to determine 
whether either molecule is  bioluminescent and hence whether either molecule is the GW luciferin. 
It would also be interesting to test both molecules with the assay system of other luminescent 
Diptera to determine whether the A. luminosa luciferin is similar to that of other Arachnoacampa or 
to other Diptera (Viviani et al., 2002).  
7.3.1.1 Possible methods for the synthesis of 4.48 and 4.53 
Given that GW luciferin is biosynthesised from XA and tyrosine, it seems reasonable to synthesise  
4.48 and 4.53 from these cheap and commercially available starting materials. One method would 
be to perform a 1, 4 addition (Saidi et al., 2009) on a suitably protected XA using the amine of a 
suitably protected tyrosine as the nucleophile (Figure 7.5). This would selectively attach the amine to 
the quinoline 3 carbon and would reduce the quinoline ring to a dihydroquinoline (Figure 7.5). 
Careful oxidation to aromatise the XA ring would then form 7.2 (Figure 7.5). Complete deprotection 
of 7.2 then yields GW luciferin candidate 4.53 (Figure 7.5) while deprotection and reduction of the 
quinoline COOH followed by complete deprotection leads to the formation of 4.48 (Figure 7.6).  
 
 
Protected tyrosine and 
xanthurenic acid 
7.1 7.2 4.53 
Figure 7.5. Attachment of the tyrosine nitrogen to the 3 carbon of the quinoline via a 1, 4 addition followed by oxidation 




7.2 7.3 7.4 4.57 
Figure 7.6. Deprotection and reduction of the carboxylic acid of the quinoline to an aldehyde followed by complete 
deprotection to form 4. 57 (the candidate LRPA). 
This method, if effective, would be ideal because it is selective for nitrogen attachment at the 
quinoline 3 carbon. However such a method would form an unstable dihydroquinoline intermediate 
which would likely undergo many side reactions (e.g. oxidation to the quinone). The method may 
also be sensitive to non-specifc radical coupling. For example in the similar condensation of 3-
hydroxyanthranilic acid with itself, the amine attaches in the correct position via a 1, 4 addition but 
the reaction proceeds to make many other products (Manthey et al., 1988) (Figure 7.7).  
 
Oxidation reactions may also be problematic at later stages of the synthesis, since the GW luciferin 
isolated in Chapter 3 seemed very sensitive to oxidation. Some oxidation could possibly be 
prevented by the derivatisation of the 4 and 8 XA hydroxy groups to prevent the formation of the 
diketo tautomer. Since oxidation proceeds from the diketo tautomer (Yanshole et al., 2010) this may 
help to prevent oxidation.  
 
Figure 7.7. The autoxidation of 3-hydroxyanthranilic acid (Manthey et al., 1988) 
Suitable protecting groups would also be required on the tyrosine and quinoline carboxylic acids to 
prevent nucleophilic attack of the amine at the carboxyl positions and to limit other side reactions. 
The quinoline carboxyl protecting group would need to be removable under conditions where the 
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tyrosyl carboxylic acid protecting is stable, so that the quinoline carboxylic acid can be selectively 
reduced (Figure 7.6).  
 
An alternative method of amine attachment would be to first brominate the quinoline 3 carbon 
(similar to the reaction shown in Figure 7.8) then perform an Ullmann condensation (similar to the 
reaction shown in Figure 7.9) (Wang et al., 2014). However selective bromination at the quinoline 3 
carbon would likely prove very difficult and it is likely that the bromine containing heterocycle would 
have to be built from scratch. 
 
 




Figure 7.9. An example Ullmann condensation to a bromide ortho to a carboxylic acid (Wolk and Frimer, 2010). 
 
7.3.2 Other further research 
The research completed in this thesis suggested that the GW bioluminescence reaction might 
produce oxidised products, in which the quinoline had lost two carbons. However these products 
were neither isolated, nor well characterised. In further investigations, when larger amounts of LRPA 
and GW luciferin are available, these luminescence products should be isolated and characterised. 
This would enable the bioluminescent mechanism to be determined. This would be interesting, 
because the research so far suggests that the mechanism to be similar to that of the 
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chemiluminescent reaction of indoles and quinolines. Such a system would be very different to all 
currently known bioluminescent systems.  
 
It would also be important to further research the GW luciferase. An enzyme was identified by 
Sharpe as a candidate GW  luciferase by differential transcriptome analysis (Sharpe et al., 2015). 
However the protein has not yet successfully been expressed and further work is required in this 
area. A source of synthetic  GW luciferase would greatly help further studies into the GW 
bioluminescence mechanism and would be necessary for  the development of a commercial GW 
bioluminescence assay.  
 
It would also be useful to investigate the GW luciferin synthetic enzyme.  If a GW luciferin synthetic 
enzyme/s capable of producing GW luciferin from XA and tyrosine could be isolated and expressed, 
it could be used to produce GW luciferin commercially. Such methods may end up far cheaper and 
environmentally friendly than today’s chemical synthesis of other luciferins. The GW luciferin 
synthetic enzyme/s could also be used as a biotech tool itself in combination with GW luciferin. For 
example, such methods could be used in vitro to detect and quantify XA which is an important 
molecule to study when investigating malaria, because xanthurenic acid (found in the mosquito 
digestive system)  is the inductive agent that causes the malaria parasite to undergo 
gametogenesis (Billker et al., 1998). Given the importance of malaria research (Kappe et al., 2010), 
such a probe could be very valuable. 
 
The GW luciferin synthetic enzyme could be discovered by separating the GW lysate by 
chromatography, and testing each fraction with XA, tyrosine, purified GW luciferase and ATP-Mg2+. 
Fractions that produced P type luminescence would presumably contain the luciferin synthetic 
enzyme. One could also test for the production of LRPA via LC-MS or HPLC. An alternate approach 
would be to study the differential transcriptome analysis (Sharpe et al., 2015) and to search for 
enzyme that was more expressed in the light organ than in the body which could possibly synthesise 
LRPA from XA and tyrosine. This enzyme, once identified, could be expressed in a model system and 




7.3.3 GW conclusions 
Previous to this research, it was known that the GW bioluminescence was caused by an ATP 
dependent luciferase luciferin system, but nothing was known about the luciferin (Viviani et al., 
2002). This thesis therefore set out to determine the structure of the GW luciferin. As part of this 
research, two glow-worm luciferin precursors; tyrosine and XA and another luminescent molecule: 
LRPA (thought to be 4.48) were discovered and this led structure 4.53 to be hypothesised as the GW 
luciferin.  This research also suggested that the GW bioluminescence mechanism may follow a 
quinoline / indole type oxidative cleavage. The research completed for this thesis has therefore 
greatly added to what is known about the bioluminescence of Arachnocampa luminosa and to the 
field of bioluminescence in general.  This research also highlighted the power of LC-MS and stable 
isotope labeling techniques as methods for studying complex metabolic systems, when only small 
amounts of material are available. In the future it would be good to use these techniques to 
investigate other less studied luminescence systems and more generally for solving other natural 
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9.1 Chapter 2 appendices 
9.1.1 Glow-worm collection details 
Appendix 2. 1. Glow-worm collection details. Permits for glow-worm collection were provided by the Department of 
Conservation, West Auckland Council and Dunedin City Council (DCC), and permission for collection was also granted by 
landowners and Ngāi Tahu. DoC: Department of Conservation, NE: not estimated. NC: not collected. 













Collectors Thanks also to 
Piripiri Rd, Apiti, 
Manawatu-Whanganui, 
rocky gorge walls 
-40.038580, 175.977327 




Te Rena Rd, Kakahi, 
Palmerston North, railway 
cutting 
-38.935711, 175.397596 





Piripiri Rd, Apiti, 
Manawatu-Whanganui, 
rocky gorge walls 
-40.038580, 175.977327 






Richmond Rd, Pohara, 
Takaka, limestone cave 
-40.839381, 172.885641 




St Peters Cave, Borland 
Valley area, Te Anau 
limestone cave 
-45.772098, 167.468511 
13_04_13 300 >60000 3/04/2013 
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Collection by Thanks also to 
Nichols Creek, bush next to 
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9.2 Chapter 3 appendices 
9.2.1 Separation of hot extracts by chromatography 
Appendix 3. 1. The separation of glow-worm components from hot extract by separations BC8 and SP5. The 
luminescence yields at each stage are shown. Mass yields not calculated because dithiothreitol (DTT) made up the 








compared to HE 
Lysate 70 261 2.00 
 
HE 28 130.5 1.00 100.0 
















Total active C18 Fractions 
  
1.00 68.1 
Concentrated combined (F6+ F7+ F8) 
  
0.12 21.0 
Concentrated combined (F6+ F7+ F8) 
Injected onto semi-prep column   
0.1 
 








Appendix 3. 2. The separation of glow-worm components from hot extract by BC10 and 11. The luminescent yields at 
each stage are shown. Mass yields not calculated because dithiothreitol (DTT) made up the majority of the mass 
recovered. Int: integrated. 
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) over 203 
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1579 17 47 P 
F2 0.2 
 
- - - - 
F3 0.2 
 
- - - - 
F4 0.2 
 
- - - - 
F5 0.2 
 
540 10 16 L 
F6 0.2 
 
513 5 15 L 
F7 0.2 
 
220 1 7 L 





1027 20 60 P 
F2 0.6 
 
167 - 10 P 
F3 0.6 
 
- - 3 - 
F4 0.6 
 
169 - 10 L+P 
F5+F6 0.6 
 
143 13 8 L 
 
Appendix 3. 3. The separation of glow-worm hot extract by BC13 and SP12, showing luminescence yields at each stage. 
Mass yields not calculated because dithiothreitol (DTT) made up the majority of the mass recovered. 
Separation 
 
Volume  µl Luminescent yield (%) Type of luminescence 
 




F1  4 P 
F2  0 P 
F3  2 P 
F4  2 P 
F5  3 P 
F6  1 P 
F7  3 L 
F8  33 L 








F10 400 0  
F11 400 4 L 
F12 200 5 L 
F13 400 16 L 
F14 400 7 L 







9.2.2 Mass spectrometry MS2 data 
Appendix 3. 4. MS
2























Similar to XA 
XA + C3H5N  
XA C10H8NO4
+

















et al., 2012) 
Unknown C C19H15N2O6
+










Appendix 3. 5. MS
2
 fragmentation of minor molecules found to be concentrated in active fraction F54. 











537.16064, 458.30734, 387.27036, 286.13928, 274.18655, 257.16019, 
187.07086, 175.11855, 159.07602, 141.06551,115.08628 
M
2+










485.32662, 484.32277, 302.09743, 274.18663, 257.1601, 211.14355, 





Appendix 3. 6. MS and MS
2
 data of major components found in light organ lysate for which a commercial standard was 
unavailable. Data collected was by Orbitrap nanoflow LC-MS. Data is compared to calculated and literature data (Horai 























 [M- CO, H2O + H]+: 175.0867 














et al., 2012) 
Unknown B C13H13N2O4
+








Similar to XA 






237.0870 237.087 146.0600 


















(Ronsein et al., 2009) 
Glutamyl valine C10H19N2O5
+



























9.2.3 Reaction of lysate with stable isotope labeled tyrosine  
Appendix 3. 7 
Lysate 3.2.5 was used to make the following solutions: Lysate A (800 µl lysate + 200 µl H2O), Lysate B 
(800 µl lysate + 200 µl tyrosine and lysate C (800 µl lysate + 200 µl tyrosine + ATP/Mg2+ solution (50 
µl). Tyrosine solution (0.2 mg/ ml; 75% SIL Tyr, 25% µL Tyr). The luminescence of these solutions was 
measured using the Cary eclipse luminometer for 2 hours until no more luminescence could be 
detected. Subsamples (50 µl) were taken at 500 s, 1300 s and 2000 s after ATP-Mg2+ were added, 
and were immediately heat treated and centrifuged in the manner of GW HE. Half the remaining 
material was heat treated and centrifuged in the manner of GW HE, while the rest was left in air 
overnight and heat treated and centrifuged in the manner of GW HE the following day. HEs were 
filtered through pre-equilibrated Sorenson Bioscience Multiguard II Filter tips containing 30 mg C18, 
with with 2 * 200 µl elutions of MeCN then dried. Samples were rehydrated with water containing 
0.1% formic acid and analysed by HPLC (20 µl injection, 3 replicates) and by LC-MS (Biochem 




9.3 Chapter 4 appendices 
9.3.1 MS and MS2 spectra 
 














































189.1122171.1016 206.1387 255.1226 337.2486 379.1354309.2272219.1743 242.2841 279.2431 347.1831
362.2536
295.2380141.0658 155.1067 397.2697178.0499 411.2854125.0961
379.1350
362.2534





171.1015 242.2840 303.2067279.2429206.1386 377.2168255.1227167.1066 362.2536142.1589 339.1292179.1066 229.1433125.0960 203.1430 388.3056 415.2358
NL: 1.77E7
15077_P9_10_15_E1_
F5#732-737  RT: 
21.64-21.79  AV: 6 T: 




F5#758-763  RT: 
21.65-21.80  AV: 6 T: 




F5#758-763  RT: 
21.65-21.80  AV: 6 T: 




F5#752-757  RT: 
21.65-21.80  AV: 6 T: 
FTMS + p NSI Full ms 
[105.00-800.00] 
 
Appendix 4. 1. MS of UL LRPA at m/z 369 Da and SIL LRPA at m/z  379 Da (Orbitrap nanoflow LC-MS).  
 





































































127.0759 219.0611160.0393 332.1266114.0726 188.0342145.0995
174.0848 198.9557




RT: 13.80-14.81  AV: 35 T: 




2_151028103436#725  RT: 
21.72  AV: 1 F: FTMS + p NSI 




2_151028103436#679  RT: 
21.74  AV: 1 F: FTMS + p NSI 
d Full ms2 379.13@hcd45.00 
[50.00-390.00] 
 
Appendix 4. 2. MS
2
 fragmentation (Orbitrap nanoflow LC-MS) of LRPA ions at m/z 369 Da and 379 Da. HCD 
fragmentation energy: 45 v. m/z 50 – 380 Da region.  
MS
2
 369.11  
MS
2










#63-348 RT: 2.13-11.74 AV: 224 NL: 9.59E5 
T: FTMS + p NSI Full ms [50.00-800.00] 












































188.1157 185.3924 182.3666 183.3748 186.4007 184.3716 185.8325 181.3706 182.7958 181.7964 184.8080 181.0726 183.8076 186.8441 187.1914 180.1170 180.3793 188.5586 187.7949 
 
Appendix 4. 3. Positive ion ESI MS (Orbitrap) of tyrosine in 50% D2O, 50% d3-MeCN 0.1% FA. m/z 180 – 190 Da region. 





#56-269 RT: 1.70-3.23 AV: 55 NL: 1.05E7 
T: FTMS + p NSI Full ms [100.00-800.00] 










































215.1254 210.0670 216.1318 211.0941 207.3965 206.3881 213.1098 207.9174 205.0362 209.1899 206.9052 212.1004 208.4049 205.7894 204.0447 214.0653 216.6615 
 
Appendix 4. 4. Positive ion ESI  MS (Orbitrap) of xanthurenic acid in 50% D2O, 50% d3-MeCN and 0.1% FA. M/Z 
204 – 210 Da region. Calculated values in bold. 
 
[Tyr + H]+: 
182.0812 
[Tyr - 2H + 3D]+: 
185.1000 
[Tyr + D]+: 
183.0874 
[Tyr – H + 2D]+:  
184.0937 








[XA - H + 2D]
+
:208.0573  
[XA - 2H + 3D]
+








   
15021_DI_TestF28_02 #77-325 RT: 6.54-6.95 AV: 13 NL: 9.37E5
T: FTMS + p NSI Full ms2 372.12@hcd30.00 [100.00-800.00]













































403.8740320.2245 341.5199 387.1887 413.4431382.9977315.9544 366.2678 392.3300 398.1303345.0232 358.8240333.4176
 















[LEP + H]+ : 369.1081 
[LEP + D]+ : 370.1144 
[LEP – H +2D]+ 371.1207 






9.3.2 1H NMR spectra 
 
Appendix 4. 6.  Full LRPA (red), tyrosine (Tyr, green) and xanthurenic acid (XA, blue) 
1
H NMR spectra. 
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9.3.3 Chemaical Abstracts search data 
Appendix 4. 7. Compounds retrieved by a search of the Chemical Abstracts (2/4/16) for molecules related to 4.34. 
Fragment searched for  Compounds retrieved by similarity search (NMR of important 
positions shown if available) 
 





CAS registry number: 359766-05-5 
NMR from (Gorohovsky and Bittner, 2001) 
 
 
9.1. A 4.34 fragment similarity search 
 
4.41. 2H-1,4-Benzoxazine-5-carboxylic acid, 3,4-dihydro-2-oxo-3-
(phenylmethylene)-, (3Z) (TA-3037A (I)) 
CAS registry number: 143651-44-9 
(Komagata et al., 1992) 
 






CAS registry number: 101097-
09-0 






CAS registry number: 917085-57-5 
(Lu et al., 2015) 
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Appendix 4. 8. Compounds retrieved by a similarity search of the Chemical Abstracts for Candidate 4.28 and Candidate 
4.29  (1/4/16). 
1
H NMR of important positions shown if available. 
Candidate 4.28 
 




CAS registry number: 91123-89-5 
(Hazard et al., 1984) 
 
 
9.6. 2-Quinolinecarboxylic acid, 1-(2-amino-1-oxo-3-phenylpropyl)-1,2,3,4-
tetrahydro-, [R-(R*,S*)]- (9CI) 
CAS registry number: 71385-66-5 








CAS registry number: 1673558-
19-4 












CAS registry number: 1233922-17-2 





Appendix 4. 9. Compounds retrieved by a similarity search of the Chemical Abstracts of substructures of 4.46, 4.47, 4.44 
and 4.45 (1/4/16)  
Fragment searched for  Compounds retrieved by search (NMR of important 






9.11. 2-Quinolinecarboxylic acid, 3-amino- 
CAS registry number: 887245-74-1 





9.13. 2-Quinolinecarboxylic acid, 4-amino-8-hydroxy- 
CAS registry number: 495409-09-1 





Appendix 4. 10.  Compounds retrieved by a similarity search Chemical Abstracts of 4.33 and 4.36  (1/4/16) 
Similarity search of 4.33   Similarity search of 4.36 
 
9.14. Oxazolidinone, 2-phenyl-4-(3-quinolinylmethyl)- 





CAS registry number: 73717-64-3 
(Zecchini and Paradisi, 1979) 
Appendix 4. 11. Compounds retrieved by a similarity search of the Chemical Abstracts of 4.33 -  4.35 fragments. 
Fragment searched for Compounds retrieved by search (
1
H NMR of 
important positions shown if available) 
 




CAS registry number: 99180-53-7 
(Tomita et al., 1953) 
 
9.18. A 4.36 fragment 
substructure search 
 
9.19. A fragment of 4.34 
Nothing 
 





CAS registry number: 
189816-60-2 





CAS registry number: 
41561-92-6 
(Sekiguchi and Shiojima, 
1973) 
 
9.23. A fragment of 4.35 
 
9.24. 1-Oxa-4,8-diazaspiro[4.5]decane 
CAS registry number: 177-05-9 




9.4 Chapter 6 appendices 
9.4.1 Correlations between tutin derivatives 6.2, 6.3 and 6.4 (X) and sucrose (Y) 
Appendix 6. 1. Relationship (linear regression) between the concentrations of sucrose, 6.2, 6.3 and 6.4 for different 
phloems and for honeydew. All correlations showed a correlation P <0.005. Sample types that showed significantly 
different gradients (P < 0.05) are marked.  
Correlation (linear regression) between 6.2, 6.3 and 6.4 (X) and sucrose (Y) 
Sample type: Gradient (A) for Y=AX, (St Dev), R
2
. 

















Source phloem (Water control): 0.019 (0.002), 98% 
Moderate correlation 
All phloems and honeydew: 0.04 (0.01), 24.5% 
Source phloem (EDTA): 0.047 (0.01), 49% 
The sink phloem (EDTA) 
contained significantly more 
sucrose compared to 6.3 than 
other phloem samples or the 
honeydew (P <0.001) Strong correlation 
Sink phloem (EDTA): 0.182 (0.004), 99.7% 
No correlation:  HD 
6.4 
Strong correlation 
All phloems and honeydew: 0.09 (0.02), 69% 
Source phloem (EDTA): 0.09 (0.01), 68% 
Source phloem (Water control): 0.05 (0.003), 99% 
Honeydew: 0.08 (0.02), 62% 
The sink phloem (EDTA) 
contained significantly 
more sucrose compared to 
6.4 than other phloem 
samples or the honeydew 
(P <0.001) Strong correlation 
Sink phloem (EDTA): 0.29 (0.09), 64% 
6.2 
Strong correlation 
All phloems and honeydew: 0.037 (0.008), 61% 
Source phloem (EDTA): 0.037 (0.006), 60% 
Source phloem (Water control): 0.035 (0.002), 98% 
The sink phloem (water 
control) contained 
significantly more sucrose 
compared to 6.2 than other 
phloem samples (P <0.001) Strong correlation 
Sink phloem (EDTA): 0.12 (0.03), 74% 










9.4.2 LC-MS traces  
 
Appendix 6. 2. Multireaction monitoring (MRM) plot for plot of a mixed standard of compounds 6.1, 6.3 and 6.4 (1000 
ng/mL), 6.2 (800 ng/ml) and dihydrohyenanchin (200 ng/mL) analysed by tutu MRM method. 
 
Appendix 6. 3. Multireaction monitoring (MRM) for sucrose standard (900 ng/ml) analysed by tutu MRM method. 
 


















-ESI MRM Frag=50.0V CID@10.0 (339.0000 -> 15300) Stan1a.d  
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9.4.3 Quantitation of tutin and derivatives 
Appendix 6. 6. Multiple reaction monitoring (MRM) transitions used for detection and quantitation of tutin and related 
compounds and their quantitative response factors. CE: collision energy, CEV: Collision energy voltage. Dwell: 50. Ms2 
res: Unit. Response factors accurate between 100 and 2000 ppm. When two product ions were monitored the initial (in 















Sucrose 1.5±0.00 341 
179/ 
119 
100 12 7 29.2/ 27.7 0.96/ 0.97 
6.1 10.2±0.3 339 
139/ 
153 
50 10 4 15.3/ 32.1 0.98/0.98 
6.2 3.80±0.08 355 109 50 30 6 207.2 0.988 
6.3 9.31±0.09 501 455 100 8 4 170.3 0.97 
6.4 9.2±0.2 663 617 50 10 6 355.2 0.98 
9.4.4 Sugar analyses by LC-MS 
Appendix 6. 7.  
The LC-MS system consisted of a Thermo Electron Corporation (San Jose, CA, USA) Finnigan Surveyor 
MS pump, Thermo Accela Open Auto sampler (PAL HTC-xt with DLW), Finnigan Surveyor PDA plus 
detector and a ThermaSphere TS-130 column heater (Phenomenex, Torrance, CA, USA). 
A 2 μL aliquot of each prepared extract was separated with a mobile phase consisting of 10 mM (770 
mg/L)  ammonium acetate in water (A) and  acetonitrile (B) by normal phase chromatography (ZIC®-
pHILIC stationary phase, 5µm, PEEK 100mm x 2.1mm i.d.; SeQuant®, Germany, Part No.1.50462.001) 
maintained at 40°C with a flow rate of 300µl/min. A gradient was applied: 0-2 min, 10% A; 30-34.5 
min, 50% A; 40-45 min, 10% A. Data was acquired by PDA (200-600nm) and API-MS (LTQ, 2D linear 
ion-trap, Thermo-Finnigan, San Jose, CA, USA) with electrospray ionisation (ESI) in the negative and 
positive mode for parent masses in the range m/z 150–1000 amu with MS3. Data were processed 












9.4.5 LC-MS saccharide data 
Appendix 6. 8. Major components of phloem and honeydew analysed qualitatively using sugar LC-MS analysis methods. 
Data shows the percentage area of each sugar compared to total analyzed sugars as measured by LC-MS. Named 
compounds have been confirmed using standards.  HD: Honeydew. RT: Retention time. Uk: unknown. Sugars were 
found as formate adducts. 
Sugar RT (min) 
Ion 
mass 
HD Sink phloem 
(EDTA)  
Sink phloem 
(water)  1 2 
D(-) Fructose 7.5 225 30.3 11.5 50.3 44.4 
α or β D-Glucose 9.0 225 11.0 2.4 16.3 3.5 
α or β D-Glucose 9.9 225 21.6 4.7 21.2 6.1 
Sucrose 11.9 387 21.2 38.1 2.5 0.0 
Uk disaccharide 1  12.9 387 0.0 18.0 1.7 13.4 
Uk disaccharide 2 13.3 387 0.0 22.1 4.9 8.1 
Uk disaccharide 3 14.4 387 0.0 0.0 0.8 0.0 
D-(+) Raffinose 
(trisaccharide) 
15.7 503 5.1 0.0 0.0 5.2 
Uk 
tetrasaccharide 1 
17.0 711 3.6 0.0 0.0 4.7 
Uk 
tetrasaccharide 2 
17.4 711 7.3 0.0 0.0 9.3 
Uk 
tetrasaccharide 3 
0.0 711 0.0 1.8 0.2 0.0 
Stachyose 
(tetrasaccharide) 
0.0 711 0.0 1.4 2.1 0.0 
Uk pentanose 1 0.0 873 0.0 0.0 0.0 0.0 
Uk pentanose 2 0.0 873 0.0 0.0 0.0 0.6 
 RT (min) 
Ion 
mass 
Source phloem (EDTA)  Source phloem (water)  
1 2 3 1 2 
D(-) Fructose 7.5 225 45.0 60.3 59.4 58.0 0.0 
α or β D-Glucose 9.0 225 4.9 9.4 12.5 1.6 0.0 
α or β D-Glucose 9.9 225 6.8 10.9 19.4 2.6 0.0 
Sucrose 11.9 387 0.0 2.2 0.0 8.4 81.9 
Uk disaccharide 1  12.9 387 0.0 0.0 0.0 8.3 0.0 
Uk disaccharide 2 13.3 387 5.7 2.2 0.0 10.1 0.0 
Uk disaccharide 3 14.4 387 6.9 2.5 0.0 0.0 0.0 
D-(+) Raffinose 
(trisaccharide) 
15.7 503 0.0 1.0 2.0 5.1 13.1 
Uk 
tetrasaccharide 1 
17.0 711 0.0 2.5 0.0 0.4 0.0 
Uk 
tetrasaccharide 2 
17.4 711 24.2 5.4 0.0 0.7 0.0 
Uk 
tetrasaccharide 3 
0.0 711 0.0 0.0 0.0 1.2 0.0 
Stachyose 
(tetrasaccharide) 
0.0 711 5.8 3.6 0.0 2.3 0.0 
Uk pentanose 1 0.0 873 0.0 0.0 0.9 0.0 0.0 




9.4.6 LC-MS quantitation of tutin and derivatives  
Appendix 6. 9. LC-MS quantitation of tutin and derivatives in toxic honey, honeydew and phloem. 
a
 Concentration 
calculated by converting the analyte monitored transition area to an equivalent compound concentration using 
compound calibration curves and adjusted to determine concentrations present in original dry material. 
Tree Sample 
Sucrose 











NA Honey 7873.25 7.94 8.33 8.41 7.51 




































501.77 0.00 12.54 2.71 3239.59 
3 HD 206.90 0.00 0.00 0.00 253.22 
3 HD 105.80 24.88 0.00 5.05 739.06 
3 HD 11662.08 191.98 922.75 196.06 157.69 
3 HD 1704.90 152 436.46 183.68 535.47 
3 HD 2290.80 331.24 483.74 553.04 991.06 
2 HD 0.00 0.00 1.12 10.29 48.69 
2 HD 774.78 0.00 1.04 82.27 83.50 
2 HD 242.34 0.00 0.00 0.00 644.78 
2 HD 2397.47 340.05 707.41 231.47 1892.91 










































































































































































924.47 57.10 66.32 51.62 695.16 
2 Leaf 2440.80 1.00 0.00 69.59 734.70 
2 Leaf 5978.49 3.41 0.00 178.33 1091.88 
2 Leaf 1187.56 1.30 0.00 33.87 262.69 
3 Leaf 1862.17 2.00 0.00 405.59 363.79 
3 Leaf 2474.07 3.95 0.00 210.95 618.28 
3 Leaf 744.48 1.64 0.00 244.63 1023.89 
1 Leaf 26400.07 0.45 0.00 112.04 47.45 
1 Leaf 34883.67 0.44 0.00 124.93 51.67 
1 Leaf 27968.77 1.08 0.00 117.67 107.17 
2 Root 302.67 1.42 0.00 3.20 23.06 
2 Root 199.44 0.74 0.00 3.23 28.33 
2 Root 261.27 0.27 0.01 0.18 28.52 
2 Tree 2 153.34 0.85 0.10 1.41 299.02 
3 Tree 3 332.46 0.49 0.00 1.88 59.42 
1 Tree 1 7507.02 2.17 0.00 6.33 255.17 
 
Leaf washing 185.63 8.86 0.00 1.23 214.28 
Adult Adult 2.15 0.00 0.00 0.00 0.07 
Adult Adult 15.94 0.03 0.03 0.05 0.29 
Adult Adult 14.71 0.05 0.00 0.00 0.10 
Larva Larva 27.01 0.05 0.00 0.23 0.23 
Larva Larva 12.72 0.04 0.00 0.00 0.03 
Larva Larva 7.94 0.00 0.00 0.05 0.92 
 
 
